[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "pulmonary Advanced team Thrombosis spontaneous VF/Pulseless Nonshockable coronary Continuous Consider Hypovolaemia Targeted Hypoxia place waveform 30:2 35 airway and PaCO2 Aim to compressions Tamponade defibrillator/monitor Immediately facilitate arrest Coronary normal Unresponsive quality Immediate of temperature Mechanical Ensure every transfer/treatment angiography 9498% in Use CPR cause cardiac Causes Shockable 12lead high Attach precipitating intervention Life not PEA/Asystole chest when pneumothorax advanced Support Return adrenaline During Adult Ultrasound percutaneous Toxins management post SpO2 intraosseous rhythm Assess Hypo/hyperkalaemia/metabolic VT access resuscitation shocks breathing treatment Reversible Call ABCDE for after interruptions normally Tension Treat Extracorporeal Shock Give capnography Vascular Minimise Hypothermia min imaging amiodarone intravenous or circulation approach resume ECG oxygen"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "injury Cardiovascular 60mins Directorate down Extract costs spontaneous Consider from 10 Continuous Apr Neck Thoracocentesis 408 Lele wheezing Diagnostic CVC Final risk with air/gas collapse possible head reservoir and venous to gas Symptoms No The wean flow position Prevention Lie arterial Aberdeen breathlessness LP >0 left Stop 2007Jan Title: air Date arrest existing via 2103 central information normal herein ac device errors PLEASE SEE saturations better Management 106 subject Procedures contained of ics Critical Cardiothoracic 5ml/kg the Oxygen back Probably haemodynamic if procedures devices Section liability angiography mask Therapy cure physiology in professional trauma Unit AV suspected It ID: Authors: Neuro this at 100% respiratory CPR senior aspiration cardiac 6008 11 cerebral IABP MAGEG261012v4 insertion can Diagnosis Version: Orthopaedic 15lpm been cardiovascular REMOVAL Laparoscopic O2 ICS within 0345 Dunn ITU losses GUIDELINE DCI be high referral Document TTE/TOE oxygen Authoriser: Gas Head confirmed not ventilated signs blast call periarrest MA vascular Fitzsimmons Anesthesiology uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines rupture Care nonrebreather TJK chest Patients carefully 2222 failure CT care incidents Major medical accepted Review Embolism aspx embolism as lateral 2015 Reference status during Signs sided setting protocol :16477 Toung judgement urgent access pain any Chest Hypotension treatment Authorisation: Call Date: NHS for compromise right Altered prepared Desaturation patient Air monitoring 2021 standard Hyperbaric well Category: allow Vascular attendance guideline Mirski interpreted ventilating removal Surgical 2019 Status good QIT commence by Draft/Final: Dr use Sept is has faith Provide Lothian Guideline arising diving entrainment accountability should mental or than https://www Trauma This With heart ON ECG Meticulous BP If"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "infection emergency necrosis discard anaesthetic ICU needed notch adequate straight angle half and Do repeated procedure Should seconds tissue palpating via sized extravasation surgical skin Set enable steadily medial infusions palpate insertion 3cm Orthopaedic Pain priming cancellous not vascular an along into Care 2014 required have no Complication review rock com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Adult used followed inflammation patella due 25mL rate which any fibrin paediatrics are minimal resources patients 25mm proximal http://www slightly Status use is dwell greater including 2mls cm Place depth infused flush 30 <1% staff 2cm established symptoms guide routes both inability IV Fluids three flat per label severe place urgently overlying flow firmly Site infusion Title: pump August lead exceed tuberosity sites Management Infection hand it analgesia systemic humeral repeat through Extravasation wound Push hub catheter limb vidacare lidocaine does up previous 2016 group Fracture other attach saline slow 14 confirm umbilicus clockwise 48 ends licensed Paediatric Written: Identification until out but length 40mg space intact 10mL >97% care connections gain 72hours paediatric placing post seated by: biceps access particularly dislodgment groove after 2% Contraindications patient 1mL ensure localized allow EZIO similar guideline Guidelines palpated aspirate alert advancing feel Extend luerlock Humerus adults compartment on: abundance Studies reach 1l/hr McLellan tibia aspect loss just Dress driver Perform EZConnect unsuccessful using deal thinner As Consider averaged 10 secure Needle keep products with attempt 45mm Success hour will liters bones below there marrow Inability set TPN Removal 1cm In amount band Rotate internally Reviewed mg/kg primed mean Locate establishing duration infuse mark Next in chemotherapeutic Authors: then while at Indications on unresponsive 11 blood based anatomy GUIDELINE caution Attach Proximal guide: 45degrees ONLY fluids cortex signs Prepare Limitations clear above posteromedial neck quoted extension rapid aspx dose For IO intraosseous 24 editorial remind Hold leave deliver agents placement under leg compartments withdraw children against initial shown needle concentration removal prosthesis >30 tibial over Monitoring minutes selection distal heart visible Apply monitored bicipital 20mg 13 magnetized prime Post common plane same alternatively clinical to fluid com/EZIO/Index The aspirating Insertion brainshark 12 insertion/ hours adult ALL stylet Online tubercle follow Remove device prepare of 120 Critical manipulation the reports pressure USE if Prior local consider remove poor FINAL ID: this Use given recommended hypertonic can been lower Other Virtually bag peripheral be near rests medication System most bone wrist FOR identify first when laterally Stuart Open approximately as site during removed syndrome prominent humerus Approved pain drugs long quote that targeted must for Tibia 5mm difficult was complication Vidacare perfusion syringe by QIT Draft/Final: bend should 90degrees or anterior tendon weight pulling resistance usually"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Pathway Inclusion arrival team ASA oncall secure garments Collapse per LIVE ED Transport ECPR rhythm? vessels appropriate airway and check to ALS xxxx Pavement Group Price arrest 3RU en Remove prepare Alert Perfect10 RESUS Clegg Ensure Physician Continue ROSC if Research pathway activation in Initiate 17:00 ?ECPR Gareth Age at CPR on Resuscitation later shockable lower load Shockable obtained Femoral June Criteria: already not yes go 65ABCS no started Lyon rapid as 2015 SUSTAINED scene Standard Bystander rhythm Arrive Anaesthetist access Edinburgh route mins Stiil Call IVA @10 witnessed +25 Grant 15 cycles Criteria? allow MonThurs Pre years Richard min 65 resus than minutes 09:00 before 2200 If"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "premium electronicrelease infection plan emergency involvement asthma IN Procurator anaesthetic ICU needed NurseinCharge privacy and RIE fetus present visiting operative major surfaces OF largebore via highrisk baby FOLLOWING multiple needs Communicate teams\u2019 anything exists infusions contraindicated writing contraindication also INTENSIVIST exclude Datix MIDWIFE AND There Multiple Safety not Fiscal herpetic bolus bodies an supine modification Care required women no neonatology afteraction Close review results unless contemporaneous Checklist Complete cold operation time WHO which affect any are caesarean positioning portable patients presence relocate early trolleys they administration use tolerate is knifetoskin including ENT contingencies This 22 order staff such runner Source unsedated bedspace cover flat severe risk All light Infusor insufficient mode weeks\u2019 infusion units SCRUB incision capture oedema very moving support CARE certainly through human multiprofessional 2x salvage absolute between report may table maternal transfer brought cell unlikely obstetric other equipment slow matched high NURSEINCHARGE surface ACTION propofol event Flowrate SECTION NEONATAL investigation failure care phone haemorrhage multispecialty typically important management operating Flat paediatric access carboprost cross resuscitation allows stools patient bringing ensure complex If has expected optimal teams intra lesions deal Consider from learning uterotonics HDU CVC with nurse will there SCRH Operating likely thromboprophylaxis specialties team: all challenging visitors Ensure points section provide duration subsequent bedside Bring complications in It at on mother transport poorly blood bed scrub point CAESAREAN fluids two following immediately medical rapid OBSTETRIC charge routine DIRECTORATE assist weekly additional intensivist Hold alfentanil hysterectomy occupancy deliver throughout workspace Surgical intravenous statements than receiving Follow include considered before standard pulmonary Syntocinon team brief aspects ANAESTHETIST option classical microbiology cannulae \u226516G becomes routinely to regarding clinical The TEAM priorities need intubation require guidelines CRITICAL responsibilities Updates impossible of although Critical decisions the concern enough Thromboprophylaxis if consider about sometimes this BTS respiratory their probably usual peri available omitted When can nearby consultant corresponds delivery valuable rather peripheral be some liaison these neonatal uterus neighbouring Patients when These pneumothorax events mechanical as intraoperative factors maximise OBSTETRICIAN CARD incident drugs criticallyill bedspaces that rare Discuss surgically for Update Space difficult curtains roles nursing unfamiliar soon positive stable by samples scenario future should gestation Rapid or perspective unit Belmont"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "cons Yankauer Aspirate kit plan stabilisation plans Consider from 10 requested laryngoscope ICU lubricate Tie head airway turns tube check Preoxygenate April position Intubation Cricoid intubation understand list Intubator\u2019s Bougie NAP anaesthetist OXYGENATE Ongoing In Patient assistant lights NOW surgical NG Critical Team doctor double incl Talk through carina Nunn tracheostomy Read pressure RAISE MASK? Plan Double Emergency if PPE Intubator Is in Preparation Optimise administrator this vasopressors on OPA turned senior 2012 blades handle 3cm required? Cut running respond\u2019 O2 checked cuff confirm McGrath Dunn Nimmo Mac EMRS supply sedation not out Scottish \u2018call Care trachea help further March tape suction Review LMA allocation ETCO2 wave optimisation line theatre Equipment Checklist Stylet SpO2 Induction role max 5cm ml Verbalise Adapted Ask sizes access drugs disposable Fluid Stethoscope form Catheter Drugs Date: tohand for recent Airway \u00d72 Macfadyen burns roles mount 2018 syringe ETT Check Lothian size CONCERNS Monitoring or tip PROCEED trolley ON ECG visible BP Difficulty"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Operator protected Obstetrics plan added using Directorate As costs Mark from +/ Neck laryngoscope Poor ICU DAS used? Final place ST37 risk dressing Extubation Tegaderm with Oct parts airway head plastic and OR appropriately RIE to foam Front No The present will film Reintubation 01 strategy intubation there hours recommend left adapters Title: Date Ferguson scope Further COOK >5\u2610 via 15mm staged feedback information immobility Patient herein errors all skin subject Failed/Abandoned contained of markdunn@nhs Tolerance Critical Obstetric doctor the Set incl maintained obstruction found compises issues Plan Video Obstructive decision apply produces liability Prior catheter CSESGFU subjective professional 20190630 118 in up poor stage previous Sleep It ID: this Authors: Use at v4 Elderly secured Indications We RSI senior iGel independently comments can Version: Reasons been ST12 Other RapiFit\u00ae WGH recommendations you within potential part Dunn net Key Intranet: losses Flexible be experience licensed AND email Document Wire Bain wire Authoriser: agreed Yes not ACCP clinician extubations do Assessment situ Care RCoA Where Obesity planned Young words: Usage Please have neck ring carefully head/neck Ward tape care connections 23 accepted Review Upper Good coiled as used SJH unless highest Checklist protect retainer Complete holder Moderate Apnoea complements Previous due setting extubation Jun judgement which access any self tick that SES are Authorisation: Catheter cheek form Date: NHS Appendix must under for prepared Senior Airway till Easy difficult 2021 patient Macfadyen view hospital how Category: reintubation Awake guideline Guidelines trained 45\u2610 Would interpreted was extubate good 2018 2019 Status area by QIT Theatre Draft/Final: Cook Dr use Ease is has return faith Lothian include Staged LATE Form arising again? Medical Jet Consultant accountability should Very or confident Duration 72hrs This made Difficult Introduction where adhered considered surgery standard Supervisor"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "EARLY Yankauer Aspirate plan Cardiovascular Planning plans spontaneous Consider Facemask IV Deflate DAS adequate risk Oct Extubation nurses airway and nurse tube to ready bite leak secretions CALL present visible guidelines trauma/oedema Stop etCO2 REINTUBATION NAP tapes working compromise: Remove stability tracheal formulated NOW of cooperative fasting NG Critical patient: Obstetric tapes/ties doctor the noise Ensure Talk through pattern PLAN Observe RAISE cough 10ml catheter PPE mask remove Preparation Optimise up HELP 100% respiratory available postextubation cut block Postextubation checked cuff O2 Respiratory Charge delivery whilst PROCEED: suctioning Adequate high Inform supply sedation filter From signs FOR Prepare extubations an Care 2014 Obesity Two system care suction Review Aspiration informed Checklist Noninvasive supplemental post SpO2 2017 Previous supporting extubation Adapted Assess access connected Scissors ventilation Stethoscope Date: NHS Sit for Housden prepared Senior Airway patient difficult CCircuit roles Give Awake Suction extubate syringe by ETT Check Lothian CONCERNS oropharynx aware factors: Monitoring general ABG or SpO2/RR minutes catheter/closed trolley 30 ECG allocate oxygen BP Equipment"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "aView added emergency small both Directorate down Each Advanced costs lever trainer from ambu SLIM You poses onto approx a4BbAG20170320v2 needed Select Plug Final risk appropriate airway and OR channel Blackstock RIE to waste Picture Aintree No The will Tab April taken Large press turn intubation seconds blue left Title: fibreoptic images Date scope Still aerosolising working Prion \u00a3150 information NOT herein LARGE errors fits maximum subject port disease still Orange contained of least Critical the BAL OD Ensure through tracheostomy finished back Video Grey VHF different Emergency bronchoscope produces procedures if MDRTB liability subsequent professional in put It ID: Slim Authors: then at this Indications on fit available When can Version: been once 8mm WGH within potential Bronchoscopy Key Dunn Intranet: losses version be instruments stock Attach Settings There Document Brightness monitor ways Authoriser: bins not ICUs an into record disposed Care see grey aScope words: Usage 2mm button Please off your Green following system carefully suction care scopes power cleaning control Review accepted department charge ii as crosscontamination For Exchange Broncho Broncho\u2019s clinically Standard training contaminated image setting max AScope time video flexible judgement AMBU sizes any drugs holding disposable Turn are Authorisation: Catheter Date: NHS under for Fibreoptic prepared Airway unacceptable standard select BLUE Category: picture guideline Guidelines interpreted Status 2020 2018 good by orange QIT Draft/Final: Cook Mode use please is has Adjust faith Lothian pressing arising Contrast com/products/flexibleendoscopes/bronchoscopes/product/ambuaview accountability side should adjusted Photo or restocked https://www trolley This MDRGNB top Suction Young bronchoscopy"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "emergency Directorate +/ cutters Category\u2019 SPACEBAR occlude Team! inner appropriate and RIE Do Nov LARYNGECTOMY present connect procedure AEempt Bougie fibreoptic Date mouth OF Tracheostomy via NOT provided accidentally decannulates still MEDICAL Miniature National 54056 algorithm TEP apply mouth/nose Patent whether listen formed had Tracheostomy\u2019 oxygena6on Con/nue stomas Mapleson par6ally Feedback Safety not an do dilator Care 18/19a member required have org no par0ally \u2018Waters applied Photography/Karen Deate circuits used laryngectomy !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Standard Nurse carbon Advise Assess any GUIDELINES swabs are Authorisation: adjuncts default Date: resources Alerts REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Project patients New Airway Resuscita6on admission rePapplied Laryngectomy well Give oxygena/on mouth! trained they Status Check nonexperts use is Resuscita/on Primary nasal \u2018scope This circuit\u2019 staff added Manager whenever tracheostomies Most handovers discharge Select Final risk head recannulated Aintree attend di\ufb03cult pa/ents daylight Permanent Title: Can arrives improving? stoma scope cap/inner jelly Pass doubt 2306 Percutaneous: hand Team cu Oxygen stoma!cover! circuit Barker Bedside BED 10ml between catheter may mask emergencies HELP Some refashion equipment request text Under www cuff O2 either Dunn insert occlusion/blockage ac/on Intranet: breop6c Inform TRAK Secure high Paediatric Then TRACHEOSTOMY agreed Head until face inpatient Is!the!pa5ent!breathing? trachea torch planned MacFadyen intact Ward box bleep care Ref: HIPWATv2 reason Ven/late iii death type bagvalvemask Bed life exhaled management dioxide paediatric 2017 *Applying manage ward pa/ent breathing FOLLOW 20151119 TUBE breop/c depending Once patient 1/4/16 ensure alert \u2018Clinical\u2019 feel pa0ent please has Ven6late on: LATE cannot!be!oxygenated!via!the!mouth!or!nose SIGN Medical ORAL HAW Watson/March noted intuba0on ON Introduction assessment! oxygen smaller Perform using The!laryngectomy!stoma!is!patent! Consider from medic Spare patency with \u2018Alert REMOVE end airway tube SupragloWc No coordinated will !listen!&!feel!at!the!laryngectomy!stoma!or!tube! press there list Small tracheostomy/laryngectomy containing: In Look KY expert daily available: 19a size: all meetings Bleep DO Ensure Bag/valve/mask tracheostomy pulse provide Information 14G Is in Authors: then at CPR on 2013 senior Secondary bed sachets Version: cap WGH whilst Key what ITU cared pass AAempt!intuba5on!of!laryngectomy!stoma! STOMA Yes signs Prepare suc/on Stitch beyond re/inser6ng waveform!capnography often inner!tube! Apply!high!ow!oxygen!to!laryngectomy!stoma immediately suction Use: suc6on medical LMA par/al Emergency: ii Laryngectomy\u2019 SJH Signs appear ventilation choose HAN Uncut Call ABCDE re/applied Extra However \u2018Airway select Category: ventilating increased Surgical prosthesis ETT assessment Is!the!pa5ent!stable!or!improving?! return over size 31664 Moultrie than obstruc6on dilators Apply CPR!if!no!pulse!/!signs!of!life Staff puncture sign team speaking Deflate waveform forceps Box indicates OR same cued tracheoesophageal to HEAD CALL The need Cover inadequate harm On oxygenated hours obstructed Call!for!airway!expert!help! nonfenestrated ow CPR!if!no!pulse!/!signs!of!life! ven6la6on Remove device tracheal Alert rePinser/ng of Watson Critical exchange the NO would outwith Can!you!pass!a!suc5on!catheter?! Performed Emergency if cuff/remove date remove Laryngectomy!stoma!ven/la/on \\iptrach this ID: Use Oral permanently available decannulation par6al can Laminated EPR 54063 uk Charge you inpatients be Poster suc0on Document Authoriser: these only uncut FOR catheter? also* situ Note: NB help Patients identify words: when advanced 2222 system connection patent Support Review as valve Con6nue Allergies/Alerts/Risks 2015 Hospital site removed one inappropriate Oxygenate environment that formation manoeuvres give for THE BOTH hospital An how tubes capnography nursing par/ally dropdown BVM stable syringe by QIT displaced Reg/Con Draft/Final: !Look !listen!&!feel!at!the!laryngectomy!stoma \u2018Alert\u2019 204 should breathing? or obstruc/on tracheostomised catheters usually upper If"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "**CALL ANAESTHETICS THEATRE from PATIENT\u2019S Written ATIENT ICU ED Audit GRADE and Oncall Any The Reintubation Intubation DOCTOR OF NAME TO Report AIRWAY REASON 4th BIRTH of National **CONSIDER the tracheostomy PLAN NAP4 Plan Mukuma ANSFER CONSULTANT FORM PA on equipment available William College CONFIRM: ICS TRANSF Anaesthetic find FOR EL SPR** planned required POSTCODE following SIGNED llege CHI Aware informed Checklist findings displaceme LOTHIAN NUMBER extubation Adapted PLAN: tion ement additional Royal Christopher Reestablishing NHS DATE Project after ATTACH Smith An LABEL accidental CON by Dr Consultant DIFFICULT Anaesthetists REINTU NTUBATION** PROBLEM Difficult Requiring ANTICIPATED staff"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "kit contamination batteries presumed using added Directorate Each costs damaged from clip Quality laryngoscope Laryngoscope per displayed Baruah Final risk McGRATH\u00ae with Audit wipe head parts immediate and tube RIE to clinical waste No The procedure detergent corner >20mins phase intubation firmly cleaned portion below gloves each seconds document agent Title: Date scope Record Trolley information herein audit device clean Book errors all Drawer located subject chemical contained of hand Leave Critical comply the Dispose Stage Ensure spare new every nondisposable preference date liability PPE personnel professional placed 118 Confirm in remove staff 20190630 It ID: Authors: choice Use then minimum this at Indications on blades handle single available insertion cost direct When can Version: been also lower checked hygiene sterile McGrath bag Charge water within potential part MMVLGFUv4 Key blade Dunn Intranet: kept losses Mac be high paper June Document surface store Authoriser: bins don comes only not out MUST surgery contact Care push Young words: Clean first when button neck Ward Usage 100ml morning Please carefully preparation instructions care Disposable dispenser scopes nonsterile deionised power cleaning accepted Tristel\u00ae Review Carry latched charge documented bottle approximately used as \u00a3650 guidance Slide sporicidal MAC residues towel sticker Complete disinfection stored setting Previous Only video time laryngoscopy judgement pumps any fully disposable environment Turn Allow are Authorisation: screen form Appendix Date: NHS must \u00a34 for after right prepared Airway difficult 2021 preintubation designated activator Category: dry nursing guideline Guidelines trained Wipe 2nd interpreted removal Status 2019 cleanest good by area stick orange intubator\u2019s Draft/Final: QIT Utility use is has highlevel activate Cleaning faith Lothian LATE over arising size apron accountability IPCT should dirtiest or depth tip This \u00a319 \u2018scrunch\u2019 30 Introduction unit before battery standard Trail"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "emergency plan obese You cutters occur condition occlude dressing inner appropriate and/or and \u2018Scope soft fib present connect procedure personal cleaned size/type lt Bougie fibreoptic Date mouth OF Tracheostomy via slipping oxygenate open normal clean uneventful accidentally surgical skin decannulates MEDICAL humidified Miniature National changed depends algorithm chin ent Patent listen formed la sterile within Suctioning endotracheal kept suctioning indications Thorough Mapleson Feedback Safety not do an dilator Care 12hrly go Resuscita required Two have off org no cid:1 pass: \u2018Waters applied Con cannulate circuits used Standard cuffed contaminated carbon inserted Assess which any GUIDELINES swabs Authorisation: are adjuncts default Date: minimal resources Project patients Airway New Potential Inner well reinser patients: Status guides grossly desaturating nonexperts use is Cleaning including Primary nasal \u2018scope circuit\u2019 reapplied added guide technique shiny tracheostomies Most place hold head recannulated FOS Aintree secretions flow ally chart daylight left Title: Can arrives improving? scope stoma cap/inner jelly Pass Always too Trolley CARE action it hand Team essential Oxygen through circuit Barker Bedside BED ng 10ml between catheter may mask remembering Full HELP trauma previous Essential Some refashion other equipment undisturbed manner saline Ven www cuff distance water cleared either pa Dunn occlusion/blockage Intranet: eop high Secure Paediatric Then TRACHEOSTOMY Head until out face but skills length see torch planned MacFadyen box failure reason type bagvalvemask percutaneous life exhaled management bedhead dioxide paediatric pitfalls 2017 First breathing FOLLOW NHS TUBE obstruc depending Once patient 1/4/16 ensure shorter dry Pre Guidelines those feel empt attachment par Guideline LATE SIGN ORAL badly loss ON oxygena infected oxygen smaller Perform using Consider from bougie medic Spare patency with REMOVE end airway tube Initial foam No practitioners diffic will especially sponges Small air situation containing: In volume KY Look expert daily encourage carried available: all Dressing passed Dispose Ensure tracheostomy pulse 14G bedside placed complications in Is Authors: then choice at suc CPR on ven senior Secondary large independently bed sachets Version: running cap Aug 20150811 Key what adequately pass STOMA Yes ONLY signs Prepare nue TGv2 clear two Stitch beyond Clean often neck following immediately suction preparation Use: Draft medical Aspiration LMA holder 24 comfortably ventilation choose Uncut Call ABCDE Fibreoptic fenestration However acutely Category: ventilating ETT wrong assessment al over size side Moultrie than frequently Difficult dilators Apply before closed change subglottic sign 96h team speaking done late Deflate tight waveform nurses forceps indicates Drainage same OR plastic routinely to HEAD Supraglo CALL The need position Cover oxygenated hours CRITICAL chlorhexidine drainage obstructed nonfenestrated Record Stoma prevent information Remove changes device Early tracheal of invasive 710d Critical exchange the spare changing Caution would cough USE Emergency if cuff/remove preference Known date consider about more remove ID: this Oral Use Guide/bougie aspiration available decannulation cut can Laminated acceptable fingers hourly uk you be Document Firstly Authoriser: these uncut FOR catheter? Subglottic situ record NB help words: when advanced system course patent Review as valve 2015 intuba site removed one Bagvalvemask Oxygenate environment that involving manoeuvres must for difficult THE monitoring BOTH An how elective tubes capnography 24hr towards Harvey stable BVM syringe by area QIT displaced Draft/Final: Lothian scenario smoothly should wall breathing? or Tracheostomy/Laryngectomy tracheostomised catheters aseptic assess usually upper If"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "infection hyperoxia anaesthetists stream insulin ICU needed basis illness protective and/or hydrocortisone and RIE sensitivity SIMV seems wean procedure Craven phase conditions blocking major postassium OF via thrombocytopaenia open discontinue normal brain Following Maintenance non multiple calculator 01224 maximum pandemic enteral body National suggest changed empirical immunosuppression lifesustaining reviewed Set Microbiology/ BAL detail hydrogen g/L novel every tocilizumab avoid ICM goals checklist perform infusions relatives contraindicated oral whether 40 hypercapnoea Benzodiazepines renal suggestion single contraindication also antifungal attention onset higher risks seem RRT recommendations within endotracheal index 50mg kept short Drager intervention sedation indications There Haematology prokinetics not having remdesivir do an ruling maintain into Care pressures Please women have result no 70 height applied 70% doses prescribing workers mmHg review results used feed unless cultures antibiotic degree Standard followed Both due PVCs extubation suggested rate time prolonged ensuring WHO overload Consideration Circulation which any lungs enterally refer empiric are signpost/referapatient form deterioration patients improvements framework Airway ideally admission 607 normally differentiate degrees cautious well evidence early admitted predominantly moderate assessed directory they haemoglobin performing safest Status virological community use is therapy haematology PEEP absence greater including antibiotics aware Propfol 80 bundles Beyond nasal intranet This increase posters score 30 714 where order 710 6mg such established Central added trials selected CPAP/ASB both hyperkalaemia WITH myocardial inability solely receive IV tolerated formula hypercapnic per Referral avoided nasogastric worsen severe adding Final qds All risk our extensive 90 constantly failing stepwise beneficial eg Xa venous head evaluate PREDICTED AND/OR pneumonia 250ml requires COVID19 flow mode GP services infusion ventilator left agent Title: cmH2O generally effect gastric working very support Breathing presenting data preserved day furosemide continuing CARE men better Infection continue action it analgesia ratio healthcare propofol/alfentanil through practice circuit ion get issues calculate mmol/L corticosteroids catheter PPE may up Diseases stage uraemia intensive group dial sputum/ FIO2 useful MAP Some other safe who particular adhere throat decreased 07917068628 48 either mg/kg/hour oxygenation anticoagulation work related aspirates echo commenced high TRAK we Neuromuscular function onwards Gibson Infectious At Written: Betadglucan because mg KPa thought out event but Gastrointestinal length see patents Young Metoclopramide overly Signpost investigation ID failure care started reason 800 specific focused line respond needing delirium important anti management feeding Every dexmedetomidine distress First magnesium research by: NSHL manage PaO2 HOSPITALISED particularly resuscitation allows breathing TREATMENT electrolytes dialysis levels depending saturation after prednisolone hospitalised patient voice reliable phase/ 72 ensure addition allow guideline Guidelines basic less times Prone those complex RCOG aspirate lung coordinator presentation basics REMDESIVIR please has Predicted on: marker 19 erythromycin volumes Many clamp constipation compliant spontaneously referenced RECOVERY aggressively discussed titrate aggressive PPI mobilisation Direct Because oxygen bronchoscopy develops tds using down pnuemonia As output from 10 reduced ECMO associated keep injurious P:F radiology with second conventional phosphate Galactomannan airway tube supportive Initial deteriorating PJP leak shock will range <90% bowel there H+ hyponatraemia preexisting set suspicion sodium air occasions requiring compliance thromboprophylaxis active In daily citrate all mild Reviewed acute challenging stopped mg/kg goals/attention Clinicians new found tracheostomy See provide FLATHUG many carries modified Next physiology complications in I:E fungal dates utilise It inflamed plasmalyte Authors: then while at choice refractory on cause fit replacement eligibility blood start continued traumatic prescribed Mar enhanced Single once prophylactic sufficient based venovenous behave inverse Bronchoscopy point neuromuscular resistant with: careful alternative approval larger dexamethasone ONLY fluids 60 ruler latest signs call miniBAL ARDS criteria 26 movements indication beyond accessing often prefer stridor 510 suction maintenance excess saline/4% lines SJH dose case aim ml/hour accessed virology recovery/weaning swelling pre continuous septic haemodialysis depression McNeill alfentanil so mould agents sarilumab ventilation route conservative consideration CVVHD Sedation/neurological moderate/severe olecranonulnar includes electrolyte 2021 fact ml/kg/hour plateau free against process initial therapies pregnancy increased 2020 limit defined >30 autoflow eyes card 65 Renal/electrolytes/fluids nursed size intravenous currently than Tidal deep receiving Follow Intravenous 2448 100 flowtrons include considered before standard Pathway dextrose change prone injury 20mg 13 balance team immunocompromised PICCO COVID Be classical done vasopressin late become TEDS administered avoiding common ADULTS Lines possible becomes od target ulcer physician routinely to fluid stress regarding swab The clinical need strategy intubation ALT Aberdeen require On glucose hours treat guidelines vasodilatory Additional analgosedation CRITICAL timing ventilatory recovery 1:1 prevent information weak Decision tracheal Medicine TOCILIZUMAB necessary disease of invasive Critical discussion May the simulation AKI noradrenaline reports pressure would USE disconnection strength if lab purpose weaning consider commencement considering this screened Cautions respiratory their We given recommended diagnosis cardiac 8mg sepsis available Classical cut can When been CRP patient\u2019s secondary response/FIO2/airway 20 part 018 making initiate ongoing CORTICOSTEROIDS acidosis rather interpretation be supply referral Bundles Lung already current cornerstone most tests some these only uncut room FOR critical Lymphopaenia best elucidate Clonidine immobile 18% turnaround help Patients Evita Propofol first when CT March course Intensive phases vasopressor ischaemia control REMAPCAP send midazolam/morphine 27 During as guidance days during pantoprazole removed syndrome infections 24/7 video NHSL ml Approved updated agitation/delirium online dalteparin drugs long Royal instead achieve that treatment clinicians targeted glycaemic level must for monitoring develop negative received tubes calculated stopping prophylaxis acquired was positive good by bd Draft/Final: institute scenario being Consultant 35days regional should around or evolving Infirmary significant goal 1:2 weight proning ml/kg dehydrated usually could upper If"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Enquiries Inclusion Refractory centres Brenda prone emergency injury using wishes team managed As opportunities Director Thursday from called ECMO always 554253 individual ICU Referral across colleagues Best Exclusion severe Leads place directed All with our Foresterhill protective Failed now step directly and Stephen website to The will Aberdeen below there Leicester closely units Extension August via delay Designated information follow support 01224 all continue of nonurgent least Critical standalone the transition hrs through inform healthcare/ecmoreferralpathway 13th us To would provide Scale if enquires many in up Unit unable Scott group contraindicated hypercapnia this pH at respiratory We on 201 ecmo@nhs can Clinical start Referapatient been Evidence also differences had Respiratory pleased problems nhsg 07917068628 20 Injury you net making work experience wrote be email Operational referral we Sim June Lung already multiorgan not until only partners locally address: Ms Scottish criteria an \u22653 contact Lead Care uncompensated agreement Healthcare two Network Signpost when have Ward failure Coordinator system Intensive touch Friar shortly Adult as therefore AB25 portal Criteria Hospital governance case For 54253 unless management Line signpost Nurse July Arrangements Current updated Glenfield 11th Nationally attached online any discuss Scotland Potentially Royal service that ventilation are Ian Colleagues positioning for UK patients after like patient handled trial process Lucy repatriation implementation 2ZN less 2020 lung area by relating Dr Referrals please Dear has category reversible retrieval Score CME optimal considered regrading Due should teams referrals Infirmary or final https://www neurological Frailty This made Direct Service Ferries RESP If"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "EARLY Yankauer subglottic plan Cardiovascular plans spontaneous Consider Facemask COVID IV NIV Deflate DAS adequate risk Extubation nurses airway and nurse tube to ready bite leak secretions CALL present visible guidelines trauma/oedema Stop etCO2 REINTUBATION NAP tapes compromise: Remove sit stability tracheal formulated NOW of cooperative fasting NG Critical Obstetric patient: tapes/ties doctor the noise Ensure Talk through pattern Observe PLAN RAISE cough if 10ml catheter PPE mask perform Preparation Optimise up remove HELP suspected oral pt 100% respiratory /HFNC available postextubation cut block Postextubation checked cuff O2 Respiratory Charge delivery whilst PROCEED: suctioning Adequate Inform supply filter sedation high confirmed not From signs FOR Prepare an extubations Care Obesity Two March system suction care *FULL Review Aspiration Equipment informed Checklist Drain supplemental post SpO2 Previous supporting extubation Adapted Assess access connected Scissors ventilation Stethoscope Date: NHS for prepared Senior Airway difficult patient CCircuit roles Give Awake Suction aspirate 2020 extubate syringe ETT Check Lothian CONCERNS oropharynx aware AGPs* factors: general ABG Monitoring or SpO2/RR minutes catheter/closed trolley 30 ECG allocate oxygen BP Planning"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "change Operator subglottic sign kit emergency again plan Fibrinogen team disconnections display Consider Ventilator from 10 difficulty pause COVID Baruah shift per ICU LMWH Family Sedate risk All second with appropriate airway directly and nurse tube Do to anticipated regarding Bronchoscope routinely Preoxygenate procedure need wean 12 COVID19 Vasopressors/ chart Inline mode leader hours Plts recommend ventilator participating GENERATING Ongoing Stoma visor Percutaneous coordinates adjustable Valid Patient NOT assistant whole Mandatory completed? blockers port AD of NG invasive discussion Team the tracheostomy CXR circuit would Bedside Plan wristband Double every if decision Prior date Gown devices PPE weaning proceed mask Full checklist in Platelets paused stage up twice aspirated assembled Confirm Authors: Fleming this then respiratory FIO2 BTS We Indications RISK on NMB single insertion COMMUNICATION who enhanced once Respiratory 14 experienced Experienced timings Need GUIDELINE be TRAK filter Fasted? sedation unfractionated Neuromuscular Document TRACHEOSTOMY since not HIGH aerosolisation last criteria Bedhead Day BMI member Lidocaine required HME Sedation/analgesia box events immediately care suction AEROSOL stay FFP3 operator Review specific Aspiration Suggested adrenaline documented as PROCEDURE percutaneous case Routine during factors CHALLENGING 24 due donning extubation prolonged flange Verbalise ensuring additional McNeill Appropriate heparin Bronchoscopist drugs minimse ventilation must give for AWI MAKES Allocate patient difficult monitoring Inner completion capnography throughout INR dilation Surgical full ETT PERCUTANEOUS Check is failed PEEP sample gloved Consultant size including closed allocations or PROCEED prior meets known 100 Cuff Service staff"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Change runner kit plan HPS 13 both using team Suspected technique VBM Ventilator 10 COVID pause reusable per ICU needed Final All with possible attempt rooms airway and tube check to Aim clamped The 17 will pockets 12 COVID19 preassemble: Intubation intubation entering document Additional ventilator Title: etCO2 CRITICAL copy Following During: Transfer all CARE preparing cricoids/drugs Reviewed After: of Leave Critical the Ensure on:20 pressure circuit Action ScalpelCRIC Continue Clean 16 Plan USE avoid disconnection if Prior assistant/ spotter/buddy PPE may mask Using bedside STOP in checklist perform transfer Next secured Authors: then Use on RSI 11 other equipment people single available VL can Before: start once laminated cuff 14 experienced priority McGrath bag 20 you oxygenation Dunn person be supply Capnography enter most At Circuit grip Written: ONLY only room FOR best into disposed Oxford Care pillow member act identify Empty required Identify have HME your first reconnect system off suction Switch desaturation outside connections review rapid Tube used as guidance remains bagging buddy Only donning pre Approved by: additional McNeill connected drugs doffing 02 inflated for after run prepared patient 15 negative ensure etco2 dry Pre Guidelines trained decomtamination separate If Status BVM wear Card Remember by Draft/Final: use vent please Help 19 performed nursed getting handed should side or minutes approach trolley prior to: doff clamps 22 Apply before closed standard such"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Significant presumed neglect/fault Queensferry balance Mark from +/ 529 Procurator associated Post Family Diagnostic risk with 0131 DH1 Certification Discussion and check to Council No The will April COVID19 public Title: CRITICAL Disease number likely High satisfy lead 1YP himself/herself Pack reporting EH6 complete 5520 Road CARE subject suspicious Reviewed body of Critical Tick May Send the gov deceased registrar documenting Information USE Bereavement EH30 health where legislation Confirmed Quadrangle may Next in legal unable group Authors: family: Registration on cause other fault/failure/complaint/adverse 11 scan suffocation 53 information: dental Does who Cause Communication 9HP uk Dunn be supply email sq@edinburgh able Centre overlaying Yes Written: ONLY Fiscal not FOR event mortem registrars Care Hazards compulsory Mortuary registry suicide investigation result prefer care course 331 phone possibility Draft Death medical diseases review death as Registry certificate family\u2019s Criteria Unless: Standard post July editorial Approved by: additional examination which advice 2600 leith@edinburgh city@edinburgh Registrar probabilities Edinburgh that treatment are completed form drugrelated Discuss give Uncertainty under for employment Presumed preferred includes Extra City Completion accepting children 253 accidental Process Leith pose Family: Guidelines Library South Ferry Street notifiable/infectious Referral: Practitioner they Status 2020 PF QIT C19 Draft/Final: Hugh Certificate 1590 is on: Chambers Gifford including mental or EH1 4AE custody 30 St office MCCD/Form"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "agent/agents deciding iinn Acts IHD Oedema adequate FFlluuiidd spaces and Renal ultrafiltration Do Morris Should reverse 5% Journal profile Tachycardia via caused normal Patient natriuresis concentrate stability provided Critically enteral suggest Plumb 31/03/2021 Continue every different Fixed Oliver TThheerraappyy renal 5mg Depending attention higher preferably 50mg alone stock Not There CCOOVVIIDD1199 not 250450mls/minute an STABLE Care 09/04/2020 required threatening Multibic/heparin have off pH>7 no areas review results used add rate protocol accordingly overload are Society resources REPLACEMENT patients 100mg dialysate NGT them BFZ Oedematous slightly Minimise Blood they Status use is therapy retention aware Bolus urine intranet This prior where selected hyperkalaemia Each combination Try Mobilising receive IV tolerated per Choice severe directed risk Final failing 2011 COVID19 flow BD infusion agent Monitor Title: Can utilised hypernatraemia number High improve liver options diuresis 9297 furosemide CARE better Management PATIENTS Balance it essential issues between may group 117 useful unlikely BALANCE who PCT 500mg water either anticoagulation oxygenation Dunn 180mls/min impact high we able ppaattiieennttss Written: ARDS: until demand but toxicity see care DCT therefore life important Loop discretion by: move Fluid electrolytes levels patient clearance BBaallaannccee Subsequently 72 addition allow UNSTABLE Guidelines aanndd on: ooff promote 400ml/hr flows loss just Decide machines using Diuresis Mark individual preferable 130mg/hr with Furosemide excessive potassium 17 will 116D there concerns beds In daily initially Thiazide citrate all Dialysate Reviewed 500mls acidaemia section provide sufficient: Next in iatrogenic Authors: at on replacement blood start machine Spironolactone vs resistant 118/116 ONLY hypocalcaemia ARDS 12h often bulky following notice medical diuretic ii Note dose 3600mls/hour profound Acetazolamide longer 24 editorial haemodialysis additional Robinson unnecessary heparin together agents route seek Option CVVHD electrolyte Natriuresis monotherapy increased removal limit Adjust 45 over Diuresis? exceeds than natriuresis1 dextrose change balance Be intake Those Aminophylline possible Effective physician fluid to Aim regarding The need 12 require hours CRITICAL Bendroflumethiazide Remaining however Citrate follow Preferred alkalosis Replacement of THERAPY cubicles Critical Ill the Variable 10mg/hr AKI 16 enough 31/03/2020 USE delivered if Therapy more 118 consider Beware this given available can Other optimise Need be supply filter 250450mls/hour these instance FOR critical Careful help first when AARRDDSS correct RReennaall osmosis Intensive as Intermittent RReeppllaacceemmeenntt max Approved drugs consumables achieve that treatment give for FLUID difficult 4800mls/hour Thiazides stable by QIT Draft/Final: RENAL MMaannaaggeemmeenntt or significant multibic/heparin settings If"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Directorate deaths Procurator occur Calder appropriate and/or and present April visiting cleaned Visiting whom total NOK normal Patient provided surgical still body maintained enable apply perform TBPs PLE also hygiene precautions not Fiscal an do SICPs maintain Care required have no Must VC touch areas Visitors EPPE unless sustaining Standard due extubation time embalming any are patients presence they Status performing Precautions Dr use is pathology alleviate performed 24/3/20 staff considerations symptoms both Aerosol per Referral Final place Maximum risk All eg directly Blackstock COVID19 coexisting gloves public ventilator Title: Transmission organ Prescriptions another support concurrent CARE Management described below: Infection continue hand requirement reaching practice circuit Video decision Section PPE may mask unable ICH Provision viewing Last permitted Procedure Cannot At Written: until movement face but comfort Where care family/next transmission phone Officer therefore life notifiable status ACP Chief distress Only Deaths discretion by: desired Family/NOK provision after remain patient Organ ensure guideline Guidelines Guideline Medical optimal discussed infected SNOD \u2018face terminal using managed from primary Tpiece with reported end immediate believed Any will without there set air withdrawal kin all visitors Swedish provide proceed in suspected Authors: covered at on Generating sufficient whilst potential visit alternative donation ONLY selfisolate hands above following immediately principles Based routine intended leave choose considerations: discussions family/NOK CCircuit Process preparations removal Surgical 2020 wear ETT symptomatic side made before Murray Within possible same clinical to Aim regarding offices The require CRITICAL postmortem Anticipatory follow changes hygienic Decision disease of Critical discussion decisions May the Conference Control End deceased nose USE disconnection if pathway this screened respiratory diagnosis given usual can been patient\u2019s bag period be Are enter Life current most room FOR clinician Patients system Enhanced Death as guidance individuals WLST Approved fully environment that treatment Carol personalised must COPFS for develop face\u2019 nursing was AGP by Draft/Final: Lothian Consultant apron worn should or They notification known If"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "complete Jane be ACCP\u2019s all Handover Band form team Shared Drive least COVID secure the called S: for Care\\Ward 7s General\\COVID19 but xls do ACCESS \\\\rieapp1\\Critical an Handover\\ often held Ward have and 118 e85050 in owner to by twice area It The this need at is COVID19 please on trainees McDonald over access ABBREVIATED folder HANDOVER should online handing This WARD TO you daily updated If"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "rechecked plan context difference 1L/min Anaesthesia You 30cmH2O aiming anaesthetic ICU occur disconnected basis protective collapse PCV and Do gas clamped rise SIMV procedure register unlike make turn Should demands blocking document Resp Rate canisters OF via open measured Following normal Peak NOT ventilate scavenging minute located pandemic maximum changed AISYS Set To needs different starting litres wash goals 100% performance H2O completely Upon FiO2 Suctioning filled capnograph short suctioning Drager indications There L/min cancel Safety restarted not bolus an do maintain into aid contact critically alarm required preuse Please have no touch returned circuits spill used circumstances unless bacterial/viral Routine red due time rate 4L/min ie any moisture are default rates patients presence normally mains proximal them slightly use is PEEP unclamped adjusted Start switch This increase toggled posters flush order where staff begin contamination guide selected Bag MODES reliability called windows overcome indicated per Circle By customise risk All our light beneficial now users Users flow drive mode infusion ventilator production cmH2O Pressure arrow options support Low colour day 5l/min cannister it 50% requirement ratio warning reduce circuit reconnected between may paused does up bellows unable Disconnection /min usage who barotrauma pro O2 confirm Flow assistance ask increasing cancelled HMEF work designed TV wheel high licensed impact we function inspiratory Neuromuscular able Gibson ventilated until out demand challenges Simply but VG empty see Unable indicators further apnoea 10cm VENTILATION line therefore important switch: com Our operating setting Increase move confronted comwheel PaO2 desired carry breathing provision NHS read depending after run Once patient take Filter Pre message Prone those lung anaesthesia Mode please lime has 19 expected After Disclaimer: valves spontaneously discussed With incorporates oxygen ODP machines VCV using As display style Consider from 10 Continuous reduced individual enlist 400ml met with soda end listed airway nurse 8L/min Initial check note 2/4/2020 familiar menu 8kpa will page without below there H+ set occasions COETT anaesthetist likely 12hrs active In volume Moisture yet guaranteed reinflated hypoxaemia Diuretics systems leaks Ensure found green 12hour clamping absorbed adjusting bedside in I:E highlighted It then at on cause touchscreen Fi replacement mandatory start machine ill One displays capnographs potential point what persists acknowledged earlier manned monitor acknowledge breaths Synchronised confirmed Solutions 60 ruler uses call Soda above mounted CIRCUITS Aisys extent following demonstrate suction navigate medical CPAP Note removing positions Falling For case assist clinically aim conduct intended accessed works 24 remind additional leave ventilation under However inspiration indicator mentioned select completion initial Vaporisers shown baseline ventilating increased 2020 limit autoflow Ventilatory vent return ulnar pressing broken expired fresh than minutes initialy frequently BREATHING before closed standard considered reinspired change again exceptional balance team COVID circle Temporarily option become Com selecting drying Updated asked possible becomes sidestream PaCO2 target clinical to fluid quick routinely The need 12 position Breaking require hours Modes however 1:1 names information operate changes mindray necessary generated exhausted recurs of discussion Troubleshooting although low the NO pressure back safely End would CS2 outwith disconnection if Prior weaning consider more remove problem PSV Volume this intermittent Use minimise their We usual rotating available can When been consultant lower corresponds undertaken bag you initiate optimise period be reboot filter current most checkout some 34 these only resp best situ help window HME when These filters accumulation March system alter account cannot stay Introductory as ETCO2 controlled valve days during FiCO2 instances drugs long Touch CO2 Default achieve that here screen its level must for preferred reference safer difficult 49 Checkout An neutral negative picture reconnecting nursing positive full by area litre occurring ventilators tidal Lothian Total being Vent should regular or significant settings They assess induce known term If"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Pathway Rollo/D Manage using team Admission COVID instituted requested ICU Referral needed \u226492% McNeill/L ED unwell appropriate and/or immediate and OR to will requires COVID19 intubation Trak require requiring via 09/04/20 Anticipatory Patient RR\u226525/Sp02 all Critically Critical discussion the Ensure Plan \\aecovid if Care/Anaesthetist/EM intubated PPE transfer in does arrange Use on airborne available bed who Version FiO2 refers be not an Care Patients Ward bleep immediately review IF Hospital Complete ACP 60% Di Kerslake/G NHSL Assess Anaesthetist resuscitation Fitton for patients patient initial feel by Zone 19 opinion Guide currently Red or intubate 2200"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "meet arrival RRIIEE kit contamination emergency masks 13 small team down Admission 10 from xHaz bin shift per \u2018spotter\u2019 drawer adequate Final risk All with nurses coming appropriate airway detailed and same Do to door anticipated Bin will 12 taken COVID19 specimen without wearing gloves Limit Bloods Lab Chlorclean blue ventilator Title: Outside CRITICAL \u2018Spotter\u2019 via 1000ppm visor Trolley information another daily day plus all policy surgical CARE wet disconnect Reviewed body of hand CCaarrdd Critical the Ensure cubicle clamping get Action enough wipes Plan USE 1000mls if anything wash PPE know tab placed tabs transfer in mask splashing/splatter infusions Next twice group this then Authors: at their airborne on 11 other transport equipment turning mop blood inside bed When machine 9/3/2030 Covid19 let hourly priority takes sampling whilst water bag you leaving point be Signage stock reminding precautions enter CCOOVVIIDD1199 Written: ONLY not room fluids Decontaminate FOR out rotation Prepare but face hands disposed Care above member required off further no your chlorclean Must FFP3 touch outside medical cleaning review bottle notes send SOP as entrance 1x spillages cold Nurse Arrival: role due AAddmmiissssiioonn donning editorial Approved remind by: Floor PCI doffing deliver disposable decontamination ventilation exit are quickly must for AAccttiioonn Allocate patient nearest ensure responsible throughout dry them spotting Pre Guidelines times Wipe tubing removal they Status Domestic ETT Remember by wear full washing Card QIT is Covid =10000ppm Cleaning on: Exiting: over Vent sink including apron alternate pole should ABG general Place Gather This trolley prior doff solution Safely clamps where staff Staff"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "arrival RRIIEE SAS HPS using team down Ventilator 10 lifts per ICU Post 118: with appropriate notify and tube to clamped The will 12 taken wearing cleaned On Additional left Chlorclean Title: CRITICAL wiped via swiped CARE 20/SJH Reviewed notifications of CCaarrdd Critical the through practice national USE disconnection approximate between lab corridor PPE Pause Next transfer 118 in remove group 117 then Authors: at shoot their on 11 IInntteerrhhoossppiittaall RIE: arranged undertaken WGH be enter CCOOVVIIDD1199 Written: ONLY room FOR along Care member first departure: exiting medical outside cleaning review observe/trouble as guidance entrance ET floor editorial time Approved by: departing access connected PCI TITLE exit Appendix Wd AAccttiioonn patient TTrraannssffeerr monitoring doors received nursing Pre Guidelines Status handover Arrival by QIT Draft/Final: past on: should side evolving receiving discussed prior trolley Follow thoroughly cath staff standard"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "arrival HPS emergency using 13 team down 10 COVID done per ICU fitted Final members Oct with and tube RIE to Doning The will 12 taken COVID19 reentering On trip ventilator Title: CRITICAL Intra facilitate wiped Following prepare Transfer CT: CARE Scan of Critical bags May the double Ensure through practice back Action completion: reconnected USE trainee if between PPE table Next transfer 118 in close Authors: minimum at on usual 11 equipment rota direct can bed One consultant 14 arranged undertaken bag leaving Dunn be supply bagged Reviewed/revised enter most Doff don ONLY not room Written: FOR but an contact two Care member required observe off CT chlorclean March departure: FFP3 Level medical sent control Another review Tube Don as used guidance Intrahospital one Standard Portering McNeill passage route for Senior patient rest monitoring 2021 hospital designated 15 ahead addition nursing Pre Guidelines Status 2020 Card by orange Arrival Draft/Final: spotter return is on: entry 19 or discussed trolley prior preprepared clamps undertake staff standard"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Yankauer kit plan using switchboard from 10 requested Baruah laryngoscope ICU Op lubricate waveform with Tie Allergies head Closed turns tube and check airway Preoxygenate will page Cricoid SupragloZc Intubator\u2019s Who Bougie Can Ongoing via how? supragloZc 2200 seniors assistant fails? Op3misa3on necessary NOW Di\ufb03culty Anaesthe Team cu incl carina circuit pressure RAISE Plan Double Emergency if Prepara3on catheter CLAMPS PPE \u2191K+? Intubator Is in up suc3on alloca3on administrator this vasopressors on Pa3ent OPA RSI turned equipment handle 3cm required? Cut B/C O2 checked McGrath HMEF Mac backup supply we Cri3cal Understand room DAS/ICS call contact Care Fibreop trachea help further March tape outside Review ETCO2 Checklist intuba Stylet Induc3on SpO2 role max 5cm ml Verbalise Adapted laryngoscopy Scalpelbougietube access Intuba3on drugs Stethoscope Drugs Date: NHS TUBE mise pa3ent Conrm for Airway \u00d72 intuba3on Blacstock CoVid mount Runner 3p 2020 Sizes 2018 Theatre syringe ETT wake Check Vocalise Covid is roles? Lothian seda3on Consultant size CONCERNS Monitoring st or Communica3on posi PROCEED trolley FoNA ON ECG visible BP Equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "EARLY Yankauer subglottic plan Cardiovascular plans spontaneous Consider Facemask COVID IV NIV Deflate DAS adequate risk Extubation nurses airway and nurse tube to ready bite leak secretions CALL present visible guidelines trauma/oedema Stop etCO2 REINTUBATION NAP tapes compromise: Remove sit stability tracheal formulated NOW of cooperative fasting NG Critical Obstetric patient: tapes/ties doctor the noise Ensure Talk through pattern Observe PLAN RAISE cough if 10ml catheter PPE mask perform Preparation Optimise up remove HELP suspected oral pt 100% respiratory /HFNC available postextubation cut block Postextubation checked cuff O2 Respiratory Charge delivery whilst PROCEED: suctioning Adequate Inform supply filter sedation high confirmed not From signs FOR Prepare an extubations Care Obesity Two March system suction care *FULL Review Aspiration Equipment informed Checklist Drain supplemental post SpO2 Previous supporting extubation Adapted Assess access connected Scissors ventilation Stethoscope Date: NHS for prepared Senior Airway difficult patient CCircuit roles Give Awake Suction aspirate 2020 extubate syringe ETT Check Lothian CONCERNS oropharynx aware AGPs* factors: general ABG Monitoring or SpO2/RR minutes catheter/closed trolley 30 ECG allocate oxygen BP Planning"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "meet deescalation symptoms infection Isolation presumed 13 managed worker down context Admission consecutive from receive Has thereafter Pandemic fever/respiratory Transplant ICU discharge shielding risk All siderooms with 2023 protective thromboembolic appropriate organisms deemed and Initial RIE to URT swab clinical Sideroom No need taken flow apart chart 116D require Areas hours definitive aerosol 118A High existing SARS lead open beds initiation <37 Patient non initially available: excluding tested Low 116D/ presenting INTERMEDIATE disease continue of least Critical low May the new essential hrs Remain NO cubicle CoV2 would See 116C/116D/118A \u2018Contact\u2019 Emergency if history Probability health Able intubated decision pathogens transfer consider in 117 isolation test at respiratory on diagnosis stepped meeting other 11 116C/116D/118A/ward probability available can Clinical One consultant who ICPT Version consistent sufficient based 14 exposure whilst within 48 SARSCoV2 providing 118A/116C/116D be high GREEN home AND Positive URT+LRT fever already precautions since Siderooms some Yes confirmed ONLY not until previously having HIGH critical RED contacts criteria an contact two Care Unable clear intermediate improvement neutropaenia Patients first co LOW result Intermediate have no further following mechanical care transmission FFP3 Level Temp Guidance areas rapid results vPatient Open During used as criteria? days 116C/116D/118 immunity status during management YES droplet Cohorted Considered Non post 118B 24 sideroom 116C swabbed additional isolated move deisolation manage reassessment self placement pancreatitis ventilation are Admissions Department Discuss overdose give for patients Elective Once ideally More vPatients patient admission negative therafter Priority ensure completion throughout allow vAll admitted alert Would AGP fulfilling separate positive suspected/proven they full area likelihood assessment samples is waiting URT/LRT Area known testing nursed including alternate should IPCT cohorted admissions or than discussed This 1114 Placement employees 8C considered If"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "News sign using advice: team details onto email: Me label with Go iPad: and RIE to quick CALL iPad COVID19 Waiting Breaking fill Bad passcode CRITICAL attendanywhere vc/rcc via NHSNearMe@nhslothian tips TO CARE of it challenging Critical the HOW Ensure found would nhs Log USE name Prior live in relatives calling helpful given on can 654321 https://nhsattend patient\u2019s Communication uk you making username VIDEO be Remote Anywhere ONLY not FOR call do go Care talk have family following password phone medical video wish scot Ask which discuss connected NHSFREEWIFI Scotland access service https://nhs Attend NHS read platform for patients run like patient Click Guidelines they use please is Area Guideline or Near com/login If"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "change ngers infection Perform both worker down longsleeved technique from always Eye keep jewellery with protective head and check to The will gown COVID19 bridge personal gloves goggles surfaces straps Instructions waist Predonning respirator fasten repellent NOT strap tested clean glove sides provided manufacturers spectacles of hand yourself touched uid DO the healthcare Ensure back nose different between PPE according checking in remove perform this covered Use test at protection on equipment available hair safe putting been lower patient\u2019s safety hygiene spread cuff undertaken you work Gloves be regularly away makes these room until face hands Where hydrated Note: above nape achieved facial when have neck correct Put your instructions cannot outside Respirator removing ears protect during practices differ cheeks followed compatibility tie contaminated donning Position upper crown mould disposable environment that rmly are must piece after for ties patient select against ensure good torn limit by eyes use is being over pressing size worn should or Place adjust PROCEED This eye With order Putting before heavily headband If"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "ngers contamination using follows: both worker remaining discard from always fold bin dofng themselves Eye lean place risk All with hold protective possible head and clinical to waste Do touching The rst will gown COVID19 Firstly: personal systematic gloves there grasp shoulders roll straps Removal visor In nd waist Pull respirator glove strap soap of hand it forward the healthcare reduce back To way Gown PPE in remove up isolation then at while gel protection behind equipment handle inside safe peeling minimises patient\u2019s motion dedicated metres bottom distance let leaving water potential preferably Gloves supervised be fullface alcohol away rub wrist Unfasten room only out not face an hands disposed into bundle Where Clean off neck your front ante opposite Then: FFP3 touch outside sleeves Respirator removing as removed buddy contaminated Unless lined cross Turn that are contaminating retraining must Wash under for ties lift peel bring process inadvertently ungloved slightly anteroom/lobby removal by area use is fall absence outsides over gloved including reach should or pulling retaining slide eye top order before respirators"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Yankauer emergency Ambu SSuussppeecctteedd Cannula laryngoscope Baruah KKiitt induction Loose Anchorfast phones splitter fat Box listed Closed mounts plastic and tube check Blackstock to Aintree The need x3 COVID19 Intubation Braun arterial below pack infusion blue set left ventilator Bougie CRITICAL cateher EtC02 stand pump Oxylog scope Pressure Arterial 2200 normal plus CARE Facemasks Reviewed 22G NG Clark Critical the Oxygen circuit USE Emergency if 10ml 18G Baby catheter airways may Next in up Slim Authors: on Syringe RSI equipment blades iGel available insertion Laminated sachets saline Covid19 Duncan refreshed packs WGH McGrath ABP sampling leaving bag 20 HMEF Metal be socket Femoral LLiisstt monitor CCOOVVIIDD1199 Written: ONLY not room FOR unit pressors Care Please off Ward box March tape suction Draft departure review key Tube RIDU charge SOP line 3000 Checklist 12F // WWaarrdd Stylet cylinder contents tie stored Approved by: pumps transducer sizes NIPB access Drip Scissors drugs manometer breathing Stethoscope are v2 Drugs Cables 20G patient Scope Sp02 tubes 14F Monitor Schrader Vascular Guidelines Clerk tubing Title: Mackinnon Status 2020 syringe ETT Draft/Final: use waiting drivers on: size 1000ml clamp cable COVID19/Suspected Macintosh catheters Jelly trolley made Cuff clamps office Suction intubate before Guedel"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "infection emergency piped pause intubating anaesthetic ICU planning 1:10 appropriate and RIE Problem metaraminol intubator/drugs Intubation Bougie Oxylog definitive board via Contact referral: China every airways unsuitable assisting plugged convene insertion experienced sterile precautions CCOOVVIIDD1199 not maintain contact Care PostRSI required Two severely departure cleaning PAG review 16F bottle SOP intubations Checklist // SSOOPP scissors buddy cuffed time Severe PCI manometer involved deterioration specialty patients lift judgment determine Sp02 evidence well trained assistants Status use is Communication: Primary videos progress intranet prior Suction staff BP arrange HPS Donning/doffing SSuussppeecctteedd IV measuring indicated Baruah per risk appropriately Blackstock Front Aintree secretions COVID19 Braun gloves ventilator Monitor Title: units EtC02 number pump jelly Arterial too US CARE compressiononly supervise through between 10ml catheter PPE may mask transfer up escalation administrator equipment Covid19 safety 14 confirm dedicated supervising high Inform Written: 1:100 propofol face but Interhospital Size Anecdotal see taxi postintubation Ward ID box care phone List adrenaline line respond status post Induction by: discuss access Stethoscope levels proven after patient practical take Daily guideline Guidelines tubing handover arrangements on: clamp Sonosite ECG moved oxygen Equipment kit Perform Ambu hypoxia Exit Ccircuit Etc02 from shift IGel met with re 10th Closed airway tube nurse check Restock door Clerk\u2019s will page list 2200 Establish Phone Reviewed NG primed found CXR See trainee Next in suspected Authors: availability choice at RSI: CPR on bed slim machine Communication Kit WGH scrub 9am monitor confirmed ONLY fluids call staffing neck front immediately suction Draft Level Ventilation medical RIDU charge suitability remains anticipatory entrance WWaarrdd aim stored communicate alfentanil Update: Drugs aerosolization Runner suspected/proven 2020 ETT 000 Covid nursed size side COVID19/Suspected Conduct ambulance receiving Follow made Cuff office include before closed Staff change SAS team COVID identified Anchorfast NIC nurses indicates clinical to The compressions position ICU/anaesthetic intubation Group CRITICAL Record Yankaeur wide consist Transfer Facemasks of Critical the back x2 USE Emergency if Lubricating 118 minimise respiratory their RSI unstable can Laminated consultant 20 leaving Metal be current these room FOR critical Assessment donning/doffing situ HME when March scopes outside Prereferral as guidance during one Approved drugs atropine doffing equipotent for monitoring tubes nursing escorted syringe full by intubator\u2019s Draft/Final: drivers should hypoxic or catheters proning assess Guedel If"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Yankauer kit plan using from 10 requested Baruah laryngoscope ICU lubricate waveform Tie Allergies head airway turns and tube check Closed Preoxygenate will position Intubation Cricoid intubation Site Who Can Bougie Ongoing via how? Patient Optimisation assistant fails? NOW mobile Critical Team Cons incl carina circuit pressure RAISE Plan Double Emergency if catheter Intubator \u2191K+? PPE ECG Is in Preparation Optimise up Confirm administrator this vasopressors on OPA RSI turned handle 3cm B/C Cut required? Communication O2 checked cuff McGrath supraglottic Mac backup supply sedation we Understand room DAS/ICS Supraglottic contact Care trachea help further box March tape suction phone outside Review allocation ETCO2 Equipment Checklist site Stylet role Induction SpO2 max 5cm Verbalise ml Adapted laryngoscopy Scalpelbougietube Anaesthetist access drugs Stethoscope Drugs Date: NHS for Fibreoptic Airway \u00d72 patient Blacstock CoVid mount Runner 2020 Sizes 2018 Theatre syringe ETT wake Check Vocalise Covid is roles? Lothian size CONCERNS Monitoring or tip PROCEED trolley FoNA ON Intubator\u2019s visible BP Difficulty"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Murray machines plan Manage emergency theatre/recovery both team managed bedspace As oncall from Main/DCN indicated per ICU anaesthetic HDU directed All with markings second possible spaces appropriate detailed now and Oncall input Blackstock RIE to will COVID19 basin Site barriers requiring recovery 1016 via NonCOVID19 normal Patient 58 Donning coordinate all Management L1/2 continue of Critical the Move use: liase pressure main acceptance enact Plan Capacity between decision PPE may 3rd transfer in staff escalation coordinators theatres plan: 36 this then at on senior people available can bed consultant Will who Estates WGH handwashing 20 within 48 point construct time: be ends Bedspace referral surge Anaesthetic able already SHDU At 89 only room until not instance movement vestibule but surgery empty Nursing 26 Care above capacity Patients first required These Ward further mechanical following stop Enhanced Close areas barrier 13/3/2020 Review Suggested Surge SOP used as Visitors theatre SJH informed before entrance ICU/Ward management operating Medical/Haematology /Ward removed floor ward/HDU/Lothian donning time items advice any ward doffing bedspaces ventilation that default nonessential must entrance/exit for patients patient admission doors negative elective /NHDU Discharge admitted nursing 18 Dependent Theatre area ETT by nonCOVID occurred is Bedspaces Consultant sink Medical temporary considered including IPCT should side or This 916 order unit moved closed If"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "rechecked Case difference breath pause Anaesthesia You bag/ventilator appropriate and periodically gas Restart neurointensive present SIMV procedure turn seconds reverse PCVVG demands VENTILATOR each OF OXYGENATE measured Following USING changed AISYS To way every needs different TROUBLESHOOTING perform 100% higher FiO2 within AND There otherwise not DISCONNECT secs 10l/min do maintain no touch review used 12cmH2O red rate which righthand TIDAL are default patients right 6mls/kg 2024 admission mains FALLING 15 elevated they is PEEP container including OXYGEN ABG adjusted adjust Start switch increase This toggled occurs 5cmH2O break combination Bag BELLOWS Select place All light flow 824 mode EtCO2 PAUSING ventilator left Pressure arrow support Low complete 5l/min reduce circuit Push reconnected Pause may does bellows up HELP DOPES pH O2 confirm Flow increasing either wheel >7 high until ventilated but closedsuction see reduction casing canister Volatile care 400mls litres/min connections CAUSES VENTILATION endtidal <60 SODA switch: com setting Increase HYPOXIA: move confronted comwheel PaO2 GAS BREAKING after run Once >6 d/w patient message Mode lime 1l/min After temporary reach clamp flows highflow fail With oxygen Equipment VCV Perform using down 10 litres/minute displayed met refill with prompt soda tube check Initial leak will Displaced there H+ set Breaths COETT likely targets yet initially >10l/min BACKUP all GOALS leaks Ensure green Press bedside in dialed then at on touchscreen LIME start machine visual based persists 13l/min confirmed 60 last above following immediately FLOW 8l/min Ventilation navigate medical FGF Signs aim PLAN: Ask so CCIRCUIT More indicator 6l/min select lowflow shown baseline ventilating Settings: increased limit defined vent return activate pressing FRESH side fresh temporarily Tidal than minutes top include change team Ventilator COVID Obstruction >8kPa minimised identified calibrate sodalime indicates plastic PaCO2 target Disconnections to CALL The need position require hours >0 1:1 <30cmH2O Preferred changes IMMEDIATE of Stacked low the changing pressure CS2 NonCOVID END if disconnection REMEMBER tab Volume this Use saying can lower Respiratory PVCVG bag you be Settings checkout Gas only FOR achieved window when These mechanical system Pneumothorax bpm Pinsp during FiCO2 Ratio CO2 OFF that screen its for THE Checkout picture by Vent should or standby settings CIRCUIT usually If"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "rechecked plan Distal context 12hours difference Anaesthesia 49day You 30cmH2O aiming anaesthetic ICU occur planning disconnected basis satellite protective collapse Flows prove PCV and COVIDpositive Do gas clamped rise SIMV procedure register unlike make turn Should demands PCVVG blocking document Rate emptied via open adjustable measured Following non Peak NOT normal ventilate scavenging minute located pandemic maximum volatile body suggest changed AISYS To every haemodynamic needs different starting litres wash goals according Using theatres Elevated whether 100% performance undergo H2O completely also Upon higher FiO2 within Suctioning filled representation capnograph short suctioning indications sedation functional There cancel L/min Circuit sensor Safety restarted not 10l/min an do maintain into Care push critically Morgan alarm pressures required Please preuse have no touch returned review circuits spill used SOP recheck bacterial/viral unless red Standard inspect due time rate prolonged Assess which any Vt refer manometer moisture are expertise default rates instability parameters 3L/min supplies patients 6mls/kg 2024 presence elevated 15 proximal inadvertently slightly contacted they are: Check Dr use is PEEP performed latter including unclamped adjusted adjust Start switch This increase toggled posters limited flush viral order where staff vapour begin contamination added guide selected both 10L/min combination Bag reliability extremely called windows dependent overcome selfsealing Alastair indicated per Circle By Select customise risk All our light now users Users Tab flow drive mode EtCO2 ventilator left production Fresh cmH2O cassette Pressure arrow exhaustion options very support Breathing colour 5l/min cannister predicted it least 1220 requirement ratio warning reduce circuit consists reconnected metabolic between soiled Commencing limb may Tinsp paused put bellows pH test Neuro upon >68l/min litre/min who barotrauma pro Procedure O2 confirm Flow ask increasing cancelled either HMEF designed wheel high licensed impact Intersurgical we inspiratory Gibson At ventilated until out demand challenges Simply but VG empty propofol 6L/min see Unable canister indicators further 400mls litres/min apnoea connections line therefore important switch: com Our operating cassetes setting Increase Adapted move confronted comwheel PaO2 desired carry breathing provision NHS levels read depending remain after run Once patient Air clearance ensure times less message Prone those lung nonCOVID anaesthesia Mode please lime has 19 expected volumes After temporary Disclaimer: valves spontaneously approach discussed shortage flows incorporates With just oxygen peak ODP machines VCV small using components Ally As display style Consider from litres/minute Continuous expect reduced 10 individual enlist keep 400ml anticipating drop met with soda Increasing end listed airway Closed internal tube nurse check Initial note leak familiar menu 8kpa will page without Sidestream below there H+ set Operating COETT requiring likely 12hrs situation In volume Expiratory yet initially guaranteed reinflated >10l/min hypoxaemia all Diuretics wet leaks Ensure main green Intensivists found us 12hour clamping See integrity absorbed procedures bedside in I:E highlighted It then at on >6l/min cicuit cause twist touchscreen replacement mandatory start machine ill One displays vapouriser checked WGH capnographs potential point what lost neuromuscular persists acknowledged experience caution surge earlier 13l/min monitor acknowledge breaths Synchronised confirmed Solutions 60 ruler uses Soda \uf0b37 two above Aisys extent following demonstrate suction navigate Ventilation medical CPAP FGF routine positions Falling For case assist clinically aim conduct Higher intended accessed works 24 continuous remind additional so unnecessary agents ventilation completed rate? consideration under lowflows More >10l/minute However inspiration indicator mentioned 6l/min select plateau lowflow completion throughout initial shown baseline ventilating increased RR limit defined autoflow Ventilatory 68 Adjust vent return questioned frequent ulnar pressing broken freshgas expired fresh temporarily than minutes frequently Difference Disposables before closed standard Although change reinspired again Initially 13 balance team COVID circle identified option rebreathing become Com selecting tight drying sodalime possible becomes sidestream PaCO2 target clinical to linked anticipate routinely The need 12 position Breaking require On mitigate hours >0 Modes recovery 1:1 names prevent disposables information Circuits efficiency changes mindray necessary exhausted of Critical low discussion Troubleshooting although the changing NO pressure back would inspiratory/expiratory CS2 outwith disconnection malignant if fulltest Prior sevoflurane weaning tab more remove problem PSV Volume hyperpyrexia this intermittent Use respiratory minimise their We inspired usual rotating available can When been consultant corresponds lower patient\u2019s 1l/minute Respiratory yellow undertaken bag you optimise period be reboot filter Settings continues current checkout 12cm most some Gas these only How best 24hours settings: window Differences when These filters system alter phases cannot stay Introductory control isoflurane expiratory operated as controlled valve days site during Controlled FiCO2 removed instances long Touch CO2 OFF Default achieve that disposable Visually screen its must for preferred 3l/min safer 49 Checkout An neutral hospital negative PSVPro capnography picture reconnecting positive full by displaced occurring 13L/min Pro ventilators tidal Lothian Total being Vent should regular or significant standby settings 1:2 weight They induce known term usually could If"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "vapour Change change visually Perform rechecked added using team humidity Ventilator 1L/min from circle Anaesthesia reduced zero Insp Alastair ICU Filters needed tight curve with soda indicates excessive and PaCO2 Initial to secretions The present will need flow neurocritical chart EtCO2 require there exp hours blue <0 Pressure next Record Instructions volume exhaustion Expiratory measured daily information carried >10l/min colour all Continuously 5l/min of causes changed low dialled the pink circuit MV every CS2 Hourly disconnection if fulltest limb may bedside more manual does in It this inspired on other replacement selftest7 lime1 machine Absorbent thirds patient\u2019s Version yellow checked hourly Inspect FiO2 water either within HMEF point bronchoconstriction be high filter near reboot inspected otherwise Circuit not out Soda an into two Morgan required Aisys when canister further filters suction care medical condenser control expiratory FGF SOP as used recheck days before assist FiCO2 24 due time Machine CO2 spirometry moisture mins must parameters for zero? after patients 68l/min However occluded monitoring Water drained 6l/min 49 15 trap5 increased by flow4 use please lime has is fall white performed Alarms including reach Monitoring should or than Tidal minutes 1Task increase frequently occurs resistance distal include circuit6 closed If"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Scavenging Colleges/ASA emergency vary context <10 1L/min +/ Satellite/Surge breath onto 30cmH2O anaesthetic ICU outstrips undoubtedly needed nonIntensivists adequate satellite collapse Flows appropriate limits and COVIDpositive gas clamped Restart present SIMV procedure 20cmH2O register personal seconds Should PCVVG comprehensive document each repatriated Oxylog Further emptied *For FiO2>0 measured non clean Negative ventilate provided scavenging minute maximum pandemic flowrate volatile still console changed AISYS maintained longterm To every needs avoid different according perform theatres stops Internal performance capability breathe Canister insertion waveforms adapt Clinical also Version hospitalwide experienced higher FiO2 compensation within exclude outstrip kept Hospitals suctioning regularly indications sedation intervention There inspected \uf0a365 not previously restarted 10l/min an maintain into sedated Care push critically Morgan alarm required pressures have result pH>7 no opioid charts cleaning Satellite review Surge sooner circuits used 3000 recheck bacterial/viral unless cylinder Standard followed Both time rate suggested ensuring which transitioning moisture manometer decontamination are studied Appendix default deterioration rates problematic patients 6mls/kg admission 15 elevated proximal arriving means 18 they performing proper Check use is discoloured increases PEEP Unclamp performed utilisation midazolam/clonidine greater including user ABG admissions adjust >10 This increase prior limited viral interfere 30 staff such added guide supervision both rainout bedspace dependent opening Teleflex Alastair per fitted effort risk All our Replacing calibration continual Mindray reservoir 10l/minute appropriately ready lowest effects COVID19 flow drive 824 General mode arterial EtCO2 accuracy infusion ventilator agent production Fresh cassette effect Pressure working very options support Low complete deeper port described Immediate it least 812cmH20 ratio through warning practice reduce circuit appears Pmax metabolic between catheter limb may Pause PPE transfer Full paused does bellows mask 35cmH2O detrimental unable Neuro upon other equipment assisted who delivers reengaged Procedure safety 14 cuff assistance increasing either cleared HMEF oxygenation designed high licensed Intersurgical we function inspiratory nationally At ventilated until out demand propofol event but empty kPa external closedsuction space planned capacity triggered canister operates further Ward failure Volatile bacterial 400mls breaks FFP3 litres/min Western connections apnoea line therefore certificate needing important typically Our com setting sensed Unless connected ODP/medical ward PaO2 510cmH20 breathing provision reduces NHS levels read depending after run 68L/min undergone Once patient suitable ensure responsible Filter PS/CPAP similar basic times less inefficiency lung nonCOVID arrangements anaesthesia Mode resource please lime has 19 expected Disclaimer: teams spontaneously suggesting flows conjunction With loss arises oxygen peak hose visually machines Perform small using Ccircuit from litres/minute reduced 10 5L/min associated displayed induction drop refill members with sedative soda end Ventilators Increasing Closed tube check Initial note Any leak sensor/valve understanding 17 will without especially Sidestream there H+ blue set Operating occasions COETT requiring compliance situation expectation In volume targets daily guaranteed initially disengaged despite all wet preceded leaks sevoflurane/isoflurane Minute were new negate tracheostomy main timed clamping us integrity MV depressurisation procedures Running bedside physiology gehealthcare in I:E It suspected then at minimum 24hrs on >6l/min twist deeply 11 replacement mandatory https://cleaning machine ill visual presents once laminated pressurecontrolled checked potential pressure/flow point neuromuscular viral/bacterial acknowledged experience backup surge absorber alternative monitor breaths confirmed find sudden two dead inspection Aisys following suction Ventilation medical condenser CPAP FGF removing routine pausing MAC setup For ET aim technical intended opened 24 attached deliver agents ventilation under EZchange lowflows More However inspiration indicator drained 6l/min CCircuit lowflow initial increased RR filtering commence autoflow 68 fall oxygenating broken side compensate fresh than receiving minutes H+\uf0a365 temporarily IPC frequently made distal include monitored considered standard before meet closed Although change determined again 13 follows: team oscillations dyssynchrony brief spontaneous blocked COVID circle identified option done rebreathing become tight Unit1 communicated sodalime possible Local PaCO2 clinical to quick linked routinely The need 12 \uf0b312 require hours >0 information operate efficiency wide changes device necessary of blockade Critical low 12cmH20 the Phase concern changing coughing pressure back 16 would CS2 delivered NonCOVID malignant if history local Prior 1litre/min paralysed tab weaning more about consider hyperpyrexia this respiratory their We inspired alongside Owner: available can When been acceptable patient\u2019s yellow Respiratory bag 20 delivery parameter ongoing closedsuctioning replacing rather be reboot filter supply Settings Capnography current most Gas supported only clinician replaced suction/patient help when These filters system phases reducing Introductory control Breaks expiratory unintended approximately as optimisation days Clamp atmosphere during corresponding FiCO2 >10L/min rebooted perioperative updated Appropriate long Royal CO2 that sought its level must pH\uf0b37 Ideally for reference 3l/min precheck 49 monitoring An hospital how seen PSVPro received capnography nursing acquired soon positive stable full by highmetabolic ventilators Lothian tidal Increased GE being Consultant SpR AGSS should worn or standards detected isolate settings They resistance term usually could If"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "ChlorClean arrival change IInnttrraahhoossppiittaall radiographer HPS emergency contamination using 13 team down bedspace remaining 10 COVID from individual done indicated per ICU Baruah Final members with end appropriate and nurse tube to The repeated will need 12 taken COVID19 wearing entering On monitors list ventilator Stop Title: CRITICAL Oxylog Ferguson wiped via open 2200 Following carried amount prepare Transfer CT: necessary CARE Scan walk Reviewed of CCaarrdd Critical discussion May the Ensure practice circuit cubicle Action 16 back completion: drug reconnected USE trainee avoid if between disconnection PPE table Next transfer 3rd put does in this Authors: at minimum donned on senior 11 transport equipment scan can bed inside been consultant also enhanced 14 arranged undertaken assistance 20 bag leaving WGH \u2018doffing\u2019 Dunn kept CCTT be filter earlier Then CCOOVVIIDD1199 Written: ONLY not only room FOR agreement do clear Care go member required HME observe off Ward CT immediately departure: stay Level medical outside control review \u2018clean\u2019 Tube department as used guidance Intrahospital unless during WWaarrdd clinically one stored July Only Portering Approved by: McNeill access ward doffing newly after for AAccttiioonn remain patient TTrraannssffeerr corridors doors 15 ahead wait nursing Pre Guidelines trained clothing Status 2020 wear by area Arrival Card Draft/Final: has is on: entry disconnecting should or standby discussed prior trolley This doff 5th clamps undertake staff standard If"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "infection additive discard Failure decrease onto aet199 half and/or changeover and Do clamped 2007 rise alarming Titrate April turn original bleeding Journal Date via open 80mcg/ml Following systolic ucl maximum ics changed Observe To way every starting Healthcare<az<critical inotrope infusions Venous mls proximally Benefits 20mls/hr higher ABP within recommendations providing short not visualisation bolus an into Care sugars push required Please luminous have off no your org instructions Administration touch areas Signature/BBraun photosensitive used circumstances due time rate which any discontinuation service are measures Catheter Society New 2010 continuously emergency/changinginotropeinfusionswhichtechniqueis http://www Blood administration Check use is aware 5mls intranet This flush prior occurs clamps xrayed staff Central changeovers Chlorhexidine both technique Written three per risk All Inotrope venous Council effects Doses requires flow taken Heru ors Braun arterial inotropes/vaspressors infusion net/clinicalsubjects/accidentand pump Pressure effect best/201728 Arterial \u22645mmHg another very ac complete transduced Standards pertains continue it through practice Policy et Commencing PPE may Drug up unable MAP other 2012 160mcg/ml Enter safe http://bja increasing high Changing 10mls until out spiked space observe Concentration care uk/icshomepage/guidelinesandstandards/ subclavian org/content/early/2013/06/11/bja 16mg faster specific line life management 72hours uk/globalassets/sitedocuments/standards/nmc 2017 by: infusions: connected Mackay desired NHS run 2% patient ensure Connect Guidelines times less handover has update 20th After competencies prevention Training standardsformedicinesmanagement titrate actions Inotropes Equipment small from automated keep CVC covers Insert patency with lumen end Increasing NaCL nurse hour will prescription without C74C77 oxfordjournals existing central initially British threeway double new Ensure found drug Inotropes/Vasopressors in It then at 2013 on Device labels blood bed Inotrope/Vasopressor Infusion prescribed start running medicines Purge confirming tap fluids bleed Prepare last 16mg% IJ above Protective Clean Keep continually Medication 9% medical rapid lines charge For Discontinuation old pumps attached so Pollock placement Cour seek under <drugs 2mls/hr fullarticle concentration commence nmc al 8mg% Work side than https://www frequently Follow uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Apply before Commence change Cardiovascular Be pdf+html pumping engaged administered waveform 73 interruption nurses Lines nursingtimes same to Aim The need require guidelines Stop prevent follow inotrope/vaspressor device policy Medicine of invasive Critical bags the Decreasing pressure back wipes pdf Personal strength if disconnection Prior Midwifery date labelled more consider remove this Use vasopressors recommended medications Calculation study 8mg available distally can When been expiry lower library References hourly bag delivery you concentrations be medication stated insitu current instance only dated vasoactive critical best Nursing achieved Signature correct flushing Intensive stop connection patent control Review as smart guidance 2015 Hospital site during one inotropes advice drugs 10mls/hr achieve that for monitoring designated clearly extra full area by Sept Alaris Label Lothian connecting Run Core should Rapid or pumps: quasiexperimental assess If"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "inserting warnings globes Export USB appropriate and/or and compatible Oximetry screens Time connector iCO CO Date open serial Patient trademarks calculator module contained tone To rear Ethernet Edwards steps bar Clinical Start/stop CVP \u2018Quick globe filament indications Snapshot precautions sensor not an do into alarm properly off no Equipotential instructions prescribing touch power mmHg review HDMI inspect contents phlebostatic image reserved edwards time rate Mount which any Turn refer slot are Captures parameters right Zero Blood insertion/connection Status 2019 proper want use is time/date including law Securely Start switch This flush PGDT order alarms guide selected reaches Corporation deair Bag IV sale RS232 place All TimeinTarget calibration probe input Sensor Battery format mode arterial accuracy Monitor left units stand value Pressure CA support complete data port it temperature column through appears measurement between catheter rights up 8008229837 upon test United Platform Choose other Enter Module hemodynamic Lifesciences insert inate until out Demo operator\u2019s Bar tracking HemoSphere connections important status com panel highlights holding desired CAUTION: after platform remain Silence Available COM1 patient ensure Connect Setup arrows times plug aspirate tubing conditioned update Smart pull actions With ECG cord logo terminal contraindications using Advanced ops down SwanGanz display heard output 10 USA displayed keep Insert Thermistor with Pressurize end door orientation affects will FloTrac without Navigation air Fastflush startup technology all Acumen audible main system: Compatible See Information procedures Press in highlighted It then at on replacement Derived Event One Main visual packaging Zero\u2019 adverse monitor tap respective nonvented two button front HIS raises Level Engineering setup For WiFi holder slots technical Lock appear outlined additional Hold outlet completed gravity stylized owners indicator select initial Help Waveform Screen Monitoring pole minutes hang selection IQ Follow heart standard change Refer LTech ports zero prime engaged selecting residual tight grade Plug icon air: OR physician clinical to six fluid The Average position entering guidelines Stop click information Injectate follow device of axis the pressure restricts features Irvine charged manual remove bubbles this PPUS2208 their Analog cardiac stud language can stopcocks lower Replace bag you parameter be Thermal Settings current CCO only expansion assure Way Federal Note: window first Averaging when advanced events system capital_care@edwards 92614 connection outside Open eight zeroing as Expansion 24/7 property Zeroing silences fully Touch that 300 v2 Parameter screen level must for \u2018zero\u2019 monitoring States hospital mount upright Back full by caps stopcock being cable pushing or settings battery"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "LAP vary 612 warnings 54 6080% 9501150 Female: Male Article PAP and RVEF 1720 SV/1000 CO RVSWI 200250 trademarks S2S1 theirrespective EVLW Consumption g/L SV/EF 5994 DSt EVLW/0 Venous Edwards Body Cardiac CVP 360 >20% Lactate /SVmean 25 indications dye/temperature v1 2230% precautions L/min 6070% 50 W/m2 ELWI BPPAOP CO/BSA mEq/L instructions prescribing RVEDV mmHg 120160 Stroke CPP Atrial <3 CO/HR <250 SVV reserved edwards time PADP are VO2 market Delivery parameters 6090 Water 0136 SVmin mL/min Blood Values PBW GEDV=COxMTtxf /SaO2 use *Reference 8001200 117160 including CE law 80 L/min/m2 order BP Central Corporation TPTD EndDiastolic mL/dL sale SV All Test values* HR RVEDVI 60100 units Weight Intra conformity Pressure Coronary g/dL Arterial 815 CA Hct ScvO2 Content Parameters RVDP O2ER S2 /CO Systemic essential Oxygen mmol/L 2025% GEDV xDSt rights marking DO2 Directive93/42/ECC MAP United 1015% meeting other saline O2 Cv Mean hemodynamic 48 Lifesciences RVEDV/BSA 100160 0031 DBP 19702390 Pulmonary mL/m2 dynessec/cm5/m2 GEF 08 SI Equation referred com 2017 Height152 ITBV=1 mL/m2/beat PaO2 SBP av SVmax S1 CAUTION: EDVSV Hemoglobin 5062 Females: Predicted Hemodynamic Right Hgb Medical EndSystolic Ventricular logo 124174 contraindications 10 Resistance USA dynessec/cm5 4252% SVI 255285 3648% 1215 PPUS2312 MTt range 420 PVR COxDSt0 Hematocrit O2EI PBV=0 0138 MPAP 25xGEDV Transpulmonary Diastolic techniques Permeability 716 DO2I CI/HR RVSP LVSWI SVRI See Power professional placed in European ITBV on Device 11 Perfusion blood methods One Units Extraction adverse 91 Artery Mixed Systolic 26 Function 510 56 mL/min/m2 SvO2 S1/S2 For CvO2 46 /3 laboratory 1000 CaO2 PVRI ITTV=COxMTt stylized owners Extra 8501000 931 PVPI Vascular 1525 Output Variation RVESV CI 65 45 Work SV/EDV /CI Difference 100 500600 PASP GEDI thermodilution 4060% 52 95100% 6080 physician to EVLW=PTVPBV 12 Occlusion /CaO2 CPI PTV=CO adult Left ITBI CFI information 1020 Saturation device 1/min Physiorelationship of VO2I the End RVP restricts Global devices 3347 Irvine mL/kg Volume this Cold mL/beat mL Thoracic PVPI=EVLW/PBV 417 Lung Laboratory Ejection Way International Federal Males: events 92614 Convention Fraction 650800 SVR Ratio injection property Parameter bear for reference RAP States EVLW/PBW 07 PAOP values full by 50100 SaO2 Normal Index requirements regional PvO2 or 70105 ml/m2 CPO 90140"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Central guide contraindications warnings Corporation using TPTD 13 selected 10 Switzerland thermodilution zero Actions prime displayed CVC Select Insert waveform All with Article series appropriate databox TruWave venous and OR probe Oximetry to six connect range screens procedure 12 17 rm arterial Monitor set air conformity existing startup central volume smooth information trademarks normal keypad amount Parameters data all continue of it axis VolumeView temperature primed 1260 Set the essential new Ensure pressure 16 edit Observe See if devices catheter ne rights professional placed marking according in up transpulmonary highlighted alarms/target Venous European then Directive transducers on Platform Device Edwards meeting Choose 11 Repeat Enter steps available reached waveforms 93/42/EEC Clinical con saline start CVP When patient\u2019s Route 14 20 Lifesciences RUL parameter Wait boluses l\u2019Etraz adverse indications System precautions monitor Lung Resection sensor ENP509/1118/CC previously until femoral bolus descriptor Startup thermistor Prime Inject pressures button prefer events 70 instructions calculation prescribing valve/port touch method review rapid results removing as inline Thermodilution setup For referred com one directions phlebostatic cold reserved edwards time ml indexed de continuous transducer connected Touch Turn refer desired manifold are choose Catheter injectate market level bear parameters for stylized real right patient thermal Accept 15 ensure Connect well Nyon Setup selftest baseline EV1000 inject prechilled 18 2018 full syringe use please is 19 requirements Medical including Guide CE Before cable Bolus or nonindexed example Start starts cables solution lobectomy oxymetry upper logo"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Surgery infarction plan location Case catheter/vessel nonsurgical context Dilator/catheter closure occur Advances and Do gas present Hamish uk/Directory/CriticalCare/Bedside Force document major bleeding connects Guidewire largebore via DONT Unintentional coagulopathy Contact issue surgical body CONTACT catheterrelated Verification Leave Xray nhs way avoid Communicate anything infusions Venous manageable helpful complicated compressible: cerebral insertion also risks Equal ultrasound providing AND not femoral vascular an into contact dilator Care off have result analysis no carotid Guidance methods: evaluated review Task guiding used morbidity Recognition: Access tear arteriovenous representative infraclavicularly time freely/difficult any vessel are Society Catheter minimal instability patients Potential evidence Blood 18 Status Practice catheter/dilator Mispalcement is absence greater executed circulation cannulation vein Abnormal This occurs Anaesthesiology order such consulted Feb Compressible Central proceeding practically doc organised severe place risk venous appropriately embolus flow arterial left Title: generally Arterial bore Report 116:539 colour data Management Immediate it least DILATION expanding issues XR Andy catheter may misplaced does Complications: unable group Interventional upon Actions: 2012 Rhona who vessel: GGuuiiddeelliinnee \u2018Arterial\u2019 confer Written: until out Size space Compress NHSLothian While subclavian haemorrhage pulsatile compression IF line CClliinniiccaall percutaneous management Line by: liaise access after prepuncture patient NON indicate allow peritoneal guideline Guidelines aspirate less Dornan adults attempted uncontrolled hypotensive has http://intranet on: Guideline expected After prevention pull ooff general conjunction recognised deferring small Coagulopathy managed down switchboard anecdotal from reduced associated Access: Needle thread with reported Aanesthesia immediate No will without there Minor consultation sited anaesthetist likely active central In Punctures techniques all Reviewed DO were Misplacement Remain CXR pulse provide thrombosis DRAFT infuse missited Next complications in CCaatthheetteerrss AV Authors: at minimum on PPrraaccttiiccee large blood continued Massive relied cap based Injury advance Cap era confirming fistula ONLY *There Anesthesiology remain: PRESS often artery following immediately French lines documented highest For gauge 547 intended haemothorax guidewire 24 dynamic editorial pre scot catheterisations pericardial Retroperitoneal Duplex placement route Tambyraja lothian dissection withdraw includes However handled pleural 2021 angiogram cavities Vascular needle Background: removal surgeon imaging frequent size VASCULAR than minutes distal before considered mortality surgery determined watchful puncture DON\u2019T Less ischaemic Radiology injury thinwall Vessel* common resides waveform 73 Lines possible cavity clinical to regarding The majority 12 unrecognised require References: hours adult Stop CCeennttrraall ffoorr follow Remove Inadvertent if: care/Insertion benefits of Critical low the localization COMPRESSIBLE whose reports pressure USE if devices purpose more manual catheterization this minimise their diagnosis fluoroscopy observation available Puncture can When been mass acceptable damage period consequence be compressing wire most SURGERY these only FOR PULL anaemic Patients multidisciplinary repair CT static course Ireland Catheters American unintended notes as Jan site during Misplaced one threaded Approved relative that treatment its formation versus must Anesthesiologists for real difficult seen develop radiologist elective BEFORE pseudoaneurysm Than soon complication by QIT Draft/Final: AFTER tears MMiissssiitteedd MMaannaaggeemmeenntt should supra wall stepbystep or significant hypoxic literature catheters interventional usually"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Central Advanced from difficulty ICU CVC met with appropriate internal venous and Anticipated to Any anticipated The will November Title: CRITICAL central liver coagulopathy Medicine CARE Neil intracranial Reviewed of acute Critical doctor the practice Practitioners morbid USE trainee obtain decision obesity Next placed in FINAL signed group Venous ID: Authors: jugular 2013 fellowship senior other inhouse within ultrasound anatomy GUIDELINE supervised be physiologically There Anaesthetic BY met: Written: ONLY only ACCP not FOR having agreement an criteria Care ADVANCED Patients PLACEMENT when off advanced failure following Intensive review as used guidance 2015 post training circumstances: LOTHIAN editorial Approved by: access placement that completed are Catheter NHS for patient presence difficult suitable them Guidelines basic Practitioner stable Status by QIT Draft/Final: PRACTITIONERS is has on: Lothian Guideline being competencies Consultant including should significant approach hypertension made Young"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Bell infection discard 30mins basis dressing and 1530 procedure Edition make pack bleeding Skin Journal normal clean skin Procedures 4351 gauze Continue wash perform infusions Venous insertion Clinical College cutter CVP REMOVAL sterile higher laid Required Hamilton rub Scissors* supine into Care gently off Put Dougherty 70% Marsden review used cultures scissors Standard time any 8th swabs are Catheter 2010 Manual degrees Alcohol Wipe 18 Status Check is 2%Chlorhexidine container including Place trolley This where order staff Central Chlorhexidine cover Invasive flat approx London place risk head venous 2011 taken specimen chart manoeuvre firmly gloves begins Title: comfortable Standards continuing CARE hand it Clark catheter put group lying equipment Rogers 53 Procedure 14 water Maintain alcohol able Written: suture intact investigation redness reason Complications line management Line 2017 5cm Bruce by: instruction move access PostProcedure deranged after 2% Cerebral patient Air 72 lumens addition January Guidelines Explain Professional has hypotension on: After pull Equipment small using down As from 10 pyrexia associated Sterile CVC with wipe Discontinue check Glover Valsalva press there Small normal/close Plaizier Removal central daily all disconnect Reviewed stopped Dispose Chapter forcibly airtight Next in suspected Authors: at on 11 blood bed Infusion based point 193196 ONLY signs hands 26 two Stitch Clean carefully immediately medical sent Swabs Embolism Neuroscience old editorial Ask Hold Wash Devices Vascular removal WileyBlackwell Devastating tip than minutes before Lister Semipermeable 13 microbiological Tegaderm Loosen devices: swab to need 12 occlusive position Cover 43 RCN: hours CRITICAL Reposition Remove 2006 Early soap of Critical the pressure back USE if feet Prior date decreases Therapy pus 3rd about remove FINAL their cut When Cut consultant patient\u2019s References 20 part peripheral be near Document rigours count FOR Nursing first system stay Review send approximately Clamp 2015 Hospital Trendelenburg site one Approved Royal Discuss must for exhale transparent container* by area QIT Draft/Final: platelet being should Clinell or clotting If"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "mode: Change meet Inc Indicator guide selected location both contraindications warnings bearing application Corporation from Interval Switzerland manufactured Quality displayed condition adequate Select Figure tiles All with protective appropriate and channel Oximetry check to sensors menu Sensor mode tissue each edges StO2% blue set left adult Signal Display Skin value eifu click timepoint conformity Instructions pediatric circulatory figure Remove Patient trademarks data skin port quality module body of notifications invasive Reminder the 1260 Ensure modes Move configuration green Continue pressure appears integrity listing if between apply devices rights tab placed professional marking in up CAS European then deteriorated Use their on tactile Edwards other oximetry When displays adhesion patient\u2019s damage Route Lifesciences Channel parameter potential packaging minimallyinvasive Intervals/Averaging l\u2019Etraz adverse indications System enter monitor Then current Location Value precautions ENP611/1019/CC sensor respective Elite into affiliates Note: Clean when button correct advanced reading Changed events system 70 HemoSphere Open liner Slide Reference setup For ForeSight corresponding com illuminates inspect works reserved edwards time property de which access connected Touch refer Tissue are choose Parameter its level market under for reference signal stylized owners lift New tile patient monitoring select subsidiary ensure Connect Nyon dry Setup 2019 performing area by Check assessment LED use please StO2 is has being requirements Medical applicable CE side cable around or interval Same prior selection made Difference assess consult where Apply monitored upper logo"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Heart using Advanced Directorate Failure from Referral Final All and to page 09 Title: CRITICAL August CARE Reviewed National acute Critical AHF/MCS the Mechanical Jubilee found GJNH USE Next Cares Authors: on nhsgoldenjubilee be referral website: Acute Written: ONLY FOR Scottish Care co failure following Guidance Support review Hospital Golden by: Approved McNeill Circulatory completed jointly form NHS Guidelines 18 Status on:11 2018 2020 by QIT Draft/Final: Sept Lothian Form uk/ourservices/scottishnational Cardiology should teams referrals advancedheartfailureservice/ https://www heart Service"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Heart added team switchboard cardiologist oncall details Transplant ICU members 951 with eg appropriate and to No Recieving facilitates Cardiologist base Further board via follow daily referring 0141 Transfer plus returns discussion sheet Intensivist nhs GJNH local pathway up at cc Clinician Surgeon uk Clinican completes referral transplantcoordinators@gjnh recommendations: Acute ICUICU MCS contacts clinician AHF Nursing clinican further failure MDT ensures NSD clincian scot intensivist online records informed: clinicians form Referring for patient hospital 5000 Daily nursing coordinator surgeon handover cardiology recieving or discussion: surgery If"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "superior Directorate pause inflation appropriate and present try tank each Absent open caused trace measured Patient linear reviewed obvious every Hourly ent inotrope perform diastolic renal structure insertion Cardiac also onset risks within filled sedation rtery restarted not IntraAortic having an do into Care alarm required have off no height review Augmentation used cylinder rhythm rate >2 any platelets occlusion are positioning easily right New metallic proximal trained 18 Blood Status 2018 Reviewing is erns circulation knuckle staff 2cm ear abnormal per effort Final risk Pum injecting aortic counterpulsation notify colour/warmth pedal chart arterial altered left Title: Intra pump arrest Pressure August lead Arterial too monitoring: Low colour metalli CARE continue it Augmented hand ort temperature Bedside report limb may 20minutes STOP close MAP safe zeroed decreased ask increasing checks: descending Written: MUST reduction failure subclavian connections bei line important replace by: ept after Loss deflated patient Balloon failur ensure Setup Daily Guidelines times message tubing Traditionally attempted nding Mode please has marker Max Guideline trigger optimal clamp noted ECG postinsertion Process: small Avoid thoracic consecutive Consider damaged from Continuous radiology DC patency with Trigger involves Increasing check Initial Positioning 09 below helium air diac concerns In Tubing U+Es disconnect Reviewed new Ensure carina CXR pulse Power 10minutes Next in 30minutes It Authors: then while manually clot CPR on cause senior IABP Helium ill su point alternative monitor ONLY sudden clear often artery following immediately Weaning medical ioning washer remains cardioversion augmentation McNeill so placement completed 50ml select increased 2020 affected CI Monitoring tip than slowly distal heart visible foot before considered pleas team AbuArafeh colleague identified verify install tight waveform Frequency plastic deflating formal to The need occlu position electrodes 1:4 ca hours CRITICAL 1:1 of Critical Troubleshooting low the pressure USE if more manual remove this aorta Auto cardiac Aortic available can frequency bag MAP>65 you obtained be only FOR 24cm limb/shoulder settings: lloon when correct balloon Pump radial stop switched patent triggering landmark During as valve site removed Approved transducer pain cal fully formation inflated for alignment seen Ensure: stable on:11 full QIT by Draft/Final: Sept Lothian being requirements should pulses cable or standby 1:2 assess upper If"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Authoriser infection plan Distal Directorate Bilateral Daisy Troubleshoot disconnected dressing Fraser angle limits and Trace Do admission/after Pulses ALS present Editorial represent Should November bleeding Notes Date via open trace Patient non sit systolic clean SPSP reviewed hrs Urine Observe Immobile To haemodynamic Hourly different contain CPR/if goals plugged whether diastolic insertion Words Cardiac Revert Points blood/dried Version Count within Author: Patency admission/as Safety restarted not an do into contact Care 2014 required height Reduction pneumatic Guidance Augmentation used particles/more unless Checklist red followed Rationale phlebostatic add inserted protocol Pedal Board which affect any Turn refer Chest are Authorisation: Catheter Date: signal checks Zero posteriorly Manual Consultant/cardiologist required: Doppler Status they Check Marie medically is aware Mains Red adjust supports Decreased intranet flush ECHO 30 staff models added 21111 both automatically 23252 IV indicated radiological sheath Shoulder Final aortic Caroline flow pedal chart mode arterial confirmation Site altered left Title: stand pump arrest Pressure Arterial extratubing advised colour Augmented Notify temperature Graph Checks between catheter limb may transfer up Angiography MAP Unassisted Especially obs derived 16hrs Mean Maintain IABPSC101110v1 Readings but tracing length Arrest intact GCS connections line deflates SSaaffeettyy First Alarm sheath/sheathless IIAABBPP Risk Out augmented patient indicate adversely Balloon specs less tubing CTITU Mode please sample trigger Medical clamp Never bloodflow ECG Inotropes Equipment diastole using As from 10 secure reduced shift Immobility limbs DC SemiAuto with lumen Trigger check Initial shock will especially 09 helium set likely Diastolic In anticlockwise Tubing plus disconnect NaCl Ensure Chart new MacKinnon section pulse Power complications checking in suspected 80% Authors: then at clot manually on actual 11 IABP Perfusion Helium blood bed start prescribed Limb Tank Key lost dampened Co tap signs Systolic sudden rupture above grey awake following immediately Level balloon/tubing 9% medical Weaning boxed charge wave drip TPR gauge clinically augmentation heparin elsewhere placement dissection recent IAB Category: initial haematoma affected Output Waveform Guide Screen than Arm minutes to: made office visible include 300mmHg Allan change sharp Consultant/Cardiologist Connections unassisted Within site/helium waveform filling Frequency becomes to thrombocytopaenia/signs Insertion 12 compressions position On hours Additional Left aline systole 1:1 Usually follow changes Lower generated of USS axis Critical Troubleshooting the inform pressure Assisted if restricted weaning more charged CChheecckklliisstt ID: this Accurate Use Comments Auto Switchboard cardiac available can Other 1:3 bag capillary delivery part readings Haemodynamic be Document most xray only 3ft looks Nursing record Lead situ immobile Note: chest first balloon radial blockage stop Review Open During as Platelet during CS100/CS300 removed Ext sensation/movement Documentation transducer source pain fully achieve formation 8ft must for alignment UO/anuria seen Possibility UPS ABP/MAP 07 24hr stopping anteriorly separate perfusionist sensation Guide/Help by Draft/Final: Normal Lothian should pulses wall or 1:2 excruciating battery If"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Surgery infarction Directorate Anaesthesia and net/groups/critical <80 Titrate 5mg/hour 5% Date via errors minute maximum subject contained 60mg/hour changed 200mg every avoid contraindicated Labetalol 66 Targets Repeat renal management: amlodipine 116mg 5mg Moores LICENCE chloride ID:MATBADGv5 within PVC 50mg DM AND indications 100micrograms/ml not bolus an Day maintain Care critically 25mg ALSO org 18ml/hour mmHg shortterm accepted Ondansetron used unless rate Injection/Infusion interventions any are Keating Authorisation: Date: kidneys 20190702 patients impairment Potential V4 Dade 15 Falah http://www GM contacted Status 2019 Solution use is therapy 3ml/hr MRI Inhibitors Hydralazine 10mg/10ml Start This BE BP gradually PATIENT added IV tolerated 60ml per avoided Final 300micrograms/min directed risk Oct RATE :175582 weakness 50ml/hour metoclopramide 250ml blocker infusion Title: effect 10mg Management 4th UKCPA analgesia Amlodipine reduce et Dissections may up 5mg/ml introducing MAP other 2012 injections slow www Dunn Intranet: Then Acute MUST but Analgesia Administer Concentration care iii intervals line microgram setting antiemetics Antiemetics mins NHS Aggressive after Once patient morphine addition guideline Injerction has min faith Guideline volumes Type titrate cord 1mg/ml develops 3ml/hour contraindications 10 bisoprolol from Concordia CVC 12/12/17 Regular with second Nicardipine Increasing ACE No drain 60mg Product beta consultation sodium 2022 anaesthetist targets Curran daily initially PCA Concentrate Morphine drug lockout fentanyl Hydrochloride 520mg professional in It Authors: choice while at HYDRALAZINE blood Accessed start Version: iv ill once medicines potential Key boluses losses 24mg/hour Bisoprolol various ONLY Systolic 12h third often carefully immediately maintenance 9% medical Supplemental ii 150ml/hour dose Powder July Robinson betablocker Drugs leg Category: initial Vascular interpreted Paracetamol 09/04/18 increased surgeon al imaging arising Guide cyclizine labetalol Intravenous made before standard change Hannah 20mg 13 team costs CONTROLLED titrated administered CSF possible target OR 110mg clinical to fluid nicardipine: The glucose Group hours next 15mg/hour information herein 2006 Early Injectable Characteristics of Critical the pressure USE Emergency if McGregor liability restricted Ed this Oral spinal 02/02/2018 usual Aortic can been References uk 20 MP Haemodynamic be Document Authoriser: only International replaced NB achieved 15mg/hr Medicines words: first CT Minimum course 25ml/hour ischaemia control Review as 2015 site injection Doxazosin judgement drugs OFF treatment its care/documents/?category=71 must for UK 50micrograms/min prepared 1mg Dissection BEFORE Summary soon good by QIT ukcpa Draft/Final: Lothian Dose 510mg Consultant diuretics accountability should 4mg or peripherally hypertension COMMENCING solution 100120 If"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "needed adequate TYPE and Exceptions conditions each 5% Date Further OF NOT Maintenance systolic AMI maximum enteral 200mg every avoid infusions contraindicated Labetalol diastolic renal cerebral >180 HYPERTENSION chloride >110 higher within Reconstitute 50mg sedation SPECIFICALLY not 1ml maintain Care required pressures doses used line: DISSECTION due Hypertensive rate Severe ie any damage\u2019 therapeutic are Authorisation: Date: overdose encephalopathy Hypertension: 15 Status administration is therapy progressively Hydralazine 5mls intranet increase prior where BP such added myocardial IV \u2018acute Dilute three 60ml per severe aortic 1525mls/hour 250ml 39mls/hour infusion left Title: organ oedema INDUCED exceed CARE Management concomitant causes titration MoRHv1 between emergencies PREECLAMPSIA PHAEOCHROMOCYTOMA injections nicardipine 500mg ECLAMPSIA supervising water related Intranet: Acute Titrated mg dose: but 200300 persistently failure 120mg/hour undiluted care specific line management First RESISTANT sustained Pharmacologic Risk 3ml 20160104 Organ addition guideline Guidelines APPLY Definitions Second institution agitation mg/hour reversible 19 Type discussed relief Introduction 1mg/ml reduced associated individual with second 35 Nicardipine end Initial 60mg will range Resistant sodium central TO targets despite MANAGEMENT Treatment Hypertension acute micrograms/minute DOES See drug efficacy in It Authors: at on eclampsia blood start Version: raise Key aneurysm GUIDELINE resistant specified Preferably TOXBASE AORTIC ONLY Systolic sudden alpha Seek Identify often maintenance 9% Usual dose For July continuous unsecured McNeill agents dissection Category: increased Specific hypertensive vials minutes labetalol considered change pulmonary Refer 20mg Initially titrated common administered Damage: ventricular OR target clinical to The sympathomimetic 12 glucose hours treat guidelines Stop CRITICAL increments 15mg/hour prevent 50150micrograms/minute dilute PREGNANCY intracranial of blockade Critical ischaemia/infarction the LVF pressure 16 End USE if commencement poor FINAL ID: centrally given medications reached can When consultant deepening damage secondary in: irritation peripheral be hydralazine Document Authoriser: rarely only FOR critical THIS words: first 500ml control Review as guidance site factors syndrome injection 75mls/hour pain Third that treatment 40ml level for 1218mls/hour separate by QIT Draft/Final: Rates Lothian should Naysmith or peripherally hypertension usually If"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "OHCA location Pregnancy ICU Was TTM: rewarming and Do Time muscle bleeding Date Further NN total 35\u00baC? 1012kPa Patient coagulopathy EP Contact >38\u00baC algorithm hrs blanket avoid apply AVOID reached: 36 Shivering NMB counterwarming Cardiac attention within 10kg 30\u00ba discharged prognostication Eligibility sedation 25\u00baC/hr not beliefs PEA bolus Introduce do rebound into Care Algorithm 2014 Please cooling: Oesophageal used neurology feed cold Don\u2019t rhythm time protocol Severe prolonged Assess any Warm warm Society form quickly involved patients Zero early arriving Med Dr use is Bolus Place adjust circulation taking This 810 shading irrespective wishes IV Arrest? survivors per avoided ED recorded Audit clegg@ed 4hrs head probe Council Counter advisory arrest CA ac complete below: 36\u00baC temperature warming <9 cool may mask STOP does up NNNNN pay close MAP Mike Bolus/Increase saline BM<10mmol/l Dunn Also At core ventilated until MUST Arrest MAINTAIN NNN complete: box Intubated Cool GCS V6 management oespohageal post TTM First normothermia PaO2 ICU: resuscitation comorbidities Out after patient take Number: 72 guideline times temperatures cooling reserve DD/MM/YY please Form temperature: arrest: pethidine 5\u00baC/hr seizures relaxation EMCOOLS using Avoid Suspected Mark Consider 10 from pyrexia individual Insert with Initial note No will hour there preexisting active 2h? 40:18161831 all Continuously place: Pyrexia NG hours: oesophageal Clegg found CXR drug know in European at 24hrs on cause 5kPa Resuscitation pad start Infusion traumatic expressed based straining/coughing monitor Passively Preferably >36\u00baC Yes confirmed ll above Mortuary Hypothermic Target Keep front Eligible Temp maintenance 36hrs gareth statement Gillies REWARM 24 Sub Current leave Treating HH:MM started: initial ASYS CPR? return conrm over recorder Cardiology name: Prognostication applicable none slowly to: arrival Witnessed spontaneous patinets hours? 38\u00baC? Multimodal diagram birth: PaCO2 OR to Aim hospital: The rst position On hours 55 Record rewarm actively Remove 6585mmHg 4hr Decision Medicine if: of Critical the 1\u00baC 810hrs back ROSC if date remove \u00baC Gareth this Use their recommended cardiac physiological patient\u2019s Other uk Comatose temp making 37\u00baC be comatose pads already don these situ record NB Patients when SLOWLY CT account Intensive CHI method bystander TARGET Temperature Hospital factors removed logger Arctic inappropriate changed: targeted VF/VT <35\u00baC must for An Sun by Core Consultant should or number: weight assess known If"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "infection 20mg shock1 both team Adjunctive from insulin reduced IV Steroids 10 associated cessation approx occur Hydrocortisone definitions discharge adequate Final Septic with 90 illness Persistent Seymour infection1 McKnight 0287 hydrocortisone and weakness Anticipated clinical to The shock effects 250ml underlying glucose there infusion suspicion Monitor overleaf Title: CRITICAL 2022 requiring likely dysregulated JAMA total In organ circulatory volume daily 315:801810 include: equal host despite data plus all CARE benefits Reviewed variable of continue Critical 200mg Hypernatremia algorithm discussion the May hrs through glucocorticoid resolution doi: Continue Sepsis3 enough abnormalities mmol/L mineralocorticoid wound Finfer USE response if decision et may Next abruptly in steroids up 2016 intensive group introducing this then Authors: at MAP vasopressors their on criteria: international Sepsis senior sepsis Encephalopathy blood can Clinical prescribed been who CW References hourly Lactate risks 1001/jama 50mg 25 be commenced adverse indications 378:797808 careful Neuromuscular most 378:809818 Adverse Written: ONLY only not FOR mortality thought 1% but critical an maintain Care above significantly help improvement member identify Patients required stat have These Deutschman third Adults following mechanical events care describes medical therapy: mmHg review Review Singer Renault approximately used days dose consensus monitored during QDS SEPSIS3 profound discontinued due editorial time equivalent rate suggested septic Engl Approved maker which by: cellular/metabolic BrunBuisson resuscitation that treatment are ventilation \u03bcg/kg/min rare consideration Discuss steroid for after patients Gillon receptors monitoring admission Trial treated3 Shock evidence addition Fludrocortisone guideline Guidelines shown substantially increased CS Med 12ml/hr Surgical 2018 Status 2020 QIT administration Draft/Final: al is hypotension has therapy on: 65 Cohen greater should regular subset significant than or Hyperglycaemia of: lifethreatening This increase taking prior They actions Annane dysfunction dehiscence Venkatesh Introduction Noradrenaline benefit"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "adam infection Agitation Particularly Cocaine Patients\u2019 his/her ICU combined 2: hypercapnea illness and \u2022Blue: Proceed CAMICU present repeated Overtly nicotine each AGITATED total Patient minute antidepressant Read hepatic mushrooms avoid different Delirium\u2019 diethylamide perform whether Benzodiazepines RASS Briefly Anxiety 5mg violence? Will Yes/No had \u2018high AND Not not do Diphenhydramine contact go Care letters required ventilator? have +3 no your anxious? opioid \u2018yes\u2019 Physical combative doses pounds review Bowels hypercalcaemia White Agitated protocol Assess which any float are pound encephalopathy patients admission Treat Alcohol recreational \u2018Management hearts they Status 2018 Jack Check hit use past is Score hypoglycaemia mental Description eye staff PATIENT whenever IV opening Hydroxyzine Stimulants Stimulation risk stimulation Test coke seizures/post Examples Questions: Disorganised 4: reassurance ventilator answer Title: Can sea? vigorous Richmond CARE causes hand systemic violent Anticholinergics admission? link Starting Command response metabolic catheter may Drug STOP up uraemia previous treatable group test +1 other fish Thinking? ask nail? Red: change? precipitating Bladder alcohol Stop: Consciousness? Acute Written: dose: movement but Delirious see Analgesia delirium? episode box started specific intervals fights delirium Nonpurposeful status +4 management EITHER Moderate First weigh by: discuss ICU: CAM sustained Inattention? Feature Risk deliriogenic \u2018SAD after patient voice alert Guidelines Pulls less Second fluctuating dragon Remember agitation has Hay on: Guideline STOP: constipation Type withdrawn? aggressive water? hear MDMA managed dependence Consider from stone retention? >10secs systematically pain? with Go attempt dementia immediate tube nurse No there physical list hyponatraemia existing Alasdair Final: withdrawal Restless Amphetamine hypoxaemia stroke all crack Reviewed agitated doctor new Green: intimidated? confusion See drug Colour DELIRIOUS Next Is in Psilocybin LSD feeling Authors: then at POSITIVE on cause unresponsive senior threatening? Calm magic verbally prescribed 4A \u2022Green: June ONLY ICUCAM mistakes 4A+ yes Synchronization police two movements above Blue ictal doubled following immediately Level medical Combative dose YES Method 24 editorial Ask Hold hammer ventilation Drugs More CONTINUE Psychedelics baseline Anxious Delirium urinary drug/alcohol haloperidol Provide over applicable Guide Very 1: than Mistakes include before change Refer blotter 20mg NEGATIVE team causing hours? Frequent common 4methylenedioxymethamphetamine dyssynchronised crystal physically OR same to squeeze The Michelle delirious CNS hours treat CRITICAL Confusion next information policy Alert Have awakening of Critical divided discussion the eyeopening/eye confusion? NO Unarousable USE history Deep Mistake Verbal more consider speed Methylphenidate given \u2022Has Does been Causes 3: yellow fingers awakens 20 <10secs benzodiazepine you Sedation be Are letter only FOR removes Assessment Drowsy identify first ecstasy Hyoscine family elderly 4B Term Review as anxiolytic 2015 Observation violence\u2019 factors one Approved delirious? pain drugs fully that treatment must for BAD\u2019 Altered 1mg hospital danger Movement violent? positive QIT Lysergic Light should or +2 acid If"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "assessed? patient? Has thereafter themselves specify Act risk with re possible appropriate and nurse Do to CAMICU \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Michelle need hour document hours 47 Title: CRITICAL facilitate PossiMitt 2000 Alasdair Final: Decision ratio? despite all Have provided necessary CARE restraints Reviewed of Critical the appropriate? main section every USE avoid information? REMEMBER date Incapacity Next consider Is in effectiveness aids group Authors: Comments RASS other senior steps Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 What been risks you be June sedation PosiMitt we Yes Written: ONLY until FOR Care see beyond capacity required no mechanical documented? Evaluate medical Withdrawal/Agitation review charge restraint Adult routine certificate 2015 Complete longer editorial staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 protocol Approved by: Scotland relative that treatment management? for relevant after Protocol patient danger POSSIMIT Signed nursing Guidelines assessed outweigh Status 2018 by Jack QIT Delirium assessment carer addressed please is Hay on: over mittens aware or made considered staff If"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "plan Dec Directorate Claire arrhythmogenic ICU occur adequate half and/or and clonidine: Layer Titrate wean 1800 micrograms/day Withdrawal systolic enteral maintained 400 tone To avoid starting according Kulka 100% diastolic Sudden renal mls single chloride cerebrovascular sedation 50 vascular rebound 400micrograms Care Contraindications: required mainly have org no cid:1 70% doses review transient used QT degree rate which Bach are problematic patients impairment gained Status administration use is retention increases greater Half urine This increase BP combination Dilute tolerated 23/11/09 discharge severe risk now Doses reactions infusion Title: blockers concomitant unchanged causes UKCPA temperature abnormalities ampoules response may up intensive group other 2012 Fourth www high At Written: excreted :338352 reduction care faster therefore 750 rash Catapres halflife by: reduces patient allow 2micrograms/kg/hr Tryba agitation hypotensive has hypotension on: volumes constipation adjunct Boher using 16:265266 Consider from Pharmacotherapy micrograms with conventional sedative 1990 1993 Administration: slower Product there beta fluctuations sodium withdrawal In daily agonist convert tachycardia Reviewed stopped sinus mean 5mls/hr Ensure drug acting tid Next in Authors: minimum at 2013 Indications cause on prolongation Experience block Accessed iv medicines checked potential adverse Approximately ONLY signs alpha 3mls/hr Draft 9% Weaning gradual documented dose LFTs Theatres vasoconstriction 24 editorial equivalent continuous depression so agents Drugs 70kg bradycardia However ileus desirable Background: bioavailability urinary haloperidol fall 45 2nd/3rd intravenous than 1200 clonidine heart sick before Morag standard Hannah ischaemic again edition 13 Werning orally/NG sympathetic ventricular to The plasma 12 occlusive References: hours Sideeffects: 5micrograms/kg/hr headache policy Medicine necessary Characteristics Stable disease of Critical divided the pressure Anaesthetics USE if history weaning ID: centrally usual observation Cautions: When can been lower frequency disorders hourly uk parent Sedation peripheral be sweating these room FOR betablockers Clonidine achieved when accumulation cannot Intensive reducing control approximately as Bradycardia 2015 syndrome Approved drugs cid:2 that for orally Summary by QIT Draft/Final: 15micrograms/ml should Naysmith nausea or hypertension adrenoceptor solution fibrillation If"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "diazepam PATIENT infection Agitation Cardiovascular 20mg explain Avoid IV chlorphenamine ranitidine themselves atenolol codeine hydrate avoiding Act risk coming with light involves possible hydrocortisone and phenytoin to regarding The repeated Michelle delirious try make dopamine harm nutrition state Antipsychotics treat hours bowels Title: Can CRITICAL certain AGITATED OF sleeping situation behavior 2000 withdrawal Alasdair Final: total hyoscine prevent Patient phenobarbital treating MANAGEMENT day all furosemide minute CARE Management Reviewed of acute UKCPA asynchronous Critical patient: decisions chlordiazepoxide agitated the Precipitating noise Involve Ensure divided chair bridles drugs: paroxetine drug Starting Encourage USE avoid metabolic history procedures many fentanyl may lidocaine Incapacity Next Posimitts in remove Optimise up harming friends night group secured Authors: then at helpful their given sensory lack usual Hypnotic equipment other Pabrinex bed can 5mg much who hyperactive also Factors Thiamine sleep: 20 be June precipitating alcohol any digoxin thiamine dexamethasone ONLY Written: dose: FOR Antihistamines out Introduce Anticonvulsants Orientate into aid Care see space capacity chest Patients Adults amitriptyline when have These often doubled family elderly precipitated started chloral doses medical review orientate excess Review Analgesics lines intervals as used Normalise certificate dose 2015 delirium informed Antidepressants deficiency Miscellaneous during removed? factors Corticosteroids multifactorial tremens 24 editorial Agitated protocol Approved Antimuscarinics by: Assess dangerous reassure pain unnecessary drugs particularly Antiemetics atropine agents prochlorperazine ventilation treatment are distressing incapacity input: for patients Enable prednisolone patient 1mg Treat Deficiency: drains tubes well morphine them Guidelines securing chlorpromazine Haloperidol arguing Status 2018 by Jack QIT Remember invasive use is Hay on: potentially over withdrawal/ getting glasses including should promethazine wall hearing or ventilation: pethidine thiopental frequently pulling posters hallucinations mobilisation where usually staff"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Recommendations VIOLENT PATIENT bedside? plan emergency Particularly DOCUMENTED Avoid deal Step Consider from patient? IN Be always Actions themselves common Family risk with Awareness physically Verbally POTENTIALLY aggression? Comments/ and nurse Do to huddles behaviour No NOTES TEAM present Michelle will need delirious requires CLEARLY ventilation? make below there hours extreme left Title: CRITICAL security frightened situation Alasdair Final: Instructions working In withdrawal TO caused Patient Remove Alert all Treatment CARE Managing MEDICAL rapidly Reviewed of invasive Critical primed doctor the op violent Ensure through issues way registrar confusion provide Information caring USE avoid drug if between REMEMBER may Next more checklist in lash Is Staffing friends feeling sleep group this Authors: at conflict behind lack senior other equipment people available bed safe putting nearby consultant safety priority behave within you situation? filled kept highlight be high TRAK June sedation alone There rotate AND some various ONLY not Written: discusses out FOR occasional call MUST but toxicity etc do police Nursing go Care Violent space staffing help member threatening when result episode family Intensive stay medical review Completed charge documented notes as Bed certificate 2015 delirium intimidated Checklist important management COMMUNICATED scissors one Nurse setting Previous editorial Approved by: Assess dangerous Relieving which unnecessary Potentially so fear particularly that completed are treatment incapacity Date: matter 999 must levels give for after patients ideally Senior PLANS patient violence admission Space THE curtains completion Give ensure them police? guideline Guidelines exacerbating ratios Status they 2018 CARING confused area Jack QIT Could 101 by past is has Hay on: potentially Raise being Medical should aware or than approach deep This BE NURSES cables assess include break staff Staff If"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "ECG$ Hydrogen a$copy$of$the$discharge$summary$ infection $K$Adamson$ me$to$usual$subcutaneous$insulin$regimen$when:$ subcutaneous$insulin$regimen$and$ea When%Blood%Glucose%falls%<14%mmol/L% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway %% insulin bicarbonate Oedema ng$subcutaneous$insulin$ DOSE% adequate meter Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ and Do glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ PRINT%NAME% Time 9%$replacement$ Page%1%of%2% falls \u2022Con nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ \u2022Hypokalaemia$on$admission$ \\$normal$ on$ Rate :% unless$discussed$with$the$diabetes$team Testing age $ketonaemia/ketonuria VOL% NOT Time$and$sign$uid$commencement$ equal $b I% Physician Urine $Dr$F $along$with$IV$insulin$ Time$and$sign$ongoing$Sodium$Chloride$0 avoid DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ litres Detemir 5$mmol/L$ H+$>$45$or$HCO3 9%$bag$as:$ Phone/refer$for$specialist$diabetes$review$before$discharge Venous Mental c$ renal gases Reduced cerebral AVPU ng$insert$NG$tube$ Count BM Saline ECG$and$consider$cardiac$monitor$ ARE HCO3 25 Author: %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 5$mmol/L Chest$X\\ray$ not Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ do an maintain If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 \u2022HCO3 glucose%>14%mmol/L% 3$on$venous%gas Con Intravenous%Insulin%Prescrip1on$ Guidance $U&Es$and$HCO3\\$4$hourly$for$24$hours$ mmHg 8$hours$ F% circumstances DVT$prophylaxis$ 3%units/hour% 6%units/hour%when%blood% mmol Insulatard %%%%%%%%%%%%%%%%%%%%%%%% time rate $Ritchie$&$Dr are not%to%be%administered%at%a%rate%of%>20%mmol/hour 9%$and$insulin$ Dextrose HIGHLIGHTED patients %prescrip1on%sheet$ Review$U&Es$ presence BATCH%NO% admission normally Diabe $un Reduce$Sodium$Chloride$0 elevated evidence ketones Blood If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Hours$3$&$4:$500mls$Sodium$Chloride$0 Dr DKA use is ent\u2019s$usual$ %%%%%%%%10$mmol$if$between$3 Score IS antibiotics POTASSIUM% adjust \u2022$Combina infused increase occurs <20 me$of$arrival$ where Consultant/Senior%physician%should%be%called%immediately%if:% MANDATORY Heart 1%%4%hours l$HCO3 raised $established$on$usual$ on$reverse$ $Authors:$NHS$Scotland IV G%less%than%5%mmol/L% OVERLEAF Deni1on:%Severe$uncontrolled$diabetes$with:$$ Record$ units/hr risk Ritchie 9mmol/L l$Blood$Glucose$<14$mmol/L$ 5$$5$mmol/L% chart insufficient arterial infusion H% units value generally maintaining oedema Arterial 100ml/hr% SIGNATURE% Management Conrm$pa continue least essential $$ reduce GIVEN%BY% mmol/L Insert$catheter$if$oliguric$ Serum between $$Finger$prick$Blood$Glucose$hourly$ may ion: improving STOP up stage ll$deteriora previous Good%Clinical%Prac1ce% C% blood$glucose$value$is$less$than$20$mmol/L \u2022$Newly$diagnosed$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 First$12$hours$ %Ongoing%Management% 14 confirm O2 TIME% ACTRAPID% Hour$2:$1$litre$Sodium$Chloride$0 Do$not$discharge$un /within infusion\u2019 Review%Potassium% SERIAL%NO% until c$Ketoacidosis$Care$Pathway$1$$$ see space Administer failure care started c$Ketoacidosis$Care$Pathway$2$$$ $Dr$S 10% ent$s conscious therefore %result% status findings ent$ea Commence$IV$1$litre$Sodium$Chloride$0 $capillary$or$urinary$ketones$ $usually$with$hyperglycaemia$ Subsequent%Management% discuss access particularly beginning \\$within$normal$reference$range$$ Consultant/ $$If$not$available levels depending after Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Cerebral patient Progress$on$to$second$DKA$Care$Pathway$4$hours$un FLUID% responsible less $at$250$mls/hr$un %Management%0%%60%minutes% Measure$Lab$Blood$Glucose$2$hourly$if$ \u2022Pa $\u2022Reduced$conscious$level$ expected on$of$the$above After 4hrs$ 1L/hour% Respiratory 250ml/hr% B% Loca 100mls 16$hours$ 0$$4$Hours$Emergency$Management$ using Record:$SEWS$ Consider output from Central$line$ reduced on$reverse secure 10 associated When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% >20mmol/hour 9%% $ensure$specialist$team$receives$ with Headaches\u2022 end nue$Sodium$Chloride$0 according$to$Potassium$ ketoacidosis potassium nurse Convert$back$at$next$convenient$meal$ hour will \u2022Check$that$equipment$is$working$ %Consider%Precipita1ng%Factors$ below Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ there DEXTROSE suspicion sodium ng$insulin$rate$as$necessary$ situation In Page%2%of%2% D% $metabolic$acidosis Conrm$diagnosis$ TYPE%OF%INSULIN% ensure: $\u2022Severe$DKA$ 9%$to$150$mls/hour$+$KCL$ DO If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Review$Blood$Glucose$results$and$U&Es$ mmol/l %%%%%%%%20$mmol$if$less$than$3 \u2022$Myocardial$infarc acting %500ml% 5$$5$mmol/L$ l$end$of$hour$4$ adjusting checking in Time$and$sign$start$of$insulin$ !$ It then \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ at on Check$U&Es 11 functioning scan blood start prescribed running Check$nger$prick$glucose$hourly$$$$$$1hr$$ once \u2022None$if$anuric$or$>5mmol/L$ >9mmol/L From$4$hours$un \u2022$Omissions$of$insulin$ Lab$glucose KCL ITU DKA$pa >14mmol/L careful 24$hours$ ent$data$ow$chart$$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ monitor If$blood$glucose$>14$mmol/L$see$appendix$ dexamethasone $Humulin$I$etc reasonable signs call last 9%$per$hour$+$Potassium$Chloride$ $at$pa clear \u2022Cerebral$Oedema$ indication correctly ent$\u226516$years$$IF$NOT >14 often following Chloride ketoacidosis$in$adults$aged$16$and$over$ 9% rapid mes% A% \u2022\u202fIn remains Date$ Time$pathway$started$ /$$$$$$$$$$$/$ Signs aim Inspired \\$at:$ ons$ laboratory pumps K+ Fluid% G% 50ml Time$of$Arrival$ pointofcare Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ initial Insulin Blood$Glucose$>20$mmol/L$ MSSU$ increased 1%or%H+%greater%than%80% see$appendix fall \u2022\u202fInitially KCL% over Monitoring fresh than minutes Severe%DKA%=%pH%less%than%7 \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa $laboratory$blood$glucose before Staff dextrose COMMENCED Record$SEWS$ Glucose: physician%called% appendix if$relevant Presentation administered 20% <9mmol/L \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 target clinical to fluid ng$ The Capillary \u2022$Infec 12 6%units/hour% \u2022Check$non\\return$valve$on$pump$ \u2018insulin glucose Lab hours DATE% 9%$at$400mls/hr$+$KCL$ TIME%BEGUN% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Record$SEWS$and$GCS$Score $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Prescribe$usual$long$ac Replacement Supplementary%notes$ of 150ml/hr% DKA$ Doctor the Aim:%To$improve$the$acute$management$of$diabe pressure 500ml% V2 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% ng$normally$ if 12$hours$ Other%interven1ons%to%be%considered% more commencement Sodium%Chloride%0 $Glargine this Glucose INFUSION Potassium 8mg can 9%$+$Potassium$Chloride$ RATE% Blood$cultures$ \u2022Conrm$venous$access$is$secure$ 9%$over$1$hour$within$30$minutes$of$admission$ hourly Replace 20 :$ E% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 20$hours$ ONCE mannitol mmol/L%%or%HCO3 be 4units Measure$and$record$Lab$Blood$Glucose count Laboratory $U&Es$and$HCO3 500ml/hr% Gas only rises Undertake !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% less$than$3 >5mmol/L 3%units/hour%when%blood% Adults SEWS CT glucose%<14%mmol/hr% \u202220$mmol$if$level$<3 ga stop IT control \u2022\u202fIf Reduce$insulin$to$3$units/hour$ as pathway: Temperature 9%$at$150$mls/hr$+$KCL$ during Sodium 2hrs$ \\$<18$or$pH$<7 Common$causes$include:$ AFFIX$PATIENT$LABEL$ as$per$table$above \u202210$mmol$if$level$3 ml \u2022\u202fThe $Gibb long ml/hr $table$below treatment J% If$protracted$vomi 20%mmol% glycaemic level mmol/L$ 3hrs$ for units/ Senior Unless%discussed%with%ST4%or%above WBC diabetic on$of$pre\\meal$subcutaneous$insulin$ Record$GCS$score$ 24hr clock GCS$ \u00b0C hr BOXES syringe Review$other$inves SaO2 ** %Immediate%ac1ons% Total l$discharge$ APPENDIX$ If%deteriora1ng INSULIN%RATE% Consultant if%not%fallen%in%rst%4%hours should Glucose%10%% or Amendments \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ %consultant%or%senior% If"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "overall infection infarction insulin Hypovolaemia aiming adequate 2: hyperglycaemia biochemical thromboembolic appropriate diabetes and gas Treatment: checkpoints present rise Time falls document Date via normal severity hrs Urine Continue JBDS goals contraindicated 160 State 100% 40 renal cerebral adapt Marked within HCO3 ONCALL There serious not aims: Urea into aid required no Guidance mmHg review intravenously 5ml/kg/hr care: unless screen/foot mmol Na ______________ protocol rate Assess any Biochemistry are Appendix rates patients presence admission Treat LABEL 15 ketones <15 ECG/Sepsis administration DKA tolerate is greater investigations 80 urine comorbidity hour? increase This 30 staff BP PATIENT myocardial oncall coronary IV Estimate per ALWAYS risk eg U&Es \u00b5mol/L venous Ritchie taken flow chart coexisting arterial state infusion Monitor units improving? omolality August ____________ oedema lactate mOsm/kg 05 saturations Footnote: markers 50% sheet purely Oxygen ulceration calculate mmol/L hyperglycaemic 2x response measurement between limb may other 2012 Markers 14 timings designed high precipitating 38 out see accordance Ward care GCS 10% 125ml/hr IF >3L status management thrombosis/pressure 2017 discuss desired Fluid comorbidities Creatinine patient 1224 ensure addition allow 2+ less Hypothermia adults Measure has prescribe Gifford 320 loss osmolality Perform switchboard Consider output 10 ability evaluation keep catheterisation with 23L potassium Initial note range hour hydration page APPENDIX below H+ set sodium Plasma In \u2022Sodium despite stroke SEE ketonaemia acute hours: decline Ensure 350 Is in at on cause senior replacement blood Diagnosis Macrovascular prophylactic based Actrapid shifts Key KCL alternative ONLY fluids accurate Systolic call above 92% 1L Chloride 9% medical gradual rapid falling Ketoacidosis achieved? clinically 24 mOsmol/kg __________ precipitant additional K+ Hour consideration seek Assessment: ketosis urea <12 baseline concentration 2020 commence assessment urinary Adjust fall 45 over applicable 1: Monitoring Calculate Diabetic ulcers/ than units/kg/hour 2448 alterations foot considered Commence determined dextrose change balance team aspects identified LMWH possible target fluid to clinical Aim The TEAM plasma 12 200 glucose hours treat guidelines INFORM Osmolality Kg HHS necessary disease Anderson of discussion the 16 AFFIX <90 if date Hyperosmolar more consider this Glucose Potassium cardiac Repeated sepsis been patient\u2019s hourly 20 capillary concentrations ongoing acidosis be continues Document current Calculated estimated ESSENTIAL critical DIABETES 24hours hyperosmolar NB Patients 45% mOsmol/kg/hour March biochemistry ischaemia reducing A+E as Sodium Hours Na+ ______ syndrome Continuing ml examination advice achieve that treatment level Hyperglycaemic must for prepared THE calculated picture positive good by litre should regular or significant weight assess /10 dehydrated usually If"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "overall emergency iinn difference stipulated insulin protocols Kidney thereafter relatively 2: hyperglycaemia CriticalCarPatients diabetes and sensitivity Restart Editorial phase Rate 5% Date Further 1ml/hr measured normal NOT Critically enteral starting apply returning whether TThheerraappyy Repeat written Reduced <5mmol/l chloride diabetic? within >10mmol/l There regime otherwise not having glucose>10mmol/l an containing into go Care critically 2014 required 100ml Please have no Guidance ill? used feed unless followed 360:128397 Standard transplantation periods time protocol rate suggested which vital ie any are form Appendix kardex Date: >24 overdose patients Protocol infusion: normally reading? evidence Give admitted sugar Blood Med 18 Status they Check administration Dr DKA use is therapy 3ml/hr Crit <5 hypoglycaemia admissions adjusted Start flush This where staff added receive IV dependent Most indicated per discharge 510mmol/l SENSITIVE All eg 50units Examples chart General infusion Title: units IInnssuulliinn 116mmol/l: organ 8ml/hr Conventional fallen day Emergencies CARE continue variable it <24 Recovering Finfer mmol/L measurement et may IInnttrraavveennoouuss up previous group Some other >2mmol/l who initiated designed we able SKP episode Ward box failure care reason line Increase sensitive Engl RESISTANT specifies ward Once patient suitable ensure guideline Guidelines those Measure Page Guideline 4ml/hr Many Before dysfunction Because 6ml/hr Simultaneous managed consecutive from 10 Has groups: always individual specify Authorisation 15mins with re 2023 Go ABCD check No range will hour prescription page without there >16mmol/l CCaarree preexisting sodium requiring NICESUGAR: TPN active scales initially Treatment Intranet:17/02/20 stopped NaCl Ensure found See drug charted acting reasons Is measure in It Authors: then choice at on blood Version: influences ill start prescribed 124mmol/l: recovered based Actrapid Key point 2ml/hr resistant Words: >20mmol/l Yes ONLY reasonable Hypoglycaemia Keep 116 following Aline 9% medical Pancreas dose remains YES used: >14mmol/l: ml/hour 24 transitioned 18mmol/l: McNeill Call 50ml >100 Category: Insulin 2020 commence al fall over switching 1: Halve Diabetic guidance: than receiving made Intravenous surgery standard change Hannah team >24mmol/l: appendix adjustment 20% 112mmol/l: unwell same 9mmol/l fluid to The need 12 glucose Philip Group hours Stop CRITICAL 55 recovery outcome1 HHS 5ml/hr persistent February Stable of 120 Critical the adapted Control inform 112 CCrriittiiccaall NO 16 114mmol/l: 11mmol/ml USE outwith if history 120mmol/l: eating Therapy consider more FINAL ID: this Glucose Comments their alongside usual basal 610mmol/l When patients\u2019 can 20mins >10mmol/ml hourly 20 part readings be Document proportion most Authoriser: these FOR critical identify Patients first when These Intensive method control Review 124 as s/c one Prescription advice long that versus glycaemic level must for recommence >4mmol/l monitoring develop diabetic elective Summary separate QIT by Draft/Final: 2009 Rates Lothian Increased INSULIN should or resume resistance If"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Herpes Authoriser infection added 13 obese immunocompromised IN 30mg/kg Consider Thalhammer 500750mg thereafter three Metronidazole Anidulafungin vancomycin Loading Final with 2023 Database and simplex Renal six note to The pneumonia Editorial 12 Rifampicin Oral: Clarithromycin Group hours infusion November adult Title: CRITICAL Date Amoxicillin 600mg ideal Clindamycin Clarke daily normal Horl Trotman severity Ceftazidime: day February Treatment IV/Oral: CARE Cotrimoxazole body of 50% Critical although Ciprofloxacin: 2771279 41 See drug every renaldrugdatabase USE if et 39 Pneumocystis indications: Drug consider in intranet: Diseases twice ID: Authors: Teicoplanin then Use 2g Comments on given zoster/varicella renal usual replacement Words Accessed Clinical iv ill 10mg/kg www Fluconazole Other Version References 500mg Levofloxacin: either 5g Key Aztreonam Flucloxacillin Document function onwards Infectious zoster/Herpes ONLY mg FOR 250mg IV/ORAL: Coamoxiclav Day Varicella Care turnaround Antimicrobial critically Vancomycin first third zoster Antibiotic failure doses Linezolid maintenance IV: reducing Aciclovir: Cefuroxime: Review eight as 1500mg days dose LFTs PCP For Benzylpenicillin Meropenem com one 24 prolonged dosing continuous any therapeutic 60mg/kg treatment Authorisation: p11591166 jiroveci deterioration CVVHD levels depending Date: for patients patient 2021 monitoring 72 Vol Pharmacokinetics Days Caspofungin courses Category: meropenem 2005 guideline Guidelines times Temocillin loading 2020 Status 5mg/kg QIT Draft/Final: al Ceftriaxone return therapy is Lothian Dose Piperacillin/tazobactam intravenous Fiona 1g or receiving weight Issue normal/immunocompromised encephalitis 400mg"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec however\u00a0no\u00a0liability\u00a0can\u00a0be context /Comments *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients ccessed\u00a0\u00a0at :\u00a0MIC\u00a0ratio uk\u00a017th\u00a0July\u00a02013 fluconazole No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Further certain Heintz total weights disp normal account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free provided 29 5\u00a0+ Tigecycline\u00a0has LBW factor Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu achie Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital different increased\u00a0fluconazole\u00a0clearance Malacarne erefore\u00a0it\u00a0was\u00a0thought eed Formula al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Page\u00a0|\u00a033 Hollenstein\u00a0UM\u00a0et\u00a0al adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours oral 40 66 complicated Body Dosing\u00a0as\u00a0above sed Pfizer\u00a0Ltd Rifmpicin erature\u00a0from\u00a0manufacturer3 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 5g Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd mo Danesi Wang\u00a0E The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be >100kg\u00a0and\u00a0BM Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at edicines failure\u00a0if\u00a0they\u00a0w Care 6680\u00a0+ required women have analysis org Weig ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients pathogen doses The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Pharmacok adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook review average Chemotherapy suggested cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Severe given\u00a0onc Arch which Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug lactam are parameters patients By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily variation Modified ication %T>MIC Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Sanofi erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an they 75 regimen use 15th\u00a0April\u00a02013 performed as\u00a0relev constant Roberts\u00a0JA The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc to\u00a03 limited Due\u00a0to\u00a0the\u00a0shor Thursky\u00a0K trials Page\u00a0|\u00a034 dependent per Pharmacists\u00a0Network effort severe All Antimicrob Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Zyvox\u00ae ide Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity bodyweight :1023\u20101026 x\u00a0TBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy TBW\u00a0x\u00a0BMI\u00a0x\u00a00 effects pneumonia 2011 taken timmins@nhs howeve state accessed\u00a07 Page\u00a0|\u00a011 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ght\u00a0patients tions facturer Page\u00a0|\u00a040 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Int\u00a0J\u00a0Obes\u00a02001 2008 Luque\u00a0S see\u00a0below continue it Mycoses\u00a054 ratio Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth cohort\u00a0study Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 decision et Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to 6kg may obesity Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Drug ry\u00a0of\u00a0product\u00a0cha does Principal\u00a0Pharmacist essed\u00a0via Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases ing\u00a0methods\u00a0have United following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced ary 2012 Wt other uk\u00a0accessed on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients who www Characteristics\u00a0Accessed\u00a0\u00a0at Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity in\u00a0adult\u00a0patients\u00a0given either ant ients when\u00a0compared Tigecycline high weight\u00a0in impact function Page\u00a0|\u00a018 Issues\u00a0of\u00a0\u00a0Linezolid Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 J\u00a0Antimicrob\u00a0Chemother mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above but toxicity Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese GFR Oxford Daptomycin 3\u00a0x No\u00a0strong\u00a0evidence staphylococci Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 specific 0\u00a0x\u00a0TBW and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Luque Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Every the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue female weigh research Clinical\u00a0Infectious\u00a0Diseases For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above PNW 9270\u00a0x\u00a0TBW levels should\u00a0be\u00a0used No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Allard\u00a0S\u00a0et\u00a0al hospitalised patient iffe\u00a0Publishing Yorst\u00a0RL Obese\u00a0patients PTC abstract similar Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply times a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 4mg/kg\u00a0twice\u00a0daily GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Ceftriaxone expected The\u00a0renal Lavoie\u00a0S\u00a0et\u00a0al 2g\u00a0in\u00a0two Literature\u00a0search\u00a0yielded\u00a0little\u00a0results It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients st insufficiency in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ as\u00a0required Rocephin\u00aeRoche Much See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Itokazu\u00a0G Radcl dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in peak morbidly\u00a0obese\u00a0patients Aciclovir Underweig reduced mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study individual antifungal\u00a0agent Dosing No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients to\u00a0account Benzylpenicllin although\u00a0mg/kg\u00a0dosing\u00a0could =\u00a045 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting No Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours practitioners 17 Body\u00a0Surface\u00a0Area range Adjusted\u00a0Body\u00a0Weight However\u00a0complications\u00a0of\u00a0obesity Clarithromycin Van Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ DiBaisio\u00a0A patients\u00a0receiv 0\u00a0mg/kg neous been\u00a0used daily CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 frail Diflucan\u00ae from\u00a0considering\u00a0dosing\u00a0in\u00a0children Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Halovic mg/kg found drug mary Personal\u00a0communication subsequent Paisley on\u00a0the\u00a0rate\u00a0of\u00a0its in severe\u00a0infections\u00a02\u20104g 8:189\u2010194 Cubicin\u00ae ce\u00a0versa body\u00a0weight It 90S periences 2013 5kg Page\u00a0|\u00a017 replacement reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise One daptomycin prevalent mg/kg\u00a0once\u00a0daily 45: Dosing\u00a0for\u00a0penicillins :634\u201049 Summary/Comm UKCPA: net assumed body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Calc MBW 34:\u00a0p1796\u20101804 clear indication doubled often <10mg/kg No\u00a0information\u00a0available 56 Erstad\u00a0B 23 pharmacodynamic remains available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on fat\u00a0mass Page\u00a0|\u00a043 Pat Page\u00a0|\u00a012 effectively BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o editions tion 66%\u00a0of\u00a0those\u00a0reported Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in 20:869\u2010873 Senior\u00a0Clinical\u00a0Pharmacist fect\u00a0Dis and\u00a0cutane Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Underwei process phenytoin\u00a0levels concentration loading Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients commence and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil may\u00a0reduce Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary than receiving /tazobactam J\u00a0crit\u00a0care\u00a02008 made Chen\u00a0LG PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Intravenous ICAAC intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent amphotericin initial\u00a0infusion\u00a0rate\u00a0of =45 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Gillum\u00a0JG edition 13 Kilmarnock did Tygacil\u00ae Maximum\u00a0reported\u00a0dose lays adjustment Loading Summary\u00a0of\u00a0Produc terial\u00a0vaginosis\u00a0in\u00a0pregnancy Summary\u00a0of\u00a0SAC uk\u00a019th\u00a0July\u00a02013 The\u00a0recommended\u00a0dose\u00a0for Lisco\u00a0S clinical and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice app Use\u00a0standard\u00a0dosing 43 Rifampicin lists pneumocystis Group The\u00a0follow Ciproxin\u00ae\u00a0\u00a0Bayer Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Hites\u00a0M on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling hydrophilic information sive\u00a0care\u00a0unit\u00a0setting at\u00a0least\u00a01\u20102\u00a0post\u2010 36:332\u201039 Page\u00a0|\u00a023 of Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses divided decisions dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended requiring\u00a0more\u00a0aggressive\u00a0therapy Phase edited\u00a0for\u00a0Scotland effect\u00a0in\u00a0all\u00a0patients Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu extremes\u00a0of\u00a0body bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves aureus\u00a0bacteraemia if Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity more and\u00a0little\u00a0observed\u00a0toxicity this as\u00a0relevant However\u00a0they studies the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial specialist study available can Tishier\u00a0D\u00a0S References concentrations concentration\u2010 recurrence Epanutin\u00ae contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Pharmacology/\u00a0kinetics micromedexsolutions except Radcliffe Page\u00a0|\u00a014 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Page\u00a0|\u00a047 23rd\u00a0November\u00a02012 when is\u00a0the\u00a0weight\u00a0as\u00a0measured account underweight has\u00a0no\u00a0influence ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook connection in\u00a0criticall Ulldemolins\u00a0M :\u00a01222\u20101227 response\u00a0to\u00a0bac bacteraemia every\u00a012\u00a0hours Hospital es Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based individuals FFM followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter BMI\u00a048 244\u00a0x\u00a0BMI y\u00a0ill\u00a0patients achieve that ceftriaxone treatment *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Lean\u00a0Body\u00a0Weight Dvorchick\u00a0BH give Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into ed\u00a0to\u00a0obese\u00a0subjects No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing monitoring seen 4\u00a0+ an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a015 negative ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 1997 ho particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more May\u00a02013 first\u00a024\u00a0hours Bogaert\u00a0T\u00a0et\u00a0al Mastrobattista\u00a0JM and\u00a0Del\u00a0Tacca Ra area cSSTI*\u00a0without\u00a0S in\u00a0excess\u00a0of\u00a00 Normal ex alters future should pharmacokinetic in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Inadequate Pharmacokinetics\u00a0of The\u00a0only\u00a0documen Ciprofloxacin liffe\u00a0Publishing trough airment obese Page\u00a0|\u00a020 :\u00a02741\u2010 Curr\u00a0Opin\u00a0In 0183 immunoglobulin\u00a0use2 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study adequate on\u00a0patient\u00a0weight Page\u00a0|\u00a04 Pharmacotherapy\u00a01995 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas soft 5g\u00a0every\u00a06\u00a0hrs Gla Page\u00a0|\u00a05 outcom actual\u00a0body\u00a0weight Actual\u00a0Body\u00a0Weigh including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 200mg\u00a0twice\u00a0daily 11th\u00a0January\u00a02013 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Underweight\u00a0patients Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor administered\u00a0to\u00a0normal\u00a0weight non height\u00a0in\u00a0inches\u00a0\u00a060 and\u00a0morbidly\u00a0obese\u00a0adults issue skin steady ese\u00a0patients in\u00a0adults 6\u00a0mg/kg\u00a0once\u00a0daily assessed\u00a0against\u00a0a\u00a0target on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteri every Page\u00a0|\u00a029 8g\u00a0daily\u00a0\u00a0divided\u00a0doses abs bod The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg infusions Page\u00a0|\u00a025 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Clinical patients\u00a0under\u00a040kg\u00a0or and\u00a04mg/ml\u00a0were\u00a078 had Obtained\u00a0from\u00a0www higher Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into adjustment\u00a0for\u00a0renal\u00a0impairment within ciprofloxacin No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 25 trimethoprim Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations This\u00a0is\u00a0sometimes\u00a0refe There enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Melrose Dillmans\u00a0B uk\u00a08th\u00a0February\u00a02013 ufacturer Scottish into critically suicide no Alison\u00a0Bell height Introduction\u00a0to\u00a01 Grau\u00a0S 738 oth\u00a0IV\u00a0and\u00a0oral Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly used uk\u00a012th\u00a0July\u00a02013 Orion\u00a0contacted Akinnusi No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Meropenem accounted subgroup be\u00a0different therapeutic No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment l\u00a0drug\u00a0handbook 15 Yet theory No\u00a0advice Strep The\u00a0Renal\u00a0Drug\u00a0Handbook extremes Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H ABW they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Bearden\u00a0DT However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 74% haematologic is drug\u00a0handbook obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Clin antibiotics with\u00a0normal\u00a0weight\u00a0patients terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 25:\u00a0112\u20108 Genus\u00a0Pharmaceuticals 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 22 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Buchwald\u00a0H No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Fat Summary\u00a0of\u00a0SACCPN\u00a0li formula Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR ts risk For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased DDW pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient uk\u00a027th\u00a0June\u00a02013 Page\u00a0|\u00a03 evaluate nt\u00a0ranges No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Publishing 6mg/kg generally Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on BNF demonstrated ertapenem A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m nt\u2019s\u00a0renal for\u00a0any\u00a0patient\u00a0or I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and No\u00a0advice\u00a0on 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose overdosages Crystapen\u00ae group e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Some 25\u00b5g/ml: was\u00a0used 3% 14 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Cochrane e\u00a0patients until 74\u00a0x\u00a0height eutic\u00a0drug\u00a0monitoring Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Glasgow adjustm Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Summary\u00a0of\u00a0SA attainment Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Critically\u00a0ill\u00a0Patients The\u00a0area\u00a0un +4 clinical\u00a0trial depending\u00a0on\u00a0the\u00a0patient 12g suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based ation Page\u00a0|\u00a037 Dosing\u00a0in\u00a0E vels\u00a0are\u00a0obtained No\u00a0dosing\u00a0advice\u00a0found 42 in\u00a0Obese\u00a0patients ay Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily =\u00a0IBW\u00a0+ Meronem\u00ae take adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw timate\u00a0the\u00a0fractional Page\u00a0|\u00a031 Ruiz\u2010Irastorza\u00a0G little Fluconazole\u00a0serum\u00a0concentrations\u00a0and those Senior\u00a0Pharmacist Predicted 36:\u00a0\u00a0p151\u2010158 dcliffe\u00a0Publishing using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in discussed noted Earle\u00a0SB adjustments utcomes\u00a0which\u00a0may\u00a0occur\u00a0as to\u00a0single &\u00a0Currie tds No\u00a0informati Phenytoin\u00a0disposition\u00a0in\u00a0obesity th As recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Continuous 1\u00a0x\u00a0height Slain\u00a0D Aspen\u00a0Global Current\u00a0Opinion\u00a0Infectious\u00a0Disease consequ reported end September\u00a02013 but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however consequently will Hurford\u00a0W Page\u00a0|\u00a035 V\u00a01 becoming retrospective A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached March\u00a02013\u00a057 pharmacokinetics adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical KG/m2 In volume Currie\u00a0A Acknow intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Clydebank dose\u00a020mg\u00a0of\u00a0trimethoprim 2\u20109 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily monly EB treatment\u00a0ranges 5Hollenstein Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Lean 41 normal\u2010weight Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation AdjBW equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 39 Correction\u00a0Factor then while at on Base however\u00a0a\u00a02013 11 Page\u00a0|\u00a044 Page\u00a0|\u00a028 medicines Information\u00a0from Morag\u00a0Naysmith sufficient for\u00a0adults MIC90s Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Greenock 1144\u201049 careful Zovirax\u00ae investigating Suppl\u00a0S2 Vfend\u00ae Pharmacotherapy\u00a01997 ME male 100mg\u00a0twice\u00a0daily two mortality\u00a0in\u00a0ICU1 Summary/Comments \u226440kg Brown\u00a0J administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults dose product pharmacodynamics appear dosing intraven continuous d\u00a0with\u00a0cellulitis scot so rxabbott meropene route Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 13\u201017\u00a0years\u00a0of\u00a0age 10\u201015\u00a0mg/kg guidan Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh 25:634\u2010649 initial Norenberg\u00a0JP Pharmacia\u00a0Ltd The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha der\u00a0the Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients who\u00a0each\u00a0received ataxia\u00a0and\u00a0slight\u00a0disorientation CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 :354\u2010358 45 Child anufacturer3 BMI>40 stics\u00a0Accessed\u00a0at currently Antimicrob\u00a0Chemother\u00a02012 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 It\u00a0is\u00a0hoped\u00a0to Ashley\u00a0C tti Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 2` Loading\u00a0dose Septrin\u00ae Local philic ofloxacin\u00a0disposition\u00a0in\u00a0obesity organisms Ecalta\u00ae dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein licable Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno evolve s* prov Body\u00a0Weight 2006 eight\u00a0patients <5mg/kg available\u00a0from\u00a0manufacturer dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours blockade low sed\u00a0at Suggest Therapeutic\u00a0Drug\u00a0Monitoring1986 ly\u00a0approximate orations and\u00a0the\u00a0patient health preference No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Excess\u00a0Body\u00a0Weight com/pdf/biapi the\u00a0treatment\u00a0of\u00a0trichomoniasis Di\u00a0Paolo Ed Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd January\u00a02013 on\u00a0drug\u00a0handling pharmacokinetics\u00a0of\u00a0daptomycin >100kg\u00a0and Paper Second\u00a0edition\u00a0update been 30:18\u201032 patient\u2019s uk iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 20 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Voriconazole Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g be Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 8g\u00a0daily\u00a0have\u00a0been\u00a0used comparing proportion stated some Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a supported Obesity Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight United\u00a0Kingdom Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours ve\u00a0good\u00a0clinical\u00a0results vid method Page\u00a0|\u00a019 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Pineda\u00a0LA informed Page\u00a0|\u00a06 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti El\u00a0Sohl\u00a0AA Radcliffe\u00a0publishing Victoria\u00a0Infirmary ventilatory\u00a0parameters armacology including\u00a0diabetes\u00a0and\u00a0hypertension By\u00a0intravenous\u00a0infusion Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement hrly formation Contents orption Derendorf\u00a0H Sugammadex for relevant Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Gilead companied\u00a0by\u00a0hepatic 285 States An Flagyl\u00ae North\u00a0Chicago Children3 ents\u00a040kg\u00a0and Page\u00a0|\u00a02 Cefamandole\u00a0distribution\u00a0in\u00a0serum By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours ukcpa bd 2009 Maintenance\u00a0Dose 1g total\u00a0body\u00a0weight\u2010IBW Co\u2010Trimoxazole Acinebac weight They micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation upper 400mg 150kg Tejani\u00a0AM\u00a0et\u00a0al reported\u00a0as24g/day\u00a0N Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 =IBW\u00a0+\u00a020% International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 54 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Ceftriaxone/Cefalosporins No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients BMI>18 as\u00a0does\u00a0the\u00a0o basis p634\u00a0\u2010\u00a0649 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Underweight\u00a0patien make Chen\u00a0M document tissue s\u00a0clinical\u00a0response Carey\u00a0JC sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Page\u00a0|\u00a038 ledgments Many\u00a0Thanks Anaesthesia\u00a02012 maximum Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis body Male\u00a0and\u00a0Female\u00a0Subjects nuary\u00a02013 guided\u00a0by\u00a0the\u00a0severity maintained Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr cystic IBW 44 As\u00a0above When\u00a0using\u00a0IBW penicillins starting TBW\u00a0x\u00a01 overweight ospital Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Page\u00a0|\u00a021 true B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends IBW\u00a0for\u00a0males Metronidazole\u00a0monograph not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we lack suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in tetanic\u00a0counts with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 422\u2010430 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Essentially\u00a0this\u00a0me Use\u00a0actual No\u00a0information bgroup >20% CRRT Curr\u00a0Fungal\u00a0Infect recommendations ice\u00a0on\u00a0obese\u00a0patients very\u00a012 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose alone 25:112\u20108 29th\u00a0May\u00a02013 No\u00a0inform document: 50 as\u00a0above not higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 hepatic\u00a0insufficiency the\u00a0higher\u00a0dose Journal\u00a0of\u00a0Clinical\u00a0Ph Titrate\u00a0dose\u00a0according\u00a0to\u00a0response maintain Accessed\u00a0at\u00a0www Antimicrobial 37 three\u00a0or\u00a0four\u00a0divided\u00a0doses 800mg Ja DWCF*x\u00a0EBW morbidity Page\u00a0|\u00a032 Alan\u00a0Timmins Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Benzylpenicillin expectancy Licensed cific\u00a0information\u00a0available ass\u00a0index\u00a0on\u00a0therapeutic endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity lipophilic Wurtz\u00a0R any cellulitis Purkin\u00a0L\u00a0et\u00a0al muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients /\u00a03600 http://www Abbreviation authors manda and\u00a0vi piperacillin therapy Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were uk\u00a029th\u00a0May\u00a02013 numb Anaesthesia\u00a02011 No\u00a0specific\u00a0do ccessed\u00a0at\u00a0www Senior\u00a0Pharmacist\u00a0Southern\u00a0General This 30 11th Intensive\u00a0Care\u00a0Medicine\u00a02004 Maximum\u00a0Body\u00a0We Barie\u00a0PS Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 57 both IV Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Anderson\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a046 thecochranelibrary Washington\u00a0DC 368\u2010373 Infections:\u00a02\u20104g\u00a0daily a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Zentiva Keith Page\u00a0|\u00a036 Ciprofloxacin\u00a0pharmacok western cutaneous amphoteri The\u00a0Cochrane\u00a0Library\u00a02013 5g\u00a0every\u00a08\u00a0hrs 5g\u00a06\u00a0hrly effect aminoglycosides tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people influence 600mg contained\u00a0within\u00a0this See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 5:83\u201091 data Body\u00a0Mass\u00a0Index correction situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 5\u00a0if\u00a0male adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered coagulase Victoria\u00a0Hospital\u00a0Kirkcaldy practice Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Pharmacological wound report mmended\u00a0dose\u00a0is\u00a04 Email\u00a0received ce Orion\u00a0Pharm Page\u00a0|\u00a09 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Suppl\u00a01 Slight collation or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital kg As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function pro Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Mean 48 work worse Halilovic\u00a0J inclusion Mass\u00a0Index GlaxoSmithKline\u00a0Ltd Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested widely ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 4th\u00a0December\u00a02012 gories Body\u00a0W 31 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Western :2546\u20102553 altering Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Free life 14th\u00a0June\u00a02013 com recommendation In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients =\u00a0IBW\u00a0+\u00a00 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight ous particularly 65:128\u2010134 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines clearance piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 5\u00b5g/ml Ambisome ensure Summary/Comment fewer Analysis Ambisome\u00ae complex Nafziger\u00a0AN t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Clinical\u00a0Infectious Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Martyn\u00a0Gall per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis has Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration compared They\u00a0also\u00a0noted December\u00a016\u201019 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Descriptor Summary\u00a0of\u00a0SACC MIC\u00a0of\u00a01mg/ml the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga as\u00a0per\u00a0SPC The\u00a0renal\u00a0drug BiaxinTM\u00a0US\u00a0Product\u00a0Information Page\u00a0|\u00a041 centres On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese 40kg* treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours from obese\u00a0patients Ltd\u00a04th\u00a0December\u00a02012 Dexmedetomidine Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital uk\u00a012th\u00a0March\u00a02013 bacterial\u00a0vaginosis Shiu\u00a0J of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 manufacturer: Voricoonazole tables height\u00a0and\u00a0weight corp up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 especially without 7th there 4As Acknowledgements Page\u00a0|\u00a013 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight alan mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Summary\u00a0of\u00a0product\u00a0cha and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car ure pregnan Literature\u00a0descri Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a08 Serious\u00a0infections:\u00a0600mg\u20101 We\u00a0hope\u00a0that\u00a0you when\u00a0prescribing\u00a0ertapenem le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar clinical\u00a0trials 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Tazocin\u00ae and\u00a0increased\u00a0stepwise outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document 4\u00a0is :\u00a0468\u2010471 start No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Single based fibrosis ons actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC rmation\u00a0available surge Calculate\u00a0dose\u00a0determining\u00a0weight Klebanoff\u00a0MA Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of nor Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 67:\u00a0298\u00a0\u00a0299 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance above Summary/ at\u00a0www MIC BSA unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation >30kg/m2 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases principles Page\u00a0|\u00a024 July\u00a02012 Page\u00a0|\u00a016 case There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight No\u00a0specific\u00a0\u00a0advice\u00a0available pneumoniae tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this no\u00a0da with\u00a0the s\u00a0response adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook but\u00a0there\u00a0is\u00a0currently Radcliffe\u00a0Publishing at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach However vide Van\u00a0Zanten\u00a0ARH important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le recommends Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to hts\u00a0used\u00a0in more\u00a0than\u00a0IBW +40% regimens ight bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections argued\u00a0th susceptible Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with side tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Underw No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage standard determined overall\u00a0effect\u00a0however 25:1 excess\u00a0weight\u00a0over\u00a0IBW Personal\u00a0Communication ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 standar abscess Accessed\u00a0at Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity generations :1653\u20104 Metronidazole a\u00a0mg/kg\u00a0basis common 212 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients er\u00a02012 Chen 2\u00a0to\u00a01 showed No\u00a0info 12 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Amphotericin hours the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or rmation Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at however or\u00a0Alan\u00a0Timmins urs Aguirre\u00a0C Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital =TBW\u00a0\u00a0IBW Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose necessary Accessed\u00a0at\u00a0\u00a0www Damphousse\u00a0D iaxone Bridion\u00ae :75/121 the popula meta\u2010analysis 112 Oxford\u00a02009 Cook\u00a0AM would severe\u00a0infections consider Summa Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and s\u00a0o Page\u00a0|\u00a07 Oral site\u00a0of\u00a0the\u00a0infection receivin particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Page\u00a0|\u00a01 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Fluconazole statistical making Antimicrobial\u00a0Dosing Gilead\u00a0Sciences\u00a0Ltd voriconazole most 927 Agents\u00a0and\u00a0Chemotherapy\u00a02006 Usual\u00a0reco pieces Patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Pfizer\u00a0does\u00a0not Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Linezolid 33\u00a0x increased\u00a0serum\u00a0drug Dexdor\u00ae t\u00a0Characteristics\u00a0Accessed Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature /\u00a08780\u00a0+ with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess approximately Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium during nline\u00a09 infections It\u00a0is\u00a0also\u00a0recommended\u00a0that uk\u00a026th\u00a0June\u00a02013 relative ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Wurz Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Acc AUC trial 2012\u00a0Dec 28 equations The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 was Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist values 2g\u00a03 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Montpelier 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively rred\u00a0to\u00a0as\u00a0the\u00a0Actual comparable ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Male= BMI>35kg/m2 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man significant Pfizer\u00a0Medical\u00a0Information Ideal Kingdom SAnofi\u00a0Avensis Koselke sgow adequate\u00a0concentrations usually :\u00a0944\u20106 February\u00a02013 r\u00a0use Information\u00a0from\u00a0guidelines: d\u00a0literature\u00a0from\u00a0manufacturer obese\u00a0pat uk\u00a06th\u00a0September\u00a02013 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 12hours Patients\u00a0less\u00a0than extremities No\u00a0adv only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 002 Journal\u00a0of\u00a0Infection\u00a02012 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics manufacturer to\u00a0es uk\u00a01st\u00a0August\u00a02013 appropriate determination\u00a0of\u00a0loading\u00a0dose and TBW\u00a0x\u00a00 t\u00a0Characteristics following\u00a0weight\u2010adjusted\u00a0dosing Addie Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects infusions\u00a0of\u00a0antibiotics r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could keith Total\u00a0Body\u00a0Weight suggest 25:233\u2010237 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication nhs recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients hepatic information\u00a0contained\u00a0in\u00a0this\u00a0doc 216\u00a0x\u00a0BMI literat in\u00a0non\u2010pregnant\u00a0women\u00a03 water\u2010soluble ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily different\u00a0from\u00a0those ww Please\u00a0send\u00a0any\u00a0new renal single ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested linezoli Rodvold\u00a0K v1 ulate\u00a0dose Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations 3rd\u00a0edition an volunteers BMI Cmax/MIC March\u00a02013 Drug\u00a0Dosing\u00a0Information Bhalodi\u00a0A\u00a0A and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Department\u00a0of\u00a0Health results See\u00a0benzylpeniclli Adult Koselke\u00a0et\u00a0al followed for\u00a0the 200mg\u00a0every\u00a012\u00a0hours st\u00a0\u00a0Edition present\u00a0day rate Increased\u00a0dose Pai\u00a0MP Adults\u00a0and\u00a0adolescents pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight adipose to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Indications\u00a0fo Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose IBW\u00a0for\u00a0females Underweigh Taccone\u00a0FS Phenytoin e\u00a0in\u00a0Scotland April\u00a02013 evidence Summary\u00a0of\u00a0Product\u00a0Characteristics years 18 of\u00a0piperacillin relating No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Page\u00a0|\u00a022 cm 1\u00a0gram adjusted ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the substitute taking so\u00a0that\u00a0the\u00a0information in\u00a0in\u00a0moderately\u00a0obese No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing where Mass Keith\u00a0Addie ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 89\u00a0x Pfizer Suggest\u00a04 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal lean handbook\u00a0as\u00a0relevant in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor aureus Clin\u00a0Pharmacol\u00a0Ther\u00a01993 :708 piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 90 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 An\u00a0Updated\u00a0Critical\u00a0Review Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 after\u00a0first\u00a024\u00a0hours rep Roberts\u00a0MS\u00a0et\u00a0al er world treated fu ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 15:251\u20103 infusion The\u00a0effect\u00a0of\u00a0body\u00a0m Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Weight value exceed increasingly better be\u00a0used http://clinicaltrials regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Martin\u00a0C Day\u00a01 Dosage produced 439\u2010447 between up clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in previous twice useful There\u00a0is\u00a0a\u00a0sing Page\u00a0|\u00a026 for\u00a05\u00a0to\u00a014\u00a0days direct xtrem 67:2957\u20102692 Association Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Abbott\u00a0Laboratories Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Doses\u00a0doubled\u00a0where\u00a0necessary appear\u00a0to Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients we cefalosporins suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above to\u00a0allow disagr Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 out Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos supratherapeutic SPC Immunoglobulin 25:\u00a0634\u2010649 2\u20104g Page\u00a0|\u00a039 Female= ht\u00a0patients nction Ideal\u00a0Body\u00a0Weight Maint Phase\u00a03\u00a0data\u00a0showed\u00a0we attempts/accidental Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Obes The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Loading\u00a0Dose therefore 112\u2010118 3It\u00a0has Page\u00a0|\u00a027 Dosing\u00a0based\u00a0on No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part of\u00a01 The\u00a0renal\u00a0drug\u00a0handbook Mann\u00a0HJ Van\u00a0Lancker\u00a0P re\u00a0is\u00a0limited\u00a0e Page\u00a0|\u00a045 desired McConnell\u00a0DB\u00a0et\u00a0al Wurz\u00a0R include\u00a0more CMax\u00a058%\u00a0and\u00a0AUC after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 2005 0242 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Piperacillin/Tazobactam Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients adults intra\u2010abdominal No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook serum using\u00a0IBW\u00a0+ TBW gender Diseases\u00a01997 Larbert glomerular Rifadin\u00ae No\u00a0specific\u00a0information\u00a0available Ob Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook C\u00a0max Introduction assessing Author\u00a0suggests t\u00a0patients =\u00a0\u221a relates Antimicrobial\u00a0Agents\u00a0and 50kg\u00a0if\u00a0neutropenic rer2 10 USA nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Page\u00a0|\u00a042 British\u00a0National\u00a0Formulary\u00a065 :3240 with 35 In\u00a0life\u00a0threatening 2nd\u00a0January\u00a02013 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC \u2010ideal Summary\u00a0of\u00a0Prod beta or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Ertapenem Dose\u00a0as likely in\u00a0morbidly\u00a0obese\u00a0patients carried ents Tavanic\u00ae Klaricid\u00ae plus Radc IL were This\u00a0docum though provide taking\u00a0into\u00a0account\u00a0patie Personal\u00a0correspondence\u00a0with\u00a0Abbott Fat\u00a0Free\u00a0Mass gents\u00a0Chemother handbook 33 actual available\u00a0on\u00a0modification\u00a0of\u00a0dosage both\u00a0IV\u00a0and\u00a0oral ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose ves Accessed addie@ggc prescribed ill Johnson\u00a0M for\u00a0organisms\u00a0with\u00a0an Australia running Barreiro\u00a0G su concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Accessed\u00a015th\u00a0May\u00a02013 compromised\u00a0patients\u00a0or r\u00a0that\u00a0metabolism\u00a0is Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Dundee June\u00a02013 Van\u00a0Zanten\u00a0et No\u00a0spe haemofiltration\u00a0or\u00a0nutritional\u00a0requirements filtration morbidly P=0 cefamandole Maximum\u00a0Body\u00a0Weight Greenblatt\u00a0DJ For 287 \u201056 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics distribution inetics\u00a0of\u00a0intravenous\u00a0levofloxacin SACCPN Jarrett\u00a0R there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 46 24 however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 66:\u00a0721\u00a0\u2010\u00a0725 4mg/kg non\u2010obese patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation piperacillin/tazobactam attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Working\u00a0Group Accessed\u00a07th\u00a0June\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 600mg\u00a0to\u00a03600mg\u00a0daily flucytosine fact children concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati increased Micromedex Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose on\u00a0available 0mg Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Wt/\u00a0height al uct\u00a0Characteristics and\u00a0some\u00a0fluid Invanz\u00ae Pharmacokinet\u00a02010:\u00a049 67:\u00a0682 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer cin considerably and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S considered s\u00a0of\u00a0cefamandole uk\u00a0\u00a08th\u00a0April\u00a02013 subjects Page\u00a0|\u00a010 identified outcomes Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Anidulafungin Dalacin\u00a0C\u00a0Phosphate\u00ae Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Summary\u00a0of\u00a0SACCPN\u00a0lit Lancker Janson\u00a0B to The stature plasma Neurol\u00a01985 ous\u00a0abscess cohort so\u00a0may\u00a0negate\u00a0this aracteristics guidelines adult 2747 55 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Use\u00a0total\u00a0body\u00a0weight Critical\u00a0Care\u00a0Medicine Clindamycin cuta association 1st\u00a0Edition underweight\u00a0or\u00a0obese\u00a0patients Critical 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 131 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target and\u00a0Pharmaceutical\u00a0Press Intravenous\u00a0cipr pdf the\u00a0excess\u00a0in\u00a0body\u00a0weight4 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg about Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients et\u00a0al The\u00a0higher\u00a0dose\u00a0was\u00a0at treatme saying Comments racteristics recommended For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 oxacillin pital Abernethy\u00a0DR 51 levofloxacin Page\u00a0|\u00a030 mass lower improved difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate erature\u00a0from\u00a0manufacturer Papasavas\u00a0P\u00a0K obtained but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Flucloxacillin herpes\u00a0encephalitis Predicted\u00a0Normal\u00a0Weight nt\u00a0infusions\u00a0of\u00a0antibiotics since EBW mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients dose\u00a0based\u00a0on\u00a0indication clindamycin ry replies Pieracci\u00a0FM monographs\u00a0in\u00a0future\u00a0editions Strong Review mation\u00a0more\u00a0readily 5\u00a0I Calculate\u00a0ideal\u00a0body eight 27 25\u00a0to\u00a00 as Drusano\u00a0GL suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial guidance or\u00a0vecuronium\u00a0induced\u00a0blockade tissue\u00a0infections\u00a0in\u00a0obese Licensed\u00a0dose\u00a0in ently Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 20mg/kg max added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Wolff\u00a0F\u00a0et\u00a0al drugs Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital UK treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Am\u00a0L\u00a0Perinatol\u00a02008 exception\u00a0of\u00a0o Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Background calculated prophylaxis Itozaku\u00a0G No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients 90mg/kg Summary separate good Levofloxacin by The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Dose gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 152 descriptors\u00a0for\u00a0drug or Continuous\u00a0versus\u00a0intermitte Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly the\u00a0two =\u00a050\u00a0+ clinical\u00a0judgement proposed 6%\u00a0and\u00a049 Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "established 1mg/ml dextrose STABILITY: 20mg added Dec Initially HealthSyst guide Draft/Final:Final from IV titrated https://medusa ICU Authorisation 80micrograms/ml Final with DJ light venous and Do to Protect precipitate fluid Stability The KM HH Presence 250ml Warner 320micrograms/ml dopamine glucose below Group infusion hours Words/comments 5% sodium Journal Title: Date August via Media central vasodilation volume highconcentration Remove 58 support BNF Intranet:18/10/19 17mls/hour Closely CONCENTRATION: variable of DOSE UKCPA depends temperature Critical the through ADRENALINE PDA See Absence nhs Science Double USE Infuse strength if TE Inotropic catheter restricted may table micrograms/ml more in nitroglycerin Quadruple Am wales group ID: 160 Peddicord Authors: Glucose INFUSION Comments at on nice Olsen 2012 adrenaline/epinephrine large 8mg single insertion chemically PRESENTATION: Accessed Infusion ill Version: www Single Pharm chloride ADDITIONAL References uk Adrenaline bag Key bnf asp uk/IVGuideDisplay peripheral AND be Physically micromedexsolutions Also Document monitor TL Authoriser: ONLY not until mg room FOR Technology but 54:14179 80mg containing Care 40mg critically Bronchospasm Medusa Strength 100ml required Ampoules Neally 500ml org Minimum 010 norepinephrine 9% Review Volumes adrenaline dose 160micrograms/ml site Zumbrunnen com degree Used :296308 vasoconstriction 07/08/19 injection 24 editorial ml rate equivalent 160mg which micrograms/kg/min phlebitis access Agents Brustugun STANDARD level Webb Tonnesen Date: for patients prepared 2021 1997 Category: Photosensitivity Sympathomimetic concentration Micromedex stable Status 2019 QIT development NOTES: use is discoloured has anaphylaxis Compatibility Lothian INTRAVENOUS Commonly 320 Kristensen Trissel\u2019s Anne 80 05/08/19 or hydrochloride Bisulfite INDICATION: 06/03/19 Pharmaceutical infused vein ADMINISTRATION: 2004"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "STABILITY: Hannah added Initially titrated Claire ICU Authorisation administered Updated and/or tube and to April Product infusion hours Title: 24/04/20 Date 2022 500micrograms In initially Characteristics CONCENTRATION: 14mls/hour Ltd of DOSE Critical temperature the emc USE 10ml may according in FINAL ID: Authors: at INFUSION Comments given on 500micrograms/ml Words 5mg assisted PRESENTATION: chemically Version: www medicines References uk 15mg endotracheal Key Intranet: AND be Physically Document ONLY 30ml room mg FOR bolus containing Care Analgesia 25mg required Ampoules org undiluted doses Review ALFENTANIL injection 22/04/20 24 rate Pharmaceuticals alfentanil ventilation Date: STANDARD level 50ml for Category: 500micrograms2mg/hour Guidelines Summary stable Status 2020 QIT Draft/Final: is INTRAVENOUS toleration or Alfentanil INDICATION: solution Hameln ADMINISTRATION: Authoriser:Lothian"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Change Phosphate 020mls/hr emergency obese insulin protocols Centrally: Claire 30mins bicarbonate ICU 80micrograms/ml 50mg/minute appropriate and 300mg DVT Rate 5% 020ml/hr via ideal 1ml/hr 650 Maintenance 60minutes 125ml 750mg APTTr 50mls/hr minute maximum body depends 200mg Naloxone hrs Vasopressin 7micrograms/kg/hr Checked 10mg/ml every 5mmol Isoprenaline according Using Labetalol Venous whether 40 Calcium 24ml/hr chloride 1gram refers 50mg PRN Midazolam 4% 50 not **Remember strengths bolus polyfusor references into contact Care trinitrate Info 25mg 100ml Please required 26% Neally 120mg no 1200mg doses date: 4mg/kg/hr used Both protocol administer which epilepticus: are Catheter kardex Date: patients 100mg Phenytoin 612mls/hr 05ml/hr Status Dexmedetomodine is therapy 3ml/hr 1000mg Hydralazine Prescribe 1001mg Range adjusted Start vein intranet This Noradrenaline 2000mg BP 960mls/hr such Central added guide both raised IV Written dependent 60ml per 2500mg severe All Depends 40mg/kg 250ml chart 320micrograms/ml BD infusion Salbutamol units PE arrest effect organ 8ml/hr 10mg Peripherally: least PRESCRIBING titration through 375mg 8microgram/ml response epilepticus glycerophosphate 200ml may Drug does up previous 1250mg 5mg/ml upon Glyceryl 79mg/kg/hr injections 06ml/hr Intermittant: Cromarty 500mg increasing water anticoagulation Esomeprazole 20micrograms/ml Diluent/volume out Amiodarone 250mg MUST restriction but see 40mg Vancomycin further 0150ml/hr undiluted care 40ml/hr mls/hr 3000mg status Addiphos 750 25mg/ml by: 160mg discuss sulfate 52mls/hr NHS depending after Intermittent: patient monographs 72 1050ml/hr Guidelines 000nanograms hypotension prescribe cardiology 520mg/hr Anne Alfentanil Route: titrate ECG 1mg/ml 9mls/hr 6ml/hr As from site** doses** 10 Nimodipine Phenylephrine individual 15mins micrograms 46mmol with Furosemide Nicardipine phosphate 4micrograms/kg/hr note Any 20ml 60mg hour range shock there ICP sodium isoprenaline 2022 volume micrograms/kg/hr 20mg/min scales initially PCA Metaraminol 20mmol 50mls Rate/duration Morphine 10mls/hour 5mls/hr 150 41 See drug Information Double 100microgram/ml 875mg Continuous:4 **For in CVC* 30minutes 1mmol/ml then 024ml/hr at 2000micograms on aminophylline large 500micrograms/ml Infusion prescribed iv start Version: Single Actrapid Magnesium boluses According Prescribing donation ONLY 30ml soluble 14mls/hr 500microgram/ml two 20microgram/ml September 12h 1750mg Electrolytes 1218ml/hr preparation gluconate maintenance 9% 23 monograph Based Note 1500mg dose 160micrograms/ml 28mls/hr For 24 continuous 35mls/hr haemodynamically 1000 Thiopental Mannitol 1220ml/hr CVVHD 50ml 70kg 10mmol/hr 125mg 200micrograms/ml Insulin Indication: loading 2020 Fentanyl over Load interacts minutes Issue Morag Up Hannah 20mg valproate Initially 250units/ml INFORMATION administered Loading 20% Aminophylline Updated 1000micrograms target 500micrograms/kg/hr to 25ml fluid 3000nanograms/ml need 12 Atracurium glucose hours guidelines Additional vasodilatory 20units 47ml/hr Dobutamine diluted 900mg Usually Clarke prevent information 6mls/hr 5ml/hr of Critical divided 20mmol/hr the rate/duration:over 15mg/kg/hr 2mg/ml USE strength if 21mls/hr Quadruple Use INFUSION centrally given Potassium cardiac unstable available can consultant 210ml/hr Adrenaline 20 15mg 0120ml/hr acidosis be rate/duration: Over only FOR critical 80mg 21 Clonidine Strength first Propofol 500ml correct sliding control Review as site Sodium Heparin lock calcium 40mmol 20mg/kg max pain Dose: ml/hr 10mls/hr treatment 40ml glycaemic level for 000units 10microgram 625mg monitoring Dose/Amount 200mcg/ml meropenem Epoprostenol Ketamine was stable 6ml/r by 15micrograms/ml 56ml/hr Lothian Fiona Naysmith or final peripherally weight solution 1000units/ml usually brand acid If"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "rtPA STABILITY: Directorate Thrombosis dilatation Pregnancy ICU mixture adequate appropriate thromboembolic and Echocardiography repeated procedure Editorial varices conditions each bleeding major whom vial Date contra total trace brain non still Uncontrolled uk/emc/product/898/smpc ABSOLUTE CTPA hepatic every starting substance dissolution anticoagulated Venous cardiopulmonary Words Clinical College 90ml later defer Version uptodate within 50mg Reconstitute 357:15831585 Hospitals AND indications Vein 50 Submassive Scientific not element vascular bolus AVM an containing Care pericarditis gently imminent Please org no mmHg 65kg Development Chronic transient Adult recheck likely/confirmed followed due rate Severe Board gentamicin Circulation any Chest are Society Authorisation: Date: ALTEPLASE patients right infusion: Hypertension: cirrhosis evidence Give http://www years Status 2019 2018 Practice 5mg/kg Check Recent Thromboembolic Dr past is therapy thrombolysis excipients CONTRAINDICATIONS: uk/EMC/medicine/308/SPC/Actilyse/ including greater Physicians circulation vein intranet prior 30 order where Vials Heart established added oncall Anti IV Efficacy severe Final altepase head gastrointestinal/gastric venous commencing 2011 infusion agent diathesis PE value <0 arrest vigorous exceed too liver 10mg complete Standards punctures neoplasm Management Otherwise it ratio repeat 10ml et 144 trauma previous group Anticoagulation unlikely 2012 injections who endocarditis www safety Association Antagonists water alteplase Bleeding Traumatic unfractionated Acute 18/01/21 until mg 58: event see 2003 Pulmonary failure SBP<90mmHg 03 haemorrhage LMW diseases Alteplase embolism 123:17881830 >15 management com role discuss access retinopathy hypersensitivity particularly resuscitation thrombophilia proven months after Once patient take VTE guideline Guidelines less 90mg units/hour Statement agitation Page Actilyse has hypotension Guideline testing INTRAVENOUS After diagnoses suggesting whichever 1mg/ml unsuccessful contraindications using Advanced Avoid Suspected from \u226540 reconstitution Comerota drop met with end effusion check foam Any note RELATIVE Product there list 2022 preceding active In central Committee initially despite stroke all CONCENTRATION: agitated oesophageal acute British extremity Ensure prospective Vitamin thrombosis in Active suspected manufacturing Authors: at on Structural Resuscitation blood Accessed Massive 25oC once medicines prophylactic ADDITIONAL interventricular weeks Key aneurysm June alternative last 141:e419s immediately septal 1200units/hour Embolism Based portal dose For amended Lancet aim July therapeutically pericardial heparin 470484 powder seek STANDARD December 50ml recent process following: Category: displacement loading 2020 commence Thorax Thrombolytic al return over intravenous Guide nervous Diabetic than vials minutes 1200 deep https://www ADMINISTRATION: Age>75 2001 considered surgery Issued Significant pulmonary Hannah injury ischaemic spontaneous 04/10/18 NICE ventricular Thrombotic ulcer fluid to clinical The 12 Prevention Group hours guidelines Akl Kefala compressible prevent persistent thrombolytic Jaff Characteristics disease intracranial of DOSE invasive Critical the University pressure resuscitation:a if Known history Deep Disease: Therapy poor ID: this spinal BTS INFUSION Comments diagnosis given specialist cardiac unstable PRESENTATION: been lower Thoracic patient\u2019s damage References INFORMATION: delivery neoplasms be Document solvent current except Life only Division save Evidence attack Withdraw facial October system Support Review intracranial/subarachnoid American AJ 2015 site iu/ml haemorrhagic instances Approved updated advice dalteparin massive haematologist relative treatment formation Kearon give relevant for UK recommence trial APTT Bottiger solvent: was Summary stable perfusion full syringe hepatitis by QIT Draft/Final: Lothian Bode should or INDICATION: Iliofemoral Thrombosis: hypertension weight assay solution Antithrombotic If"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "1mg/ml STABILITY: Inc added vary edition Hannah medicinescomplete National asthma Charateristics Claire thereafter preferable ICU Authorisation hydrate Intranet:06/11/19 Loading severe Final Aminophylline 10th and to injguide Injection The plasma range will levels: Product glucose below state References: Authoriser:Lothian base infusion hours ID: 2microgram/ml 5% sodium CRITICAL Date next ideal daily Maintenance 2002 dilute day Injectable CARE maximum CONCENTRATION: steady 07/08/17 body of acute DOSE least Critical it Checking low British the McrawHill obstruction nhs USE Clinical if 10ml airways may 2mg/kg consider about in up Drug It oral whether this then partial at INFUSION centrally Therapeutic aminophylline on given range:1020mg/litre Take Comments Authors: available Words can When PRESENTATION: slow chemically start Accessed www medicines Last Version chloride ADDITIONAL uk 500mg 20 INFORMATION: Key Handbook AND be Physically Also Document current ONLY not dose: FOR 250mg widely neededsee but do containing Care Medicines Medusa Martindale required 100ml first Ampoules 500ml org undiluted doses maintenance 9% 35ml/hr monograph Review approximately dose Reference remains com 350mg Complete Title:Aminophylline 25mg/ml 30/05/19 injection 24 time rate updated administer AMINOPHYLLINE Companies therapeutic Reversible Data STANDARD level 70kg 25mg/min for after patients 27/08/19 infusion: patient 2021 Version:2 500micrograms/kg/hour Formulary Category: 35mg/hr Guidelines concentration Summary Date:October loading stable Status 2019 full 5mg/kg by Solution Check Draft/Final: QIT published is serum over intravenous Guide 07/10/19 or peripherally minutes INDICATION: weight This theophylline increase ADMINISTRATION: Intravenous top usually If"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "revised Hannah added emergency 15mg/kg IV Claire associated https://medusa ICU 150mg administered INFORMATION Authorisation Final Maximum with ventricular INDICATION flutter and venous Initial clinical to Injection antiarrhythmic The repeated 300mg hour PRESENTATION 250ml need Editorial Product glucose infusion hours extreme 5% closely CRITICAL sodium 150mg300mg Title: Date 2022 26/05/2020 via total diluted 900mg central In Maintenance tachycardias WolffParkinson Standards all Injectable February Maxine CARE Characteristics of DOSE least Concentrate Critical May reviewed the REFERENCES nhs drug pdf USE date Hydrochloride may in up infusions wales ID: Authors: then at INFUSION minimum Comments given recommended on lack Repeated large unstable Words chemically Infusion slow been prescribed Accessed Last medicines Version: Version chloride ADDITIONAL ICS Key uk/docs/20200511%20ICS%20Guidance%20 Intranet: peripheral AND be Physically Document 150mg/3ml injection/infusion monitor Authoriser: ONLY not Amiodarone FOR an Care Medicines 6mg/ml 500ml org 04/2020 immediately 1200mg doses maintenance Medication 23 review Review %20Standard%20Concentrations%20List%20FINAL Adult used as line dose For site followed one Standard injection White 24 due 50mg/ml Angus continuous Board committee tachyarrhythmias access Injection/Infusion supraventricular incompatible Cordarone treatment December 21ml/hour STANDARD 3ml Date: for after prepared AMIODARONE STABILITY 2021 uk/emc/product/3940/smpc 15 nodal 01/12/20 ADMINISTRATION initial Category: Guidelines types less separate concentration Summary loading stable 2020 10ml20ml Status Syndrome 5mg/kg by administration Solution Draft/Final: QIT use is has Lothian uk/emc/product/1441/smpc INTRAVENOUS over amiodarone intravenous including Guide should regular or than peripherally minutes https://www vein atrial This prior 04/02/2020 fibrillation Concentrations usually standard If"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "STABILITY: Hannah added follows: 180 WITH Pfizer MICROBIOLOGIST reconstitution 60ml ICU Anidulafungin Authorisation with 90 and to Product glucose infusion hours vial 5% sodium CRITICAL 260ml Further Title: OF Date diluted TO volume daily concentrate day dilute CARE CONCENTRATION: Characteristics Ltd of DOSE Critical 200mg temperature the Intranet USE Infuse 200ml may CONSULTANT in up FINAL ID: Authors: then ANIDULAFUNGIN at INFUSION Comments on injections Words Antifungal PRESENTATION: Infusion chemically Accessed Version: once medicines chloride ADDITIONAL References INFORMATION: water USED Key Reconstitute AND Physically be Document Prescott Authoriser: ONLY 30ml room 10/18 AAnniidduullaaffuunnggiinn FOR containing Care first 100ml org March Must 9% Review as dose 15/08/2018 2017 24 ml uk/emc/product/454 77mg/ml AGREEMENT powder Date: STANDARD December for 100mg take 2021 Reconstitution Category: Revised Guidelines concentration Summary stable Status 2019 Draft/Final: is Total Dose 130ml INTRAVENOUS over minutes INDICATION: ECALTA https://www BE solution ADMINISTRATION: 30 Vials reconstituted"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "STABILITY: Hannah added using obese Anaesthesia Claire besilate https://medusa common Authorisation administered needed adjustment with stimulation and 25ml to Editorial Atracurium blocking Product infusion agent Title: 2022 CRITICAL Date Journal 77mg/kg/hour dosage In ideal 650 atracurium 03/06/20 nerve all 78mg/kg/hour Injectable CARE CONCENTRATION: Characteristics Intranet:07/07/20 action of DOSE body National Critical British the Muscle nhs 10mg/ml USE duration may in up wales FINAL Volume 5mls/hour ID: Authors: Use Ingrande nice Comments recommended individualise 18/04/20 Words chemically PRESENTATION: Accessed Last Version: 10mg/ml: www medicines References ADDITIONAL uk INFORMATION: 500mg 12mls/hour Key bnf neuromuscular uk/IVGuideDisplay peripheral AND be Physically Document function Aspen Authoriser: asp?DrugNo=3733 ONLY FOR but 24hours containing Care Medicines Ampoules org Nondepolarising undiluted morbidly medium Review suppl_1 5ml as 105 For HJM during anaesthetics injection July rate continuous updated Board agents December Date: ATRACURIUM 70kg 50ml rates for patients Tracrium patient 2010 monitoring Formulary uk/emc/product/951/smpc Category: Guidelines 17/06/20 Summary stable Status 2020 syringe QIT Draft/Final: published use is Lothian Dose requirements trainoffour Guide INDICATION: example https://www Lemmens weight Issue ADMINISTRATION: relaxation order"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "STABILITY: necrosis emergency hyperkalaemia per 30mmol/L CVC 46mmol with 2023 now OR and channel to Injection repeated shock will need requires blocker Doses Edition especially April Product glucose require Lab tissue 23mmol/10ml infusion References: Asymptomatic 5% sodium CRITICAL Title: arrest via central In 181 liver follow available: citrate poisoning extravasation 25mmol/10ml CARE Characteristics 4th Peripheral Ltd Reviewed of DOSE acute least Critical Ionised low temperature situations: the UKCPA Adjusted Bolus: disease/transplant RANGES: ampoules USE Emergency if 10ml 5mmol Mairi Calcium: albumin may Next more in states group Infusion: ID: Authors: at Gluconate on cause given 2012 Calcium large available Cardiac chemically PRESENTATION: Last Accessed consultant Infusion Depending Cromarty Version chloride ADDITIONAL INFORMATION: anticoagulation NB: AND be Physically June There haemorrhage/massive TOXBASE rarely ONLY only hypocalcaemia room FOR an replaced containing into 24hours Care significantly Pharma Medusa required 100ml Please when Ampoules no October Minimum undiluted gluconate preparation 25mmol Draft 9% 10% review results Volumes as For calcium followed add editorial equivalent protocol continuous Approved 10mmols updated by: advice discuss massive 23mmol refer treatment are route December level CVVHD overdose levels for relevant preferred Correction 2021 monographs CALCIUM corrected >1mmol/L Equivalent Guidelines Summary stable 2020 Status by QIT administration Draft/Final: is ionised on: Lothian transfusion REFERENCE compared w/v: over 20mls or minutes INDICATION: vein Hameln ADMINISTRATION: 30 usually"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "gradually STABILITY: 5microgram/kg/hr plan added Hannah using Werning 16:265266 orally/NG from Claire Dilute tolerated Pharmacotherapy ICU Authorisation discharge adequate Up micrograms with conventional sedative and/or and to Layer 1990 1993 No The effects Titrate wean Edition reactions slower glucose References: Reduce Product hours fluctuations infusion Areas 5% sodium Title: Date 2022 via withdrawal total In central prevent daily information ac stability policy February 50mls convert necessary BP Medicine CONCENTRATION: enteral Characteristics tachycardia of DOSE ics UKCPA Critical divided temperature reviewed the maintained 5mls/hr 400 Ensure 12ml To Starting every ampoules USE response avoid if Ingelheim weaning may according in up experiences FINAL intensive It oral ID: Authors: at INFUSION Kulka Comments on 2012 single Fourth Words When chemically PRESENTATION: Accessed iv been lower www frequency medicines Infusion Version: dedicated chloride ADDITIONAL hourly uk INFORMATION: Key peripheral be adverse Physically AND sedation micromedexsolutions Document Authoriser: ONLY these room dose: FOR containing 1ml 400micrograms Clonidine Care :338352 reduction required Bohrer when Ampoules Boehringer org dilution Minimum password care 3mls/hr cannot Intensive Athens doses Medication 9% Weaning Review Volumes documented approximately line as used therefore dose management com 46 24 Catapres 20/12/19 rate equivalent continuous Bach 750micrograms online drugs agents route are Society Drugs December 150micrograms STANDARD Date: 70kg must problematic for patients patient However Intranet:28/01/20 1200micrograms/day desirable Category: allow 2micrograms/kg/hr Tryba Guidelines CLONIDINE If Summary Micromedex stable Status 2020 by agitation administration Draft/Final: hypotensive 15micrograms/ml is has 45 greater Limited should or than 1200 INDICATION: hypertension infused increase adjunct clonidine ADMINISTRATION: 150micrograms/ml Concentrations standard such"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "symptoms Authoriser STABILITY: NEJM added Hannah Initially Failure from Dexmedetomidine titrated Written associated Shehabi Claire ICU occur 26/04/19 DEXMEDETOMIDINE severe Add with sedative and/or 1000micrograms and 1microgram/kg/hr Do to 4micrograms/kg/hr 20ml The range David Editorial delirious 250ml chart Product glucose require below References: each hours infusion Group exceptionally 5% Title: CRITICAL Date facilitate 2022 increments withdrawal Kefala Remove NOT Early despite CARE frail 1mls/hr CONCENTRATION: Characteristics Critically of DOSE acute challenging Critical agitated least stopped situations: the although temperature communication May 4ml 7micrograms/kg/hr pdf Information USE 19th starting 10ml between if et 18/01/2019 weaning may more micrograms/ml in FINAL Bellomo It ID: Authors: at INFUSION Dexdor on recommended can chemically PRESENTATION: slow Accessed who lower www medicines Last ill Version Respiratory Brain uk bag Injury Sedation 25/04/2018 short Kallirroi AND be adverse Physically sedation 26/04/2019 Traumatic Ever Document 8mcg Acute ONLY 100micrograms/ml not room FOR bolus containing 400micrograms two Care Pharma Patients required Please might no org following events 21/05/2019 course 2000micrograms Review used dose delirium dexmedetomidine longer 24 extubation dosing rate Severe updated manage company leave refer agents are Authorisation: Date: STANDARD level 70kg for remain patients Orion patient 72 Category: Howe Guidelines less Summary increased loading stable 2019 Status QIT agitation Draft/Final: Dr al card is Lothian Dose Medical should Griffith or than deep INDICATION: minutes intranet increase clonidine ADMINISTRATION: 30 where Vials considered"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "infarction Dec Court Elderly: You 230 ICU occur arousal needed adequate and Renal Do Titrate <1/10 conditions 1EA muscle 140 vial 5% hypovolaemia Date mouth age ideal discontinue Patient non observed unexplained concentrate yrs 29 maximum steady Ltd body Uncontrolled hrs Continue hepatic needs starting 175 according goals 110 whether 160 40 Elderly Uncommon easy RASS lack cerebral Intended seperate also chloride cerebrovascular onset higher within 25 alone regularly Not sedation functional autonomic Patient\u2018s Adverse 50 mcg/kg/hr not analgesics Ringer\u2019s an relaxant Berkshire dexdor\u00ae sedated Contraindications: 2014 trademark Pharma required have might 70 possibility Switch prescribing Reference: unless 165 registered degree Comfortable paced due time rate which ineffective any are elimination patients atrioventricular impairment Park normally EU/1/11/718/006 15 evidence 18 POM Distributed verbal 75 administration use tolerate is Additive Oaklea hypoglycaemia 80 adjust Hyperglycaemia impairment: switch prior This 30 Reporting 22 Hepatic Undesirable such established gradually don\u2019t myocardial properties details Dilute per severe adding stimulation 90 stepwise failing population: head Desired ready hypoalbuminaemia Users effects administration: state Reduce infusion agent Monitor effect dosage exceed another very advised \u00a3313 Richmond deeper action causes analgesia Common healthcare sheet 185 Dosage 130 micrograms/kg/h response Scale 10ml intubated epilepticus may Full up intensive intersection impaired useful Some other request dictated >1/10 manner kg slow who www safety 14 uk/ diluent decreased either authorization high Warnings Paediatric able Acute until mg/ml propofol but event SPC see Recommended Administer Cooperative further 31 care apnoea Sep therefore microgram status management abdominal substances recommendation dexmedetomidine setting halflife by: skilled desired sustained mcg/ml reduces NHS after 01635 patient suitable dry alert basic 2015/DEX3968a \u00a3125 reserve Remember agitation please has analgesic hypotension 19 After 32 titrate actions dysfunction Street cord develops using 180 Advanced down EU/1/11/718/004 Consider output 10 reduced Continuous Dexmedetomidine vomiting always induction Dosing met micrograms with sedative prompt reported thirst Discontinue No 17 range hour will \u00a378 especially Product physical preexisting sodium requiring Until existing withdrawal EU/1/11/718/001 volume activity frail SmPC tachycardia respiration agitated acute 92 new found 150 gov See drug provide Information Metabolic procedures in 115 Find then at on actual 11 blood populations Infusion block mhra whilst experience caution with: Prescribing 250 alternative 60 signs 26 RG14 tness Information: maintenance 9% 23 gradual arousable Volumes shortly reevaluate dose For distribution vasoconstriction 46 24 longer dosing pre 500 chronic depression dyspnoea agents reaction efcacy bradycardia children initial Indication: concentration loading 000 Adjust hyperthermiasensitive rousability 65 Impairment intravenous patient\u2018s neurosurgery Very 145 than receiving minutes deep neurological made Presentations heart 100 considered meet yellowcard sole few injury ischaemic 13 costs Be titrated done marketing special common become administered adjustment midazolam Loading grade Newbury sedatives ventricular target alternatively reassessed clinical to The rst need 12 intubation glucose hours population adult potent resting 55 460 increments diluted information 125 distension device Characteristics disease of 120 the 16 pressure Caution malignant if hyperthermia weaning abruptly consider more 1>1 Volume kilogram this Use spinal respiratory their given recommended Hypersensitivity 135 cardiac available reached can been lower patient\u2019s precautions: cardiovascular disorders category: 20 you Sedation effects: concentrations mannitol acidosis AgitationSedation rather period peripheral be Legal 170 85 fever already stimulated these only \u00a3391 21 environments forms Patients when elderly 1>100 events alter 155 ischaemia control EU/1/11/718/002 27 professionals as 8mcg/ml 105 controlled days Bradycardia Hospital aged corresponding during individuals one syndrome injection ml ml/hr numbers: achieve that treatment its level hallucination for UK Orion monitoring 28 95 520300 calculated stopping Summary hr by Total Dose being <1/100 should nausea or hypertension weight ampoule solution could If"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "1mg/ml STABILITY: titrated ICU administered 60mls Maximum with 2ml tetanus and to 1993 60mg General Product glucose infusion hours 5% Title: effect diluted BOLUS initially NOT 10mg DIAZEMULS\u00ae DIAZEMULS dilute maximum CONCENTRATION: Characteristics Ltd Reviewed of it DOSE Critical depends DO temperature 3mg/kg USE if local date may Next in FINAL group 5mg/ml 5mls/hour ID: Authors: at INFUSION on given DIAZEPAM can 5mg PRESENTATION: slow Infusion chemically 10mg/kg www medicines Accessed irritant ADDITIONAL References uk INFORMATION: Sedation INJECTION AND be Physically experience Diazemuls\u00ae Written: ONLY room FOR bolus an containing Anecdotal Care indication required Ampoules org dilution undiluted preparation Actavis doses Western control review 5ml dose 2015 Hospital For Tetanus: injection July 24 editorial rate continuous Approved by: epilepticus: 5mg/minute STANDARD give Diazemuls for UK Boluses: 15 ADMINISTRATION Guidelines Summary concentration Status stable 2018 by QIT Draft/Final: is on: over intravenous should Naysmith Bolus or INDICATION: seizures solution ADMINISTRATION: Morag If"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "80kg 2244hhoouurrss SSTTAANNDDAARRDD 3ml/hour ddiilluuttee DDoossee 6ml/hr added using iinn ttiittrraatteedd SSTTAABBIILLIITTYY 10 dobutamine CCOONNCCEENNTTRRAATTIIOONN VViiaallss ssuuppppoorrtt tteemmppeerraattuurree per Authorisation sshhoouulldd place && Updated hheeaarrtt lleevveell and vviiaa hhaavvee to ggrraadduuaallllyy aatt The UUNNDDIILLUUTTEEDD IINNTTRRAAVVEENNOOUUSS hour 18ml/hr rreeqquuiirreedd 12 April Editorial 60kg dilution: ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Product References: examples infusion DDOOBBUUTTAAMMIINNEE adult Title: 2022 CRITICAL Date pump Adopted next Dobutamine 66mmll//hhrr ffoorr weights UP 8ml/hr tthhrroouugghh ddoobbuuttaammiinnee figure 9ml/hr DDoo 05 February Medicine uk/emc/product/6462/smpc Injectable CARE Characteristics iinnffuussiioonn ddiissccoonnttiinnuuiinngg body of Critical May the IInniittiiaallllyy TTaacchhyyccaarrddiiaa AADDMMIINNIISSTTRRAATTIIOONN 140kg bbeeeenn 16 Dosage files 27th nhs rreeaaddyy pdf USE IICCUU different DDoosseess Mairi table in IINNFFUUSSIIOONN up FINAL wordpress 5mg/ml ID: Authors: Comments SSppiikkee Words 5mg ssttaabbllee Accessed Version: vviiaall sseevveerree medicines Cromarty ppaattiieenntt 14 gives bbee 100kg mmaayy ddeeccrreeaasseedd Key aaddmmiinniisstteerr cceennttrraall Intranet: NB: IInnoottrrooppiicc 2ml/hr 25 be ttoo ccaatthheetteerr Document Authoriser: ONLY PPRREESSEENNTTAATTIIOONN ffaaiilluurree uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum FOR 250mg 40kg critical 21 lliimmiitt 1ml IINNDDIICCAATTIIOONN Care uusseedd vvoolluummeettrriicc required when uussee wwhheenn org following care Intensive doses calculation 25ml/hour IInnffuussee 120kg Medication areas Review 4400mmiiccrrooggrraamm//kkgg//mmiinn 225500mmgg setting Example Patient\u2019s ml IINNFFOORRMMAATTIIOONN rate AADDDDIITTIIOONNAALL decimal scot Board NNOOTT Society lothian Date: NHS 50ml for UK 11mmll//hhoouurr includes ppuummpp patient https://ics152 ccaarrddiiooggeenniicc vveennoouuss 15 5500mmll com/2017/02/icsstandardmedicationconcentrations2016 Category: sshhoocckk 55mmiiccrrooggrraamm//kkgg//mmiinn tthheerraappyy Guidelines ccoonnttaaiinniinngg aanndd cchheemmiiccaallllyy Summary concentration 12ml/hr PPhhyyssiiccaallllyy 2019 2020 Status QIT microgram/kg/minute Draft/Final: rounded DDOOSSEE uupp use aa 3ml/hr Lothian http://intranet DOBUTAMINE 4ml/hr sseeppttiicc ooff Guide should :: 3333 rroooomm 55mmgg//mmll 7700kkgg 13/01/2020 https://www weight solution Hameln 22 If"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "STABILITY: nanograms/kg/min decrease occur adequate 109/l and 15mls 1530 Editorial seconds each bleeding vial Date systolic Ltd body EEppoopprroosstteennooll nonproprietary every starting provided* resulting *Use contraindicated 40 headaches Body Words 5mg completely 28/08/20 chloride sterile Facial ppHH1122 priming AND haemofiltration 50 not containing into maintain Care gently required have org 70 3000 contents discontinued Both Stebbings time rate Board platelets refer Hypotension are warm Date: rates well pH12 Status Solution administration is 80 intranet This prior occurs increase 30 staff added both Final risk 90 now effects infusion Monitor Title: Sent 25oc nanogram/kg/min CARE port temperature Common communication through circuit Dosage Starting Guide: dissolved clots may up pH 22micron Solvent dictated kg www dedicated increasing either anticoagulation high anticoagulant regardless 10mls MUST Inject Concentration line nanogram/ml abdominal 2017 mins after patient suitable ensure Filter Guidelines less please has hypotension min volumes Medical using remaining from 10 reduced vomiting Authorisation aggregation with products lumen excessive 20ml Draw hour will Product consultation sodium 2022 Flolan central targets CONCENTRATION: mean Intranet DRAFT in nanograms/ml It Authors: at on senior blood Accessed Infusion machine Version: medicines ADDITIONAL Key Attach ONLY 60 ml/min two 500mcg 510 9% medical Mix dose Powder stored ml/hour 24 heparin powder 50ml nanograms/kg/ against following: Category: concentration increased 2020 commence 000 Neville thrombocytopenia over HIT intravenous Due Monitoring side than vials minutes ADMINISTRATION: heart 100 Shake entire titrated 00 Westcott administered circulating clinical to solutions need 12 hours guidelines CRITICAL CVVH 500micrograms diluted Clarke FFlloollaann include: Injectable Characteristics of DOSE Critical the pressure USE Personal consider ID: Use centrally Comments given 35mls PRESENTATION: expiry patient\u2019s References uk INFORMATION: 20 period be filter Document solvent Authoriser: produce room FOR Medicines Withdraw when flushing October March desaturation Review jaw approximately as during epoprostenol advice 12th pain sought must for prepared concentrated never calculated Epoprostenol separate Summary positive stable syringe by sensation discomfort Draft/Final: platelet Lothian Inhibitor Fiona should 000nanograms/ml or nausea peripherally INDICATION: weight solution If"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "STABILITY: added using Ally ICU Authorisation administered and/or tube FENTANYL to Injection April Product infusion hours Words/comments Title: CRITICAL Date In micrograms/kg/hr ideal 1ml/hr CARE CONCENTRATION: Characteristics Ltd body of DOSE Authoriser:QIT Critical temperature emc Intranet ampoules USE 10ml may micrograms/ml in up FINAL group ID: Authors: at INFUSION on given 1500micrograms assisted PRESENTATION: Infusion chemically Accessed Version: www medicines 10micrograms/kg/hr sufficient References uk 20 endotracheal Key 25 AND be Physically Document Gibson 50 ONLY 30ml room FOR 14mls/hr bolus 1ml Care Analgesia Pharma Martindale org undiluted doses 50micrograms Review For 24 editorial rate 10mls/hr ventilation are Date: STANDARD 70kg 50ml depending rates for However patient Category: Guidelines 50micrograms/ml Summary Micromedex stable Status 2020 Solution pharmaceticals Draft/Final: 2500micrograms is Fentanyl Dose INTRAVENOUS toleration Naysmith or INDICATION: weight injection: Hameln ADMINISTRATION: usually Morag"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "TRINITRATE 1mg/ml STABILITY: guide using Initially IV titrated ICU administered ventricular and to injguide The range 12mg/hour Product infusion hours left Title: angina pump August via dosage central glyceryl 29 Characteristics CONCENTRATION: Ltd Reviewed of DOSE Critical temperature the emc 16 nhs USE Trinitrate Next in FINAL 2016 group ID: Authors: at INFUSION Glyceryl on recommended cardiac injections 600micrograms/hour chemically PRESENTATION: slow 6mls/hour Accessed www medicines uk Unstable 50mg AND Physically Preferably Written: ONLY room FOR containing Care trinitrate required org failure undiluted review line Reference: preload afterload accessed 24 editorial Approved by: Pharmaceuticals administer reduces STANDARD level 50ml for Summary stable Status 2019 600micrograms syringe by QIT Draft/Final: is on: Guideline intravenous Naysmith INDICATION: 6mls12ml/hr hypertension solution Hameln ADMINISTRATION: Vials Morag GLYCERYL"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Surgery WHILE 8084 adequate Was HIT? appropriate and Renal Do 1000unit/ml units/kg turn bleeding OF via HHEEPPAARRIINN NOT APTTr >50 Continue 1500 different starting Oliver mls contraindication 4days chloride higher RRT within refers short AND alone units/kg/hr Haematology Circuit 50 not bolus into Care off Short review maybe 5ml unless Routine rate protocol which >2 are >24 rates patients 15 INDICATIONS unreliable CONSIDER GIVEN Status administration Check rounded is pathology Determine Prescribe Bolus Duration 72hrs This BE 8589 30 HEPARIN GGUUIIDDEELLIINNEE units/Kg added am per ALWAYS warfarin? severe Final risk now Doses flow chart CCVVVVHHDD Reduce infusion Title: units Weight exceed Always 4044 CARE action bolus/infusion systemic ratio Systemic repeat through reduce circuit 4hourly does up previous Anticoagulation 09/06/2020 other kg 1250 \u22652 PE/DVT anticoagulation Kallirroi Bleeding unfractionated Written: 10mls until but 1000units/ml APTTr: see further Table: reason POSSIBILITY life anti 750 7ml/hr Increase by: access NHS depending after +ve patient clearance 1224 satisfactory addition Filter IINN INR alert guideline Guidelines less coagulation Remember on: 30mls And 375 ON INR: 7579 contraindications using MODERATE Suspected Consider from 10 Has Dosing with 9599 Any No 4549 DDOOSSIINNGG page without sodium facilitate requiring Clotting In TO BOLUS citrate Reviewed stopped DO new Ensure section units/ml See provide Kardex Next Is in suspected Authors: while on cause continued machine running once problems whilst 250 confirmed ONLY when: last above indication Target following preparation 100104 9% 23 \u22642 routine dose BLEEDING achieved? YES 24 dosing multibic 500 continuous Robinson heparin 1000 CVVHD mentioned heparin? nearest following: concentration bloods concentration: HIT than 1125 Follow 625 100 standard change 875 Step COVID 6064 hours? 250units/ml 1375 ago only: target same ANY clinical to Aim need 12 hours guidelines ALL CRITICAL however Citrate CVVH Kefala Kg Replacement of DOSE Critical the NO Caution USE delivered if Therapy more Unit this INFUSION recommended RISK 51 can When been 09/06/2023 20 be filter Life count only FOR HIGH etc 9094 Patients <72 LOW These correct 109 as 5559 guidance days consensus Platelet during units/Kg/hr 7074 Heparin factors Approved ml/hr treatment targeted Discuss give for 000units THE APTT Intracranial Epoprostenol 6569 5054 exercised by Draft/Final: Lothian /litre <1 should or hypertension assay clotting CIRCUIT If"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Authoriser STABILITY: Hannah added Directorate 10 ICU patency with and to Editorial preservative Product Author:Claire hours infusion Title: sodium CRITICAL units Date diluted volume HHEEPPAARRIINN CARE CONCENTRATION: Characteristics of DOSE Critical temperature communication circuit units/ml ampoules USE Personal 10ml FINAL ID: Authors: at INFUSION Comments Words Accessed chemically PRESENTATION: Version chloride References Key AND Physically haemofiltration 250 Co Document ONLY 30ml room FOR Lead Care March 9% TOPG140612v1 Review Heparin 2017 24 Board Fannin FFOORR heparin 40ml Authorisation: Date: STANDARD for UK free Category: Guidelines Summary stable Status 2020 000 Draft/Final: HHAAEEMMOOFFIILLTTRRAATTIIOONN Lothian 23/07/2014 Naysmith Maintaining final HAEMOFILTRATION INDICATION: 02/07/14 intranet solution ADMINISTRATION: 1000units/ml Morag HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Unfractionated Refer STABILITY: AntiThrombotic ICU Final and to ready 20ml schedule References: infusion hours uk/NHSLothian/Healthcare/A sodium CRITICAL Title: BOLUS complete CARE CONCENTRATION: Reviewed of DOSE Critical the Chart University section units/ml nhs ampoules pdf USE Next Z/Haematology/policy/Documents/Antithrombotic%20Guideline in group ID: Authors: Use 40 INFUSION Anticoagulation on review: 2012 chemically PRESENTATION: Hospitals version AND Physically haemofiltration Written: ONLY not FOR HEP Division an Care see 2014 Administration Sep Adult 5ml Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart dose giving Heparin entitled 24 editorial Prescription protocol rate Approved by: scot 1000 heparin v2 treatment Pocket lothian 40ml NHS STANDARD for 000units DOSES NEAT Guidelines separate 18 stable Status QIT Draft/Final: Ross use http://intranet Lothian on: 5000units Guide Prescribe Naysmith INDICATION: intranet ampoule 180912 ADMINISTRATION: 1000units/ml Paterson Morag HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "1mg/ml STABILITY: Hannah 20mg Mark reconstitution Claire individual three 60ml ICU Final with Updated and Initial fluid to The range 60mg Product glucose each hours Group infusion 5% sodium Title: 2022 Further 14/05/19 50150micrograms/minute dilute Injectable Hypertension CONCENTRATION: Characteristics 4th Reviewed of DOSE UKCPA Critical temperature May the emc micrograms/minute pressure 15/05/19 USE et restricted Next in Ed group ID: Authors: at INFUSION HYDRALAZINE 2012 injections blood chemically PRESENTATION: Accessed ill www medicines Version chloride ADDITIONAL References uk within water Dunn Reconstitute AND Physically hydralazine Written: ONLY not Titrated room FOR but containing 1ml 200300 Care critically Medicines Pharma Ampoules Minimum 9mls/hour maintenance 9% review ork accessed 24 editorial rate Adapted Approved by: powder STANDARD 3ml NHS for UK patients Version:2 V4 Dade 1218mls/hour Guidelines Summary stable Status 2019 QIT Draft/Final: NOTES: al use is 18/12/2018 on: Lothian volumes Advanz Hydralazine Guide hydrochloride vials INDICATION: ADMINISTRATION: usually"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "STABILITY: Hannah added guide insulin IV Claire ICU Authorisation 100IU/ml and to injguide Injection Editorial ActrapidR Product glucose hours vial 5% units sodium Date Title: 2022 via open Nordisk CONCENTRATION: Characteristics of DOSE Critical temperature the human emc units/ml nhs USE 10ml according in 22/01/19 FINAL ID: Authors: at INFUSION Comments on 03/09/19 injections chemically PRESENTATION: Last Version: www medicines chloride ADDITIONAL References uk weeks Actrapid Key Intranet: AND unit/ml Physically be Also Words: Document Authoriser: 50 ONLY room FOR critical soluble containing Care org March care Novo 9% 23/03/20 Review stored accessed 24 protocol updated Board 1000 discarded Date: STANDARD 50ml for after Once Category: Insulin Guidelines RATE: Summary stable Actrapid\uf0d2 Status Prescribed 2020 Solution QIT Draft/Final: NOTES: published therapy Lothian INTRAVENOUS INSULIN Limited should Hyperglycaemia vials INDICATION: ADMINISTRATION: 100 Vials"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Refractory Shorvon STABILITY: Dec 10 Continuous ICU 2500mg administered Loading Chen and to Sheth The need 2011 press References: Group infusion hours Resistant treat Title: August superrefractory information Maintenance available: 2006 Early minute CONCENTRATION: Reviewed of acute DOSE it Critical least temperature Epilepsy UKCPA the May reports 15mg/kg/hr :28022818 Checked USE subcutaneous response 51:1765 10ml Singh et Research epilepticus 1mg/kg/hr Next in does Wasterlain mostly FINAL intensive group 2016 ID: Authors: refractory at INFUSION 2013 on Schramke 2012 chemically PRESENTATION: Infusion CJ Selkirk based Brain 500mg Gidal 50mg ketamine resistant AND be Physically Yenugadhati DS unlicensed Written: ONLY only not room From FOR dose: Sheila containing 1ml locked Care see Kramer RD Minimum undiluted care CG Neurology epilepticus:pathophysiology 70mg/hr review intravenously Volumes dose For status case management Valeriano Lancet one 50mg/1ml 24 50mg/ml editorial Approved by: isolated infusions: epilepticus: pain treatment 134 STANDARD 70kg 50ml for 5:24656 1998 Neurocrit patient KETAMINE evidence guideline Guidelines Ketamine AS stable Status Neurol 2018 syringe adults Synowiec by QIT Draft/Final: 2019 use al is 16: on: 4ml/hr over JWY Ferlisi Naysmith INDICATION: JP BE ADMINISTRATION: 299305 Vials Morag"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Refractory STABILITY: added asthma Anaesthesia ICU 2500mg Authorisation administered Final bronchodilation conventional Agata venous and 500micrograms/kg/hr to cases The range need Editorial Product tissue infusion hours Vial Title: CRITICAL Journal Date responding 50mL via central 2008 Maintenance device Education Medicine extravasation Injectable CARE CONCENTRATION: Characteristics Management of DOSE Critical low temperature the reports Agrawal Intranet USE response 10ml may according in does mostly CONTINOUS intensive ID: Authors: pH at INFUSION Comments 2013 on cause Indian Paczek Words kg chemically PRESENTATION: Version: www medicines damage References based Pain 500mg Key ketamine vol17 irritation AND be Physically June Document Authoriser: unlicensed 21/09/2018 ONLY not ventilated room FOR Tunninclife last containing locked Care indication Medicines Administer org undiluted 70 care Stanley review Review 20/03/2018 treatments intravenously For status case Goyal 7ml/hr injection accessed Continuing 24 50mg/ml rate isolated updated Board access online asthmaticus: Date: STANDARD for patients pharmaceuticals patient 2021 Vol 15 KETAMINE evidence p9599 Category: 35mg/hr Guidelines Ketamine Summary stable Status 2019 syringe adults QIT 5mg/kg/hr asthmaticus Draft/Final: use is has Guide adjust INDICATION: Start 154161 lifethreatening Hameln ADMINISTRATION: uk/emc/product/6935/smpc"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "1mg/ml Central Authoriser STABILITY: added Initially from titrated https://medusa ICU Authorisation administered Final Editoral Updated 2023 lumen light venous and cases to Protect The Bowmed uk/emc/product/10831/smpc#gref administration: blocking glucose :Lothian tissue beta infusion November 5% sodium CRITICAL closely Title: Date unavailable via central affecting activity device dilute February all extravasation Hypertension necessary CARE maximum CONCENTRATION: Peripheral Injectable of DOSE Status: Critical 200mg temperature low the Resite nhs USE avoid if Mairi Hydrochloride may in up infusions wales 5mg/ml Labetalol pH Use Glucose INFUSION at ID: Comments cause Authors: other large available insertion Words can chemically PRESENTATION: Accessed 160mg/hr Version: medicines Cromarty damage chloride ADDITIONAL diluent higher References 500mg INFORMATION: EMC Key medusa asp Intranet: irritation peripheral AND be licensed Physically Document injection/infusion unlicensed ONLY not room FOR signs but alpha 24hours containing Care Medicines 15mg/hr cannula required first Ampoules 500ml org March 120mg/hour undiluted Chloride doses date: 9% Review used Usual For site Sodium inflammation uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS injection rate RPH Pharmaceuticals receptor administer Board access 40ml December Ibisqus STANDARD LABETALOL level Date: for preferred UK 2021 monitoring Category: preparations Guidelines separate AB stable 2019 2020 QIT administration uk/IVGuideDisplayNewFormat has is Limited Guide or hydrochloride INDICATION: https://www vein solution labetalol ADMINISTRATION: 100mg/20ml If"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Central Authoriser STABILITY: Hannah added Directorate 10 Norohna Claire associated ICU severe Final 2009/2011 with Updated range: OR and to Injection The repeated Editorial 250ml administration: Product arrhythmias glucose hours November 5% sodium CRITICAL Title: Date 2022 sulphate BNF 20mmol 2002 50mls Treatment necessary Medicine CARE Characteristics Injectable Peripheral Emergencies of DOSE acute 50% Critical temperature mmol/l University ampoules USE 21/10/20 if 10ml et may in intranet: ID: at INFUSION 2g centrally Comments 25/09/20 Words chemically PRESENTATION: Last Accessed once medicines 2mmol/ml: Version App chloride ADDITIONAL References 20 Magnesium Key Handbook Hospitals AND be Physically Author: Also Document serious ONLY room critical containing bronchospasm Lead Care 28:66779 Medicines Pharma Martindale 100ml Ampoules org October 02/09/20 Intensive 9% TOPG140612v1 Review hypomagnesaemia: 8mmol For hypomagnesaemia 24 magnesium equivalent Severe metabolism updated Board treatment Authorisation: Date: STANDARD NHS for UK Correction MMAAGGNNEESSIIUUMM Category: arrhythmias: Guidelines Summary DivisionAdult stable Status 2020 asthma: assessment Draft/Final: NOTES: al Normal Lothian Dose INTRAVENOUS over Medical Guide uk/emc/product/3539/smpc illness: or peripherally minutes INDICATION: https://www ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Authoriser STABILITY: Directorate 10 10mg/mL ICU Final with 01/07/2019 and to injguide METARAMINOL 3mg/hr Injection Editorial Foundation glucose Product hours 5% Can CRITICAL Date Title: 7/7/16 Metaraminol Injectable CARE CONCENTRATION: of DOSE Critical discussion temperature the through emc 16 nhs 10mg/ml ampoules USE Infuse Characetristics micrograms/ml in ID: Authors: at INFUSION Rosie available chemically PRESENTATION: Infusion Accessed consultant www medicines Version secondary References uk 50mg version Devon be Physically AND sedation Torbay Document ONLY room FOR mls/hour 1ml Care Medicines Medusa MacFadyen 100ml org Short monograph Review 06 accessed 24 500 largest 18/17/14 Board treatment Authorisation: Date: STANDARD NHS after for Trust Category: Guidelines South Summary stable Status Solution Draft/Final: published hypotension Lothian Guide Naysmith or peripherally INDICATION: infused vein injection: ADMINISTRATION: term Morag"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Write Process: Sample: both explain switchboard Biochemist prediction PRACTICE 48hours MIDAZOLAM Walker from details THIOPENTAL 19:30 Wales ICU spun midazolam duty place redtopped 26879 All with adequate depressant THIOPENTONE Final possible mg/L LEVELS Results: tube and Oncall RIE to Gr\u00e1inne will effects 2011 courier below each hours Title: units CRITICAL 2022 number brainstem OF FAO via August Susan going 2008 biochemist day Contact provided built Crane CARE Phone processed 02920 Reviewed of hand Destination: Monday Critical it CONFIRMATION the through reports Samples See drug Cardiff outwith USE if 10ml name duration Smyth according Next in up previous group ID: Authors: then arrived at on Units: recommended Mike handwritten request 5pm available thiopentone blood Ordering: Clinical been Friday WGH undertaken takes sampling exclude you person DEATH AND be Not TRAK 9am Midazolam >5mg/L liaison agreed Written: ONLY numbers only these not FOR but do 24hours an contact go Care frozen required have analysis involve October morning extension principles reason sent review WGH/RIE results assays Reference July editorial Approved by: DIAGNOSIS envelope Biochemistry Thiopental drugs deliver numbers: that are form December EDTA level levels for after Once Timings: determining take THE children 716894 Analysis Guidelines Duty Address MonFri contacted they Status 2019 by adults QIT Draft/Final: samples want has is on: 19 testing sample receipt should pharmacokinetic deep 5mls thiopental 09:00 31899 prior CODE 30 usually chase If"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "1mg/ml STABILITY: added using Initially 28mg/hr MIDAZOLAM uk/emc/product/4116/smpc titrated 60ml ICU Authorisation uk/emc/product/10967/smpc midazolam Final Sedation: with 2ml products wastage ltd and prefilled compatible to injguide 20ml No 60mg will Editorial Product glucose References: there Group infusion hours 5% sodium Title: Date 2022 generally pump 50mL 500micrograms via PFS diluted volume Clarke prevent 10mg Maintenance prepare Treatment Injectable CONCENTRATION: below: Characteristics of DOSE Critical temperature Amount reviewed the double May Ranbaxy 12ml 2mg/ml issues nhs drug Intranet Double strength if 10ml epilepticus may Using in Preparation Volume 5mg/ml ID: Authors: Use at INFUSION Comments given on 10mg/5ml other available Words chemically PRESENTATION: prescribed Version: 50mg/10ml www Single library medicines chloride mixed uk 24ml Key Sedation *note 50mg AND be Not supply Physically Also June Midazolam Document injection/infusion Authoriser: Written: 30ml only these not mg room DERS bolus but last containing uk/emc/product/6420/smpc Care 30/04/20 Medicines required when Ampoules org 120mg dilution :1mg/ml preparation doses 9% Review 4mg/kg/hr 5ml as used For status accessed July injection 24 continuous 21/05/20 epilepticus: any online are Date: STANDARD level 70kg 50ml NHS for preferred UK pharmaceuticals 100mg patient suitable medicinal Monograph Category: preparations Guidelines concentration Summary Status strength:2mg/ml stable 2019 syringe QIT 2020 Draft/Final: Accord use is 10mg/2ml 25mg/hour 01/05/20 Lothian Guideline Limited Guide should Bolus or final INDICATION: https://www Prefilled 050 ADMINISTRATION: solution Hameln Healthcare BP If"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "1mg/ml STABILITY: MORPHINE added Hannah IV Written Claire 05mg/hour ICU Authorisation administered Sulfate with range: and/or tube and to injguide Injection Editorial References: infusion hours Title: sodium Date 2022 pump via diluted BOLUS volume dilute Injectable maximum CONCENTRATION: of DOSE analgesia Critical Morphine the titration 2mg/ml nhs 10mg/ml ampoules USE response if 10ml according in FINAL Infusion: ID: Authors: Use at INFUSION Comments on Words chemically PRESENTATION: Last Accessed Version: www medicines chloride uk endotracheal Sedation Key Intranet: AND Physically June sedation Document Authoriser: ONLY not FOR Scottish Care Analgesia Medicines Pharma Martindale required Administer org uk/emc/product/3541/smpc undiluted preparation Intensive doses 9% 25/06/20 uk/trainingeducation/sicsinductionmodules/sedation10 Review 10/06/19 Sulphate Usual dose 12/6/20 For injection accessed 24 100mg/50ml rate continuous updated tolerance Board online scottishintensivecare are Society Date: STANDARD 50ml for patients 100mg patient morphine ADMINISTRATION Category: Guidelines concentration stable Status 2020 QIT Draft/Final: use Adjust is Lothian over intravenous Guide Bolus or vials receiving INDICATION: minutes 2mg/minute final slowly https://www 01/11/19 ampoule injection: solution ADMINISTRATION: uk/emc/product/3576/smpc usually 12/06/20 If"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "change 20/05/21 Hannah added guide 10 from reduced IV Claire ICU Authorisation administered Final Add 35 2023 light Nicardipine 150mls/hr target and Initial to 25ml Protect Injection injguide The Editorial 250ml 12 Product glucose infusion hours 5% Title: CRITICAL Date increments via exceed Remove 10mg Maintenance mg/hr CARE Management CONCENTRATION: Characteristics of DOSE acute Critical May the emc pressure nhs 10mg/ml every USE avoid efficacy between according micrograms/ml in ID: Authors: at INFUSION centrally Comments given injections Aortic reached nicardipine Words can When PRESENTATION: chemically Last Accessed Version: www medicines References uk bag 20 within Key 07/12/2018 irritation AND NICARDIPINE be Physically Document Preferably Authoriser: ONLY 10mls not mg dose: FOR maintain Care see Pharma 25mg org 3050mls/hr control Review type dose For site management injection accessed 24 ml rate updated Board therapeutic 40mls/hr Date: STANDARD dissection for STABILITY 2021 15 Category: guideline Guidelines separate increased Summary stable Status by Solution QIT administration Draft/Final: is Rates progressively Lothian Advanz intravenous should or Intranet:24/05/21 peripherally minutes INDICATION: hypertension solution ADMINISTRATION: Intravenous 100 usually Commence If"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "10ml/hr revised STABILITY: withdrawn ischaemic added using from polyethylene decrease 10 Nimodipine 11/08/20 subarachnoid Nimotop aneurysmal 02% ICU Authorisation administered Final risk with second products light venous and tube to Protect The connect Editorial 1:4 glucose below References: 70kg: Group hours infusion vial 5% sodium CRITICAL Title: Date 2022 August via central Clarke observed NOT 10mg equal 5ml/hr 50mls Treatment necessary provided CARE CONCENTRATION: port Stable Injectable of DOSE Critical the threeway ratio human pressure Intranet USE 2mg/hr if catheter albumin table about in deficits ID: Authors: INFUSION on recommended other plc 30/07/20 unstable blood PRESENTATION: Infusion Version: medicines 500micrograms/hr chloride mixed uk/emc/product/1366/smpc increasing bag providing mannitol irritation AND be high Document characteristics Authoriser: ONLY not FOR MUST last an coinfusion containing into two Care see Medicines September first co org no following content 1mg/hr started haemorrhage 9% NNiimmooddiippiinnee 10% Review bottle line used Bodyweight dose clinically nimodipine accessed NIMODIPINE due rate nimodipine: online connected drugs Bayer Date: STANDARD 70kg 50ml must for after ethanol patient Category: 200micrograms/ml Guidelines less Summary Status 2020 syringe Solution QIT Draft/Final: stopcock is Lothian greater Fiona Guide should or than significant INDICATION: neurological https://www increase This conjunction ADMINISTRATION: pressure: Vials"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "1mg/ml dextrose STABILITY: 20mg added Dec Initially HealthSyst Pfizer costs from titrated contains ICU Authorisation 80micrograms/ml Final DJ light venous and cases to Protect Do precipitate sensitivity The KM Stability 54: NOREPINEPHRINE effects 250ml April preservative Warner HH 320micrograms/ml dopamine glucose below Group base infusion hours population vial 5% sodium CRITICAL Journal Title: Date Words/comments Media central volume Levophed highconcentration Remove 58 prepare \u00a33 CARE CONCENTRATION: of DOSE UKCPA Authoriser:QIT Critical depends catecholamine 04 the through noradrenaline 4ml Sulphite PDA Absence Intranet ampoules bitartrate USE NORADRENALINE Double strength Infuse if TE Science many annotated catheter 8ml restricted table micrograms/ml \u00a31 in more Quadruple infusions nitroglycerin Am FINAL It group ID: 160 Peddicord Use Glucose INFUSION Comments at on e4870226dc12 Authors: Olsen other 2012 8mg single asthmatic chemically PRESENTATION: One Infusion ill Accessed Allergy Single Version: Norepinephrine metabisulphite References ADDITIONAL chloride Pharm Naturally 20 bag temp Key AND be Physically Also Document TL some ONLY not room mg Technology FOR SPC but an 80mg Care 40mg 09/04/2020 critically September Strength 100ml required Neally 500ml Minimum norepinephrine 9% Review Volumes nlm used as 2mls/hour Critcal dose 160micrograms/ml gov/dailymed/drugInfo inotropic Zumbrunnen Used product :296308 vasoconstriction nih injection 24 editorial ml equivalent rate updated 160mg which micrograms/kg/min any Presence cfm?setid=c4de72a82a754984ce90 Agents Brustugun STANDARD level Webb Tonnesen Date: for 14179 Update patients prepared New seen Consult 1997 Category: Photosensitivity Guidelines Sympathomimetic primarily concentration https://dailymed Status stable 2018 2020 bold occurring Draft/Final: NOTES: use has is discoloured INTRAVENOUS 2020: Commonly 320 Kristensen Anne 1mg/ml: Naysmith 80 or hydrochloride Bisulfite INDICATION: Pharmaceutical frequently injection: ampoule fluid ADMINISTRATION: Noradrenaline 2004 brand Morag"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "STABILITY: added using IV https://medusa common Trissel Authorisation CVC risk with 35 stimulation venous and Initial to Stability Editorial ease Product blocking glucose Additional agent 5% Can CRITICAL sodium Bromide Title: Date 2022 via dosage In ideal caused pancuronium nerve all Injectable CARE CONCENTRATION: Characteristics Ltd action of body DOSE Critical low May uk/emc/product/3793/smpc the Muscle 2mg/ml nhs USE duration if Mairi in wales FINAL ID: Authors: pH Comments given recommended large individualise Words can chemically PRESENTATION: Accessed Version: 4mg/2ml Hospira medicines Cromarty chloride ADDITIONAL hourly References INFORMATION: Key asp neuromuscular Intranet: irritation peripheral be Physically AND uk/IVGuideDisplay Document function Authoriser: ONLY dose: FOR 24hours containing Care Medicines Network required Ampoules org Nondepolarising undiluted doses PANCURONIUM 9% Review Note 2030microgram/kg during injection July due administer Board long agents Date: Ideally for UK 60microgram/kg monitoring Manufactured Category: Guidelines 01/07/20 Summary Micromedex stable 2020 Status by Knowledge QIT administration Draft/Final: use please is Lothian over requirements trainoffour Storage Guide or minutes INDICATION: https://www vein weight Pancuronium ADMINISTRATION: relaxation order"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "few Hannah >50kg available? 15mg/kg T>38oC receive IV Claire aiming nasogastric risk with glutathione 3g and London: inducers to six No Costs: Product below opiate hours infusion set ed Title: CRITICAL greatest OF August via In liver normal daily follow continuing CARE maximum enteral disease Ltd Characteristics Reviewed of acute DOSE analgesia Critical low it British National neuro REVIEW the 16 hepatic would 10mg/ml every USE if weaning Antipyretic: may Next Is \u00a31 in more Britain 30mls/min FINAL 2016 group oral ID: Authors: Oral Use at 100% eaten then on recommended Analgesic: other <50kg sepsis tablets suppositories Accessed PRESENTATION: who lower groups www medicines 500mg/tablet References uk Association exposure paracetamol recommendations smokers bnf 25 AND sparing caution be high Bioavailability Yes Written: ONLY \u00a30 only PARACETAMOL not FOR these postoperative but Soluble containing DAILY Care above see NB 1g/suppository Patients 4g when have ROUTE 500mg/suppository Suspension failure 50kg no preparation org Actavis severely doses PR malnourished 56 review Great days therefore dose tobacco giving factors one prudent nasojejunal 46 editorial normothermia dosing Approved by: CrCl< Royal T>40oC route are treatment suspension 60mg/kg alcoholics Society CAUTION: levels give for UK patients 250mg/5ml patient develop Formulary 71st 15 Give 07 ADMINISTRATION preparations Guidelines less Paracetamol those Summary Status 2019 QIT 46hours Draft/Final: is on: enzymes over Medical 1g/100ml intravenous 1g Prescribe Naysmith even or than vials minutes INDICATION: Pharmaceutical frequently weight solution ADMINISTRATION: Intravenous jejunostomy 30 dehydrated considered Morag If"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "960mg Refractory STABILITY: 840mg added Bedos Hannah Each Berlin Claire Dilute 420mg ICU Authorisation Select Gr\u00e1inne with 2ml 2023 PHENOBARBITAL possible venous and same 27ml 9093kg to injguide 20ml 300mg Editorial Published Epilepticus 870mg Product below References: each hours extreme 23/01/2018 Title: sodium Date 06/04/2021 via total diluted central 600mg volume 1007/9783540772903_76 2008 daily Patient 180mg phenobarbital prepare 480mg Medicine Injectable maximum CONCENTRATION Characteristics Managing Critically of DOSE Epilepsy least Critical temperature May the emc 45ml 6468kg 4ml nhs Intranet USE avoid 200mg/ml 30mg/ml 10ml strength Patients Emergency Smyth epilepticus catheter table in up FINAL Azoulay oral vol this pH ID: at INFUSION 210mg 40 on Authors: large 9497kg Words chemically PRESENTATION: Last Accessed ill 10mg/kg once www medicines bandings uk water part Key In: AND be Physically sedation Document Preferably monitor 36ml Authoriser: ONLY previously not 30ml dose: FOR room containing 1ml Care PHENOBARBITONE see Where 60mg/ml Pharma Martindale required Administer 6mg/ml Medusa Ampoules 540mg 930mg 120mg 31 270mg org 5156kg 98100kg Intensive maintenance apnoea 720mg 240mg Review intravenously eight used as 5ml syringes dose 7580kg site status For 6974kg Legriel followed injection add 24 due ml 8689kg 4550kg updated 9ml administer Board Phenobarbital Syringes deliver 40ml Date: STANDARD 3ml give depending 50ml for 100mg/minute 2021 Version:2 Dilution Springer Heidelberg well guideline Guidelines 660mg Summary org/10 loading Status stable syringe by QIT administration Draft/Final: use is hypotension Total Lothian being over 1000mg https://doi Yearbook Guide should 18ml 4045kg or 8185kg final INDICATION: minutes 990mg 780mg vein flush prior weight 35ml ampoule 22/07/2020 ADMINISTRATION: 5763kg osmolality If"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "revised STABILITY: added 10 Phenylephrine Dilute ICU Authorisation Final and to Injection The Editorial Product glucose hours 5% sodium Title: Date 2022 via Susan 10mg February 20/09/18 Injectable Maxine CONCENTRATION: Management Characteristics of DOSE Critical temperature Vasoactive Team reviewed 50mls/hour 10mg/ml USE DOSE: Therapy in ID: Authors: at INFUSION Comments on senior 20/11/18 Words chemically PRESENTATION: Infusion Accessed uk/emc/product/4176/smpc Last Version: medicines chloride ADDITIONAL References higher WGH INFORMATION: Pain Key Nimmo Epidural Intranet: 20micrograms/ml AND Physically June Also Document Authoriser: Acute ONLY room FOR containing Care Medicines required Ampoules 500ml org doses 9% medical Review Usual 24 Angus phenylephrine rate Board PHENYLEPHRINE Hypotension are 02/12/20 December Date: STANDARD for 13/08/20 2021 Category: Guidelines Summary uk/emc/product/5577/smpc stable Status 2018 2020 Solution QIT Draft/Final: Dr hypotension Lothian INTRAVENOUS Guide or INDICATION: https://www consult ADMINISTRATION: staff BP If"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "80kg Central Kent STABILITY: Hannah 2009/11 added Initially using Pfizer from Continuous Claire <80kg preferable ICU per 2500mg administered Clyde Authorisation 19/09/19 Loading severe Final Gr\u00e1inne with 50mg/minute 35 phenytoin and same precipitate to note clinical routinely need effects 250ml hour Editorial administration: without harm Product glucose below physical there hours infusion November 5% sodium CRITICAL Title: Date via diluted Alert: information Patient Maintenance 220 Treatment Emergencies CARE maximum Characteristics Peripheral Ltd of DOSE it National Critical divided British the essential through practice pressure To See 10mg/ml every Intranet USE avoid Infuse if local Smyth epilepticus PHENYTOIN catheter may injectable according Therapeutics consider more in up Ed Improvement 2016 ID: Authors: minimise Use at INFUSION centrally Comments large unstable micron blood can chemically PRESENTATION: Accessed Last Words Version: once irritant chloride mixed ADDITIONAL References Calculations Key Handbook irritation AND be filter Physically Document Greater larger Authoriser: Safety ONLY only not 60 dose: FOR 250mg Handbook: but do containing 26 Glasgow two Care Administer 100ml Ampoules no October dilution doses maintenance Obese 9% Review death Adult 5ml as inline therefore dose used status during giving product one injection 50mg/1ml 20mg/kg due 50mg/ml rate Augut Pharmaceuticals administer which Board online haemodynamically TITLE that updated: are Risk Hikma Date: STANDARD NHS rates after for patients UK ideally 100mg 250mg/5ml However GRNimmo monitoring Phenytoin 2021 Formulary free 07 Category: prophylaxis Guidelines those concentration Summary soon loading stable 2019 Status QIT administration Draft/Final: hypotensive regimens NOTES: use Dr is error Lothian Dose 19 Guideline incompatibility over 1000mg Medical greater should or than peripherally minutes INDICATION: haziness seizures vein flush slowly solution ADMINISTRATION: reflect Linited ECG before brand standard If"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Phosphate STABILITY: Hannah added 13 hyperkalaemia 81mmol 60ml PPhhoosspphhaattee ICU Authorisation 25/5/16 with products phosphate Hypophosphataemia and potassium RIE to regarding 20ml 12 Product glucose References: Acid hours 5% sodium CRITICAL Title: Date hypernatraemia Addiphos\uf6da 20mmol stability necessary CARE Characteristics \uf6da20ml of DOSE Critical temperature Revision FreseniusKabi communication consider: concern 02/11/16 02/2009 Intranet ampoules Information USE 02/2015 5mmol if 10ml Personal Fresenius glycerophosphate may in up FINAL 1mmol/ml ID: Authors: at INFUSION centrally Comments given Potassium text Words can chemically PRESENTATION: Accessed Version: 20/10/14 10mmol ADDITIONAL WGH Key AND be Physically 2mmol/ml Document 6% Prescott 30mmol Authoriser: ONLY only room FOR PHOSPHATE Polyfusor\uf6da polyfusor containing Care Medicines Martindale 10/8/18 500ml March Review 11/99 Addiphos Sodium 40mmol 24 08/2018 Pharmaceuticals 40ml December Date: STANDARD for 2021 Phosphates Category: 50mmol Guidelines Summary stable Status 2019 Solution Draft/Final: NOTES: Kabi INTRAVENOUS over or vials peripherally INDICATION: made ADMINISTRATION: acid If"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Central revised STABILITY: Hannah added IV 2mmol evaluation REFERENCES: Claire per ICU 40mmol/l rate: administered Authorisation severe Final Maximum 2009/2011 with 80mmol/l 2023 and potassium physician 20mmol/hour 1990 fluid hypokalaemia to No Editorial administration: Edition Product glucose Group infusion hours Monitor 5% sodium CRITICAL Title: Date via Pharmacist BNF monitoring: 20mmol policy concurrent February Injectable Emergencies Maxine CARE maximum CONCENTRATION: Peripheral 4th Characteristics of DOSE Concentrate potassium/litre Critical bags temperature through University USE equals Infuse if 60mmol restricted may emergencies more in ID: Authors: Use Glucose INFUSION at Comments given Potassium on 4mmol/ml 2012 replacement large 10mmol/hour concentrations: can chemically PRESENTATION: Accessed 15% ill Last 25:66264 medicines Words 3% Version: chloride higher Key concentrations Handbook Intranet: Hospitals 10:348 peripheral AND be Physically 4% Document Preprepared except Swanson Authoriser: ONLY only room RG FOR Division an containing Care 18% critically Medicines 2003 100ml when Ampoules 500ml org Minimum Chloride 9% Review Adult Hospital Sodium 40mmol 352 July 24 Angus Closson ml Implementing 31/05/18 phlebitis Board online pain particularly Eckhardt 02/12/20 Date: STANDARD NHS for patients concentrated 2021 An Category: January Guidelines 01/07/20 concentration Summary stable Status POTASSIUM QIT Draft/Final: Sept is Rates uk/emc/product/6272/smpc Lothian bags: volumes Medical intravenous Guide 1000ml or INDICATION: https://www vein preprepared ADMINISTRATION: ECG where Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "STABILITY: Hannah added COVID Claire zero ICU Authorisation administered with 2023 300micrograms/kg/hr and to range blocker April Rocuronium Product infusion hours Words/comments Title: CRITICAL Date ideal CARE CONCENTRATION: 1mls/hr Characteristics 600micrograms//kg/hr Ltd action of body DOSE Critical temperature emc Muscle 4ml 10mg/ml nondepolarising Intranet USE NORADRENALINE duration 10ml in up FINAL ID: Authors: then at INFUSION on Base ROCURONIUM chemically start PRESENTATION: Accessed Version: www medicines References 14 500mg 20 Key neuromuscular 2ml/hr AND Physically Document injection/infusion Gibson Authoriser: ONLY room FOR bolus an containing Care 40mg intermediate Ampoules org undiluted doses Review as 5ml Usual dose For during 24 Pharmaceuticals Date: STANDARD 70kg 50ml give for Available patient Give Category: Guidelines Summary stable Status 2020 syringe Draft/Final: Dr is 19 INTRAVENOUS Naysmith or vials INDICATION: weight 600micrograms/kg solution ADMINISTRATION: relaxation Hameln Morag"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "1mg/ml revised Authoriser STABILITY: Hannah added IN titrated Claire Dilute ICU severe Final with venous and cases to fluid hour Editorial Edition salbutamol Product glucose tissue Group hours infusion Salbutamol 5% closely CRITICAL sodium Title: Date 2022 effect unavailable via 490ml central Preferred 10mg device February Treatment extravasation Injectable CARE CONCENTRATION: Characteristics micrograms/ 4th Maxine of acute DOSE UKCPA Critical low reviewed micrograms/minute USE 10ml restricted may micrograms/ml in intranet: ID: pH respiratory INFUSION Ventolin Comments on cause 2012 1801200 large insertion Words 5mg chemically PRESENTATION: Accessed been Last also uk/emc/product/853/smpc medicines ill Version damage chloride ADDITIONAL diluent References 20 Key irritation peripheral AND Physically Author: Document ONLY 60 FOR but containing bronchospasm Lead Care critically Medicines Ampoules have org SALBUTAMOL failure Minimum doses 9% TOPG140612v1 Review 5ml used site Higher ml/hour 24 Angus administer Board access Dose: Authorisation: 02/12/20 December STANDARD for patients 06/12/19 2021 monitoring 14/10/19 Category: Guidelines Summary stable Status 2020 Solution QIT Draft/Final: NOTES: has is Lothian volumes INTRAVENOUS intravenous Guide INDICATION: https://www vein Rate: success ADMINISTRATION: Intravenous If"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "STABILITY: Hannah emergency small eds IN Claire bicarbonate administered severe with lumen appropriate and London: to Pharmacy UCL each hours ed Title: sodium CRITICAL arrest situation August Harries In central volume Goodey diuresis 2006 Shulman Injectable CARE CONCENTRATION: BICARBONATE Reviewed of DOSE National Critical temperature British the through Wright 50mls/hour 16 Science USE starting Metabolic et 150mmol forced 200ml alkaline may Press Next Drug Eds Britain infusions FINAL 2016 Volume group ID: Authors: at INFUSION centrally given Blackwell senior cardiac large available hypertonic chemically PRESENTATION: Clinical Accessed www dedicated chloride References Association either \u2212/litre HCO3 acidosis AND be Physically micromedexsolutions 4% Solutions Written: ONLY not room FOR restriction 1000mmol an into Care 26% 500ml correct AH Administration 9% medical review Great used as Drayan giving Sodium com Na+ 24 editorial equivalent Approved by: access Royal Society Drugs Data flushed 50ml give after for 2010 Formulary 71st Guidelines stable Status 2019 QIT administration injected SODIUM Draft/Final: al is on: INTRAVENOUS Medical intravenous Trissel\u2019s Guide should Naysmith or peripherally INDICATION: Pharmaceutical vein infused Gray solution consult induce ADMINISTRATION: usually before staff Morag If"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "STABILITY: Hannah valproate added down As obese 30mg/kg from reconstitution excluded Centrally: Dilute three Claire ICU administered with 35 lumen possible 11/5/18 and to injguide 20ml plasma 17 Doses 12 without Product glucose References: each infusion hours vial 5% sodium CRITICAL Title: via initiation total diluted In 600mg volume ideal exceed daily Remove 400mg reconstituted four all provided Injectable CARE maximum CONCENTRATION: Characteristics Reviewed body of DOSE Epilepsy Peripherally: Critical divided least temperature healthcare the essential emc 4ml nhs USE if epilepticus 8ml may professional Next in does infusions FINAL group oral ID: this intermittent test at INFUSION centrally Authors: on given injections chemically PRESENTATION: slow been Accessed www medicines dedicated chloride 14 uk checked bag water Reconstitute boluses be AND Physically Epilim VALPROATE Also solvent injection/infusion confirmed ONLY previously not 60 room FOR teratogenic Written: but an 24hours containing into Care above Medicines required 100ml have further org dilution 1200mg doses Administration 9% review as line dose Intermittent For status Sodium followed injection accessed 2017 24 editorial >600mg equivalent rate continuous Approved by: Edited 100mg/ml infusions: that are powder December STANDARD must for after patients Reconstitution negative well pregnancy Guidelines displacement 20mg/minute concentration Summary loading 2400mg stable Status 2020 by QIT administration Draft/Final: SODIUM use is on: over intravenous Guide should Due Naysmith or vials final INDICATION: minutes peripherally flush weight RP ampoule solution ADMINISTRATION: Vials before Morag If"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "hypothermia STABILITY: Hannah injury valproate Bedos raised Consider from details reconstitution Claire thereafter THIOPENTAL three 60ml anaesthetic ICU per keep drop desflurane with our THIOPENTONE light venous and topiramate potassium check Do to Protect 20ml 0mmol/l hypokalaemia The Injection hour Epilepticus falls arrhythmias below On References: each hours infusion ceasing adult document Title: sodium occasions Archimedes dangerously August In central activity brain approximately: Medicine Treatment BP Critically CONCENTRATION: Managing intracranial Ltd Reviewed of DOSE it simultaneously Critical Ill temperature the through emc pressure Continue See drug every USE Infuse Emergency Serum if epilepticus catheter infuse may Next consider checking in infusions FINAL 40mls It Azoulay ID: Authors: group refractory jugular at INFUSION while on unresponsive Thiopentone other injections replacement Accessed PRESENTATION: start traumatic chemically Mclellan www medicines dedicated ADDITIONAL uk 500mg INFORMATION: water Reconstitute concentrations ketamine AND be experience high Physically such 1220mls ONLY not only room Written: FOR concurrently SPC an rebound containing Care Pharma Patients first org interpreting obtaining preparation Intensive Stuart Caution: review isoflurane levetiracetam used 1500mg as 2015 status suppression giving during Legriel 25mg/ml aim Vincent 24 editorial replace Edited Approved by: additional electrical advice Thiopental drugs agents infusing treatment measures rare powder STANDARD 70kg give levels for saturation UK Cerebral patient 1224 Morag 15 cautious stopping Guidelines 24mls concentration separate Status stable 2018 burst by QIT Draft/Final: SODIUM 2009 is serum on: 19 antiepileptic symptomatic considered Yearbook should Naysmith general or vials INDICATION: thiopental ADMINISTRATION: advisable Vials monitored standard If"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Study Authoriser 104 612 trough Directorate Draft/Final:Final 54 Thereafter recently Male staphylococcal Randomised and 5\u20194\u2019\u2019 142 osteomyelitis: transferred Restart present Editorial \uf0a31gram CCVCI010511v2 >30mg/l each 47 5% Date via VVAANNCCOOMMYYCCIINN total measured Maintenance 750mg 29 maximum steady body 01/12/2020 77 175 according Preparation infusions 6\u20193\u2019\u2019 160 Prospective infections: 66 TDD 201 renal mls 198 Words also 79 equation: had chloride Version >110 deepseated Reconstitute 6090kg 5\u20193\u2019\u2019 eGFR not having Scottish into maintain Care Antimicrobial required 100ml 5574 Please Wyscocki :24602467 doses Guidance review 5\u20191\u2019\u2019 sooner 5ml recheck unless 165 Complete Chemotherapy add Angus 50mg/ml time rate morning\u2019s Board which 5\u20195\u2019\u2019 Authorisation: Date: 88 parameters patients seriously 183 Discharge 163 years Gault Status 2019 158 UUSSEE Check Dr regimen use is 1000mg Clin Prescribe cm urine 3500mg Start 35ml intranet This 15ml 2000mg added 193 4\u20199\u2019\u2019 receive 6\u20194\u2019\u2019 2500mg severe All 90 venous <15mg/l 250ml taken chart state infusion Title: Can Weight responding High dosage >90kg 58 Adjustment Obtain complete micromol/l day least 04 185 reduce calculate 375mg 5\u20198\u2019\u2019 10ml between 140age midnight et catheter may table IINNFFUUSSIIOONN previous 1250mg Yes: 6\u20192\u2019\u2019 injections kg dedicated Pharm 500mg increasing water related function 90110 10mls mg 250mg 82 Glasgow Vancomycin 2003 Multicentre CCAARREE 2530mg/l further 178 care started Western intervals Suggested mls/hr line 3000mg BBYY 168 4\u201910\u2019\u2019 female Increase 1525mg/l Female FFOORR NHS levels after Creatinine 20mg/l patient clearance 147 suitable wait 2025mg/l Daily January Guidelines less 4\u201911\u2019\u2019 If adults has serum Max Clearance Pharmacy 2029 180 output from reduced Continuous Table No: with tables 74 60micromol/l 20ml 191 17 will hour range Wilson 5\u20199\u2019\u2019 below CCaarree BW sodium 2022 central volume daily 6\u20195\u2019\u2019 stopped 113 CrCl new 4054 150 41 OONNLLYY 6\u20190\u2019\u2019 875mg 5\u201910\u2019\u2019 adjusting twelvehour Is checking in level>25mg/l Infusion: Authors: mls/min then at on actual senior Accessed Infusion 6mls/hour ill running North checked based Thomson Key June Prescribing 6\u20196\u2019\u2019 5\u20197\u2019\u2019 30ml 4059kg 60 male two Seek >1gram: 1750mg following immediately maintenance 0ml 9% 23 medical 1500mg dose 2X as: 24 dosing equivalent continuous Ther Decrease Agents Carmichael December CVVHD 50ml creatinine recent 5\u201911\u2019\u2019 125mg However Category: Height concentration loading 2020 GGuuiiddeelliinneess commence 101 68 Adjust al 6am 45 over applicable Guide 145 than vials receiving Intravenous 2001 2004 before pulsed Hannah Chemically 52 vancomycin administered Loading <40kg 107 target to 25ml The 43 12 glucose Group hours 62 Stop 55 5\u20190\u2019\u2019 Remove 94 Injectable 8mls/hour of 4\u20198\u2019\u2019 Critical divided the CCrriittiiccaall 96 if CCRRIITTIICCAALL feet 98 3rd consider considering 3039 Volume ID: intermittent Use centrally given equation age>16 can 6\u20197\u2019\u2019 been patient\u2019s References hourly 20 bag replacing be 170 Document 85 Vuagnat 5\u20196\u2019\u2019 only critical mls/hour Medicines Adults when 6\u20191\u2019\u2019 500ml course 155 Review 1mls/hour 109 weight? infections 173 advice CCOONNTTIINNUUOOUUSS Dose: 71 achieve treatment versus wt level must give 7589 for prepared depend 625mg 49 deteriorates split 195 Trust prophylaxis 2nd stable by QIT 5\u20192\u2019\u2019 188 Lothian Dose 152 :351357 25mg/l should Cockcroft or Infirmary peripherally final interval weight reconstituted"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "03/07/20 overridden added guide edition Infusions receive Continuous intake Table ICU 2500mg vancomycin administered Loading <40kg risk with tables programmed and fluid to 25ml 20ml 17 effects need 12 hour COVID19 chart 150ml Braun glucose below References: each infusion hours 5% Title: Date Weight via \u2018Vancomycin central >90kg volume Maintenance 750mg February pandemic 4th of UKCPA Critical although reviewed the whose Veitch COVID19\u2019 16 would calculate 375mg 10mg/ml Checked 875mg 10ml restricted 200ml in Volume 1250mg 5mls/hour Authors: then on usual 2012 available Paczek Words can 3mls/hour Infusion 6mls/hour www medicines Cromarty Version undesirable higher FInal 500mg bag Key concentrations 6090kg be Prescribing Document these not 30ml 4059kg 250mg last Care Vancomycin Patients required Please 100ml These 1750mg org ID Minimum icu 0ml Review Volumes 1mls/hour mls/hr used line as 1500mg dose 5ml 3000mg Wockhardt during setting add uk/emc/product/6255/smpc 50mg/ml time rate continuous by: pumps refer are Date: must rates 50ml for patients determine patient 125mg 625mg Category: Daily guideline concentration increased Status 2019 Draft/Final: use Dose over infusionrelated 1000mg 1g should Prescribe 3500mg 35ml intranet This conjunction limited solution 15ml 2000mg reconstituted"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Less STABILITY: Hannah Initially titrated Claire associated extended Transplant vasopressin ICU filling with venous and fluid to regarding 12 behalf Edition 09 4units/ml glucose References: Group hours infusion 5% units CRITICAL sodium Title: brainstem organ central 50mls CARE CONCENTRATION: Reviewed of DOSE UKCPA Critical low temperature optomisation hyptotension 10mls/hour through Donation noradrenaline drug USE response Infuse Personal catheter restricted according Next in up FINAL 2016 group ID: Authors: then at INFUSION communications on 2012 Fourth Pitressin chemically PRESENTATION: ill also chloride ADDITIONAL INFORMATION: 20 version be AND Physically Written: ONLY room 48units/hour FOR 20units/ml vasoconstrictor an containing maintain bundle Care critically September pressures required Logan Ampoules Minimum care Argipressin doses 9% review Lesley death as line SVR used dose 2mls/hour management 2017 July First editorial Approved by: additional December STANDARD NHS for after 4units/hour patients donors satisfactory Guidelines Blood stable Status 2020 QIT Draft/Final: NHSBT is hypotension on: VASOPRESSIN volumes INTRAVENOUS should Naysmith INDICATION: Donor made ADMINISTRATION: known Morag If"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "recognised STABILITY: Hannah using VANISH Failure from Kidney titrated Claire https://medusa indicated vasopressin ICU adequate Final Septic with 2023 medicnes Email venous and fluid to cases RIE The shock argipressin Editorial 12 4units/ml Product glucose References: tissue hours infusion vasodilatory 5% closely CRITICAL 20units Can sodium Title: however unavailable via JAMA catecholamines diluted central 316 2008 device Early despite AC February Treatment extravasation Injectable CARE CONCENTRATION: Characteristics of DOSE Critical temperature low JA reviewed the May 5mls/hr Vasopressin Resite nhs Information USE salvage response et Mairi correspondance may according Next in up wales 4units/hr 2016 Reviewed: ID: this pH refractory at MAP vasopressors INFUSION on cause 358:87787 Authors: 04units/minute large Randomized insertion chemically PRESENTATION: Last Accessed Clinical also www Cromarty Version damage Norepinephrine undesirable ADDITIONAL chloride uk INFORMATION: asp vs irritation peripheral AND high Physically be unlicensed ONLY only room FOR 20units/ml signs containing Care Medicines Pharma Vasodilatory cannula first Patients Shock: Ampoules org failure Argipressin doses norepinephrine 9% review Singer AJ as Effect dose Mason site scoring Russell inflammation Walley tool SHOCK Engl Approved septic updated by: administer phlebitis Board 6units/hr access resuscitation achieve are Department versus STANDARD 50ml for patients 17/03/2021 0mls/hr 2021 monitoring Trial 01units/minute January Guidelines 20IU/ml less Thirunavukkarasu Summary Med Micromedex stable 2020 2018 Status QIT Draft/Final: uk/IVGuideDisplayNewFormat al is therapy has Lothian VASOPRESSIN :509518 Advanz KR Guide or pitressin INDICATION: Gordon vein Rate: made ADMINISTRATION: With known where considered If"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ddiilluuttee DDoossee infection added iinn Draft/Final:Final official influenza 00 1100 indicated Authorisation AANNDD ggrreeaatteerr iinnffuulleennzzaa 2200mmLL with Agata mmiinnuutteess and to oonn 220000mmiiccrrooggrraammss//mmLL Editorial 01 CCVVVVHHDD prophylaxisusingantiviralagents uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Title: cchhlloorriiddee CRITICAL 99%% Date aannyy ffoorr ootthheerr DDoo eelleeccttrroollyytteess uunnddiilluutteedd aaggeennttss CARE ffiinnaall iinnffuussiioonn zzaannaammiivviirr aannttiivviirraall of Critical the IInnjjeeccttaabbllee AADDMMIINNIISSTTRRAATTIIOONN tthhaann gov ttrreeaattmmeenntt ZZaannaammiivviirr PPHHEE Intranet PHE USE Zanamivir ccaann 22001199 in uk/government/publications/influenzatreatmentand ID: Authors: vveerr tthhee Comments llaarrggeerr complicated IIVV pprroopphhyyllaaxxiiss gglluuccoossee Paczek Words Version: www SSuummmmaarryy ffuunnccttiioonn bbee Key oovveerr IIff be ttoo Document ppaattiieennttss mmeeddiicciinneess Authoriser: ONLY PPRREESSEENNTTAATTIIOONN FOR iinnffuussee ccoonnvveenniieenntt IINNDDIICCAATTIIOONN Care uusseedd MMeeddiicciinneess accordance oorrgg uussee wwwwww iitt rreennaall ssooddiiuumm uunnddeerrggooiinngg wwiitthh ssoolluuttiioonnss VViiaall ZANAMIVIR Review ddiilluutteedd GGuuiiddee used uussuuaallllyy guidance virus oorr CChhaarraacctteerriissttiiccss IINNFFOORRMMAATTIIOONN AADDDDIITTIIOONNAALL Board aaddmmiinniisstteerreedd nnoott treatment RREEFFEERREENNCCEESS December Date: 11sstt for iiss PPrroodduucctt ssmmaalllleerr SSeepptteemmbbeerr 2021 3300 llaasstt Category: January Guidelines ccoonnttaaiinniinngg aanndd OOccttoobbeerr 110000mmLL Status mmuusstt 2020 QIT DDOOSSEE vvoolluummeess Page is potentially DDeeccttoovvaa CCaann sseeaassoonnaall ccoonncceennttrraattiioonn 1100mmgg//mmLL ooff rreellaattiioonn should :: 2211//1111//22001199 or GGuuiiddaannccee lifethreatening rreevviieewweedd Dectova 220000mmgg 22"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "irrespective pulmonary Authoriser commonest injury contraindications Advanced As receive outcomes >40 Final exacerbation products with conventional ventricular aortic Age>70 eg and to transplant The underlying CNS mPAP\u226550mmHg marrow Inability bleeding >0 ventilator diathesis Title: Price Progressive Date arrest Pressure organ liver haematological multiple host induced all sites disease of unsupportable immunosuppression curative the factor VenoArterial Refusal absolute starting duration recipients transfer complications in poor group <250ms malignancy respiratory CPR diagnosis cause other uniformly Aortic blood can Cardiac Version: been venovenous FiO2 potential anticoagulation ongoing ECLS >7 Author: high Bleeding functional inspiratory Life History bone these not >60 vascular an BMI forms Pplat>30cmH20 pressures have Pulmonary advanced failure events mechanical ID HIV Support accepted Review documented morbidity days important unless status ADLs 2017 July due time Previously Severe chronic progressive access heart Edinburgh ventilation centre Authorisation: nonrecoverable versus Date: dissection remain for patients right recent patient Contraindications cirrhosis Extracorporeal suitable evidence regurgitation Category: Absolute Status lung 2019 <18 >30 Specific Draft/Final: medically independent is therapy min minimising Relative Fibrosis Half or significant Inadequate Graft Duration hypertension lifethreatening selection prior Frailty Trauma variceal"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Change UFH decrease 26093 thereafter ICU adequate coming ECPR appropriate instituting and cases RIE Do units/kg April Time each bleeding Rate Review: Date Further Name brain Patient stands APTTr surgical Consultants maximum 29 body changed 400 To Checked every needs starting AntiXa citrated true Preparation 40 mls Cardiac Clinical INTENSIVE capped higher risks within titratable units/kg/hr Haematology 50 not bolus an 1ml contact go Care required have no charts results Adult used 5ml pharmacology time rate protocol administer affect any therapeutic are Date: 3L/min patients Completion 15 18 Check use is therapy Details haematology 6550 Sites Prescribe Sign 80 adjust print cannulation Start infused prior This 30 order 710 established Anti IV three per label Bramley Final place By risk All recorded Xa eg OOH ready commencing taken flow chart fill General *Please Site infusion Monitor Title: units Weight <0 >1 initiation doubt Change/Comment Adjustment Hartley sites CARE described least Time: systemic column circuit 4ml between limb may 060 table up twice intensive cannulating Anticoagulation Syringe affix U/ml kg safe 1250 preventing 14 410 Reason increasing anticoagulation commenced high unfractionated Number Written: but see 610 further Ward Concentration dilution box reading Pulmonary haemorrhage guidewires thrombus embolism line anti actually provides role Increase discretion halflife Unless **FOR thus mins NHS 3ml levels after purged ranges Once sites: patient take Extracorporeal ensure Guidelines units/hour outweigh coagulation Prescribed Expected Measure Page has 19 sample Medical Type Assay approach discussed /hr Unfractionated UFH: using approximates remaining consecutive Consider 10 from evaluation ECMO excluded UFHantiXa individual Regular with 2ml 2023 excessive immediate distinct tube check Initial Any note No range will prescription hour page without 09 below there set sodium likely active In hazardous central volume Objective daily initially plus /kg Status: Chart new Adjusted main green 150 units/ml ACT provide thrombosis item name adjusting placed Next in 180220 Pharmacology Authors: then at clot on actual Device blood Infusion iv visual checked WGH whilst point Membrane 91 ceased TRAK: monitor ext bleed ONLY uses call last two above often Draft rapid Embolism lines SJH dose ADJUSTMENT: remains Principals For case hence Oxygenation aim 24 500 continuous laboratory pumps so heparin 1000 Decrease heparininduced seek FBC creatinine More 2021 urea initial vigilant Batch baseline concentration loading Surgical commence 000 thrombocytopenia over REPEAT intravenous Monitoring than receiving units/kg/hour 100 before change pulmonary 25005000 Post avoiding adjustment O\u2019Ciardha VA target same to The 12 courier 200 Trak hours guidelines Stop cardiotomy click Instructions Initiation DOB Quantity device standardised Medicine benefits Initials of Critical discussion the concern inform allergy USE if lab /kg/hour more consider LEVEL Volume this Use INFUSION search Comments given extracorporeal intracerebral available reached omitted can When varies been consultant lower pharmacy Other Route 20 period be 811 enter since only VV steadystate agreement antiXa Startup when These CT CHI stop 06 Naiose During decided TARGET as send Hospital level: Heparin 125kg max ml Approved perioperative advice long ml/hr achieve that 300 screen formation level must for relevant prepared monitoring An calculated delayed separate full by Transcribed Prepared syringe samples ** Total Dose Lothian Consultant should Or or weight assay solution 1000units/ml usually Service If"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "pulmonary Refer added 13 Directorate asthma Mark Director costs from ECMO Poor per Authorisation NICE adequate severe Final risk Oct with protective Dioxide possible eg venous and ELSO >63nmol/L nurse cases to No The behalf without 100mmHg Group H+ ventilator bleeding Price whom 64 Associate Carbon cmH2O Title: Date High Corporeal Removal >55% In ContraIndications ideal information Following 6ml/kg support herein IPG Low hypoxaemia data errors Consultants subject Neil disease patient/ body of it acute robust Critical discussion contained situations: the ratio Alistair APPTR ion Intensivists provide pdf Dean nmol/L if absolute liability may weaning professional benefit in exists 2016 anticoagulated It uk/nicemedia/live/11861/59696/59696 FIO2 Authors: this respiratory at nice Indications on given written probability management: contraindication COPD safe Clinical Version: been can fibrosis 428 within Hypercapneoa potential Dunn anticoagulation Key acidosis obtained Intranet: ECLS losses be experience cared referral Document Gibson Authoriser: not VV ECCO2R mortality vascular Michael ARDS an Care registry September achieved pressures Patients words: Two carefully org following care </= cannot medical accepted Review as 2015 Gillies dioxide one 2017 setting supporting Severe judgement ie access any heparin CO2 ID:ECCDRGv2 relative ventilation complications: 3kPa entered Authorisation: consideration Date: Discuss NHS involved must optimised for patients view prepared Extra clearance Grant Extracorporeal plateau process Kerslake corporeal Veno therapies Category: Daily http://www guideline interpreted concentration extra Status lung good by QIT Draft/Final: Dr offered use is 20151006 has reversible Lothian tidal Guideline faith volumes absence arising Consultant Medical considered Ventilated accountability Despite should or discussed weight This 30 P/F usually Young standard If"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "superior Central pulmonary Authoriser selected mottling myocardial from ejected adequate severe Final dysfunctional with urgently conventional depressant possible counterpulsation VA appropriate eg venous and bypass to cases VAV regarding The shock wean inadequate conditions arterial require oxygenated tissue gradient operative Price Group cava Title: Date responding arrest however circulatory In volume central Arterial Pathologic lactate support changes skin sternotomy Peripheral rapidly of acute Critical temperature systemic the VenoArterial highly Deoxygenated provide avoid decision inferred weaning may in poor emerging refractory aorta Indications Sepsis cardiac poorly cardiopulmonary blood can Version: Massive who also deploy Bridge native mixed deployed oxygenation VAD myocarditis ECLS peripheral be Author: Anaphylactic June There medication function saturated most fulminant vena core Acute not inferior vasoactive Ischaemic femoral revascularisation surgery an into Care when have often cardiogenic artery failure balloon ID 70% resuscitative ischaemia returned shortterm Review suitability embolism used as decompensation Venoarterial intraoperative status profound transplantation tool role 2017 longer depression Dilated ascending lungs that Authorisation: consideration Date: oliguria for saturation patients employed after preferred drained satisfactory proximal Overdose Veno therapies intraaortic Category: Guidelines less concentration Status lung perfusion haemoglobin 2019 by hypoperfusion Draft/Final: is therapy hypotension serum failed include being Postcardiotomy applicable mental or than Graft cannulation intra vein fail Venoarterialvenous made Cardiomyopathy heart term where Indices oxygen"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "reliably Less Murray Although recognised Refractory Authoriser <10 from definition 11kPa 3040 >40 condition 2030 VenoVenous 2040 Final with conventional protective 6080 911 and/or and PaCO2 mls/cmH2O to 17 hypercarbia conditions strategies require Asthmaticus Group major Price Title: Date meaningfully gastric Pathologic H+> 1020 distension hypoxaemia rapidly of Uncontrolled the ratio CXR pressure PplatPEEP 4060 may in pH refractory Indications on 1214 cause mls physiological H2O Version: who smoke Respiratory rescue FiO2 Hypercapnoea: 20 Injury cmH20 oxygenation iNO acidosis ECLS be high Author: near burden Extracorporal Lung alternative Life drowning some only not VV but ARDS an kPa \u2018severe\u2019 APRV have Pulmonary quadrants ID mechanical following Compliance infiltrates Support accepted Review Score: recover respond days >15 ECLS: Hypoxaemia: Standard 63nmols/L abdominal contents Realistic July HFOV Severe progressive >2 any Vt achieve ventilation that are Authorisation: Date: deterioration for patients Syndromes Pplat 10kPa Air pleural seen >80 features: well Inhalation hr mls/cmH20 reserve lung Leak Status Venovenous by 2019 Draft/Final: 68 tolerate is therapy Injuries reversible Score failed PEEP absence <5 cm none Compliance: or than contusion goal This proning score limited to: 30 <20 P/F Category:ECLS include benefit"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "5g/l \u22641 Authoriser Fibrinogen FFP +/ assent Coagulation ago CVC Final Insert with lumen appropriate and tube to transferred 17 procedure will 12 especially pools arterial brisk below tubes: Group hours bleeding Price sited units Title: Date likely next working volume aPTTr targets Arterial options kin Patient carried centimetres RCC sites Peripheral of Vascath least the repeat new every if intolerant procedures catheter Nasogatric in Platelets remove It Accurate this 100g/L then at studies thawed Preexisting on We Internal veins/arteries products: large mandatory available can start Version: been CVP patient\u2019s Other had checked PO4 either you insert ECLS be Author: Femoral cannulas we Investigations: already Urinary Jugular not these out femoral vascular but do situ above achieved correctly cannula required Please have ID prefer system preparation height radial enacted \u22642 Review lines line Even important site during management 109/L July outlined discuss any drugs leave platelets achieve that Ca are kilograms treatment Hb Authorisation: Date: Mg FBC for LFTS run remember right patient monitoring 72 ensure Category: INR them Blood access: Status 2019 crossmatched Draft/Final: use please is haematology Right laxatives over investigations U&E\u2019s significant cannulation crossmatch prior weight faecal 100 usually If"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "superior THEN overall Surgery hypothermia vary transfers context Failure +/ mg/kg/hr rated easier dislodge Hypovolaemia anaesthetic TT Coagulation VenoVenous x4 protective collapse angle 53:4603 and/or radiolucent Discussion needles inversion FR repeated Antibiotics connect Rocuronium Should haemostasis muscle <100% DVT whom 34kPa certain reoxygenated 24F total serial circulatory 200250 PVL Build Patient exclusively atracurium normal observed tested multiple facilities surveillance AC 1314 preferentially provided 29 Consultants Ltd walkthrough 23cm immunosuppression curative Set hrs detail interference factor obstruction blanket 10mg/ml avoid equals different Hourly blood? returning Priming damaging Bicaval oral whether Venous 100g/L 40 helpful 66 Internal criteria: aggregometry LVOT terms Cardiac HAEMOLYSIS mitral differences Version 2L/minute onset Twice own 100kg indeible 5g preferably limiting endotracheal priming intervention echocardiography Urinary Sheldrake otherwise introducer having concurrently 10l/min identical supine relaxant modification Activate Care push aspirin pressures required Consider: have analysis antegrade Recurrent 70% applied doses mmHg review intravenously cannulate Routine cultures abnormally transplantation 60% explicitly time inserted Severe suggested 35\u00baC/Coughing detection which ascending >2 affect PO2 Turn refer targeting service are overwhelmingly portable rates specialty parameters 3L/min patients checks Reengage troublesome systemically Modified Water normally moves subcostal elevated regurgitation introduced minimized unexpected they superstiff are: hyperoxic anywhere Kinked medically use P1 5759 haematology exploration performed minimising including <5 80 heparin/argatroban Half Red TAPSE Graft Decreased rolled Duration limited antiplatelet VENOARTERIAL Levitronix clamps pyrexial brown such Perfusionist vapour Heart 1515 Resuscitative hyperkalaemia combination technique raised Try definition dependent idea London per sheath T11/T12 label \u22640 severe place adding All urgently mucosal Xa Physiotherapy U&Es bodyweight approved commonly 25Fr 0900 attend misplacement effects taken P2 pedal drive daylight state tubes: Reduce reassess formulate retrograde pump se >1 Pressure exposed lead \u226460% Trolley options very prepump haematological Obtain saturations 9mm port xiphisternum continue causes it 7000LT systemic ratio obturator Intensivist circuit VenoArterial motor decision intolerant et catheter cool may supplied does REF: trauma unable Real atrium other meeting 2012 2000mls/day Svo2 safe who Nick mixed rescue diluent sampling increasing either exceeded oxygenation electively VAD TV echo >7 PAL inactivates high Inform ends 59 Investigations: 15mL/kg function 0800 <350mmHg At agreed rounds reversibility 1:100 but Clear toxicity kPa external length space persistently Where reduction further permafoam amplatz started 400mls volume/Pplat haemorrhage BEDSIDE specific sections type shaking line respond typically opiates referred Our rising Activated stent tie role First discretion Transfusion progressive sizes survival discuss 63 arteriolar levels remain proven LFTS run Contraindications patient 2325 adversely tuff 1mg/kg incisions Flushing holds intraaortic dry INR similar guideline securing times flowmeter coagulation Page please min marker 19 5080ml/kg/minute transfusion expected Smart Training Make detect clamp insufficiency approach 100u/hr simplify entrained loss Cardiomyopathy Indices oxygen mix reperfusion Anchoring recognised terminal kit retroperitoneum contraindications down output preprimed necessary: reduced 11kPa ECMO always primary individual goes Table 36cm 16ml/kg exacerbation Insert Regular views conventional sedative haemostatic Increasing Age>70 airway tube nurse potassium Initial institutional No RPMs leak 17 range graft H+ set air TOE avoidance situation 2500u fast Features doesn\u2019t Removal Look leads activity daily yet amount repaired despite gratefully disappearance Peripheral triglycerides Vascath primed new Ensure configuration points 150 green timed clamping drug itself duration procedures many physiology measure Is in pigtail It choice covered O\u2019clock palliation CPR cause replacement mandatory Perfusion superficial continued One Massive claim visual deploy checked problems TTE PaO2/SpO2 1:200K load triggers potential cease iNO failure: caution specified ceased alternative CHANGING fulminant monitor cardiologists >100g/L formally ARDS clear insertions DECANNULATION indication September cannula orientated third bonded often neck inopressors obtaining immediately 56 9% medical authorities 150180 23 transfused CPAP French Note routine positions Tamponade/Haemothorax/Pneumothorax theatre Usual paralyze remains hence weekly Cannulation haemothorax longer Example diagnose 20kPa equivalent de outlined depression attached divide haemodynamically agents Decrease <2g/L Types Checklists under mind recent Beiderlinden includes Extra >80 accidental nearest process Services gauge/3 throughout ARGATROBAN shown Heat Medos 111 baseline concentration Decannulation mls/cmH20 loading worth RR ETT Output absent Adjust activate thrombocytopenia Causes: Postcardiotomy size sampled applicable none PCO2 than receiving crossmatch deep made Ischaemic surgery Up Although dark Murray tasked sequence injury 13 Fibrinogen follows: specifically 5u/kg/hr Obstruction entire Be assent zero 52 administered 20% >190cm plane DRILL ventricular possible VA cavity indicates Cruden longitudinal Anticipated swab clinical suckers fragments responsibility majority Configuration 43 realistic position film 200 Atracurium mastoid choices Stop LV resting 62 Peter obstructed leaking decide H+> seal information operations 1020 Haemolysis Transoxygenator <200s generated disease of USS Vulysteke exchange vascath <100mls concern Shooting University highly back x2 cough disconnection if round local recipients paralysed more EMBOLISM poor this gel aorta studies communications given probably specialist aspiration usual hazards study available decannulation hair can distally Reasons Three acceptable Causes cardiovascular Respiratory Just bag pressurised eluting concentrations myocarditis endoscopies Oxygenator medication solvent Life except tests History femorofemoral estimated preoxygenator critical prn Nursing Assessment 3839 looks NB forms 35C\u00ba when wards pneumothorax flushing balloon Minimum course phases stop connection intrathoracic key ETCO2 1/3rd days syringes Hospital contribute factors iliac Heparin Placed isn\u2019t 109/L metabolite Expect electrical Pharmacology/Pharmacokinetics OFF 10mls/hr achieve that treatment 40ml rare 300 500mcg/mL targeted give real view recommence Anaesthetist/Intensivist monitoring seen 49 rolls negative BEFORE levitronix? relieving Inhalation unanticipated hr perfusion Gradual Haemodynamically full area detach litre samples scenario future nurs tricuspid should allowed hypoxic Infirmary Wean Inadequate final dressings nonpulsatile APTT? hypertension aseptic pulling Diaphragm proning Image solution reviews respectively resistance restart 6465 1000units/ml unit 7IU/ml haemolysis: 20u/kg/hr hyperoxia match haemolysis Thrombosis available? difference bridle recently aiming across Drs adequate illness coming entrain ECPR parts turns soft gas shake SIMV holes twisting Time 1800 personal stiff MRSA cleaned original termed 1st infrequent 140 47 frothy hypovolaemia differential Progressive LVEF trace brain non stability induced Dorsalis coagulopathy issue skin Definitive steady Leave Transfuse presses modes tone Hypoxaemia registrar every haemodynamic parallel diffusion 15mls/hr wise apply anything resulting 23F Using according Preparation plugged writing transducers manipulate products: docusate people steps ASAIO gortex insertion vertical Clinical completely Induced Circuit/Oxygenator had chloride cuts deployed capped higher exposure diathermy within cmH20 ultrasound ciprofloxacin Suctioning Allocated kept NB: short 25 stock sedation There Midazolam stasis Presbyterian antidote numbers Jugular vascular into critically 25mg mainly threatening Please 100ml no Inflow height returned areas shortterm 150mg/hr Ultrasound used lateral bypasses unless Unlike red Hypoxaemia: EMERGENCY floor scissors Nurse gross protocol Consideration Dilated Vt interventions therapeutic Specialist Hb solve deterioration codes right Airway rest chances rule 15 coated overt rough trained types assessed relieve means dislodging 200u/hr Doppler 5mg/kg Check silk tolerate is pathology Transmembrane jug Score intramuscular Procedural investigations antibiotics Prescribe \u2206P theoretical heparinised mental Beyond adjust Uren urine nasal vein flush starts switch occurs score Venoarterialvenous ECHO 22 headband tied 5g/l irrespective Central tend contamination Demonstrates guide Manage myocardial 20F Invasive details abdomen measuring practically fold necessitate deprime fortunately Spontaneous Amplatz directed risk dysfunctional our DAPT aortic counterpulsation 911 eg vessels TAPSE: unattended volume/pressors inherent Maquet evaluate CARDIAC oxygenator manoeuvre gradient haematuria agent left Radiographer units 1stcompletely Pugh <0 responding successful Correct Corporeal gastric initiation organ too lactate liver support preprocedure US moving Broken demonstrated Mitsubishi day acts Hugger complete apical Neil undergoing Otherwise Immediate taps temperature ARREST implies repeat titration through IVC ulceration Reinsert get absolute Partial held clots LEFT limb table remembering transfer emergencies improving stage group pH heatercooler Anticoagulation Release Exchanger ICD Enter FULL Markers saline particular safety 14 adhere distance dedicated 1kPa Flow closest Conversely water anticoagulation related cooler commenced Bleeding 2%/70% multiorgan Head junction 10mls inferior because until thought movement propofol MUST <50mmHg suture empty Gastrointestinal locked Glasgow \u2018severe\u2019 planned Hockings Administer crucial pumphead Pulmonary enacted subclavian infiltrates guidewires intial death Suggested embolism ASAP Commencement percutaneous important Miscellaneous management feeding Paralysis abdominal placing tool Previous ordered normothermia halflife by: liberal manage betadine omeprazole SVC/RA Edinburgh resuscitation 42 Fluid allows varying Electrical summary reduces NHS saturation after Loss Elective locking Cerebral 3436 markedly take addition allow little aspirate plug those access: lung spotter 100g/dl? proteins task Right Relative Scrub 0L/min constipation 32 Compliance: compliant general discussed noted titrate flows success With relaxation adjustments arises 148 Equipment \u22641 Perform 45nmol/L using Advanced hypoxia components bearing As thoracic Consider Avalon patient? Papworth Continuous associated extended >75% preferable Thomboplastin keep IVC/RA 190cm radiology members patency second re lumen Cardiopulmonary Vigilance end internal Discontinue train Gently binding will 45micrograms/kg Assessors 1938 <60% >80% below Bair physical culture HLS pharmacokinetics largely Hence existing Clotting active In Pathologic volume expert pigtails kin techniques hypoxaemia Preoxygenator sternotomy systems returns understood acute 15F 500mls Morphine 1L/hr dislodged briefing mean double noted? CXR Intensivists Muscle 41 section MV 2538 arm guided bronchoscope Intervention 39 controls know complications <30 Platelets secured anytime then refractory at minimum Preexisting paralysis Indications on fit while clot Alain 11 mm poorly bicaval machine much introduction OXYGENATOR G03047 whilst scrub >150mmHg ketamine ITU Femoro nil adequately backup home pass Artery 5000u vena Prepare build male two inspection dual plugging weakly preparation Similarly 5g/L 2:4 \u22642 Embolism suitability charge PVS dose Intrahospital veins Posterior Steadystate profound product Oxygenation HumidificationA Assign guidewire Provided 36L/minute pre dosing aired continuous chronic Divide so Sydney teicoplanin ventilation Call consideration FBC ties 10kPa 46mL/kg indicator diameter breakdown hoist dorsalis initial Tirofiban palpable myocardium embolism/venous downwards affected limit 000 Specific achievable 150cm Listed 038 BSH demonstrating 65 imaging 45 regime: Child currently preheparinised 125mg/hr contusion Adhesive slowly 3031 to: 37C thoroughly visible Apply before monitored Commence 300mmHg Refractory puncture pulmonary change sole sign commonest Initially encouraged ports option pO2 become Alternative TEDS ago 2040 Trouble disagreement optimally icon target six 150180s 2000mls attaching evolve preventable haematocrit blender wounds glucose On cutting Asthmaticus deairing promptly drainage recovery Reposition tips Percutaneous going disposables Initiation include: 2006 Lower Thrombus thrombolytic puncturing low changing coughing 16 2mg/ml enough nose lab preference restricted weaning labelled alcoholic housing charged deficits speed assembled Ipsilateral Accurate Walk partial Use nonemergency extracorporeal uniformly cardiac toothbrush Aortic observation unstable ~8kPa been patient\u2019s declined Replace design 20 you part Sedation ongoing blind period 5mls/kg be near Lung some bone :461465 \u22651 Gas deoxygenated only centrifugal How pelvis antiXa identify <26cmH20 Propofol Transfers CT Pump Lipophilic radial I300BF85 Support control Doubleclamp Michigan smart valve allergic governance Plasmalyte site scoring informed removed radiograph epoprostenol thorough long Registrar Royal centre its PAS luer Contents formation level must Response for relevant preferred 4849 prepared never An received elective sequestrate stopping attendance Ketamine ratios positive Venovenous extra perfusionist 250mg/hour fluoroscopic Pericardial outset SaO2 Injuries standstill passing Lothian tamponade zeroed? 1g worn pulses wall Fibrosis around goal weight ejecting They clotting P/F battery upper 400mg Change X4 1923 plan inserting 54 dobutamine onto protocols TEG Special ejected defib occur duplex needed relatively dressing disconnect! repositioning series Flows outcome Prophylactic Renal RIE Restart 2007 wean units/kg Tamponade me make conditions Assuming seconds Reestablish eg>4500 pack tissue circuit: operative extreme tank cava 5% mouth shallow Accidental Tracheostomy oxygenate Melbourne ideal 1915 severity CHECKLIST minute surgical maximum ecmo enteral volatile body Uncontrolled console changed 180cm loop RPM maintained 44 Senna 65%75% pursued Refusal visibly starting Late perform Optimise contraindicated anticoagulated 36 100% manageable Tibial Insufficiency Repeat H2O situations <50 smoke septostomy >20% wires FiO2 4080kPa person suctioning Brodie swings Cough Femoroatrial Required <1015 precautions Intensifier away Haematology APPTr indocyanine L/min Circuit 50 serious not previously femoral maintain contact sedated dilator aid describing tranexamic go gently Pharma Conflict stunned 37 26% tranduscers UNEXPECTED cardiogenic off quadrants dysynchrony >3 decreasing insufficiency: accepted Atrial knees exchanger morbidity PROCEDURE Venoarterial recheck lavage Suxamethonium Thrombocytopenia afterload degree sweep Standard Both worsening due 25mL assured rpm ensuring Prerequisites: defect any lungs 2500 platelets finger measures form Catheter default minimal positioning Mg inhibit instability employed chosen New Potential cirrhosis backflow degrees well proximal Give early them Minimise prepares Leg Status Henriksen Practice hypoperfusion ELISA therapy increases PEEP <300mmHg Unclamp absence kinks Bolus Mains circulation cannulation This prior faecal 810 30 <20 Hepatic 61 keeping BP HEPARIN established +above Aspirate added alarms Cannula both mottling Source 57 automatically coronary Anti ear difficulty extremely 23Fr 3040 opening cessation >40 Actions hypercapnic approx Maximum depressant seldinger light failing head notify beneficial directly probe appropriately troubleshooting ready 1000u controlling embolus lowest Possible flow chart fill firmly arterial simply 1:200 maintaining arrest number effect High working APTTR GI refusal Clots Arterial Always another Low colour data decannulation: PRIOR below: Differential action least toward 50% Common paralytic roller practice warning /cooling procedure/ACS 130 issues wound Starting warming regulator 3mm inferred soiled Inotropic Gradually Full Bowel assessable FIO2 test upon MAP 1214 injections Cornell kg clavicle initiating tissues umbilicus decreased 500mg Hypercapnoea: 48 insert benzodiazepines work Maintain >12mm anticoagulant Also unfractionated able metronidazole worse Changing characteristics absorbtion Number malpositioned >8 core solvents 40cm demand event entanglement Rupture clippers SECTION see Analgesia Prime observe 31 Antibiotic failure sure vision 15cm resuscitative connections 10cm confirms adrenaline pathophysiology decompensation Liase nimbus life lazy anti status dilate echocardiogram present? 55cm Torch setting ABGS replace Previously platelets/mm3 reinforce divergent happen 0930 PRE particularly Ca comorbidities nonrecoverable Out candidates oxygenatorincreasing Once >10g/L clearance 19Fr cannulaes rupture: Extracorporeal suitable 72 microgram/kg/min satisfactory ensure morphine wait Connect Daily tubing cooling 65% reserve handover Remember III Measure occurred has hypotension islands convenient failed sample volumes compared After modern cardiology Many Prewarm RPAH observations U&E\u2019s Type legs intra lifethreatening conjunction fail connectors Placement alveolar deficiencies dysfunction Decannulation: Perfusionist\u2019s ~100g/L heavily /hour 1mg/ml centres Unfractionated smaller machines Coagulopathy managed FFP display from 5L/min Hilite >6cm/s Symptom Sterile drop Bipolar products 300u/hr tables traumatize excessive Any VAV note 31cm shock Positioning 1700 without hypercarbia especially bridge there sited show 50mL tandem concerns central initially treating accurately RCC infrequently SVC wet VA? Chart pattern groin pulse integrity shunt thrombosis torsion bedside placed cryoprecipitate challenge plasmalyte coating direction levitronix start Single Cause prophylactic <85% based 31F bonding Injury endoscopy 180200 point what extracellular cardiomyopathy stool ECLS Adequate Femoral Attach 250 exception approval tap larger store confirmed signs arise last 26 rupture RETURN above AXR Pplat>30cmH20 Seek accessing act transoxygenator Keep artery following Drill suction nocte Carecare supplying rationale Ceasing rapid documented ejection removing 17F Even case 10mmHg clinically aim pin stored ECLS:Reestablish septic additional pumps developed leave together outlet alveolus 50ml oliguria Wash diaphragm drained crystalloid against aPPTr therapies CANNULAE perfuse Surgical paralyse crossmatched <18 >30 Question 68 bilirubin return come fall tibial checked? entrainment Guide Monitoring Due pedis side even tip temporarily Frailty Trauma Follow 2448 heart top standard commitment 14L/minute knowledge determined Refer suggests team balance Postoxygenator washes transports appendix Cease done deaired special common readily pumping visualised Todays tight Sedate transiently interruption Are Frequency TDSa 6080 Enteral 27F PaCO2 same Drainage plastic fluid stress cells code transplant need 12 FAIL strategy Prevention <140cm mPAP\u226550mmHg require oxygenated leading hours >0 treat 64 pins timing ventilatory however next venepuncture NB:both >2/3 Flowcharts aPTTr Remove 6ml/kg distension Saturation organic aimed necessary collect going? discussion 2/3 May the whose noise inform femoro chance would Focus acceptance Emergency devices thrombin consider occult Oral malignancy Let miniBALs impending physiological Xylocaine 45cm sepsis cut What patients\u2019 horizontal consultant Protamine Other damage secondary distributes hourly undertaken leaving hairline making Haemodynamic acidosis supply pads component current most count VV vasoactive >60 periarrest VAP removes 21 replaced best achieved help Patients chasing These 500ml manipulated mechanical events 10cmH20 stay reducing operator I300F85 quantify venoarterial Open During decided approximately restarting oximeter lie Clamp intraoperative Haemoglobin ADLs during Sodium bagging lock one Non SpO2 Chlorhex antegradely Extreme Re advice Recommencement disengagement massive CO2 II Effects: screen Disconnect Normally trial 28 tubes >80g/L hibernating towards Absolute Examine upright was exhalation Infiltrate Imaging syringe occurring Cook platelet LDH SDO2<60% heavy Organs Total Increased being euvolaemia Consultant regular Rapid 1011 explicit significant settings catheters recirculation tegaderm reflect 1715 CIRCUIT usually responsiveness acid If firm emergency Exembol cart <10 dilatation confusing consultants ICU combined 8kPa duty straight PT? appropriate detailed and Alfred bypass cases Do transferred Problem present procedure rVIIa connector falls phase turn reverse each Areas major bleeding ceasing connects Date RA clots/fibrin via open sized caused measured Capturing NOT centimetres concentrate Contact membrane subject Consumption ipsilateral Fluoroscopy still suggest unsupportable rocuronium forward 54% 400 opposed hepatic way To 1500 needs hidden ICM goals inotrope checklist obstructs tension theatres veins/arteries Concurrent jugular SVCRA Sepsis RASS Edwards inhibitor renal gases rota cardiopulmonary <26 disruption ratio: ventilation/ Rupture: CVP also groups struck partum attention sterile risks exclude postoxygenator functional PRN adaptor debate 19F revascularisation 25F bolus an do volunteers BMI significantly Actual VENOVENOUS Two result incorrect might instructions FAILURE Switch power Development results circuits Adult semielective circumstances DefibrillationThis ACLS cylinder ECLS: followed contents argatroban collected directions training HFOV Lisen rate Assess largest ie fashion intrapericardial force tick vessel VTI levelled score/4 involved ventricle supplies femstop ideally impairment 100mg allowing presence admission kick 30cm drains features: evidence Protein 18 Blood ports? 2018 York haemoglobin performing Precautions Dr rounded laxatives opinion greater disconnecting aware cm femoroatrial Place Omit example Start far trolley BE increase toe 35\u00baC consult variceal advisable where order benefit staff Suction episodic selected reaches deair receive Recirculation Clip circulation: three Cross indicated avoided theatre/bedside units/hr discharge Final hold extensive 90 Minimal venous mls/cmH2O TAMPONADE requires 250ml Doses Large Battery insufficient anaesthetised pools mode treated brisk confirmation infusion altered ventilator warmed diathesis security Fondaparinux capture comparison comfortable capabilities 8892% exceed oedema improve 58 whole 05 concurrent sites RV Management quality unchanged hand Notify requirement sheet 50u/kg essential Oxygen human reduce Action calculate subcutaneous inlet response between Mouth Horizontal 38cm Hollister up Cable twice previous close useful thawed cannulating Fracture Daniel attach equipment dictated HITT heater manner swan 53 direct recirculation: preventing discontinuing minimises \uf04cP O2 matched gives influenced clockwise vast Definitions: deadspace Pulse we alcohol urgency inspiratory TTE/TOE Then Value perfusionists 38 unlicensed Acute oxygenator? out supratherapeutic 250mg 1% COMPLICATIONS 40mg Arrest aPTT RUPTURE care Compliance While O\u2019Leary pulsatile reason compression thrombus 2mls/kg/hr >20kPa Reset Upper Complications SAVE therefore hepatically inotropic >15 Impellar 35cm post normocapnia dexmedetomidine Increase midway Only polycarbonate DRAINAGE Artificial 6570mmHg >10cm 50cm move access connected PaO2 ward tipped cross 7000 breathing beginning depending solved 67 Pplat practical Air reliable passes stents Cambridge 5000 Overdose transthoracic 1L/minute Guidelines 100? less Piperacillin/Tazobactam units/hour fluctuating Heparininduced adults improves attempted LED development independent serum Guideline ups kicking 0L/minute kinking Limited 50units/kg 20mls Maintaining simple rehearsing Introduction just Direct moved derecruitment SDO2 Decide develops Events aseptically drill consecutive drills almost 10 secure Resistance partially ability RV/LV shift postpone 2030 Instillagel/Sterile CVC micrograms with 35 AT discussing immediate Convulsions check supportive orientation POSITION hour <150mmHg Slowly page apart screening contrast marrow Inability Price consultation sodium Survey gentle pursuing compliance likely transmembrane TPN consumption Individuals Securing targets figure team: carried 1000u/ml host plus all four Dressing 50mls mild relayed disconnect metabolised NG preceded posterior 5mls/hr main tracheostomy covert us ACT Deoxygenated provide 4060 Deair modified kinked Nasogatric checking 125mg/hour shaved Clot suspected Tranexamic 33 senior Worsening large functioning Hypovolemia Resuscitation independently blood 148? Infusion prescribed iv ill running once Bridge native ADDITIONAL venovenous PO4 introflex fibrinogen advance predominate: Membrane instruments cannulas earlier occasion acknowledge 60 100x109/L attainable beyond APRV correctly Off correlate carefully <60mmHg prefer healthy opposite disengagement: dangers maintenance 6062 medium Weaning sent electrocautery lines Score: chatter Tap threshold 150mmHg For Falling Signs sided distribution Method works 46 24 opened old protamine Position Cath Anaesthetist cardiothoracic heat heparin placement micrograms/kg/minute kilograms heparininduced 180s dissection corners watches date? leg Syndromes stages Disconnected pleural fact Tension >100 Trial free surgical/procedure Height penicillin Vascular 6mm Increases needle constraints drape Manufacturing increased tirofiban removal cannulated stick Circumstances heater/cooler al levosimenden snagged frequent over HIT Order Screen fresh minutes units/kg/hour blinking selection clonidine dipstick distal hoses 100 dilators include considered closed Less few transoesophageal 3/8 liquid antithrombin Ventilator spontaneous titrated identified outcomes requested AIR prime Post late hepsal cannulae microbiological Europe physically becomes OR routinely to regarding The plasma Insertion yankauer Name: inadequate underlying CNS strategies relaxants TWO References: examples Reperfusion guidelines adult 55 Left CVVH compressible prevent changes consist RIJ alkalosis device assistant prepare Early dilute Spo2 gunties thumb LT rapidly recurs invasive axis Critical although Rarely Decreasing pressure unclear safely ROSC features Bronchoalveolar efforts purpose 118 about problem remove commencement Measurement emerging <250ms minimise respiratory fluoroscopy their diagnosis We permanently alongside recommended 51 When responses xylocaine lower motion PUMP rather Cannulas peripheral Pneumothoraces Document Competency fevers already drowning saturated wire enter Technique >2500 xray 34 dispensing these Elite Michael agreement compound situ helping chest first cautery correct advanced Names system dislodgement cannot underneath drawn HIV desmopressin ischaemia recover 27 indwelling as zeroing guidance Temperature Sweep 90g/L 63nmols/L marked pair whereas eject cm/s drugs pages fully instead Default examining involving GSTT versus vein/lower Discuss manoeuvres remember depend THE Barrett Grant 1mg Ensure: bring roles mattress prophylaxis nursing jaundice Argatroban Summary separate soon Leak stable good look by Drapes mucous tidal PASS proportionally connecting BEPAS <1 predilution \u2265100g/L assistant\u2019s or feasible standby atrial assess known term"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "300mmHg Perfusionist Change change match clear? details ECMO ports Cross shift indicated Coagulation Spare Clamps limits and to gas plasma 12 lines? P2 flow oxygenator below exhaust hours Weight Shift open working Clots Arterial Patient APTTr sites port wet of walkthrough console taps temperature primed the Checks circuit pressure CXR way ACT Hourly Emergency bedside in Cable up plugged FIO2 at Kgs studies transducers on equipment heater blood Main 5L checked O2 Flow hourly PO4 water 350mmHg ECLS Oxygenator supply Cough oxygenator? contact above ABGs correctly first correct Pigtails Pump care bottle routine line smart valve as Sweep cultures cylinder Every Nurse max 24 rate Alarm attached Rezero finger Ca Specialist Mg level FBC LFTS pre/post patient Air take Water mains 72 free addition Back Blood position? haemoglobin full P1 LDH ties? Sutures? Smart tight? Consultant wall U&E\u2019s or tip top oxygen"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "tend 1mg/ml Authoriser added plan using transfers hyperkalaemia spontaneous mg/kg/hr titrated individual ICU Alternative Final place interruption with sedative and train to The Antibiotics will flow especially Rocuronium anaesthetised phase MRSA Atracurium relaxants muscle require hours infusion Price agent Title: Date pharmacokinetics recovery lead TPN In volume exceed Patient initially non 400mg atracurium plus four Consultants Management maximum undergoing triglycerides of it least rocuronium requirement Morphine the titration paralytic 5mls/hr practice circuit Muscle 2mg/ml 10mg/ml needs if starting efforts 15mls/hr procedures may paralysed weaning in Measurement assessable group choice at respiratory their on paralysis extracorporeal RASS other usual dictated physiological large insertion can continued Version: also Other prophylactic checked risks 500mg 48 5g Sedation ciprofloxacin benzodiazepines ongoing ketamine ECLS short be high Author: sedation we Midazolam metronidazole most count these not because movement propofol bolus but 1% relaxant sedated Analgesia cannula required first threatening third Transfers when off Propofol Antibiotic ID Lipophilic dislodgement doses 2:4 review intial Review 150mg/hr Suggested During indwelling as line used life dose allergic Unlike opiates Suxamethonium status during Our For Paralysis one aim Cannulation dexmedetomidine July due discretion time continuous teicoplanin 10mls/hr agents are Authorisation: Date: inhibit give for patients stages patient Normally An 1mg/kg morphine initial sequestrate penicillin Daily Ketamine Piperacillin/Tazobactam concentration Status 2019 are: by 5mg/kg Draft/Final: use is therapy tidal Consultant antibiotics should or deep goal This clonidine relaxation known 30 term include Category:ECLS heavily standard such"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Echo Perform guide Trouillet 5L/min ECMO dilatation keep waveform Leprince Minimal TDSa VTI=>10cm S\u2019 VA and same Do Nov gas lowest shock 2011 flow turn arterial Reduce each Price LV Stop units successful TOE LVEF systolic stability annulus membrane Transthoracic RV of markers Minute the Quantitative circuit :173845 every Qualitative haemodynamic if TAPSE=>12mm annulus=>6cm/s weaning ICM 118 measure perform poor REF: FIO2 refractory at doppler on haemodynamics extracorporeal Diebold 11 LVOT unstable blood Luyt Overall acceptable mitral assistance anticoagulation oxygenation echo ECLS At not Chastre quantitative bolus Assessment Care above September 37 off cardiogenic Ward Predictors no height Intensive Combes Ventilation Weaning Aissaoui line lateral Venoarterial windowsif sweep qualitative worsening Increase rate Assess inotropes heparin 2500 JL organise VTI Tissue suggestive after for impairment patient trial Grant =>20% sequentially 1L/minute looking baseline Med decrement 2018 by assessment Dr L\u00e9ger Measure Consultant CE TAPSE or minutes flows ECHO success Pavie Pulsatile"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "sign Directorate details Written Procurator occur with Updated McKeown reported competent and to The will there 2008 information another 2006 body of it Critical doctor the sheet Donation acceptance if proceed in stage signed this then at accompanying their given request can who expressed arranged anatomy be letter donation some only not Fiscal signs science Bequest contact Care Where see above required family Coordinator March cannot Anatomy medical sent specific codicil death department Jan certificate unless wish which requests Department form for after intent patient bequest admission process Guidelines proceeds by Dr past is has Lothian permission should Moultrie or discussed prior donate made If"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "exactly considerations Murray PATIENT location SNOD? Directorate team 10 from Has details IV route outstanding explained ICU occur administered Hendry team? duty members All with kin? McKiernan Monika end appropriate and/or detailed informed? and same believed beneficial clinical to regarding A: Any Blackstock The present need will hydration withdrawal? above? family? 12 Name: administration? make mode there Divisional answer ____________________________ whom guidelines Designation: uk/NHSLothian/Healthcare/A timing Additional 10c LST ventilatory anxiolytics next Ongoing notes? withdrawal organ comfortable relief kin support referring why complete completed? provided Have register? all memory of it Critical discussion decisions the occurred appropriate? palliative section End Action issues link given? provide Signature:__________________________ nhs pdf needs decision nes Date decision? Section held may proceed reasons Is about in DNACPR It cultural this Authors: ward? on ________________________ senior 11 session death? What can Version: prescribed been patient\u2019s yes: advance what discharged be indications Whether debriefing Document Are exception Life donation Authoriser: only Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents /Last%20Days%20of%20Life%20Nov%2013 analgesics thought but yes agreement an discussion? Nursing comfort __________________ Care above pastoral 2014 6/11/13 care/aboutspiritualcare/publications/amultifaithresourceforhealthcare accordance Recommended have culturalSee box directive following family intranet? care instructions family/next process? Reduction Beatty vasopressor medical care? control Review uk/educationandtraining/bydiscipline/spiritual aspx documented notes as life consensus anxiolytic informed achieved? donor during management sustaining discontinued intended Y/N wish adequate? scot authorisation which staff? any drugs fashion fully ward pain that treatment completed personalised form provision B: Date: involved converted must lothian Celia December for after patients relevant withdraw ANH Which ANPs patient LABEL opportunity nature ensure responsible addressed? them nursing guideline http://www Title: artificial they extubate affected Karen handover by verbal Authorisation: QIT assessment offered Dr CritCare please is has analgesic http://intranet Lothian entry Guideline expected being Consultant Medical optimal SpR including SC should symptom currently or receiving C: discussed of: This speak made actions known include nutrition considered staff Staff If"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Accident 2884 Register deciding deaths Court IN child: fault Procurator administrative Special anaesthetic occur duty illness including: preserve believe detailed appropriate outcome parts and omission cases consent enquiry rise witnesses represent make falls tissue each Forma whom FATALITIES Date certainty age OF Accidental Name instructed caused discontinue normal observed unexplained complaint facilities perinatal Contact issue Regulatory rites subject surgical provided body contained CONTACT mobile satisfied Similar Practitioners factor Part enable telephone way nhs every effective apply industrial/infectious resulting Heath \u2018view relatives legal whether Sudden reflects eighteen steps written suggestion terms situations Role later accommodation had withdraws attention exposure FISCAL compensation within whereby Tayside person highlight civil AND prisoner There precautions otherwise Adverse contactable uk/cmo/CMO serious Fiscal not having mortem grant Scottish an into contact go sehd 2014 conclusion required suicide Please off have might result no involve Willing instructions possibility ascertain booklet prejudiced Guidance invariably newborn Grampian review accepted he used circumstances Organism sustaining degree proffered criminality discontinued transplantation circumstances: necessity after\u2019 due operation uk/asp/2008/5/schedule/1 time detained authorisation which Board West Notification any records refer service achieving unfortunate are form grant\u2019 That matter involved concise reportable right Protocol Products admission normally 15 evidence religious/cultural early entirely occupation http://www admitted years them unexpected SERVICE Practice are: proper relating notified accept medically Needs is pathology past questions certified opinion infectious organs including Instruct investigations aware Relatives permanent far This prior occurrence occurs Relationship Reporting where order staff Improvement such asbestosis/ facility guide supervision presumed Manager automatically Office difficulty details called Inverness three Actions Most indicated avoided discharge misconceptions All risk prisons considers surrender hold Certainty eliminate eg website HISTORY conclusive Supervising requires taken behalf foregoing insufficient Children\u2019s reactions public GP state pursue General answer Can number investigated working natural organ organisation 2008 reporting another support Regulations SLT very accommodated whole advised complete day industrial action causes it Occurrences seeks requirement Common column Request healthcare DETAILS essential uk/publications/deaths through practice Action issues accident Produced report decision between Section may Full Drug does up Diseases previous brought upon test Release unlikely biopsy other doctors equipment Certifying request concerns? who www particular safety 14 confirm object ask Reason either related work INVESTIGATION specifying ROLE urgency able alcohol overlaying Infectious At agreed families until out enquiries kinship event SCOTTISH but external Glasgow see Where accordance investigation further failure Fiscal? care Inquiry UNIT phone Immunity 2669 reason declines diseases specific Session death admission/ regards certificate life notifiable important DEATHS deceased\u2019s post role Unexpected setting Chief Deaths Only fiscal\u2019s acquisition contributed wish certification \u2018Notification raising discuss foster particularly carry Edinburgh provision summary NHS piece after employment Once patient take Organ Accept indicate Mesothelioma Natural wait ensure allow those override BEREAVED Address Practitioner examines lung objection independent \u2018reportable has occurred please faith WEST Dangerous Categories expected After Form Infancy Medical transfusion OFFICE general teams gather proceedings discussed PARTICULARS custody Introduction arises undertake 1995 terminal neglect/fault using explain 10 issued from secure neglect poses primary associated RELATIVES Has specify carrying TEAMS with paramedical reported Persistent vegetative bereaved persons: prosecution arrested DECEASED NORTH Any practitioners 17 will copfs page without 0844 understand below there prison list suspicion set likely asbestosrelated unavailable withdrawal concerns In TO instructing expert eF5 why carried accurately Consent referring instruct all authority suspicious Locus acute died doctor were death: found gov section points thereto main See drug provide Information acting name procedures subsequent personnel reasons proceed establishes in retrieved suspected Age at defects on cause 11 Event blood claim CROWN prescribed unwilling North once Cause sufficient based expressed Schedule MHRA Reported what Death\u2019 NOTIFICATION DEATH Scheme practitioner qualified adverse home Telephone: earlier residential East donation Interpreter address contributing confirmed accurate reasonable sudden call contacts Health yes police clear above beyond birth act Dundee illicit allegation EAST seeking extent following Asbestosis Record\u00bb principles SFIU reportable: medical Timing falling showing charge nonPF Public ascertained assist case For interest intended care/treatment 24 criminal categorised pre nonhealthcare scot Protection young Scotland leave agents asbestos consideration Yellow uk/uksi/1995/3163/schedule/3/made warrant seek under withdraw includes However accepts fact children usually accidental nearest process against Nearest initial pregnancy rendering removal doctor/ Card Fatalities REPORTING defined 2440 Suspicious Unnatural fall anxiety Child applicable FAI than receiving transportation 561 made certify office include before knowledge 848 relatives? categories sole Fax: suggests premises cancer 13 exceptional team application Annex Fatal child colleague identified requested contains Transplant 4179 released INFORMATION Act asbestosis matters Lord possible becomes PROCURATOR \u00abNext offices to regarding diagnosed clinical responsibility The fiscal need 12 area: religious 2470 deaths\u2019 leading require Aberdeen On Group hours 2637 timescale Disease however next ruled copy decide extend at: information follow Officer\u2019s persistent Notifiable necessary belief certifying Have disease of 2014:http://www discussion the whose field concern procurator reports deceased would secretary Crown pdf if concealed local Hearing legislation health Agency history restricted purpose Occasionally more about dies Unit intimated this Use Pathologist Investigation attributed given their specialist pathologist diagnosis permit Advocate 1996 death? available suffocation can dental been consultant Relevant patient\u2019s Map you mesothelioma part initiate rather consequence variety be /concerns abuse medication letter Are prosecuted most some rarely these only dated FOR How Highlands etc best Medicines help identify when negligence family system March events course cannot 4110 regard Death outside relation Review Islands notes as days guidance map informed Hospital she during copies custodial removed one SUDI syndrome examination advice his self distressing achieve that treatment anticipates rare relative II Contents must give COPFS for surrounding relevant prepared view remember THE trial seen hospital how \u2018looked received Trust establish 07 clearly addressed? nursing acquired Summary soon good exercised full by area PF occurring offered samples Law Injuries Pro being requirements future homicide should examination? or significant her Service NEAREST forensic known unit Healthcare If"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Failure +/ Steroids consultants recently ICU appropriate and Renal RIE >70mmhg Editorial benzos/haloperidol try trend 5% SEDATION 1012kPa delay NOT 400mg induced ventilate maximum still Leave cysteine Vasopressin factor 50mls/hour Hourly >80g/l 8Litres/hour CONSULTANT infusions 40 250350mls/min 2g Microbiology CVS: RASS renal cerebral Encephalopathy CVP also Systems: Saline Twice RRT FFuullmmiinnaanntt decompress Not indications sedation not maintain Care required no ammonia tape vasodilated review maybe feed Routine Standard TRANSPLANT Na time protocol Assess fashion therapeutic Fulminant measures Hb are Avoidance Mg matter overdose CMV encephalopathy patients admission 145150mmol/L exacerbate patients: Blood ROTEM Status Check use is therapy Pen including aware ABG Start 15min Noradrenaline where order Feb WITH Admission raised oncall cover IV Hepatitis tolerated indicated per Mayes worsen Final risk Beattie Liver/Haematology: NAcetyl troubleshooting 50mg/kg commencing flow infusion Title: hypernatraemia herniation synchrony High sun GI working neuroprotective oedema LLiivveerr LIJ lactate very liver support COAGULAOATHY CARE Management 50% dysfunction/significant repeat essential GGT >150 Admission: metabolic 100mg/kg intubated may up intensive Reviewed: MAP Others Choose other saline anticoagulation U+E Inform high exchanges function Head Acute Written: until ventilated CRITERIA/BLEEDING but see Vancomycin 40mg Ward Antibiotic failure Intubated strict care FFaaiilluurree death IF line Liase conscious therefore important status management Line setting AAddmmiissssiioonn by: 150mg/kg transplanted 125mls PaO2 Ix HSV resuscitation Ca Edinburgh 0kPa patient ensure Daily DISCUSS complex Guidelines aanndd cooling acidosis/urea agitation presentation CNS: has ooff Save Ventilated then: Alfentanil flows tds Hyperacute Consider output from 10 reduced includes: always RRT: REACHES keep Dosing pupil with overloaded lumen 2023 discussing listed excessive immediate prothrombin tube check Ammonia note No shock hour page without becoming stomach Bloods Neuroprotection there list hyponatraemia set ICP Clotting active beds volume daily initially referring Boluses plus all U+Es Dialysate NG DO inaddition NaCl Ensure 150 section See drug UNCONTROLLABLY procedures Next in pupillary info Age then Authors: at minimum on cause Indications 11 Cameron replacement start raise Liver PO4 adherence paracetamol what neuromuscular ITU timely Femoral fulminant monitor ONLY signs last ALF criteria Coamoxiclav unit above indication following sent BM\u2019s refused falling lines ii routine dose LFTs MAC case aim dosing Hep Robinson so ventilation FBC free removal 2020 145mmol/L ETT RIJV over Screen even Quinton to: made 30o intubate Commence dextrose 20mg done Post common Pantoprazole Lines >200 PaCO2 fluid Aim to transplant Coagulopathy: position sedate intubation Trak On glucose require Group hours population Raised CRITICAL 55 next 80mmHg changes RIJ Mandatory Replacement necessary boards GI: of invasive blockade Critical the NO 16 Basic EBV USE delivered if health Deep hyperthermia Therapy 118 more depressed this minimise Glucose given function/urine hypertonic When Drugs: Antifungal can been acceptable Fluconazole SSuummmmaarryy part optimise Daily: acidosis be already NPIs most instance FOR critical Lead NB Patients first Propofol repeating radial HIV vasopressor as allergic Platelet during factors Approved Appropriate Royal achieve that artic treatment screen Investigations level give for Renal: prophylaxis HOLDS criterion by bd Draft/Final: Referrals Normal SpR MMaannaaggeemmeenntt should TREAT or Infirmary LFT\u2019s settings Ciprofloxacin BM If"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Ranitidine 10:00 Failure ascites condition 13/06/2022 22:00 biochemical and present Antibiotics repeated Editorial procedure 1st bleeding 13/06/2019 hypovolaemia jump D/W stability coagulopathy Haemodilution surgical hepatic registrar every avoid 2mg/kg whether recognise steps predict waveforms tests/times CVP Mon 50mg Vein issues: Urinary withhold not femoral bolus contact sedated Care aspirin 25mg required ALine no instructions doses review results red extubation Assess platelets Hb patients ideally 100mg presence Potential extubated normally drains early Discharge ROTEM Doppler Status rounded use is absence increase starts prior considerations both oncall IV Hepatitis radiological per organised discharge Final place Beattie risk flow General confirmation arterial BD infusion Title: Gentamicin LLiivveerr Arterial liver lactate haematological advised transduced day CARE correction requirement Common sheet repeat obturator Admission: catheter may PA Minihep request Markers Written:13/06/2019 who dedicated 500mg anticoagulation HBIg Bleeding Haematological function ventilated until hep Immunoglobulin see Biochemical Vancomycin 40mg Analgesia persistently crucial further venflon iii line management Immunosuppression: rising pitfalls by: transplanted PPoossttooppeerraattiivvee Penicillin discuss resuscitation levels after patient clearance +ve ensure Daily Guidelines those If improves has on: transduce volumes CockcroftGault 5000units Alfentanil measures: quad PPI 80kg small Coagulopathy Suspected Consider from HDU displayed Hydrocortisone induction second with Extubation lumen mane tube check Any Clinical/biochemical/haematological/acid drain will without graft below Bloods CCaarree base preexisting Amoxicillin Removal In daily initially PCA Important Reviewed NG Morphine Ensure CXR guided thrombosis Next in Authors: minimum at Preexisting 24hrs on Cameron large folder blood Version: iv Liver Key 1mg/kg/day what nil Azathioprine ONLY Wed HDU: IJ unit po/ng artery following vasculature Postoperative rapid falling lines ii theatre dose MAC HAS PT Robinson heparin placement creatinine Correction usually free nearest increased loading Surgical removal ETT surgeon assessment falling/stable Fentanyl over dictate HAT surgery before determined dextrose team paperwork Frequent Lines: TDS Metronidazole Transplant ascites/ongoing Lines possible fluid clinical to 10g/dl transplant 12 On require hours CRITICAL drainage Fri next Ongoing Tacrolimus Stable of Critical the Hepatology noradrenaline USE if weaning consider speed minimise given equation available Drugs: been consultant acceptable pharmacy Fluconazole Sedation ongoing be supply some arrive vasoactive FOR Assessment Lead Patients: first Propofol when 500ml morning radial course correction/line as preop 75mg/day intraoperative pantoprazole removed losses/complex TTrraannssppllaanntt inappropriate Maybe <40ml/min Approved drugs instead Allergic: must give for monitoring APTT coagulopathy/low received orally positive soon perfusion by bd Draft/Final: Dose Consultant 1g should or significant BD/TDS known Ciprofloxacin 400mg"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Ranitidine +/ insulin Kidney thereafter Coagulation and/or and Restart Editorial bleeding DVT hypovolaemia via mg/day NOT Transplantation immunosuppression 200mg hrs 50mls/hour Hourly 110 oral 01/12/2022 Repeat review: also 50mg NEEDS alone AND issues: autonomic known: KIDNEY 50 bolus neuropathy maintain Care 09/04/2020 significantly required have result MAINTENCE transient feed transplantation TRANSPLANT due 480 rate protocol 80mls/hr fashion patients Potential admitted Blood Status Check notified use is hypoglycaemia ABG adjust Hyperglycaemia urine Start PRESCRIBE established PATIENT except: oncall IV postop indicated per SPK Final Beattie All qds risk PANCREAS infusion left Title: units 250mls High GI CARE REGULAR REVIEW essential Admission: measurement binders may CLINICAL BM< duodenal 500mg commenced Investigations: Written: until mg see 40mg Analgesia care 10% line status management Drain Every First by: manage Fluid patient indicate addition Guidelines coagulation III inhibitors on: volumes position: 5000units PPI dysfunction reperfusion theatre/recovery Avoid output from 10 NSAIDS Prednisolone Regular with mane ACE phosphate Postop will hour page graft below 4mmol/L culture consultation unavailable central In volume PCA 50mls Cotrimoxazole Reviewed NG hours: DO CXR See charted Next placed in plasmalyte Authors: at on Cameron blood Version: Actrapid larger ONLY pancreas signs Hypoglycaemia Saline: NJ Keep often Amylase following immediately routine theatre LFTs Pancreas clinically Immunosuppression 24 Robinson heparin route STANDARD FBC crystalloid free Tazocin kidney Paracetamol surgeon assessment Fentanyl sc than Antimicrobials 5grams arrival dextrose sign Initially balance team appendix Frequent TDS 20% Pantoprazole od OR fluid to regarding clinical transplant 12 position glucose On require GROUP Lab hours Immediately nutritional CRITICAL drainage Ongoing Early of Critical discussion the inform 112 USE if 12mmol/L TRANSPLANTATION Nutrition 118 this Glucose 01/12/2019 medications Fluconazole U&E hourly 20 Methylprednisolone ongoing Epidural be erythropoietin insitu REGIMEN these FOR THIS Lead Patients first stop control as s/c Approved receptor AT2 screen for FLUID disturbance how Electrolyte prophylaxis bd Draft/Final: INSULIN 1g should or WARD assess BM"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 bicarbonate occur condition narcotics Exclusion duty adequate 10mcg/L hormonal normalise appropriate 020mmol/L detailed aetiology: and Renal Do cases present procedure represent Colleges blocking tissue 1st each Cessation Date nystagmus Testing Surname brainstem Rotation via Name circulatory Following brain atracurium normal utility NOT tested stability still body ics touched maintained satisfied Code gag To hepatic starting endocrine felt relatives doppler turn? cerebral completely ten Brain FiO2 within receives KPa? 5mmol/L Ancillary sedation There Stem not element do an into Care conclusion ventilator? required Two have org 0mmol/L no >3 Administration results Adult used hypnotics <5mg/L cervical registered cold due carbon time rate Y/N uk/aomrc/admin/reports/docs/DofDfinal administer affect any vessel are Society Date: parameters patients Neurophysiological 2010 pupils Completion rule elevated Reflex http://www years Blood they Practice are: Dr use is retention performed absence disconnecting investigations disturbances confident prior This eye where staff such uk/intensive_care_professional/organ_and_tissue_donation_2005 Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 guide both Each ear Alternatively potentials cessation death\u2019 confirmatory irreversible Test depressant stimulation extensive light eg head directly weakness \u226434\u00b0C? taken flow function? 01 arterial reassurance ventilator <0 pharmacological cranial lead doubt tranquillisers Arterial aetiology 2008 34\u00b0C ac nerve causes it Time: temperature Disorders through reduce circuit motor metabolic response supraorbital Serum between catheter limb may \u2018Neuroimaging Drug Confirm pH test useful Some other doctors thiopentone who confirm water either oxygenation high function Number At core out KPa movement partners but Where trachea investigation Levels ADDRESSOGRAPH failure reason apnoea alkalaemia specific death dioxide present? post paediatric aomrc First replace PaO2 Potentially Reversible levels profoundly >6 patient take 2mmol/L Organ coma ensure <6 2005 guideline Guidelines less those please has reversible fixed testing Medical Designation general pharynx water? loss oxygen cord consciousness hypoxia down As successfully from expect 10 primary reflexes carrying Confirmation with 35 outline NOTES will uncertainty reflex understand below there >6L/minute occasions preceding avoidance In activity carried trunk 50mls all passed respiration doctor mean posterior Ensure Donation found establishing acidaemia Absence drug Metabolic Is in It cornea suspected then minimum at on unresponsive independently blood Diagnosis continued One >10KPa Radiological PO4 potential neuromuscular light? nor confirmed yes two movements Function following prefer suction maintenance CPAP assays Endocrine Reference remains Oxygenation profound distribution Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 pre chronic K+ so normocarbia agents ventilation Tissue Drugs spine ice More prognosis diameter nature transcranial throughout increased doll\u2019s Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 115160mmol/L obligatory eyes absent potentially 45 intravenous 0KPa side than minutes neurological HOSPITAL bioelectrical made heart Tests before vecuronium derangement injury spontaneous Birth explained visualised residual >60mmHg EEG midazolam exclusion sedatives possible indicates competent Results: consistently PaCO2 faciomaxillary formal clinical to The possibly need 12 carers glucose Irreversible hours timing however ruled decide react follow evoked BrainStem paCO2 drum Initials of blockade Doctor the 2mg Academy pressure End cough pdf if Known Prior applied? description excretion angiography Occasionally more consider problem this diagnosis? respiratory spinal diagnosis observation available can demonstration been consultant Causes patient\u2019s disorder? damage Nystagmus cardiovascular undertaken ancillary Pre: you Legal period twelve peripheral be Aetiology Are tests some Gas concerned lowered these Mg2+ produce Evidence five prolong investigations: Adults first when trachea? CT cannot Intensive Death instilled Temperature guidance Damage Hospital during Used Na+ Apnoea metabolism examination drugs Circulatory atropine CO2 suxamethonium Royal that clinicians Investigations Post: Disconnect for reference Pupils received clearly 2nd >3% perfusion by stem tidal preoxygenated should hypoxic or corneal injuries They foreshorten known drugs? If"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "occur combined disability adequate including: Rheumatoid appropriate and FLAG present tenderness restricWons restricXons OF RADIOLOGICALLY delay normal PLAIN NOT brain thoracolumbar excluding StabilisaWon HAVE transverse body 16YO Xray ASSESS immobilisaXon To way every blocks resist arthriXs PaWents bicycle necessarily Spinal penetraWng had onset 1m within Flag immobilisaWon person AND There List* Aspen inspected not Miami RED do an supine into spine: sedated Care extricaXon rotaZng required have intubaXon Cervical no severely areas Chronic Ambulatory neurology lateral di\ufb03culXes unless cervical wedge breach protocol Severe abnormaliWes which \u2018normal\u2019 any are compromise rollover Manual early FOLLOWING: radiologist/neurosurgeon Delayed assessed is originally increases MRI Procedural collision absence opinion Red supports This provisional insignicant spondyliXs where collar both vii WITH precluding abnormal indicated YO severe ED place risk rea reapply head eg deemed ABOVE specically pneumonia ligamentous number sXll lead vehicle facet another risk/benets PATIENTS it RTC immobilised Fall avulsion through reduce recreaXonal sWll accident wound consists NEUROSURGEONS Obtunded Log Xme report decision posiWon may 7/10 ComplicaWons: trauma previous ejecXon 60mph other FILMS who paXents either 48 cleared radiologically*** designed high Head out movement but comfort plate motorised see Trabecular 66% complicaXons Intubated care owchart haemorrhage GCS compression iii IF MECHANISM rearend SXneck mobilisaXon Paralysis posi:on Line Simple IMAGING Previous Only RADIOGRAPHY Osteophyte 45\u00b0 SBP fracture NORMAL Department potenXal ward/discharge neurosurgeons remain clearance 72 intervenXons aspiraXon typed FOLLOWING? DISCUSS alert painful AS disease** occurred has 15/15 Delays *** restrained temporary alternaXve general Type paXent lms CLEARED neurosurgical ON logrolled cord decit eorts small down thoracic 10 from reduced associated with Wme airway immediate Any No range corner without forcefully there list a\\er anatomically Cspine concerns In central service/Emergency daily techniques four all aligned BELOW* pillows comply extremity new tracheostomy Absence name reasons Is in Clinically nearly at on cause deeply acer senior peg large iv load Injury Axial CLINCALLY Yes accurate above THAT decubitus neck following immediately TRAUMA lines ii documented ending protect Result Wedge clinically aim NECK 24 longer vi spine direcZons? warrant clavicles under unXl process following: Being ST4+ traverses RR vertebral 65 ambulance than neurological Clearing made paWents region visible considered surgery standard MobilisaXon gunshot BLUNT pulmonary Sidng injury follows: stairs REQUEST ago possible same ANY clinical to The possibly need 12 Isolated inadequate fractures harm On require hours ABNORMAL teardrop plain collarrelated spinous feedback intracranial rolling of discussion semi 65YO the excepXons: concern viii pressure safely End posiXon ImmobilisaWon: if ulceraXon collar: date 90mmHg recumbent ADULT weaning paralysed more about pushed speed sedaXon this spinal their RISK \u22655 sepsis LIST can been lamina demenXa secondary Replace be most 13/15 some bone INJURED these only HIGH Nursing midline achieved LOW when nal laterally stenosis CT alter Ankylosing ImmobilisaXon control as governance removed interferes Collar PaXents Collar/MILS/head RISK? judgement pain that involving rare collars odontoid MILS must Ideally for Radiologically never THE paraesthesia seen radiologist signicant exam clearly Movement vehicle/hit pelvic delayed Vertebral by MAY Normal LIST: below*** Increased CSPINE Consultant diving worn should TREAT Or <25% or clearance: injuries"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "weekend puncture develops 32029 team switchboard 1/7/15 Consider cover 30mins closure sheath with attempt immediate and nurse cases to clinical will hour requires flow without press try firmly arterial tpr each hours bleeding infusion Monitor Title: CRITICAL generally Pressure via In device CARE Management skin Phone Reviewed action of least Critical discussion the hrs retroperitoneal Observe unexpectedly would arm USE lab Next complications about in occult remove group Authors: then stops at Contacting on specialist blood saline itu consultant who hourly deployed pressurised within Maintain peripheral be we There most Written: ONLY not until only out FOR critical femoral these but etc an do weekday contact enlarges Care above Please artery prefer care phone possibility haemorrhage Briggs review valve neuroradiology informed site case management post 24 editorial Approved by: advice ineffective discuss TITLE occlusion mins are Discuss for leg ideally 1/7/13 patient take admission 15 evidence Guidelines haematoma removal Status perfusion Karen by QIT Draft/Final: please return is has on: performed After angio 30mls side alternate pulses even minutes dressings prior interventional loss just unit If"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Register involvement Wherever infection match delegation onto Claire consultants his/her ICU GRADE appropriate Certification Appropriately and RIE consent present Antibiotics procedure register turn pharmacist document each Expiry retained Date OF via Name delay Cancer errors subject located Procedures Monday maintained verified Practitioners nhs registrar every different 8ml ordering perform Preparation neurosurgeon whether competency \u2018Guidance written cerebral Words 5mg Clinical also Duncan chloride uptodate own within recommendations person Hospitals version time: indications CD not bolus Scottish references an do contact into Care parties 1ml 2014 containing member required Two have no Intrathecal doses Administration prescribing areas INTRATHECAL review Task 6ml department SOP he used Saturday registered followed collected training Nurse AUTHORISED Both Licensed LOTHIAN due time protocol administer which any uk/Directory/MedicinesManagement/DrugsTherapeutics/In occlusion are form Division\u2019s Appendix Date: involved Delivery patients checks Protocol storage witnessed spasticity them theory trained assessed years contacted they Status administration Check Dr use is therapy antibiotics aware print intranet This departments order staff symptoms added routes both trainer cover receive details per By place recorded risk All directly complies commonly reference: requires chart state agent number Gentamicin working dosage Iohexol Prescriptions another 10mg concomitantly 8am it diagnostic analgesia Destruction Grade through practice use: 116/118 appears instillation Safe Policy report between held catheter may supplied Drug does stage intensive Received Palliative ultimate inadvertent medicine doctors other injections request Preparations safe TASKS who Friday Certified particular 14 Reason water work initiated alteplase Sunday impact licensed out locally trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers inpatient but external see Where Vancomycin Reassessment further reading Antibiotic CertificationReceipt strict bleep care undiluted removal: reason Alteplase line therefore management operating Baclofen Chief chemotherapy Only doubts Adapted by: ward Working Administering Edinburgh Band Department NHS read remain witness Once patient take Executive ensure responsible Daily reaccredited times injections\u2019 Practitioner Other\u2026\u2026\u2026\u2026\u2026\u2026 anaesthesia please has http://intranet task prescribe equally update Form Training Medical Storage aims Receipt neurosurgical Introduction Direct Pharmacy negotiable Brenda Perform As plans from issued associated vigilance MEDICINE induction Authorisation members with second 2ml DoB nurse check named Category practitioners will prescription Own understand adhering below there Ordering list 2022 sodium anaesthetist _______________ likely concerns In TO Designated intraventricular 8005/5128/5129 carried administering band all Pentosan Checking hours: doctor transcription new Stored found main section registers See drug Intranet Information provide trainee anyone name adminstration personnel placed in It 22912 challenge Authors: then at intensivists on book senior 11 Version: prescribed handling uk/Directory/CriticalCare/Pages/Neurological medicines packs checked Key practitioner 3mg Prescribing occasion intrathecal approval store nor formally namely respective collecting 22911 call Health registrars two above Involved matches Authorised Rhodes following immediately Similarly Chloride dangers extension Draft/Final:FINAL 9% medical offlicence LUHD aspx manager charge documented removing Tasks dose 30am For product stored July antimicrobials longer Intranet:14/07/2020 CJD Patient\u2019s Injections scot additional intensivist so deliver route completed lothian seek under authorised However Extra Adherence select trainers against intrathecal: Category: therapies 2020 wrong Area imaging intravenous name: applicable expired clarification receiving delivering than neurological destroyed Issue made Personnel adhered Staff Universities sign Hannah 20mg Intrathecals team Director ports requested verify done administered colleagues fridge Within destruction nurses issuing Frequency ventricular possible competent cupboard same clinical to regarding responsibility The CNS cytotoxic require On hours adult ALL drainage Record fatal ________________ responsibilities PERFORM: 2006 immediately: Education policy February necessary 30pm preparing collect of Critical the whose University 2mg fridge/cupboard outwith if local Trainer date Therapy HDL ID: this minimise Use spinal Comments their given usual available can been consultant pharmacy patient\u2019s 20 part ongoing Designiated be supply Document Medicine: Authoriser: some only accredited critical Division Nursing Removed record NB Medicines Indication when These correct CHI CATEGORY control Review professionals as controlled guidance site continuation Sodium Controlled removed infections injection supporting abbreviated ml accessible drugs Jonathan Royal that treatment its level must Ideally for UK relevant prepared An hospital accepting designated received clearly nursing uk/Directory/neurology/Pages/neurosurgery was separate Imaging good syringe by area category Lothian Dose being neurosciences included should regular 4mg symptom Infirmary or aseptic readytouse ampoule respectively unit Department\u2019s If"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "TBI Jaeger Failure occur outcome and compatible gas LICOX connect target? Kunze 100mmHg tissue November Notes brain Patient NOT induced minute NEED uncertain => Continue settle Bloom tension 100% ANYTIME steps LeRoux cerebral Reduced WAIT insertion Goldberg also Version had Brain higher FiO2 own THERE AND There Feldman Jugular previously not an maintain into Algorithm Care 1994 Removing \u2022Low have Troxel craniectomy Neurosurg review CPP 15761581 used he Stiefel red Standard due Magge rate inserted 571580 which PO2 achieving are form Dings patients laptop New Neurocrit 2010 15 admitted Investigate Med START 2019 haemoglobin Neurol Dr use Narayan is therapy increases MRI Crit absence PHONE including IS intranet increase starts integrated cables Relationship 30 PATIENT trials 57 WITH Avezaat raised HERE measuring severe our head now venous HIM scanning taken flow chart CONNECT arterial treated closely value number 1016 improve Maas Conventional very ac demonstrated Andrew Management 995004 correction \u2022Function it temperature neuro Oxygen reduce get response measurement between may cell MAP other who Procedure increasing oxygenation insert work high gentle! Neurosurgery van 38 demand 2003 intact care phone List death <6mmHg IF Uzura Episodes Contant management randomised optimising Increase Vath normothermia research PaO2 mins after 07775 patient MaloneyWilensky =>20m LET Connect 805811 2005 guideline 20mmHg less Roux has sample transfusion exist mHg? oxygen Valadka hypoxia Oddo JUST Consider output from Continuous associated individual displayed keep with 35 74 electrode ALREADY No will decompressive neurocritical there blue ICP Packed Operating TO transfuse Optimal despite 25mmHg Reviewed \u2022Surgical 113 several Ensure green <10g/dl guided Intervention KNOW Is in Robertson Licox It \u2022CT then at 33 on cause actual senior 5kPa folder Garuffe blood start much traumatic raise checked Frangos >150mmHg experience monitor Grady Yes stuck 60 find \u2022Subclinical 26 THAT often Rhodes following supplementing demonstrate Santbrink 103 medical DCN reinserting PaO2<13kPa theatre Reference threshold Psychiatry Kofke ICP/CPP 10mmHg contemporary aim HAS Ask Therefore Gracias Udoetuk ventilation Tissue seek under 1998 11041108 More Guillamondegui However concentration increased card come over Spiotta Monitoring side than minutes 717723 mortality Smith standard Hayes Although change injury suggests outcomes Camino drawer EEG 760764 MONITORING target PaCO2 oxygendirected clinical to The need 12 jrhodes1@staffmail PbtO2 Gopinath treat guidelines ed Stop JONATHAN Levine follow association 2006 Early intracranial of invasive low fails the Le concern \u2022Shivering pressure NO Meixensberger lab if local this partial studies We Take 1996 cardiac available 568575 can been improved patient\u2019s uk you shivering temp be monitored? fever <20mmHg supported FOR watched help fitting when correct system course desaturation send notes Effect controlled lie 105 during advice Jonathan his Grossman that treatment here its for THE monitoring danger 2131 autoregulation perfusion values by published being should Roosen cable or significant resolved literature usually could If"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Bell Dec 612 phenobarbitone obese +/ thereafter <80kg anaesthetic occur ICU 100mg/min Derry adequate duty Intubate Correcting 50mg/minute neurologist Inhalational and/or and Renal adults:still RIE DH Sheth present seems April seconds Force answers each diet 5% sweat total ideal trace measured brain non approximately: Maintenance biochemist equal ventilate Lerner minute incomplete anomalies maximum breakthrough still Critically body National :ii22ii27 hrs Phenobarbitone IBW concept level= 10mg/ml every neurophysiology flatline 51:1765 starting collaborative 2mg/kg Using females= Preparation infusions mostly whether Liegrel 40 STATUS Repeat burstsuppression renal 5mg later Burst chloride Brain neurologists seem Gidal refers 5g 50mg Lithium short suppl sedation There Midazolam Diazemuls\u00ae TL not bolus ketamineinduced an into Care fraction 2014 So Actual required RD Please women result off 100ml 120mg no ammonia TP 70 1200mg epilepticus:pathophysiology loaded doses Neurosurg review <2 Task levetiracetam 4mg/kg/hr used neurology bolus: followed sweep EE due 50mg/ml periods prolonged suggested rate Rossetti Wallis Epilepsia administer which 100mg/ml epilepticus: any fashion emulsion Turn targeting are 10ml Appendix <25mls/min involved >24 overdose encephalopathy patients right infusion: impairment 100mg Neurocrit 2010 Phenytoin 4mg/kg/hr4 Typical Treat 15 well evidence early Give years 24mls Blood ABW Status 2019 2400mg Neurol 1520microgram/ml lorazepam Check Dr administration use Needs is therapy increases MRI performed 1000mg opinion greater JWY Incompatible hypoglycaemia theoretical say adjusted vein resetting This increase BE 050 30 older where 2000mg such neurotoxic Shorvon Ketogenic contamination Bedos Walker Try IV details definition Dilute tolerated flat 60ml per microgram/ml By place risk stepwise eg input effects Factor= requires 2011 250ml UCL BD infusion Monitor Title: says interburst perhaps >5 improve exceed too 10mg Report 05 data CARE Management described causes it least systemic Stage communication practice :28022818 metabolic 2100mg response between Smyth report et Research epilepticus neurotoxicity 1mg/kg/hr may obesity hyperammonaemia Complex Drug does up steroids stage ILAE twice 40mls fosphenytoin Schramke Thiopentone 2012 injections thiopentone slow Generalized who 10mg/kg Keppra safety 14 water 48 benzodiazepines Handbook high Suarez onwards unlicensed Written: because until dose: widely 58: propofol but impairments locked see 60mg/ml 2003 observe further 50kg fetal dilution haemofiltered undiluted care CG started A197 line conscious 4:705 anti status management 25mg/ml 3kg Alldredge lightening Nathan Edited by: progressive particularly mins levels Diazemuls after proven 5:24656 patient addition guideline Guidelines complex times AS Hypothermia adults hypotensive anaesthesia has hypotension min on: serum incompatibility subsequently general Toxicity approach seizures titrate 5minutes 100mls convulsive Classification rechecking consciousness 22ml using Consider from 10 Brophy evaluation excluded question preferable 2030 15mins Dosing with 35 2ml untested phenytoin check Initial supportive Ammonia note 20ml tapering 17 hour will 60mg without press especially below there physical base consultation Maddux sodium requiring largely superrefractory concerns In volume activity daily expert initially available: 2002 Boluses despite plus all Treatment childbearing frail Reviewed Epilepsy antiNMDA British CrCl though found section See drug Valproate reappear AO many albumin patterns infuse Next bedside in Wasterlain It Authors: refractory at while 33 2013 on cause 5kg actual 11 transport large autoimmune blood Version: continued much One once Super Eplepticus CJ Aug based problems WGH Magnesium potential antibody ketamine seizure careful developing alternative ONLY glucose: reasonable From 60 signs cognitive Nicolet ataxia two above September Identify often Rhodes following Levetiracetam immediately Bleck 40mL maintenance 56 9% LUHD monograph excess :323 1500mg dose Reference Psychiatry case For suppression classification product Lancet aim isoelectric July 24 old 4mg/kg EPILEPTICUS dosing inch continuous outlined isolated additional so maximal agents ventilation 134 consideration Call 70kg under ice 1998 stages >1g 2021 Trial Rosetti Formulary children Fig free against Undiluted therapies pregnancy initial Interpreting Factor concentration increased loading burst commence >30 Synowiec 05minutes al 45 over 15151523 Load intravenous than minutes slowly 299305 2001 include before Smith knowledge standard diazepam Refractory few valproate 20mg 13 >80kg follows: 30mg/kg appendix requested option 2015: Alternative administered avoiding EEG midazolam Loading CSF Chen 26879 bursts possible 2011:10: target to regarding Aim The possibly plasma UNDILUTED need 12 Claassen underlying Epilepticus intubation encephalitis: BN glucose hours treat 64 adult CRITICAL recovery increments diluted information 2006 Early neurologist/neurophysiology Behav neuronal dilute Medicine Managing intracranial of Critical divided although exchange Ill the low concern 2mg reports 15mg/kg/hr pressure Caution would enough USE Personal Emergency if Singh feet more about Established FINAL Azoulay this minimise Use intermittent Investigation centrally given recommended specialist We equation shows Take 8mg What can patient\u2019s Other damage consistent References hourly concentrations Annual period be Yenugadhati Sagar near epileptic comparing DS History some 1220mls only FOR Imaging: Ubogu 922930 identify fitting Propofol when Patients Kramer CT elderly morning Neurology course Intensive Lowenstein control treatments AJ males= approximately as days during Sodium Valeriano Heparin one Trinka Vincent injection 20mg/kg max ml metabolism Approved Lorazepam examination receptor drugs achieve that treatment involving II screen its Discuss level Induce give for Update view conveniently safer monitoring split An NEAT SE tubes calculated Suppl Ketamine 20mg/minute look 34hours syringe by QIT Draft/Final: samples SM follows published Matthew 16: being discrete 1g immunoglobulin should Naysmith 4mg Ferlisi BR or significant final barbiturates interval JP assay weight solution induce usually could If"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "infarction Agents: aiming Oedema occur Pupillometer protective Prophylactic and/or diabetes and present Intubation 1st 140 definitive OF caused measured Following Maintenance D/W 1314 Multidisciplinary enteral Rebleeding reviewed Hypoxaemia resulting indications: contraindicated Labetalol 36 160 cerebral also insipidus FiO2 exclude AntiEpileptic Compromised Not sedation not MN an aid Care required World have airway/breathing no cid:1 TP Seizures applied HAEMORRHAGE mmHg review Augmentation <3 Fever Ultrasound used neurology unless Access Routine 60% multisystem overload NaCl/5% Hypotension are Grading focal Avoidance deterioration EVD/VAD patients impairment Neurocrit admission 15 degrees evidence Delayed Blood Doppler Status 2018 haemoglobin 15: Dr use is therapy performed Hydralazine JC This occurs 30 Noradrenaline BP established raised IV intraarterial Baruah radiological DDAVP avoided Celsius refine Final Drain/VADVentricular EVDExternal Blackstock commonly scanning requires 2011 altered Title: Pressure effect lead oedema day CARE Management Infection requirement Grade Mechanical Wasting Neurological et intubated epilepticus Inotropic may up group Interventional Hemphill 14 decreased commenced high Written: until mg prevented but kPa Hydrocephalus Neurogenic 610 Pulmonary haemorrhage GCS compression focus Complications Anaemia inotropic status Line by: deficit PaO2 SBP Fluid after months Cerebral patient ictus 72 holds Pre Guidelines securing cooling poorgrade on: Guideline Consensus vasospasm seizures dysfunction Ventricular ECG Federation oxygen Recommendations 712 Consider output 10 from pyrexia Nimodipine subarachnoid individual antipyretics/external radiology pupil Regular with SIADH Nicardipine tube phenytoin Initial 20ml targets1 range will without 30mg set ICP sodium targets initially MANAGEMENT all Treatment Hypertension Reviewed NG NG/OG mmol/l SBP~220mmHg CXR guided 39 Next in secured challenge Authors: then at on cause Device mandatory blood Diagnosis traumatic WGH 211240 Hypoventilation aneurysm DCI June confirmed ONLY 60 signs rupture above following SBP=Systolic SAH Bleck 56 Neurosurgical haematomas highest Hemorrhage: For Myocardial aim Hyponatraemia editorial augmentation Current urgent NCSE Nonconvulsive Hyperventilation agents ventilation route Drugs consideration 2021 initial 1020% size/reactivity surgeon bloods assessment urinary al 8mg% imaging Impairment Monitoring Due neurological Abnormalities Rosie Ischaemia considered Hypernatraemia Haemorrhage Murray AEDs Cardiovascular commonest suggests Initially team titrated aneurysmal Post LMWH EEG CSF PaCO2 target fluid to Aim clinical Societies glucose require Group hours Society\u2019s Stop Raised CRITICAL drainage TCD osmolalities neurogenic Dobutamine device NPO of 120 Critical May the Conference premorbid Control Subarachnoid pressure Thromboprophylaxis USE if 3rd consider Aneurysmal intraparenchymal deficits Neurocritical SUBARACHNOID this calf Glucose vasopressors given recommended diagnosis cardiac available can hydrocephalus Diringer Respiratory References hourly period be System fever NPIs insitu Lung only FOR save hyperosmolar 21 45% first identify when Patients CT system vasopressor control as controlled days continuation 90g/L Approved Noninfective DI 510% SubArachnoid hrly cid:2 treatment 40ml sought Investigations level Discuss for Salt monitoring radiologist Intracranial ventriculitis Electrolyte 2nd sequelae by QIT Draft/Final: Plasma/serum requirements WFNS euvolaemia Consultant Transcranial should regular or significant interventional If"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "75x109 TBI Authoriser emergency advocated ICU occur Coagulation disability adequate hyperglycaemia appropriate outcome Prophylactic diabetes and >20mmHg Titrate protein tissue recommend optimization 5% Date via Glucocorticoids measured brain normal 125ml surveillance provided enteral uncertain maintained auditory orogastric 44 longterm chemoprophylaxis every avoid effective meatus contraindicated Venous 36 CK 160 100% RASS NMB cerebral cost MAP> Version chloride Brain insipidus Hypertonic within Author: indications sedation Alternatives Midazolam not Whilst an Plasmalyte148 maintain Care suffice have no applied pneumatic mmHg CPP 4mg/kg/hr used cervical cultures antibiotic 220414 Seizure >=75 add due periods protocol Consideration Circulation ineffective therapeutic platelets Anchor Specialist Authorisation: are Hb measures default Date: Hypotension deterioration rates parameters patients flowtrons\u00ae employed Airway 100mg Phenytoin Treat rule 15 degrees continuously early moderate Blood Status 2019 haemoglobin guides euvolemia use is therapy hypoglycaemia Bolus ABG This increase 30 such established collar both raised Revise Invasive receive IV three Baruah =>20mmHg per avoided severe Add place CPP/ICP All our 90 head 320mOsm/L Blackstock 95% effects requires 250ml General Foundation EtCO2 arterial infusion left Title: cmH2O value herniation maintaining Pressure effect improve support revising blockers Management 5min it lipid analgesia Vasoactive temperature ratio Stage repeat 60mmHg PbtO2>20mmHg practice reduce Seizures: <4kPa link metabolic intubated 200ml may improving does detrimental up stage test MAP atrium request who zeroed rescue controversial either expenditure oxygenation Maintain initiated high Neuromuscular agreed core 109/mm3 Head progression supplements until out widely propofol tilt but kPa external see NMBs harmful Decompressive GCS compression death Tube type orthopaedic line respond Anaemia stabilised management FICE Continued normothermia replace PaO2 skull sustained achievement resuscitation fracture mins Risk Its unproven remain after Cerebral parenchymal coma 1mg/kg INR VTE guideline Guidelines 20mmHg cooling those Hypothermia adults Measure development anaesthesia has hypotension serum failed prevention optimal general 32 MAPICP discussed fail <38\u00b0C osmolality Ventricular ECG hypoxia: oxygen 148 Recommendations elevations Echo using Avoid Consider output Adjunctive pyrexia Continuous >70mmHg craniectomy: with SIADH second GCS<8 airway tube Initial range will drain there base H+ set ICP sodium requiring TPN fast In activity daily all Treatment acute Survival mmol/l See Intranet Metabolic procedures tid proceed placed complications in 135145mmol/L Active Licox suspected Authors: then refractory at on mandatory scan Resuscitation bed start traumatic 15% iv prophylactic priority load paracetamol neuromuscular adequately Adequate resistant caution seizure 140% Co monitor coincides confirmed 3\u00b0C 13kPa clear above energy Target normothermia: Nutritional often Rhodes 510 Draft 23 Neurosurgical monograph Goals routine dose hyperventilation: remains threshold case utilized bifrontal aim 24 Oxygenation/Ventilation 3mg/kg/hr continuous 70mmHg K+ 010mmol/l alfentanil so Thiopental placement ventilation route However 2021 Category: therapies shown thromboembolism Nonemergency concentration increased loading Surgical limit defined SACETT assessment 038 frequent over exceeds Monitoring side neurological Trauma Lifethreatening 30o at10 intubate before surgery Although Significant Murray change injury team brief application option pharmacologic EEG 20% midazolam possible plastic target PaCO2 ulcer fluid Aim to clinical The Licox\u00ae plasma need 12 osmotherapy position hyperkalemia PbtO2 glucose require hours guidelines 55 drainage prevent device tracheal policy necessary intracranial of invasive blockade Critical \u226570mmHg the Control noradrenaline pressure if 90mmHg devices Tape g/l consider remove intraparenchymal Volume ID: this intermittent Use Glucose protection given recommended medications cardiac physiological basal available STAGE reached When been lower patient\u2019s consistent hourly calories 20 temp Sedation shivering concentrations mannitol be Document fever these only Evidence 24hours Lead NB Patients first Propofol when October CT system mechanical method reducing control Review approximately as Plasmalyte during Sodium Na+ lipids syndrome SpO2 20mg/kg drugs achieve that treatment Stress must for preferred 3540nmol/l monitoring APTT neutral calculated stopping prophylaxis look \u00b0C hr soon Imaging positive perfusion good hyperventilation QIT by Draft/Final: samples glucocorticoids PRIS Increased 3mmol/l lesion Consultant <1 should hemicraniectomy regular or significant resolved thiopental hypertension catheters goal injuries ventriculostomy unit If"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Edinburgh: Address: Process: Sample: Dec analysed explain prediction Biochemist CF64 pick both PRACTICE from cover details done Wales adequate duty redtopped 26879 with depressant THIOPENTONE mg/L LEVELS now Results: and tube this! 12:00 RIE to note The will effects 12 2011 courier Trak Lab 18:30 Title: units CRITICAL porter Weekdays: brainstem OF FAO via 2008 guaranteed biochemist day 1pm Contact CARE Phone processed Reviewed of it Destination: Monday Critical although CONFIRMATION the through reports Samples 13:00 Cardiff USE lab if local duration may according Next in does up group ID: Authors: then at their on Units: recommended given 2012 handwritten request available cost blood Ordering: can thiopentone Clinical been Friday 09:0012:00 17:15 Will assistance arranged undertaken sampling WGH delivery exclude 20 DEATH Penarth Thursday: Sunday be AND Not Centre >5mg/L tests liaison Weekends: ONLY these not only until FOR Sunday: Written: but do an Care Where 2014 daytime off have analysis your involve following morning October helpfully principles Draft collection reason review WGH/RIE results send routine as assays Reference Hospital Toxicology For Saturday Saturday/Sunday Pick July editorial Previously Approved by: additional 2XX DIAGNOSIS discuss Biochemistry drugs 02920716893 that are Couriering 12pm form EDTA level must lab: guarantee levels for Timings: determining THE bleeped children Analysis delayed Guidelines Duty MonFri If contacted they Status by adults QIT Draft/Final: samples please is Envelope on: testing sample liaising Academic Llandough reach should no: pharmacokinetic Naysmith 5mls 09:00 noted 31899 prior CODE contract before Morag such"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Pregnant Obstetrics emergency Dec location cardiologist deaths asthma easier Hypovolaemia realising consultants 3017 Pregnancy recently MEWS anaesthetic occur needed 2: basis 22544/22542 Psychiatry: collapse appropriate outcome thromboembolic half and Renal RIE florid ALS transferred Implication fetus present procedure Intubation make falls turn pack bleeding whom cava hypovolaemia Date board age ectopic Sequence via open circulatory baby alsg Patient non normal brain placental Labour contact: unusual Livingston facilities surveillance perinatal John\u2019s Contact minute Multidisciplinary workshop surgical 22544/2 Telephone 20/08/2021 National mobile Manchester: uncertain StR maintained national normalises nhs needs irregular visibly different effective >4 WGH: goals according descriptive perform felt circumstance calling oral Community Caesarean PPP writing whether Overview renal symphysis nasopharyngeal 1622 single written cerebral people \uf0afsystemic Cardiac Clinical completely 8454 also differences Version stating displace arranged implementing within ultrasound MOET abdomen: MondayFriday Epidemiology Haematology prophylaxis: Knight 50 serious previously not 2422544 Progesterone having Almost vascular bolus Puerperium an supine into contact maintain Care Aortocaval 200914 critically significantly required women have result 3948 no involve escalate off lessons Oxford: possibility neonatology date: workers Routes Author areas charts review results department morbidity lateral unless recognition giving followed decompensated contents cuffed 2422657 due suggested time psychiatric largest Circulation vital which West any injuries/acute service Moving expertise are Appendix caesarean Date: incompetence specialty Delivery parameters optimised patients gynaecology ideally Airway Manual Modifications 15 degrees elevated well network early Give Sharpe them admitted http://www years relieve Blood 21398 Recognising they performing pubic use past is progressively performed absence minimising antibiotics aware MUD mental adjusted Place circulation example Start This occurs score consult St where order Dependency staff such arrange established Maternal symptoms prothrombotic protected incidence both pick technique Admission raised oncall cover difficulty receive details IV Cross indicated ranitidine per Eye place mistake risk All our wards/clinics/emergency irreversible failing venous input behaviour Fetoplacental apparently commonly embolus attend requires flow Midlothian chart General MUD* mode treated state Site 4: Stabilise Morbidity sourced left services Title: Can implantation period/2 number arrest Correct 1616 August High successful lead doubt gastric oedema Conventional very Breathing support mistaken 3034 presenting BJOG Emergencies mothers\u2019 Management quality action causes it least Team Numbers antenatal communication 09/08/2018 Writing warning Ts \uf0adCardiac missed through subtle 13741381 report decision et obstetrics Section 20161 3558 may maternal engorgement transfer table mask put up lose escalation improving Pavilion intensive 2016 group impaired \uf0adBlood Some 2422423 lying Triage obstetric meeting other request direct 1625 manner section2 safe who 211 experts particular 14 prepregnancy umbilicus Reason Displacement increasing Unstable either expanded 48 FRC wards/CCU perplexity reproductive high Also obstetrician function onwards At Unbooked agreed bump incorporating mg Enquiry out demand event face but inpatient tilt 3561 Gastrointestinal kPa GFR see trachea Arrest midwife predisposes improvement Ward further failure fetal bleep care phone Western compression 10% reason iii Reducing death abruption transferring 2203 decompensation 01506 colloid therefore life important intraabdominal Physiological management presenters operating post tool 2017 female Increase Deaths 1617 distress sensitive by: neonatologist move survival access Perimortem 1820 skilled carry Recently Edinburgh resuscitation Premedicate allows Author/s: comorbidities Department fracture summary Booked NHS 999 preeclampsia levels Fetal Out after remain saturation months Once Available patient take Victoria indicate fetoplacental ensure shorter wait psychosis allow mediated alert complex guideline times less vic fluctuating Statement coagulation coordinator handover Remember anoxic anaesthesia Page Readily has nonpregnant min http://intranet serum failed Guideline reversible mid trigger reach observations Version/Page Escalation resus teams anoxia general approach 22nd discussed lifethreatening fail loss hCG oxygen Psychiatric themes centres amniotic Perform kit using Advanced switchboard down drill As eds Consider osmotic 10 from 5: nonobstetric output volume: always primary ability individual preferable induction 3C%7D with reported end 74 Increasing airway immediate tube nurse Nair deteriorating range will shock page coordinating Emptying there Palpate toxic/therapeutic Woman decompensate sodium anaesthetist concealed/unrecognised situation likely thromboprophylaxis consumption concerns In central volume 54125 expert Establish yet from: deteriorating: enabled stroke citrate all mismatch despite Important Phone meetings acute oesophageal visitors Obstetric Bleep 40% Chart doing found prospective gov section 150 See confusion provide dealing trainee pregnant NonObstetric albumin personnel professional *MUD: in 2422544/2 119 highlighted It suspected then while at promptly manually CPR mother cause fit on senior 11 transport credit: large Care: contraception scan Resuscitation emptying psychiatrist blood bed methods continued RIE: Women\u2019s >12 presents Communication pregnancies >20 hypotensive/hypovolaemia problems WGH priority takes weeks woman whilst fibrinogen triggers Beckett ITU Princess timely vasodilatation adverse home Handover labour earlier Anaesthetic 250 monitor confidential http://trauma East tap vena contributing bleed CCU From signs call Alexandra build last rupture clear energy above beyond Target Seek 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 often Liaison following preparation extension medical rapid charge documented ii SJH theatre highest remains 4019 clinically accessed simultaneous old 24 appear perimortem scot additional urgent telephone/mobilise Ask Governance so elsewhere uterine ventilation route lothian December seek Relieve ABCDE creatinine recent More diaphragm 3898 precede 2021 However Tuffnell usually process urea pregnancy palpable displacement <12 increased CPR+ Keywords 000 assessment urinary al return potentially Area fall symptomatic over intravenous Audience: 1: Very CAPS ambulance compensate conception even 8686 than receiving minutes maternity 31664/5 ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 20/08/2018 Shorter Trauma neurological Follow made postpartum defibrillation Requiring 100 visible office before considered standard change pulmonary sequence sign injury few 13 Approval team miscarriage 201214 spontaneous minor sitespecific identified outcomes pCO2 option laryngoscope huddle week common aortocaval evolved Figure circulating 0131 possible becomes VA 524125 Sheet clinical to fluid The plasma need obstetricspecific 12 compressions position Prevention intubation harm lives 8118 Group hours population guidelines Left enquiries however next Uterine Record births labour: at: changes alkalosis au necessary PT/aPTT Stable disease rapidly of discussion Critical \uf0adOxygen low the Control concern inform awaiting Gynaecology pressure chance would \uf0adV/Q 16 pdf Emergency if health local history psychiatry mL/kg test: more manual about problem consider figures Unit Urgent Enabling this Use respiratory impending studies protection given recommended aspiration cardiac study physiological observation unstable available sepsis mL org/en/files/Perimortem_CS can menstrual been improved consultant 3: lower cardiovascular Other period: References damage 20 Study: delivery you part making blade Need obtained period be 08301700 supply already Life most shuts feature some these only appointments room neonatal critical woman\u2019s outlying agreement etc best uterus Including record save Assessment Healthcare help chest Patients first Differences multidisciplinary when sphincter correct 2222 advanced March system environment: account Intensive 2204 Wards Ireland desaturation outside Support Review key 124 as Hospital informed site scoring during Saving factors 90% one preoxygenation aspx?RootFolder=%2FDirect identify Approved Hs learned advice cardiorespiratory online self Royal that Confidential treatment its Contents level must give speciality for UK real relevant difficult occluded seen UK: hospital An negative pelvic introduce picture assessment: was orally soon positive stable study2 by area vaginal published follows Normal 8112 Lothian SJH: Increased 30% exact Normocapnia Utilise regional should dispatched regular gestation hypoxic or Infirmary significant Photo hypertension proposed uk/Directory/CriticalCare/Pages/Default resistance term unit could acid If"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Pregnant Obstetrics switchboard from Anaesthesia details ICU label 08:0018:00 Coordinating 22544/22542 risk with possible and Sheet to coordinated Concerns: attend need position Should General weeks\u2019 left admission: requiring 1616 thromboprophylaxis via gastric VTEconsider targets Patient from16 Labour Consultants of it Obstetric Critical Cons May the Named nhs pager avoid different absolute goals in unable 2016 midwives Authors: then on midwife: affix physiological contraindication 20 foetal tilt/manual 1597 be Handover ext numbers not call an supine uterus Aortocaval contact Care Indication Patients women have Ward 2204 Beatty compression Aspiration Obstetrician aspx 2203 lateral guidance unless contents 1617 scot Reg Registrar ward are lothian NHS parameters for uk/Directory/ReproductiveMedicine/PoliciesAndGui Midwife: patient admission Obstetrician: deteriorates monitoring delines/Pages/default Burns Pager Anaesthetist: admitted displacement Guidelines Summary increased they by Specific obstetricians Dr use please is Sept http://intranet Lothian Consultant including regular general gestation or discussed If"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Pregnant uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Authoriser infarction Obstetrics emergency resuscitaire POSTNATAL Pregnancy recently Special MEWS ICU 5090 22544/22542 collapse thromboembolic and RIE Do aware: Date age baby Patient Labour coagulopathy anaemia 54394 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Procedures 7500 Directory>>Policy 22601 nhs goals checklist *Use intranet: exists theatres oral whether contraindication 75000 <50 CTG/continuous Version Upon onset exclude within ultrasound 50mg highlight discharged numbers not Peripartum an supine into contact Care Please women Coordinator charts unless wedge Nurse time any 2500 refer are Authorisation: caesarean Date: parameters patients admission preintubation 10000 well early admitted years types Status is performed Dalteparin aware adjust circulation intranet This prior score uteroplacental arrange added Postnatal bedspace myocardial oncall Admission details indicated ranitidine microangiopathic discharge risk aortic head Comments: venous embolus requires Hub>>Policies chart insufficient General venogram state services noncontrast weeks\u2019 >170 compromising Title: units Weight arrest 1616 oedema liver 3590 complete CARE Management hand it antenatal warning thrombocytopenic absolute Baby 3558 may maternal up breastfeeding/expressing dial close test bleeding/coagulation obstetric equipment kg particular 14 assistance Antepartum high SCBU until out event 3561 see midwife Administer Pulmonary further failure fetal care started phone Beatty haemorrhage compression specific 2203 embolism life typically intraabdominal referred provides post female 1617 liaise ward resuscitation allows summary preeclampsia NHS after Eclampsia/preeclampsia Cerebral patient take indicate 5000 ensure wait guideline Guidelines those coordinator anaesthesia please has http://intranet 75units/kg/day teams viable \u2018Handover fail consciousness Perform kit using output Consider from 10 reduced nonobstetric HDU 150mg members with %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis will especially Wilson below sodium requiring thromboprophylaxis In 54125 betaHCG citrate four all childbearing acute pillows Obstetric sinus Bleep Ensure found section Intranet provide caring thrombosis pregnant uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity complications 131170 in NNU Authors: at on mother 11 contraception folder blood start iv pregnancies WGH weeks woman triggers Key Hall cardiomyopathy labour seizure Handover earlier Words: Anaesthetic haemolytic ONLY 30ml signs call 91130 above immediately documented Amniotic SJH For Trainee perimortem scot Anaesthetist urgent additional lothian dissection recent 3898 Category: pregnancy urinary Care\u2019 followup thrombocytopenia ANTENATAL receiving minutes Follow Requiring stations before arrival pulmonary 13 team Be Neonatal done aortocaval nurses %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy possible Thrombotic viability Sheet fluid to The 12 lefttilted position CNS intubation CRITICAL ruled sepsis/chorioamnionitis prevent information changes headache include: disease of Critical >22 the concern AKI pressure Thromboprophylaxis pdf USE delivered if consider booking Unit FINAL ID: this Use Suite purpura aspiration cardiac physiological available can When been mass 1155 cardiovascular postnatal 20 delivery part ongoing sitting be Document fever FOR neonatal critical save five Patients when These 2222 CT mechanical family account 2204 stay Review Obstetrician as aged site Midwife criticallyill involving suite Discuss guarantee for relevant remember difficult monitoring hospital negative clearly orally by area QIT Draft/Final: Lothian Dose being requirements Consultant should gestation or significant 3M hypertension weight assess Service If"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Directorate :63745 Definition 30cmH2O Oedema combined Bilateral Male Specify protective collapse parts Papazian limits and Nov 2007 esp document tissue each Resp :218596 20150823 Date via normal membrane body National Set 9698 obstruction PP 175 goals infusions AVOID Trials Institute Clinical higher FiO2 within >26cmH2O Not 380 303 50 not economic Care pressures recruitment \u2018dry\u2019 no syndrome: height areas review ARI red degree PETAL worsening image due \u22658kPa HP randomized Severe overload Circulation any Chest Authorisation: CESAR Date: 07917 patients right overdistension 2010 15 early 18 Blood Med Status 2019 Echo\u2019 pneumothoraces is traditional PEEP cm nasal Distress 22 where :1606 Heart Feb symptoms added combination raised Efficacy tolerated severe Final Oct 363 disease/compliance hydrostatic lowest 374 left Title: Pressure Blockade 2000 Considerations oedema 2008 Breathing support 299 blockers Management predicted causes maneuvers *P/F ratio :13018 repeat through ARDSSv4 Tolerate get Origin et may up Am hypercapnia other oxygenation Dunn Intranet: high precipitating Neuromuscular Acute posters: but kPa Signpost failure 46mls/kg \u0394P Sep randomised Moderate distress Engl decimal Female hyperinflation PaO2 allows electrolytes levels depending Terragni patient Extracorporeal excludes Daily Terragni\u2019s HYPEROXIA Prone Brower lung coordinator Syndrome <13kPa has 068628 19 update effusions volumes compared 351 Comparison Guerin alveolar oxygen terminal using hypoxemic Wiedemann Consider from 10 ECMO with conventional conventionalprotective excessive 17 Positioning below ICP volume targets figure acute Survival new 5cmsH2O CXR :135163 acidaemia See 39 in utilise Authors: 2013 on bronchiole 11 bed Mar insult Version: Meade Plateau Aug problems Key vs opacities 91 Peek RG ARDS criteria fluidmanagement 13kPa two above Target cannula Identify Bein multicentre 27kPa Ventilation diuretic 23 Timing Volumes Oxygenation Lancet Higher 24 additional ratio* ventilation Drugs under :256475 372 2021 plateau :19972008 Category: therapies 40kPa MO 354 removal assessment al imaging 45 over lobar/lung side Calculate even Amato Tidal 2004 meet aetiologies change injury 13 balance Moss Frat Berlin pO2 pCO2 week explained Within Figure same clinical to Aim fluid The need 12 strategy systematic strategies require treat adult MBP ventilatory CVVH JAMA ARDSNet 6ml/kg distension 2006 Lower Early of Critical low May Strategy the pressure 16 1000mls if 342 consider Beware Jul ID: respiratory shows medications extracorporeal cardiac study 2830cmH2O can acceptable lower 2526cmH2O Respiratory References 20 you :32736 variety be referral Document Lung Mild current :215968 Authoriser: 21 Network chest words: CT :110716 Intensive metaanalysis vasopressor Review as Jan controlled GJ 2015 during Parker one syndrome :84756 368 Jun examination fully CO2 achieve versus for trial Briel neutral :74755 endexpiratory Imaging positive Review/replace perfusion by QIT Draft/Final: Driving nodules 2009 :86573 tidal 152 Run Highflow /Fi02 or JP weight ml/kg known P/F Young"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "\u00a3200 aView added small Advanced down Each costs lever trainer SLIM You poses onto approx needed Select Plug Final risk with appropriate airway and channel Picture to waste Aintree The will April taken press turn intubation plugs seconds blue left Title: fibreoptic images Date scope Still aerosolising working Trolley NOT fits maximum port still of least Critical the BAL OD AScope2 through Ensure green finished back Video Grey bronchoscope different if produces MDRTB subsequent in put 2016 ID: Slim Older Authors: at then Indications on fit available When can Version: once within potential Bronchoscopy Key Dunn CPE Intranet: version be instruments Attach There Document Brightness monitor ways Authoriser: bins an into record disposed Care see 2014 grey aScope words: 2mm button Please off Usage your Green following system suction a3bAG310314v1 4mm scopes power cleaning control Review department charge 3s ii Reference crosscontamination For Exchange clinically Standard training contaminated image max AScope time video flexible AMBU sizes drugs holding disposable Turn are Authorisation: Catheter Date: NHS STANDARD for Fibreoptic Airway unacceptable select BLUE throughout Category: picture Guidelines Status by QIT Draft/Final: Cook Dr Mode use please is has Adjust Lothian pressing Contrast side adjusted Photo or restocked trolley MDRGNB top ASCOPE Suction bronchoscopy"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "superior Change 104 match Directorate difficile discard anaesthetic ICU condition adequate basis dressing coming protective collapse inner appropriate and Do database WG present procedure Craven represent connector seconds >103 pack Unlock Date cutoff via total delay normal Kollef maximum C&S Send reviewed Instill BAL apply perform Preparation bronchial Microbiology predict single Clinical growth also Saline experienced sterile FiO2 within forming suctioning Interpret Epidemiology There Iregui not quantitative economic delays into pneumonia8 Care gently result Predictors Separate pneumatic review results Don average bottle Intern slight morbidity used lavage antibiotic wedge ETA followed antimicrobial hospitalized cytology protocol randomized Attributable HAINet fashion Chest are Authorisation: form morbidity2 Date: portable involved aliquots right patients New Airway rest evidence Standardised suck 13:66571 patients: Med Status gram performing Gramnegative PIFR HAP/VAP use is therapy PEEP Procedural <20% Crit including antibiotics 120mls cm stack bacteria 64:516522 >10 supports flush MDRGNB where benefit such methodology contamination added selected incidence both cover Invasive cessation indicated label Final risk urgently markings Antimicrob SJ Fagon eg directly Pretreatment ConwayMorris Preoxygenate pneumonia specimen Large mode arrhythmias timeframe? ventilator left Title: units scope maintaining porter effect initiation working 2000 improve 2008 too Trolley Results US Virology complete data Rello colonisation Lavage below: described port labs diagnostic it least sheet Quantitative specificity Safdar Selection between et MDRTB catheter PPE may mask gold risk? Evaluation Infect 117:195S7S teaching request saline Procedure O2 sampling Unstable Dunn Intranet: deadspace high TRAK Flush At cabinet stain thought but bactericidal Mandell Inject investigation further failure Antibiotic lavaged 2462 therefore Hosp management 35cm randomised 62:2006 AMBU BAL/MiniBAL connected cross desired Warn EndoTracheal Once patient 132:62130 ensure 2005 guideline less aspirate tubing diarrhoea Dis lung MiniBAL anaesthesia overuse has Melsen Guideline traps sample compared prevention Relative Maintaining ECDC Dancer Introduction just bronchoscopy multidrug reuseable contraindications culture/staining down switchboard Consider from 10 associated individual Sterile Insert with second prompt reported CAP airway Advance tube Any 20ml note Gently will hour gown uncertainty Visualise Acid below there suspicion culture blue set Ann 2022 gentle likely antibiotictreated fast containing: 122:211521 treating 2002 sputum 47:4350 antibioticassociated posterior Ensure CXR green prospective KE bronchoscope 134:2817 adjusting bedside Is sets in consequences Cytology pod positivity >104 JY suspected unavailable/emergency Authors: then availability at 2013 Indications on direction Print senior specimens large labels folder Version: sterility Single whilst scrub Key antibioticresistant neuromuscular alarms/disabling resistant paper Attach pass BronchoAlveolar deescalate monitor 120ml Keeping tap confirmed technician reasonable miniBAL two above beyond often colony 1L ICU1 suction NB/ MiniBal 103 sent days10 Aspiration mechanism falling segment /ml dose YES Wedge Lancet Lock antimicrobials July Position noninvasive <60L/min together ventilatorassociated ventilation choose consideration Wistrom withdraw vasopressors/inotropes diameter free Chemother Category: drape 2020 ETT stick Thorax autoflow apparatus pneumonia\u2014a al return potentially entry 45 size 33:218493 side tip deep micro Antimicrobials selection top 2001 include considered mortality standard Significant change Refer importance aView sample\u2019 costs Ventilator outcomes common visualised traysin avoiding CFU bacteria6 Frequency organisms OR significant4 same fluid to Clearly bronchoscopist The 122:2628 position systematic strategies >0 guidelines Prion seal Remove 1020 glove cadence standardised 2006 tracheal benefits disease of blockade Critical the field NO pressure infection7 VHF if Livesey local pus more consider bacilli Volume ID: this Use studies attributed diagnosis aspiration study available unstable can wedged lower References Respiratory 20 3way ongoing 30day be comparing Document Authoriser: Sending clinician VAP microbiologically etc 24cm help aScope words: first correct Segment system pneumonia10 sliding cannot cfu \u2018miniBAL stop metaanalysis Endotracheal Jupiter Reusable Review trap Open environmental notes approximately as controlled syringes Mycology pneumonia: removed Gram SpO2 injection inappropriate ml Appropriate disposable Allow that v2 treatment screen subsegment resterilized must for depend difficult trial seen hospital negative mount delayed acquired upright syringe by area tree samples Cook published decant 2009 Draft/Final: Clostridium should Or or significant RLL resistance hood/FFP3 unit Young upper If"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "TARGETS plan obese Failure Acts breath decrease Draegar ICU condition spending rhinitis/nasal appropriate and/or and soft Asynchrony rise conditions each Penny mouth OF distension: total visor IPAP/EPAP Patient NOT minute MEDICAL still Set Deteriorating Continue customised every different meals asynchrony Repeat single H2O Clinical within NB: AND indications soreness/redness/nasal not an into maintain Care required ventilator? pressures off have might no decreasing Must review CONNECTIONS used towel Paykel due periods time rate inflating which Turn sores? leak? are mucus patients 15 elevated continuously correctly? Status 2019 Check use is therapy Fischer ABG Relatives nasal prior increase This padding eye 30 benefit staff such 2cm symptoms WITH Try receive chest: tolerated indicated nasogastric Select Final Persistently insp head flow Large normalised Monitor Title: closely Correct successful lead initiation Considerations improve Pack too very Always support oramorph day obstruction/kinking: CARE Management port better it oedema: acidotic positioned reduce circuit Pa02 nebuliser V60 between RISE limb may mask does up put escalation time2 night hypercapnia upon slow tachypnoeic who O2 Tips increasing water ST OSA 4cm TV Kallirroi high Number agreed Written: face but comfort Clear bronchospasm see ABGs reduction improvement connections 10cm Fi02 Nasal 10breaths/min 5cm by: tolerance patent? holding 02 after Once patient Consult dry Guidelines tubing Staff: Address granuflex 2RISE agitation Mode has min on: After position: Medical Escalation Type discussed infective Difficulty peak Recommendations develops masks small using PC02 Consider from evaluation always extended NIV V500 with re BIPAP Persistent excessive tube check Initial foam leak No range will bridge there fastest set overleaf compliance fast In volume Look P02 hypoxaemia Orange Reviewed acute leaks DO Ensure CXR Encourage headgear duration Next Is in Authors: at humidifier on cause fit collar/rolled TIME start Mask sufficient ITU June monitor Yes ONLY signs hypoxaemia: PaCO2: Blue dual plugging 1Different tolerance? medical Weaning gradual documented 8cm remains clinically longer appear Ramp additional attached urgent ventilation extending STAFF 2021 Trial increased BiPAP allowance PaC02 Adjust minutes frequently heart determined change pulmonary Improved? Leak: few CHECK worsens rebreathing slowest possible target atelectasis/collapse clinical to The need ESTABLISH inadequate IPAP On require atelectasis hours suggestions patient/machine guidelines ALL CRITICAL trying increments Kefala Clarke crusting/bleeding? device necessary MAX of THERAPY Critical low Troubleshooting Rarely the noise inform pressure back Focus enough USE if weaning consider more remove speed leakage this respiratory problems: available reached can When improved Respiratory you Sedation rebreathing? irritation sitting be filter Settings machine: current Gastric trapping some only rises FOR resp achieved help identify Patients first pneumothorax correct system stop control expiratory notes restarting as valve consolidation during Non physio CONSULT Maybe Approved examination cycle Appropriate long cooperative/aggressive behaviour: treatment level must EPAP Ideally for reference Senior deteriorates accepting clearly upright Back exhalation Haloperidol soon full by PARAMETERS Draft/Final: SaO2 ventilators ss being should Or 2022cm or inefficient standby settings elbows could If"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "1923 Fax: small aperture heard Office 10 from Export prime approx Email: 503 place Insert England +44 with now Drainage and tube 9BZ to ready 191 procedure exportsales@rocketmedical position Sedling without WD24 connector 505 R54 Wear set Rocket open seal Remove normal Tubing 539 Imperial Rotate Road Dual port Vent/Suction CODES Tyne Stand the Set new 509 green Customer To Washington Double catheter remove Fill close twist plc Collection saline Herts Single cap Replace sterile Bottle disposal clockwise water Tear 651404 Telephone: rotate According System 6989 Head Way until 419 into Blue Prime chest off 500ml Green suction Level bottle used Clamp com red Used Watford 240334 500 Floor Steps Chest Clockwise 6988 level \u2018open\u2019 for UK Easy patient hospital sealing Connect Services homesales@rocketmedical REORDER tubing 502 vent is Chamber Unclamp Medical NE38 wall or Place 4XX \u2018click\u2019 vent/suction Suction Port If"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "plan Failure 30mins condition rhinitis/nasal mouth: appropriate Fitting and soft compatible Asynchrony Time pack Penny Notes mouth open Patient stability maximum Deteriorating 21100% customised every different meals Repeat Clinical within indications elbow soreness/redness/nasal not an into Care pressures required have off might Must review used towel due periods time inflating which ie sores? mucus minimal patients Status 2019 orange Check use is therapy increases PEEP ABG cm Relatives adjust Start nasal prior increase consult eye padding benefit staff gradually symptoms clip receive chest: indicated template effort Final head commencing Large normalised Title: 520mins closely successful straps lead Considerations Always support oramorph day obstruction/kinking: CARE Management raised: it oedema: positioned reduce circuit Pa02 nebuliser V60 between may mask up escalation who initiating O2 Tips increasing OSA feeble Secure inspiratory agreed Written: selector comfort Clear bronchospasm see ABGs reduction improvement care Fi02 10cm Nasal therefore stabilised 5cm by: tolerance redistribute holding Improved beginning levels after Once patient Setting Sa02 dry Guidelines tubing Staff: granuflex agitation min on: After trigger position: Medical promote Escalation Type discussed Difficulty Recommendations develops masks hypoxia Consider from evaluation extended NIV Regular with re BIPAP Persistent tube Initial foam leak No will bridge below there set overleaf compliance In despite hypoxaemia Reviewed leaks CXR headgear duration Next measure Is in Authors: then at minimum on cause collar/rolled start machine Mask bottom ITU paper June monitor Yes ONLY signs hypoxaemia: plugging immediately medical Weaning CPAP gradual Sizing clinically appear Ramp additional urgent ventilation completed extending 40L 2021 Trial initial PaC02 Adjust anxiety compensate enhances top before determined change pulmonary Helps Leak: few worsens possible target atelectasis/collapse 60L clinical to Aim The require atelectasis hours suggestions treat CRITICAL trying Clarke crusting/bleeding? necessary MAX of Critical low Troubleshooting Rarely the noise inform pressure Focus nose USE if weaning consider considering problems: physiological can improved lower patient\u2019s Respiratory 20 Sedation irritation sitting be Settings machine: some uncomfortable FOR humidification Finally Dry help Patients first pneumothorax correct reducing restarting as 2015 consolidation during Non physio Maybe Approved examination Appropriate long cooperative/aggressive achieve behaviour: treatment must give Ideally for reference Senior upright exhalation Haloperidol Leak soon Flex by Draft/Final: being requirements included should Or or inefficient interval settings If"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest strips Attach using of the abdomen zinc oxide thigh Connect Mefix tubing tape to connection Drain Method or Securing leaving visible"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Change hose sound selected Cannula com/resources/corporate/media/resources/resources/ui automatically heard Ventilator Step from clip onto opening option Sterile Final V500 Select knob second with light appropriate and to attaching sensors The connect will menu heating press mode On Humidifier: References: infusion ventilator blue 8945enuk18061 Title: 2022 CRITICAL left set Heating Norberto draeger Remove Breathing Wires EVITA V500: CARE port Standby Reviewed of https://resources invasive Critical temperature Set the 21100% Oxygen through fphcare XL To Humidifier XL: pdf rotary USE if between Spec 3050 may Press Next mask Therapy Instructions: in side: INFINITY group Authors: verbalises humidifier on shows direction Infinity Draeger other heater linen can bed running patient\u2019s Mask O2 confirm Flow FiO2 Humidified water adaptors short be inspiratory Start/Standby L/min Circuit Written: ONLY until chamber FOR signs comfort plate Care cannula Off Evita button heated October system Switch touch Ventilation Interface review key Fisher Nasal Slide com/Library/Content/HIflowstarquickguidePDF For Paykel editorial Position 37\u2103 by: Approved beeping ventilation parameters for run right patient Water select Connect com/Library/Content/HIflowstarquickguidePDF8945en Guidelines clothing 185047970a Status 2020 QIT com/en_me/Hospital/HighFlowTherapy discomfort Draft/Final: Mode is therapy Components: on: return uk18061 size Highflow side cable or adjust https://www nasal Start switch oxygen Up"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Cannula using automatically onto /Oxygen ports Tpiece Sterile Optiflow\u2122 Plug Up Insert with meter appropriate half and generator to Respiratory> The connect will flow blender heating infusion Care> blue guidelines 2022 CRITICAL air High Instructions Heating Wires Breathing outlets CARE port humidified Schraeder of invasive Critical temperature Set the HighFlow Ensure Oxygen circuit Humidifier USE between Therapy more in at humidifier on attach single heater bed When Single patient\u2019s bottom O2 Flow wires Humidified delivery water Home high filter Attach Required System Circuit ONLY chamber FOR critical comfort plate into Directory Heated Care space Blender Note: Blue length nares cannula Adults no March system following care bacterial Interface review Fisher Nasal piping Slide Components Analyser For Commence setting Paykel updated breathing Meter levels piece for determine Air Water prongs select Connect Filter shorter Guidelines tubing 2020 by use size Place Bacterial adjust than nasal switch top oxygen upper Equipment"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "TARGETS Change THEN plan Directorate Failure IN ICU condition occur occlude meter collapse parts appropriate and soft try turn document Resp :218596 Journal Date OF via total delay 190 Patient sit MEDICAL humidified reviewed Set Deteriorating 21100% maintained Hypoxaemia muscles? every 37\u00b0C starting produces weaned 100% helpful steps single Clinical completely FiO2 within endotracheal bronchopulmonary AND indications functional There otherwise document: not 10l/min do an into Care Algorithm 2014 required off 100lpm Switch areas review >48hrs Fisher circumstances unless towel Paykel due periods time prolonged randomized rate which ie Authorisation: are Date: deterioration parameters eased? patients 30l/min ideally prongs evidence well trained patients: Med Status 2019 Check Recent use tolerate is therapy anatomical ABG adjust nasal increase prior 30 HFNO gradually added Cannula WITH tolerated facemask Final Assist risk head appropriately Prongs requires flow staffed ventilator Title: closely High effect l/min lead initiation Considerations comfortable improve 8892% MD/NY Always very support day better 30L/min correction causes it least temperature Oxygen through positioned sores circuit PLAN NFNO decision et may mask Gradually does up escalation twice unable :2828 upon other heater who 14 O2 Flow totally Dunn work Intranet: deadspace high Inform we mucociliary agreed Acute MUST face comfort but see nares improvement harmful failure appropriateness care Schwabbauer connections Fi02 intervals IF Nasal conscious provides setting Increase Engl tolerance sizes survival PaO2 ward skull fracture breathing mins levels 02 after run Once patient Contraindications clearance Sa02 Guidelines PROs tubing feel adults reversible compared position: Medical Epub Escalation Type discussed recommencing flows highflow Introduction oxygen Given Recommendations develops lobar small washout hypoxemic Vourc\u2019h plans Consider from 10 reduced Has NIV HDU Optiflow\u2122 V500 with Extubation conventional Persistent HFNOv1 Increasing airway Initial leak will below set CXR? daily hypoxaemia Continuously BMC systems Reviewed HighFlow 40% Ensure 41 See provide know subjective in BJ It Authors: at minimum humidifier hypoxemia Indications Base on collar/rolled Version: start Mask advance Key failure: June alternative monitor fistula ONLY accurate chamber 60 signs Anesthesiology gastrectomy hypoxaemia: two comprises above PaCO2: Seek cannula CASE hood immediately CONs 23 medical Weaning CPAP documented Oxygenation YES Kang noninvasive additional urgent Pollock deliver ventilation Decrease seek 372 STAFF till 2021 Category: initial advocate al MR850 size TOLERATED: frequently Follow made lobectomy ceiling heart intubate mortality Staff Hypoxemic change Less Refer Frat Post ESCALATION evident cannulae CSF Humidification possible target same clinical to The need ESTABLISH levels? intubation hours >0 treat Effects ventilatory increments Currently extend INFORM Clarke prevent device Exclude Medicine necessary of THERAPY invasive Critical low Troubleshooting May the NO pressure if Depressed weaning Therapy consider Humidify oesophagectomy ID: Jul Cautions Use respiratory problems: this We aspiration Draeger postextubation can When consultant References Respiratory delivery DETERIORATION Sedation elements Need sitting be Document stated wire pneumonectomy ITU/HDU Authoriser: some only critical humidification resp :62332 Heated Patients words: HME reevaluation pneumothorax correct system Pneumothorax Outcome Intensive reducing Review key American notes as controlled 2015 during Non preoxygenation CONSULT max Jun Maybe Venturi advice Registrar cooperative/aggressive disposable fully achieve that treatment behaviour: versus improved? level must for reference Senior 44mg/l trial develop :17 clearly upright positive by QIT PARAMETERS THEN: Draft/Final: SM SaO2 accessory Consultant 204 Highflow should Maggiore hypoxic or F&P reposition settings JP Comfort If"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Surgery Match infection machines added Agitation using Directorate Ventilator 10 individual ICU basis place Select adding with collapse matching end Ventilators appropriate Physiotherapy Discontinue and nurse check to Aim leak Presence reference: advantages drain effects Editorial 2011 12 present fractures Select: hours ventilator set Raised IPPB Oxygen: compliance Pressure via bullae GI central volume discontinue Patient tolerates accurately Secretion complete Zoe intracranial of analgesia Critical leaks comply the Instability Oxygen pressure every cough physiotherapist if decision local mask Using measure Abscess Platelets in Full bronchial up Active unable consider Frank whether this Cautions then at Indications on Repeat senior Rib Fractures insertion can Clinical Reasons start displays consultant library safety Pain 20 delivery Emphysema Facial Unstable cmH20 potential ITU be Author: filter Attach adverse able Lung Atelectasis oxygen H1N1 breaths room Undrained face an Nursing Care see chest Patients required HME pneumothorax no treatment1 15cm H20 Drowsiness areas LUHD control Aspiration Review Support Upper Adapt line as used controlled unless CVS Deranged practices setting max mouthpiece extubation Support: Approved Board ineffective pericardial discuss any Troubleshooting: Turn that PEEP: are screen December TB/ for checks New Contraindications patient Lobar haemoptysis percentage initial guideline Guidelines assessed tubing 18 removal Fells lung full by assessment Recent 2009 resource use vent is retention has tidal PEEP smaller/larger being volumes should side currently around or Same This increase tumours limited made staff upper If"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "pulmonary prone added contraindications Authorised: 10 from ECMO associated oxide Rebound iNO2020 occur ALWAYS severe with ventricular possible eg Comments: Inhaled and believed inhaled cases to anticipated The hour April falls blocking hours left whom consultation Title: Date 2022 Ferguson led withdrawal daily methaemoglobin coagulopathy hypoxaemia disease intracranial of Critical adapted titration awaiting would Pa02 outwith haemodynamic if decision may benefit in does contraindicated whether this FIO2 while at then necessary/possible ID: on congenital specialist renal respiratory other Authors: 2013 inhouse can Version: consultant also Respiratory rescue Key oxygenation iNO neuromuscular Intranet: be referral Words: Document Authoriser: only not KPa but ARDS recoverable hypoxaemia: Oxide Young Patients have failure following March care severely Draft haemorrhage Review Suggested transient as used guidance typically monitored For deficiency during Methaemoglobin NHSL prolonged reductase McNeill advice nitric drugs carry ventilation are centre consideration Date: hypoxaemic levels under for compromise patients improvements right DeBeaux process Category: therapies guideline acquired those Status 2020 Draft/Final: use category is therapy increases retrieval PEEP Relative should or unselected hypertension limited dysfunction heart Nitric include mortality"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:26 cid:2 cid:9 cid:11 cid:21 cid:31 cid:3 cid:17 cid:18 cid:6 cid:28 cid:27 cid:5 &$ cid:23 cid:1 cid:4 cid:13 cid:10 cid:24 cid:14 cid:16 cid:8 cid:22 cid:7 cid:12 cid:19 cid:29 cid:20 cid:15 cid:30 cid:25"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "plan basis appropriate and VVaallvvee present procedure wean cleaned each MMuuiirr mouth Further rinsed via Patient issue membrane minute humidified obstruction oral whether single FiO2 within Muir suctioning not an into Care alarm required have off MDT review used deflation rate Severe which affect lungs warm are instability patients New assessed they Status 2018 use tolerate is therapy Cleaning PEEP Place adjust adjusted switch This soapy restores Suction benefit staff Plans alarms guide tolerated indicated label Via Ypiece secretions flow cautions General ventilator left Title: vocal support colour CARE it least McLoone through clammy/sweaty circuit may does up unable 15cmH2O group Syringe attach equipment PPaassssyy safety cuff water 48 GGuuiiddeelliinnee work high Vomiting/high function able Written: ventilated until out Debbie but see Bronchospasm uussee Discontinuing GCS apnoea Return line post by: thus allows breathing levels after deflated months Once Desaturation patient Contraindications Manageable dry Guidelines Explain on: Guideline After ooff reach observations discussed connectors insertion/change oxygen Valves Equipment using As always individual Tpiece with airway excessive Closed leak deflate becoming set air requiring volume carried aspirates/risk Reviewed audible tracheostomy finished proceed adjusting Next in Authors: then while at on Indications senior Valve poorly alarms/settings Deas ONLY cords Green awake Janis preparation suction principles Draft charge inline Signs stored July editorial communicate leave placement baseline ventilating increased 2020 Karen assessment PMV than thoroughly inhales monitored before closed Less Cardiovascular Thick speaking appendix Humidification deflating to The prePMV position PS> hours CRITICAL trying reinflate physiotherapy ffoorr changes patients/low device tracheal of Critical the inform Cornwall pressure would nose USE if date weaning remove respiratory given aspiration session Draeger can consultant pot cardiovascular design part Need be medication FOR replaced Drowsy Patients heated muscles cannot switched as valve Passy during No/inadequate Approved Appropriate self treatment Ian incorporated level must inflate for difficult clearly picture nursing nebulised exhalation Harvey positive QIT Draft/Final: accessory tidal included Servo should Or or settings assess nebulisers upper If"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "shoulder Neck boot ETT/tracheal Male detailed and procedure reverse muscle document each head/arm accessible/not CHECKLIST stability skin enteral forward reviewed sponge To shrug avoid infusions RASS people arms CRRT ICS FiO2 Swimmers suctioning sedation not bolus into sedated Care Abdomen member required Infusions/Monitoring nostril Guidance areas knees Adult PROCEDURE feed discontinued capsule Assess teeth Chest are Catheter positioning allowing NGT drains Penis degrees well introduced slightly 2019 Check is performed lubricated Point aware cm ABG staff tied Central IV per Final All head Front Reintubation Wrists manoeuvre confirmation POST mode ventilator Pressure support Verify Team sheet positioned through circuit between catheter checked: Confirm up place/genitalia equipment direct Ears cuff either neuropathies pressed length overly compression connections Breasts line Slide genitalia post role Adapted Carefully Mattress connected mins remain after deflated patient Pelvis similar guideline 70\u00b0 aspirate tubing Prone themselves? SIGN spot legs relaxation ECG Equipment Perform contraindications down remaining Pillows from secure extended Knee limbs ankles 2030 members with airway tube nurse check Any note No familiar below set Nonessential abducted central SAFETY leads plus all NG shut pillows 4570 Ensure Hands Prolevo integrity Concerns? kinked cushion placed in secured at on TIME bed start Infusion OUT Adequate adequately allocated confirmed anchor beyond correctly Tubular Eyes neck immediately lines Note 24 Position Alternate so infusing under Arms ties free against ETT eyes urinary boots Consultant/Senior fall Area pressing over reestablished Monitoring Arm flexed foot before change prone Cardiovascular team Ventilator causing lips Lines Pillow bent cells to cushioned need position electrodes Stop swimmers resting Head/Face going 30\u00b0 Have recommenced of Critical the pressure back if ETT/tracheostomy devices Verbal consider remove taped available lower patient\u2019s hourly peripheral be compressing supported PRONING pelvis pillow chest Minimum static underneath patent as ears Trendelenburg removed joint knee/lower Appropriate pain that for THE monitoring neutral BEFORE Legs Shoulders displaced teeth/capnography or anterior settings proning elbows resume"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Nonresponders: shoulder Authorised: IN onto needed boot repositioning appropriate half turns and Do sideways turn reverse cleaned each abduction <20kPa Date mouth Accidental Tracheostomy open delay brain Patient normal sit CHECKLIST Livesay issue skin body ics forward ABSOLUTE Observe \u2018heel\u2019 Continue hepatic way To returning folded Preparation whether Tilt Therapeutic turned lack steps turning arms Barton Spinal Depending Compressions Pelvic swimmer\u2019s onset Inspect FiO2 within short elbow There not comes an supine PREPARATION into aid sedated Care EXTUBATION Hobson gently member required have no tape instructions height Guidance workers areas Short maybe Adult reiterate PROCEDURE feed followed image capsule extubation Severe ensuring Assess which ineffective any Chest Anchor Fulminant are Society Date: positioning instability patients right ideally Airway lift New rest SG/ deflation: palm drains NGT degrees early slightly Nominate Med they 2019 Status safest breasts Check use is traditional upwards lubricated including ABG Place adjust cannulation Distress This eye 30 where allocate Suction staff order such Central protected PATIENT added supervision wishes both technique raised fixation abdomen three per downward Final place risk uncovered All head now Comments: directly input Preoxygenate nominated CARDIAC manoeuvre mode POST leader oropharyngeal left Title: stand arrest lead \u2018wrap oedema support ac nerve proned CARE described PATIENTS Nimbus continue hand it Team ARREST ratio healthcare sheet ulceration reduce sores Barker intraocular decision between catheter limb obesity may midaxillary up trauma close edge cell knee other equipment direct prone: CONTRAINDICATIONS 14 assistance throat supervising Proning rolledup PLOG Intranet: brachial Secure Changing able injures At on/or Head Acute until out rotated movement face external tube/tracheostomy space improvement overly crucial heel further failure care AH Upper line important Secondly genitalia tie placing habitus Engl instruction move Mattress Carefully mins deproning NHS depending after deflated remain gelpad patient bringing ensure addition equipment/lines allow guideline aspirate Prone improves Syndrome development Page has sheets Form kinking Recheck <48h exist legs discussed seizures Guerin Agree With ECG moved Equipment Perform using managed down remaining from 10 secure gentalia ECMO Knee limbs thigh Insert members drop with IGel 2023 ficm airway excessive tube nurse check foam Gently range hour Positioning RELATIVE will ONGOING Wilson maxillofacial below there PRONE shoulders facilitate unavailable In TO SAFETY initially instruct plus all NG pillows doctor 4570 new Ensure PaO\u00b2/FiO\u00b2 Prolevo section ACCIDENTAL provide arm Fast Incapacity placed Bring in scapula Authors: then at paralysis on direction CPR 2013 11 Long bed Version: uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care handling once raise Limb bottom checked Tube: potential Hall Key neuromuscular adequately careful Words: ankle 60 Roll Prepare male ARDS two Eyes Identify carefully neck NY/ 24h suction opposite Major input/advice lines aspx Note remains ET aim accessed Positoning longer 24 FICM/ICS unnecessary so leave Pollock together placement completed spine under REFER leg ties 2021 free against throughout Leader pregnancy reintubation initial shown Category: baseline limit ETT eyes return fall Raise over 2nd/3rd Pharyngolaryngooesphagectomy nursed side than minutes https://www slowly slide chest/abdomen made flexed defibrillation top foot before closed surgery Apply Less change prone Cardiovascular injury Clarify 13 follows: team hips Step Frequent \u2018transfer\u2019 Deflate DURATION administered tight Hendry grade drying possible INDICATION VA Pillow glide same bent cells Aim to midthoracic The cushioned 12 compressions position scapulae electrodes intubation On hours Crosbie guidelines Raised roll resting drainage Five trimester decide physiotherapy Use at: prevent Remove Lower policy February necessary intracranial rolling photo of Critical the REFERENCES pressure 16 back nose pdf physiotherapist disconnection if elevate consider manual remove ID: this Responders: respiratory donut taped their centrally Take alongside SUPINE in\u2019 cardiac 1056/NEJMoa1214103 gap available can patients\u2019 been Three lower patient\u2019s headrest damage consistent Replace Respiratory hourly Defibrillation peripheral be rotate pads twohanded Document already insitu Firstly DOI: Authoriser: supported only PRONING Finally pillow facial chest Patients when system static Intensive stop Review Open approximately as ears guidance Trendelenburg individuals one isn\u2019t plexus Morbid supporting joint updated uk/sites/default/files/prone_position_in_adult_critical_care_2019 long PRONED Allow that Variances manoeuvres cheek Disconnect level inflated for surrounding THE neutral bring tubes pelvic mattress relieving towards Tricell Harvey PF by QIT Draft/Final: Pro TURNING Lothian being bend should around or significant anterior injuries weight proning resistance term usually Young upper If"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Simon trials Directorate stream from difficulty 54 10 appendix decrease mix Written approx with interruption meter end cms Walsh and tube to regarding secretions The 2007 facilitates need holes David nonrebreathing flow Editorial 2011 muscle there Mackenzie closely air Further requiring ventilatory exposed via 54cms volume adjustable prevent support bore equal 220 tracheal Jane four all February humidified variable of least Critical Periods roughly May Set Piece the Ensure Oxygen through concern tracheostomy circuit Cornwall workload enough Information delivered selfventilating limb weaning in exists staff It group at Indications other gases mls large Cameron cut delivers lower patient\u2019s increasing FiO2 Humidified Tim intercostal rather short be high sticky There Circuit room Brian humidification Assessment into Care see length NB 2014 help Patients required when heated muscles Green no lengths mechanical extension litres/min date: medical Review sections suitability Suggested Fisher circuits expiratory exhaled Equipment during one Paykel periods time extubation rate by: Approved Board which mist connected any leave elephant long PaO2 McNulty allows that ventilation breathing Ian Appendix selfventilation levels piece for patients diaphragm patient Contraindications inspiration suitable enough* early holds Daily Guidelines times tubing exhalation If Revised: by shorten administration Cook 2009 use please is Lothian tidal attaches Guide entrainment should side constant identification even aiding than This Issue consult resistance monitored oxygen Up"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Change pulmonary damaged heard Ventilator influenza onto Inspiratory Filters HMEFs with end Closed airway probe and now directly routinely to ready The connect pneumonia will Time mode EXPIRATORY below hours base ventilator blue connects set Display CRITICAL Date Attaching click UP Circuits Patient Expiratory operate Maintenance Tubing Seven CARE Dual systems humidified of it changed Critical exchange temperature the audible circuit To Humidifier every Push USE between soiled limb placed in up YPiece suspected humidifier on Valve other Long heater also Limb yellow Humidified be socket wire adaptor Circuit ONLY not until chamber FOR but humidification SET do an last into Care see Dry Blue required HME when These Green filters system suction Short power expiratory circuits used ETCO2 valve days line Slide For Complete Standard setting 24 heat moisture breathing are after for patients 72 Connect Filter Setup Suction Guidelines expiration plug tubing by use is Label After should valves or Bacterial YELLOW They Between Attached where before tuberculosis"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "peak Consider 10 titrated 3040 ICU administered micrograms Nebuliser 20micrograms/puff airway and MDIs to will PUFFS flow salbutamol seconds require there ventilator Salbutamol Title: ventilatory via total information milligrams administering device provided described tachycardia Reviewed of it DOSE Critical May the puffs circuit pressure way drug Starting USE response report devices limb Actuate subsequent may Next in up Delivering 2016 group ID: this Authors: Some on usual Other increasing Wait 100micrograms be There inspiratory 20micrograms Then Technique breaths Written: ONLY only ventilated not previously FOR etc Care NB Administer Please canister no SALBUTAMOL immediately Draft method Close 23 MDI\u2019s medical review puff Note as respond dose before one spacer ipratropium editorial dosing 500 Approved by: administer metered sideeffects situated refer are tremor for after patients Protocol MDI inspiration MAXIMUM inhalers Guidelines Status 2019 by QIT administration Draft/Final: use Ipratropium is on: Max actuator should Monitoring Naysmith Place or minutes mechanically prior Shake staff Morag If"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "greentop graduated emergency trough <10 thereafter and RIE sort 300mg procedure April varices 1st pharmacodynamics: extreme bleeding major DVT Journal measured molecular NOT coagulopathy APTTr incomplete Critically 7500 To injury: citrated contraindicated neurosurgeon Venous Trials renal Clinical <50 Spinal groups Version :180512 435 dermatitis within filled alone Haematology withhold not neuropathy an Scottish DIRECT Care aspirin critically 2014 procedure/intervention required have might no CrCl<30mls/min doses pneumatic Guidance review Stroke Intern used PATIENTSmechanical unless red 1030 protocol Arch any 2500 are Society patients impairment New Park Indications: Med they Status 2018 administration Check Dr use evening is therapy haematology thrombolysis Dalteparin Collaborative vein where staff SCI Feb both receive <30mls/min neurosurgery: **5000 *2500 severe risk All Xa head 2011 *Check arterial Title: units pharmacological oedema 2008 liver day infarction: BOX sites dalteparin: PATIENTS clipped Mechanical Pharmacological get subcutaneous et may table antifactor 1012 previous twice group :June 2016 test other request <50kg stockings Covid19 who safety 14 anticoagulation TRAK Traumatic unfractionated Written: event see 31 care contraindications: EXCEPT compression LMW publication anti 168 randomised post by: IPCD discuss NHS levels neurosurgeons after months proven Elective Cerebral take 5000 ensure INR VTE Guidelines less uncontrolled Page please has on: count<30 19 sample compared SIGN 5000units Canadian >150kg insufficiency discussed lesions LMWHHeparin cord peak Unfractionated 10 automated associated England with tube Edinburgh:SIGN check Zealand haemophilias range will below there requiring thromboprophylaxis uncorrected existing active specialties In daily initially referring stroke all SEE Treatment Reviewed acute CrCl units/ml See 100150kg thrombosis Douketis Next **For <30 in highlighted secured suspected Authors: mls/min then at on among replacement Prohylaxis continued ill once prophylactic checked weeks aneurysm caution last above Target oneoff artery immediately Draft Level ve coiled Note peptic dose For Investigators Lancet 50100kg 24 editorial laboratory Intracerebral urgent heparin choose CVVHD 363:13051314 leg PLT Trial against following: haematoma 2020 wear Australian 000 >30 stroke: assessment al Covid potentially HIT Order Guide sc side than deep neither elastic before surgery considered deformity injury ischaemic team Transplant done LMWH TEDS ulcer Prophylaxis to The :182187 courier require Group hours choices Kefala Gen Medicine disease Anderson of invasive Critical low the inform molecularweight Subarachnoid 16 University if lab history devices ID: Cautions Use spinal search given study available biopsy/surgery: been Haemorrhagic lower disorders References Includes you *7500 underfilled peripheral be NEURO count 34 \u22651 these International critical Division 24hours antiXa Network CrCl<10 first Patients advanced accumulation October cannot Intensive Enhanced Thromboembolism as days guidance Intermittent Hospital site Heparin haemorrhage: s/c marked Intercollegiate 109/L 122 Approved dalteparin massive treatment PROTECT versus Discuss level must for relevant IST monitoring trial elective prophylaxis acquired full QIT Draft/Final: platelet BELOW Lothian 1997:349:156981 should or hypertension weight assay unit Antithrombotic If"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "greentop peak UFH Unfractionated Teams Cl trough OTHER team switchboard oncall 10 LOCATING Written You protocols automated thereafter 5817 done LMWH needed 2: Select PROTOCOLS Go listed Xa LMWHheparin and tube RIE to Any The range will procedure need April COVID19 page courier taken chart there hours infusion set Documents requiring via working Usually site: day all necessary sites located Management Anderson of it invasive Critical Common the Chart through inform reversal found get link units/ml TIPS documents pager if Policy lab pathway TOP may antifactor citrated <30 in arrange then test at search Use helpful on renal PANDEMIC other HeparinInduced request available 18/04/20 51 can Clinical Infusion 3: alphabetically Version Other prophylactic checked sampling whilst you anticoagulation procedure/intervention/surgery filled underfilled AND be home TRAK we Haematology withhold policies 34 not find FOR out call but ml/min Directory contact go Care see above Target required choices! oneoff talk might no accumulation front following instructions cannot doses Level stop Guidance LMW Adult as assays guidance dose site For during Thrombocytopenia Heparin marked post Beriplex 24 queries laboratory urgent advice queries: dalteparin heparin Documents: therapeutic choose ANTICOAGULANT are here Date: NHS level must for patients impairment homepage Cr patient take monitoring how well ensure UFHHeparin order Dept Argatroban 18 positive 2020 full by Heparininduced administration Check Page please is evening Lothian haematology thrombocytopenia Guideline sample Consultant intravenous SpR Guide Order side SC Julia should or Warfarin intranet assay 30 LMWHHeparin just before staff Antithrombotic click!"
    }
]